Document

0001413329-17-000023.txt : 20170427 0001413329-17-000023.hdr.sgml : 20170427 20170427103207 ACCESSION NUMBER: 0001413329-17-000023 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 101 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170427 DATE AS OF CHANGE: 20170427 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Philip Morris International Inc. CENTRAL INDEX KEY: 0001413329 STANDARD INDUSTRIAL CLASSIFICATION: CIGARETTES [2111] IRS NUMBER: 133435103 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-33708 FILM NUMBER: 17786794 BUSINESS ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (917) 663-2000 MAIL ADDRESS: STREET 1: 120 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10017 10-Q 1 pm-033117x10qxdoc.htm 10-Q Document

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)


(X)	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017


( )	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-33708



Philip Morris International Inc.

(Exact name of registrant as specified in its charter)



Virginia	13-3435103
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)



120 Park Avenue New York, New York	10017
(Address of principal executive offices)	(Zip Code)



Registrant’s telephone number, including area code	(917) 663-2000

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer ¨

Non-accelerated filer ¨ (Do not check if a smaller reporting company) Smaller reporting company ¨

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ

At April 24, 2017, there were 1,553,143,195 shares outstanding of the registrant’s common stock, no par value per share.

-1-

Table of Contents

PHILIP MORRIS INTERNATIONAL INC.

TABLE OF CONTENTS



		Page No.

PART I -	FINANCIAL INFORMATION

Item 1.	Financial Statements (Unaudited)

	Condensed Consolidated Balance Sheets at
	March 31, 2017 and December 31, 2016	3 – 4

	Condensed Consolidated Statements of Earnings for the
	Three Months Ended March 31, 2017 and 2016	5

	Condensed Consolidated Statements of Comprehensive Earnings for the
	Three Months Ended March 31, 2017 and 2016	6

	Condensed Consolidated Statements of Stockholders’ (Deficit) Equity for the
	Three Months Ended March 31, 2017 and 2016	7

	Condensed Consolidated Statements of Cash Flows for the
	Three Months Ended March 31, 2017 and 2016	8 – 9

	Notes to Condensed Consolidated Financial Statements	10 – 34

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	35 – 70

Item 4.	Controls and Procedures	71

PART II -	OTHER INFORMATION

Item 1.	Legal Proceedings	72

Item 1A.	Risk Factors	72

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	73

Item 6.	Exhibits	74

Signature		75

In this report, “PMI,” “we,” “us” and “our” refer to Philip Morris International Inc. and its subsidiaries.

- 2-

Table of Contents

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

(in millions of dollars)

(Unaudited)



	March 31, 2017		December 31, 2016
ASSETS
Cash and cash equivalents	$	5,076	$	4,239
Receivables (less allowances of $42 in 2017 and $42 in 2016)	3,090		3,499
Inventories:
Leaf tobacco	2,683		2,498
Other raw materials	1,531		1,569
Finished product	3,793		4,950
	8,007		9,017
Other current assets	711		853
Total current assets	16,884		17,608
Property, plant and equipment, at cost	12,862		12,360
Less: accumulated depreciation	6,598		6,296
	6,264		6,064
Goodwill (Note 4)	7,485		7,324
Other intangible assets, net (Note 4)	2,517		2,470
Investments in unconsolidated subsidiaries (Note 14)	1,079		1,011
Deferred income taxes	834		859
Other assets	1,564		1,515
TOTAL ASSETS	$	36,627	$	36,851

See notes to condensed consolidated financial statements.

Continued

- 3-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (Continued)

(in millions of dollars, except share data)

(Unaudited)



	March 31, 2017			December 31, 2016
LIABILITIES
Short-term borrowings (Note 10)	$	1,004		$	643
Current portion of long-term debt (Note 10)	1,754			2,573
Accounts payable	1,746			1,666
Accrued liabilities:
Marketing and selling	576			575
Taxes, except income taxes	4,275			6,204
Employment costs	719			800
Dividends payable	1,622			1,621
Other	1,329			1,553
Income taxes	330			832
Total current liabilities	13,355			16,467
Long-term debt (Note 10)	28,588			25,851
Deferred income taxes	1,739			1,897
Employment costs	2,840			2,800
Other liabilities	662			736
Total liabilities	47,184			47,751
Contingencies (Note 8)
STOCKHOLDERS’ (DEFICIT) EQUITY
Common stock, no par value (2,109,316,331 shares issued in 2017 and 2016)	—			—
Additional paid-in capital	1,892			1,964
Earnings reinvested in the business	30,367			30,397
Accumulated other comprehensive losses	(9,265		)	(9,559		)
	22,994			22,802
Less: cost of repurchased stock (556,175,692 and 557,930,784 shares in 2017 and 2016, respectively)	35,386			35,490
Total PMI stockholders’ deficit	(12,392		)	(12,688		)
Noncontrolling interests	1,835			1,788
Total stockholders’ deficit	(10,557		)	(10,900		)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	$	36,627		$	36,851

See notes to condensed consolidated financial statements.

- 4-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Earnings

(in millions of dollars, except per share data)

(Unaudited)



	For the Three Months Ended March 31,
	2017			2016
Net revenues	$	16,556		$	16,788
Cost of sales	2,177			2,096
Excise taxes on products	10,492			10,705
Gross profit	3,887			3,987
Marketing, administration and research costs	1,469			1,496
Amortization of intangibles	22			18
Operating income	2,396			2,473
Interest expense, net	219			247
Earnings before income taxes	2,177			2,226
Provision for income taxes	541			630
Equity (income)/loss in unconsolidated subsidiaries, net	(22		)	(9		)
Net earnings	1,658			1,605
Net earnings attributable to noncontrolling interests	68			75
Net earnings attributable to PMI	$	1,590		$	1,530
Per share data (Note 6):
Basic earnings per share	$	1.02		$	0.98
Diluted earnings per share	$	1.02		$	0.98
Dividends declared	$	1.04		$	1.02

See notes to condensed consolidated financial statements.

- 5-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Earnings

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2017			2016
Net earnings	$	1,658		$	1,605
Other comprehensive earnings (losses), net of income taxes:
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $156 in 2017 and $162 in 2016	303			538
Change in net loss and prior service cost:
Net losses and prior service costs, net of income taxes of $- in 2017 and $3 in 2016	—			(10		)
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($9) in 2017 and ($8) in 2016	56			55
Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $11 in 2017 and $17 in 2016	(75		)	(62		)
(Gains) losses transferred to earnings, net of income taxes of $2 in 2017 and ($1) in 2016	5			(7		)
Total other comprehensive earnings	289			514
Total comprehensive earnings	1,947			2,119
Less comprehensive earnings attributable to:
Noncontrolling interests	63			101
Comprehensive earnings attributable to PMI	$	1,884		$	2,018

See notes to condensed consolidated financial statements

- 6-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Stockholders’ (Deficit) Equity

For the Three Months Ended March 31, 2017 and 2016

(in millions of dollars, except per share amounts)

(Unaudited)



	PMI Stockholders’ (Deficit) Equity
	Common Stock		Additional Paid-in Capital			Earnings Reinvested in the Business			Accumulated Other Comprehensive Losses			Cost of Repurchased Stock			Noncontrolling Interests			Total
Balances, January 1, 2016	$	—	$	1,929		$	29,842		$	(9,402	)	$	(35,613	)	$	1,768		$	(11,476	)
Net earnings						1,530									75			1,605
Other comprehensive earnings (losses), net of income taxes									488						26			514
Issuance of stock awards			(56		)							115						59
Dividends declared ($1.02 per share)						(1,587		)										(1,587		)
Payments to noncontrolling interests															(12		)	(12		)
Other			1												2			3
Balances, March 31, 2016	$	—	$	1,874		$	29,785		$	(8,914	)	$	(35,498	)	$	1,859		$	(10,894	)
Balances, January 1, 2017	$	—	$	1,964		$	30,397		$	(9,559	)	$	(35,490	)	$	1,788		$	(10,900	)
Net earnings						1,590									68			1,658
Other comprehensive earnings (losses), net of income taxes									294						(5		)	289
Issuance of stock awards			(71		)							104						33
Dividends declared ($1.04 per share)						(1,620		)										(1,620		)
Payments to noncontrolling interests															(17		)	(17		)
Other			(1		)										1			—
Balances, March 31, 2017	$	—	$	1,892		$	30,367		$	(9,265	)	$	(35,386	)	$	1,835		$	(10,557	)

See notes to condensed consolidated financial statements.

- 7-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2017			2016
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

Net earnings	$	1,658		$	1,605

Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	197			175
Deferred income tax provision	27			10
Asset impairment and exit costs, net of cash paid	(2		)	(14		)
Cash effects of changes:
Receivables, net	504			(175		)
Inventories	1,243			49
Accounts payable	84			223
Income taxes	(510		)	(485		)
Accrued liabilities and other current assets	(2,207		)	(922		)
Pension plan contributions	(18		)	(52		)
Other	(133		)	48
Net cash provided by operating activities	843			462

CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

Capital expenditures	(292		)	(226		)
Investments in unconsolidated subsidiaries	(5		)	(7		)
Other	(282		)	(186		)
Net cash used in investing activities	(579		)	(419		)

See notes to condensed consolidated financial statements.

Continued

- 8-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Continued)

(in millions of dollars)

(Unaudited)



	For the Three Months Ended March 31,
	2017			2016
CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

Short-term borrowing activity by original maturity:
Net issuances (repayments) - maturities of 90 days or less	$	374		$	(136	)
Long-term debt proceeds	2,482			1,978
Long-term debt repaid	(814		)	(827		)
Dividends paid	(1,618		)	(1,585		)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests	—			6
Other	(83		)	(29		)
Net cash provided by (used in) financing activities	341			(593		)
Effect of exchange rate changes on cash and cash equivalents	232			77

Cash and cash equivalents:
Increase (Decrease)	837			(473		)
Balance at beginning of period	4,239			3,417
Balance at end of period	$	5,076		$	2,944

See notes to condensed consolidated financial statements.

- 9-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 1. Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.

These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2016.

Note 2. Stock Plans:

In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to 30 million shares of PMI’s common stock may be issued under the 2012 Plan. At March 31, 2017, shares available for grant under the 2012 Plan were 19,191,050.

In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At March 31, 2017, shares available for grant under the plan were 677,539.

PMI’s accounting policy is to estimate the number of awards expected to be forfeited and adjust the expense when it is no longer probable that the employee will fulfill the service condition.

Restricted share unit (RSU) awards

During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the weighted-average grant date fair value per share and the recorded compensation expense related to RSU awards were as follows:



	Number of Shares Granted	Weighted-Average Grant Date Fair Value Per RSU Award Granted		Compensation Expense Related to RSU Awards (in millions)
2017	1,202,060	$	98.47	$	35
2016	1,212,050	$	89.02	$	41

As of March 31, 2017, PMI had $186 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

- 10-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

During the three months ended March 31, 2017, 1,938,610 shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately $151 million. The total fair value of RSU awards that vested during the three months ended March 31, 2017 was approximately $198 million.

Performance share unit (PSU) awards

During the three months ended March 31, 2017 and 2016, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency-neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation and transformation. The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is zero, with a maximum percentage of 200. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.

During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the grant date fair value per share and the recorded compensation expense related to PSU awards were as follows:



	Number of Shares Granted	Grant Date Fair Value Subject to TSR Performance Factor Per Share ^(a)		Grant Date Fair Value Subject to Other Performance Factors Per Share ^(b)		Compensation Expense Related to PSU Awards (in millions)
2017	393,460	$	128.72	$	98.29	$	17
2016	428,400	$	104.60	$	89.02	$	12

^(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.

^(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.

As of March 31, 2017, PMI had $52 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2017, there were no PSU awards that vested.

Note 3. Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans.

- 11-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Pension Plans

Components of Net Periodic Benefit Cost

Net periodic pension cost consisted of the following:



	U.S. Plans						Non-U.S. Plans
	For the Three Months Ended March 31,						For the Three Months Ended March 31,
(in millions)	2017			2016			2017			2016
Service cost	$	1		$	1		$	50		$	50
Interest cost	3			4			23			31
Expected return on plan assets	(3		)	(3		)	(76		)	(81		)
Amortization:
Net loss	—			1			44			44
Prior service cost	2			1			1			1
Net periodic pension cost	$	3		$	4		$	42		$	45

Employer Contributions

PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded U.S. and non-U.S. plans. Employer contributions of $18 million were made to the pension plans during the three months ended March 31, 2017. Currently, PMI anticipates making additional contributions during the remainder of 2017 of approximately $50 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.

Note 4. Goodwill and Other Intangible Assets, net:

Goodwill and other intangible assets, net, by segment were as follows:



	Goodwill				Other Intangible Assets, net
(in millions)	March 31, 2017		December 31, 2016		March 31, 2017		December 31, 2016
European Union	$	1,278	$	1,238	$	473	$	479
Eastern Europe, Middle East & Africa	388		372		199		200
Asia	3,626		3,596		1,079		1,074
Latin America & Canada	2,193		2,118		766		717
Total	$	7,485	$	7,324	$	2,517	$	2,470

Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from December 31, 2016, were as follows:



(in millions)	European Union		Eastern Europe, Middle East & Africa		Asia		Latin America & Canada		Total
Balances, December 31, 2016	$	1,238	$	372	$	3,596	$	2,118	$	7,324
Changes due to:
Currency	40		16		30		75		161
Balances, March 31, 2017	$	1,278	$	388	$	3,626	$	2,193	$	7,485

- 12-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Additional details of other intangible assets were as follows:



	March 31, 2017				December 31, 2016
(in millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization
Non-amortizable intangible assets	$	1,356			$	1,455
Amortizable intangible assets	1,773		$	612	1,598		$	583
Total other intangible assets	$	3,129	$	612	$	3,053	$	583

Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. During the first quarter of 2017, PMI reclassified three trademarks with a gross carrying amount of $153 million from non-amortizable intangible assets to amortizable intangible assets. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2017, were as follows:



(dollars in millions)	Gross Carrying Amount		Initial Estimated Useful Lives	Weighted-Average Remaining Useful Life
Trademarks	$	1,535	2 - 40 years	19 years
Distribution networks	150		5 - 30 years	10 years
Other (including farmer contracts and intellectual property rights)	88		4 - 17 years	9 years
	$	1,773

Pre-tax amortization expense for intangible assets during the three months ended March 31, 2017 and 2016 was $22 million and $18 million, respectively. Amortization expense for each of the next five years is estimated to be $86 million or less, assuming no additional transactions occur that require the amortization of intangible assets.

The increase in the gross carrying amount of other intangible assets from December 31, 2016, was due to currency movements.

Note 5. Financial Instruments:

Overview

PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. PMI reports its net transaction gains or losses in marketing, administration and research costs on the condensed consolidated statements of earnings.

PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Russian ruble, Swiss franc and Turkish lira. At March 31, 2017, PMI had contracts with aggregate notional amounts of $31.0 billion of which $4.6 billion related to cash flow hedges, $11.1 billion related to hedges of net investments in foreign operations and $15.3 billion related to other derivatives that primarily offset currency exposures on intercompany financing.

- 13-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2017 and December 31, 2016, were as follows:



	Asset Derivatives					Liability Derivatives
		Fair Value					Fair Value
(in millions)	Balance Sheet Classification	At March 31, 2017		At December 31, 2016		Balance Sheet Classification	At March 31, 2017		At December 31, 2016
Foreign exchange contracts designated as hedging instruments	Other current assets	$	82	$	207	Other accrued liabilities	$	10	$	66
	Other assets	291		436		Other liabilities	101		36
Foreign exchange contracts not designated as hedging instruments	Other current assets	106		161		Other accrued liabilities	96		61
	Other assets	1		9		Other liabilities	—		—
Total derivatives		$	480	$	813		$	207	$	163

For the three months ended March 31, 2017 and 2016, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:



(pre-tax, millions)	For the Three Months Ended March 31,
	Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives						Statement of Earnings Classification of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings
	2017			2016				2017			2016
Derivatives in Cash Flow Hedging Relationship
Foreign exchange contracts	$	(86	)	$	(79	)
							Net revenues	$	9		$	5
							Cost of sales	—			14
							Marketing, administration and research costs	(9		)	4
							Interest expense, net	(3		)	(17		)
Derivatives in Net Investment Hedging Relationship
Foreign exchange contracts	(249		)	(197		)
Total	$	(335	)	$	(276	)		$	(3	)	$	6

- 14-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Cash Flow Hedges

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. The effective portion of gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. During the three months ended March 31, 2017 and 2016, ineffectiveness related to cash flow hedges was not material. As of March 31, 2017, PMI has hedged forecasted transactions for periods not exceeding the next twenty-one months with the exception of one foreign exchange contract that expires in May 2024. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.

Hedges of Net Investments in Foreign Operations

PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges of its foreign operations. For the three months ended March 31, 2017 and 2016, these hedges of net investments resulted in losses, net of income taxes, of $294 million and $267 million, respectively. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments. For the three months ended March 31, 2017 and 2016, ineffectiveness related to net investment hedges was not material. Other investing cash flows on PMI’s condensed consolidated statements of cash flows include the premiums paid for, and settlements of, net investment hedges.

Other Derivatives

PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. For the three months ended March 31, 2017 and 2016, the gains (losses) from contracts for which PMI did not apply hedge accounting were $(39) million and $91 million, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.

For the three months ended March 31, 2017 and 2016, the net impact of these contracts on the condensed consolidated statements of earnings was not material.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses

Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:



(in millions)	For the Three Months Ended March 31,
	2017			2016
Gain as of January 1,	$	97		$	59
Derivative (gains)/losses transferred to earnings	5			(7		)
Change in fair value	(75		)	(62		)
Gain/(loss) as of March 31,	$	27		$	(10	)

At March 31, 2017, PMI expects $9 million of derivative gains that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These gains are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.

Contingent Features

PMI’s derivative instruments do not contain contingent features.

Credit Exposure and Credit Risk

PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors

- 15-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.

Fair Value

See Note 11. Fair Value Measurements and Note 13. Balance Sheet Offsetting for additional discussion of derivative financial instruments.

Note 6. Earnings Per Share:

Basic and diluted earnings per share (“EPS”) were calculated using the following:



(in millions)	For the Three Months Ended March 31,
	2017		2016
Net earnings attributable to PMI	$	1,590	$	1,530
Less distributed and undistributed earnings attributable to share-based payment awards	3		5
Net earnings for basic and diluted EPS	$	1,587	$	1,525
Weighted-average shares for basic EPS	1,552		1,550
Plus contingently issuable performance stock units (PSUs)	1		—
Weighted-average shares for diluted EPS	1,553		1,550

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.

For the 2017 and 2016 computations, there were no antidilutive stock awards.

Note 7. Segment Reporting:

PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Reportable segments for PMI are organized and managed by geographic region. PMI’s reportable segments are the European Union; Eastern Europe, Middle East & Africa; Asia; and Latin America & Canada. PMI records net revenues and operating companies income to its segments based upon the geographic area in which the customer resides.

PMI’s management evaluates segment performance and allocates resources based on operating companies income, which PMI defines as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. Interest expense, net, and provision for income taxes are centrally managed and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by management.

- 16-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Segment data were as follows:



(in millions)	For the Three Months Ended March 31,
	2017			2016
Net revenues:
European Union	$	5,889		$	6,143
Eastern Europe, Middle East & Africa	3,695			3,997
Asia	4,838			4,689
Latin America & Canada	2,134			1,959
Net revenues	$	16,556		$	16,788
Earnings before income taxes:
Operating companies income:
European Union	$	772		$	906
Eastern Europe, Middle East & Africa	690			633
Asia	852			778
Latin America & Canada	177			229
Amortization of intangibles	(22		)	(18		)
General corporate expenses	(51		)	(46		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(22		)	(9		)
Operating income	2,396			2,473
Interest expense, net	(219		)	(247		)
Earnings before income taxes	$	2,177		$	2,226

Note 8. Contingencies:

Tobacco-Related Litigation

Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.

It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.

Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.

We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated

- 17-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.

It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.

To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.

The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 25, 2017, April 22, 2016 and April 30, 2015:



Type of Case	Number of Cases Pending as of April 25, 2017	Number of Cases Pending as of April 22, 2016	Number of Cases Pending as of April 30, 2015
Individual Smoking and Health Cases	63	66	61
Smoking and Health Class Actions	11	11	11
Health Care Cost Recovery Actions	16	16	16
Lights Class Actions	—	—	—
Individual Lights Cases	1	3	2
Public Civil Actions	2	3	2

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 459 Smoking and Health, Lights, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Thirteen cases have had decisions in favor of plaintiffs. Nine of these cases have subsequently reached final resolution in our favor and four remain on appeal.

The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
February 2004	Brazil/The Smoker Health Defense Association	Class Action	The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.	Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

- 18-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Cecilia Létourneau	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

- 19-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
May 27, 2015	Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais	Class Action	On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.	In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

- 20-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)



Date	Location of Court/Name of Plaintiff	Type of Case	Verdict	Post-Trial Developments
August 5, 2016	Argentina/Hugo Lespada	Individual Action	On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages. The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.	On August 23, 2016, our subsidiary filed its notice of appeal.

Pending claims related to tobacco products generally fall within the following categories:

Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.

As of April 25, 2017, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:


•	63 cases brought by individual plaintiffs in Argentina (35), Brazil (14), Canada (2), Chile (5), Costa Rica (2), Italy (2), the Philippines (1), Russia (1) and Scotland (1), compared with 66 such cases on April 22, 2016, and 61 cases on April 30, 2015; and


•	11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 22, 2016 and 11 such cases on April 30, 2015.

In the first class action pending in Brazil, The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an en banc appeal to the Supreme Court of Justice. In addition, the defendants previously filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.

In the second class action pending in Brazil, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil, filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities,

- 21-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the ADESF case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the ADESF case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.

In the first class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $27.7 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the second class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion, including pre-judgment interest (approximately $11.4 billion). The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion, including pre-judgment

- 22-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

interest (approximately $2.3 billion)). In addition, the trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at 99,957 members. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award into a trust within 60 days, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD 5 billion (approximately $3.7 billion) into trust, to secure the judgments in both the Létourneau and Blais cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $27.7 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $559 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $80 million) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD 37.6 million (approximately $27.7 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of Adams, below).

In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.

In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and

- 23-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).

In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).

In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.

As of April 25, 2017, there were 16 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (10), Korea (1) and Nigeria (5), compared with 16 such cases on April 22, 2016 and 16 such cases on April 30, 2015.

In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related

- 24-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.

In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. In September 2016, the trial court entered a consent order establishing a discovery timetable that contemplates the province of New Brunswick applying by September 2017 for a trial date.

In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.

In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.

In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.

In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.

In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.

In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.

- 25-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Discovery is scheduled to begin in 2017.

In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.

In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.

In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.

In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.

In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately $53.7 million allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.

- 26-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Lights Cases: These cases, brought by individual plaintiffs, allege that the use of the term “lights” constitutes fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of April 25, 2017, there was 1 lights case brought by an individual plaintiff pending against our subsidiaries or indemnitees in Italy (1), compared with 3 such cases on April 22, 2016, and 2 such cases on April 30, 2015.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of April 25, 2017, there were 2 public civil actions pending against our subsidiaries in Argentina (1) and Venezuela (1), compared with 3 such cases on April 22, 2016, and 2 such cases on April 30, 2015.

In the public civil action in Argentina, Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina, filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.

In the public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with 272 import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB 80.8 billion (approximately $2.35 billion). The case is in the pre-trial evidentiary phase. Trial is scheduled to begin during the last quarter of 2017. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes

- 27-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

and duties in connection with 780 import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $575 million). The case is in pre-trial proceedings and has not yet been set for trial. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court.

The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws. In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties. In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $240 million), of which KRW 100 billion (approximately $88 million) was paid in 2016 and KRW 172 billion (approximately $152 million) was paid in 2017. These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (“MOSF”) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF’s criminal complaint and decide whether to prosecute. PM Korea disagrees with the MOSF’s allegations.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

Note 9. Income Taxes:

Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

PMI’s effective tax rates for the three months ended March 31, 2017 and 2016 were 24.9% and 28.3%, respectively. PMI estimates that its full-year 2017 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2017, was favorably impacted by the tax benefit of a legal entity restructuring ($61 million). Excluding the effect of the legal entity restructuring, the change in the effective tax rate for the three months ended March 31, 2017, as compared to the three months ended March 31, 2016, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences.

The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in currency exchange rates, earnings mix by taxing jurisdiction, or cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2013 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.

It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.

- 28-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 10. Indebtedness:

Short-term Borrowings:

At March 31, 2017 and December 31, 2016, PMI’s short-term borrowings, consisting of bank loans to certain PMI subsidiaries, had a carrying value of $1,004 million and $643 million, respectively. The fair value of PMI’s short-term borrowings, based on current market interest rates, approximates carrying value.

Long-term Debt:

At March 31, 2017 and December 31, 2016, PMI’s long-term debt consisted of the following:



(in millions)	March 31, 2017		December 31, 2016
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.520%), due through 2044	$	21,796	$	19,857
Foreign currency obligations:
Euro notes, 1.750% to 3.125% (average interest rate 2.402%), due through 2036	7,032		6,828
Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024	1,354		1,312
Other (average interest rate 3.586%), due through 2024	160		427
	30,342		28,424
Less current portion of long-term debt	1,754		2,573
	$	28,588	$	25,851

Other foreign currency debt above includes mortgage debt in Switzerland and capital lease obligations at March 31, 2017 and December 31, 2016. Other foreign currency debt above also includes a bank loan in the Philippines at December 31, 2016.

PMI's debt issuances in the first three months of 2017 were as follows:



(in millions)
Type		Face Value	Interest Rate	Issuance	Maturity

U.S. dollar notes	^(a)	$700	1.625%	February 2017	February 2019
U.S. dollar notes	^(b)	$300	Floating	February 2017	February 2020
U.S. dollar notes	^(a)	$1,000	2.000%	February 2017	February 2020
U.S. dollar notes	^(a)	$500	2.625%	February 2017	February 2022

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2017.

^(b) Interest on these notes is payable quarterly in arrears beginning in May 2017.

The net proceeds from the sale of the securities listed in the table above have been and will be used for general corporate purposes.

- 29-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Credit Facilities:

On January 27, 2017, PMI entered into an agreement to extend the term of its $2.0 billion 364-day revolving credit facility from February 7, 2017 to February 6, 2018.

At March 31, 2017, PMI's total committed credit facilities were as follows:

(in billions)



Type	Committed Credit Facilities
364-day revolving credit, expiring February 6, 2018	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020 ⁽¹⁾	3.5
Total facilities	$	8.0

⁽¹⁾ On August 30, 2016, PMI entered into an agreement, effective October 1, 2016, to extend the term of its multi-year revolving credit facility, for an additional year covering the period October 1, 2020 to October 1, 2021 in the amount of $3.35 billion.

At March 31, 2017, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.

Note 11. Fair Value Measurements:

The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:


Level 1 -	Quoted prices in active markets for identical assets or liabilities;


Level 2 -	Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and


Level 3 -	Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.

Derivative Financial Instruments

PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. Financial Instruments for additional discussion of derivative financial instruments.

- 30-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Debt

The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and $13 million of capital lease obligations, was $30,329 million at March 31, 2017. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.

The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2017, were as follows:



(in millions)	Fair Value at March 31, 2017		Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Foreign exchange contracts	$	480	$	—	$	480	$	—
Total assets	$	480	$	—	$	480	$	—
Liabilities:
Debt	$	32,005	$	31,834	$	171	$	—
Foreign exchange contracts	207		—		207		—
Total liabilities	$	32,212	$	31,834	$	378	$	—

Note 12. Accumulated Other Comprehensive Losses:

PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:



(in millions)	At March 31, 2017			At December 31, 2016			At March 31, 2016
Currency translation adjustments	$	(5,783	)	$	(6,091	)	$	(5,617	)
Pension and other benefits	(3,509		)	(3,565		)	(3,287		)
Derivatives accounted for as hedges	27			97			(10		)
Total accumulated other comprehensive losses	$	(9,265	)	$	(9,559	)	$	(8,914	)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the three months ended March 31, 2017 and 2016. For additional information, see Note 3. Benefit Plans and Note 5. Financial Instruments for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.

- 31-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 13. Balance Sheet Offsetting:

Derivative Financial Instruments

PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 5. Financial Instruments for disclosures related to PMI's derivative financial instruments.

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:



(in millions)	Gross Amounts Recognized		Gross Amount Offset in the Condensed Consolidated Balance Sheet		Net Amounts Presented in the Condensed Consolidated Balance Sheet		Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet
							Financial Instruments			Cash Collateral Received/Pledged			Net Amount


At March 31, 2017
Assets
Foreign exchange contracts	$	480	$	—	$	480	$	(170	)	$	(258	)	$	52
Liabilities
Foreign exchange contracts	$	207	$	—	$	207	$	(170	)	$	(11	)	$	26
At December 31, 2016
Assets
Foreign exchange contracts	$	813	$	—	$	813	$	(126	)	$	(607	)	$	80
Liabilities
Foreign exchange contracts	$	163	$	—	$	163	$	(126	)	$	(31	)	$	6

Note 14. Investments in Unconsolidated Subsidiaries:

At March 31, 2017 and December 31, 2016, PMI had total investments in unconsolidated subsidiaries of $1,079 million and $1,011 million, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses and movements in currency translation adjustments. The carrying value of our equity method investments at March 31, 2017 and December 31, 2016 exceeded our share of the unconsolidated subsidiaries' book value by $900 million and $867 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding $844 million and $810 million attributable to goodwill as of March 31, 2017 and December 31, 2016, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of 4 to 20 years. At March 31, 2017, PMI received no year-to-date dividends from unconsolidated subsidiaries. At December 31, 2016, PMI received year-to-date dividends from unconsolidated subsidiaries of $117 million.

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Société Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI’s brands.

PMI holds a 20% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis ("Megapolis"), PMI's distributor in Russia.

- 32-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

The initial investments in EITA and Megapolis Distribution BV were recorded at cost and are included in investments in unconsolidated subsidiaries on the condensed consolidated balance sheets.

PMI’s earnings activity from unconsolidated subsidiaries was as follows:



	For the Three Months Ended March 31,
(in millions)	2017		2016
Net revenues	$	840	$	777

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:



(in millions)	At March 31, 2017		At December 31, 2016

Receivables	$	394	$	289

The activity primarily related to agreements with PMI’s unconsolidated subsidiaries within the Eastern Europe, Middle East & Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.

Note 15. Sale of Accounts Receivable:

To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2017 and March 31, 2016. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the three months ended March 31, 2017 and 2016, were $2,092 million and $1,946 million, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2017 and March 31, 2016, were $561 million, and $589 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the three months ended March 31, 2017 and 2016, the loss on sale of trade receivables was immaterial.

- 33-

Table of Contents

Philip Morris International Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements

(Unaudited)

Note 16. New Accounting Standards:

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.

On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing its cost method investments and the impact that the adoption of ASU 2016-01 will have on its financial position and results of operations.

On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

Entities can apply the final standard using one of the following two methods:


1.	retrospectively to each prior period presented; or


2.	retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI plans to adopt ASU 2014-09 on January 1, 2018, and does not expect the adoption to have a material impact on its consolidated financial position or results of operations. Following the release of ASU 2016-12 in May 2016, which provided some practical expedients to the original standard, PMI is continuing to assess the standard’s policy election for gross versus net presentation of excise taxes and, related to this assessment, the method of adoption.

- 34-

Table of Contents

Item 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Description of Our Company

We are a holding company whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside the United States of America. We manage our business in four segments:


•	European Union;


•	Eastern Europe, Middle East & Africa (“EEMA”);


•	Asia; and


•	Latin America & Canada.

Our products are sold in more than 180 markets, and in many of these markets they hold the number one or number two market share position. We have a wide range of premium, mid-price and low-price brands. Our portfolio comprises both international and local brands. In addition to the manufacture and sale of cigarettes and other tobacco products, we are engaged in the development and commercialization of reduced-risk products ("RRPs"). RRPs is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. We have a range of RRPs in various stages of development, scientific assessment and commercialization. Because our RRPs do not burn tobacco, they produce significantly lower levels of harmful or potentially harmful constituents than found in cigarette smoke.

We use the term net revenues to refer to our operating revenues from the sale of our products, net of sales and promotion incentives. Our net revenues and operating income are affected by various factors, including the volume of products we sell, the price of our products, changes in currency exchange rates and the mix of products we sell. Mix is a term used to refer to the proportionate value of premium-price brands to mid-price or low-price brands in any given market (product mix). Mix can also refer to the proportion of shipment volume in more profitable markets versus shipment volume in less profitable markets (geographic mix). We often collect excise taxes from our customers and then remit them to governments, and, in those circumstances, we include the excise taxes in our net revenues and in excise taxes on products. Our cost of sales consists principally of tobacco leaf, non-tobacco raw materials, labor and manufacturing costs.

Our marketing, administration and research costs include the costs of marketing and selling our products, other costs generally not related to the manufacture of our products (including general corporate expenses), and costs incurred to develop new products. The most significant components of our marketing, administration and research costs are marketing and sales expenses and general and administrative expenses.

Philip Morris International Inc. is a legal entity separate and distinct from our direct and indirect subsidiaries. Accordingly, our right, and thus the right of our creditors and stockholders, to participate in any distribution of the assets or earnings of any subsidiary is subject to the prior rights of creditors of such subsidiary, except to the extent that claims of our company itself as a creditor may be recognized. As a holding company, our principal sources of funds, including funds to make payment on our debt securities, are from the receipt of dividends and repayment of debt from our subsidiaries. Our principal wholly owned and majority-owned subsidiaries currently are not limited by long-term debt or other agreements in their ability to pay cash dividends or to make other distributions with respect to their common stock.

- 35-

Table of Contents

Executive Summary

The following executive summary provides significant highlights from the "Discussion and Analysis" that follows.

Consolidated Operating Results for the Three Months Ended March 31, 2017 – The changes in our reported diluted earnings per share ("diluted EPS") for the three months ended March 31, 2017, from the comparable 2016 amounts, were as follows:



	Diluted EPS			% Growth
For the three months ended March 31, 2016	$	0.98
2016 Asset impairment and exit costs	—
2016 Tax items	—
Subtotal of 2016 items	—
2017 Asset impairment and exit costs	—
2017 Tax items	0.04
Subtotal of 2017 items	0.04
Currency	—
Interest	0.02
Change in tax rate	0.01
Operations	(0.03		)
For the three months ended March 31, 2017	$	1.02		4.1	%

Currency – There was no currency impact during the reporting period as favorable currency impact from the Indonesian rupiah, Japanese yen, Russian ruble and Swiss franc were offset by the negative effect related to the Egyptian pound, Mexican peso and Turkish lira.

Interest – The favorable impact of interest was due primarily to lower effective interest rates on debt and higher interest income.

Income Taxes – Our effective income tax rate for the three months ended March 31, 2017 decreased by 3.4 percentage points to 24.9%. The 2017 tax item that increased our diluted EPS by $0.04 per share in the table above was due to a legal entity restructuring ($61 million). The change in the effective tax rate that increased our diluted EPS by $0.01 per share in the table above was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences. We estimate that our full-year 2017 effective tax rate will be approximately 28%.

Operations – The decrease in diluted EPS of $0.03 from our operations in the table above was due primarily to the following segments:


•	European Union: Unfavorable volume/mix and higher marketing, administration and research costs, partially offset by higher pricing; and


•	Latin America & Canada: Unfavorable volume/mix and higher manufacturing costs, partially offset by higher pricing;

partially offset by


•	EEMA: Higher pricing and lower marketing, administration and research costs, partially offset by unfavorable volume/mix; and


•	Asia: Higher pricing, partially offset by unfavorable volume/mix, higher marketing, administration and research costs and higher manufacturing costs.

For further details, see the “Consolidated Operating Results” and “Operating Results by Business Segment” sections of the following “Discussion and Analysis.”

2017 Forecasted Results - On April 20, 2017, we increased, for a favorable discrete tax item of $0.04 only, our 2017 full-year reported diluted EPS to a range of $4.84 to $4.99, at prevailing exchange rates at that time, versus $4.48 in 2016. Excluding an unfavorable currency impact, at then-prevailing exchange rates, of approximately $0.08 per share for the full-year 2017, as well as the tax item of $0.04 recorded in the first quarter, the forecast range represents a projected increase of approximately 9% to

- 36-

Table of Contents

12% versus adjusted diluted earnings per share of $4.48 in 2016. This forecast assumes net revenue growth, excluding excise taxes, in excess of our current annual growth target range of 4% to 6%, excluding currency and acquisitions. This forecast does not include any share repurchases in 2017.

Our 2016 reported and adjusted diluted EPS was $4.48. During 2016, we did not have an EPS impact related to asset impairment and exit costs, and discrete tax items.

Adjusted diluted EPS is not a measure under accounting principles generally accepted in the United States of America ("U.S. GAAP"). We define adjusted diluted EPS as reported diluted EPS adjusted for asset impairment and exit costs, discrete tax items and unusual items. We believe it is appropriate to disclose this measure as it represents core earnings, improves comparability and helps investors analyze business performance and trends. Adjusted diluted EPS should be considered neither in isolation nor as a substitute for reported diluted EPS prepared in accordance with U.S. GAAP.

This 2017 guidance excludes the impact of any future acquisitions, unanticipated asset impairment and exit cost charges, future changes in currency exchange rates and any unusual events. The factors described in the "Cautionary Factors That May Affect Future Results" section of the following "Discussion and Analysis" represent continuing risks to this forecast.

Discussion and Analysis

Consolidated Operating Results

See pages 66-70 for a discussion of our "Cautionary Factors That May Affect Future Results." Our net revenues, excise taxes on products and operating companies income by segment are shown in the table below:



	For the Three Months Ended March 31,
(in millions)	2017			2016
Net revenues:
European Union	$	5,889		$	6,143
Eastern Europe, Middle East & Africa	3,695			3,997
Asia	4,838			4,689
Latin America & Canada	2,134			1,959
Net revenues	$	16,556		$	16,788
Excise taxes on products:
European Union	$	4,149		$	4,280
Eastern Europe, Middle East & Africa	2,218			2,395
Asia	2,597			2,721
Latin America & Canada	1,528			1,309
Excise taxes on products	$	10,492		$	10,705
Operating income:
Operating companies income:
European Union	$	772		$	906
Eastern Europe, Middle East & Africa	690			633
Asia	852			778
Latin America & Canada	177			229
Amortization of intangibles	(22		)	(18		)
General corporate expenses	(51		)	(46		)
Less:
Equity (income)/loss in unconsolidated subsidiaries, net	(22		)	(9		)
Operating income	$	2,396		$	2,473

- 37-

Table of Contents

As discussed in Note 7. Segment Reporting to our condensed consolidated financial statements, we evaluate segment performance and allocate resources based on operating companies income, which we define as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. We believe it is appropriate to disclose this measure to help investors analyze the business performance and trends of our various business segments.

Our shipment volume by segment for cigarettes and heated tobacco units is shown in the table below:



PMI Shipment Volume (Million Units)
	For the Three Months Ended March 31,
	2017	2016
Cigarettes
European Union	42,540	45,993
Eastern Europe, Middle East & Africa	56,574	63,126
Asia	55,142	65,222
Latin America & Canada	19,296	21,700
Total Cigarettes	173,552	196,041
Heated Tobacco Units
European Union	184	16
Eastern Europe, Middle East & Africa	105	2
Asia	4,145	435
Latin America & Canada	1	—
Total Heated Tobacco Units	4,435	453
Cigarettes and Heated Tobacco Units
European Union	42,724	46,009
Eastern Europe, Middle East & Africa	56,679	63,128
Asia	59,287	65,657
Latin America & Canada	19,297	21,700
Total Cigarettes and Heated Tobacco Units	177,987	196,494

Heated tobacco units is the term we use to refer to our heat-not-burn consumables, which include HEETS, HEETS Marlboro and HEETS FROM MARLBORO, defined collectively as HEETS, as well as Marlboro HeatSticks and Parliament HeatSticks.

- 38-

Table of Contents

Our net revenues by product category, which include excise taxes billed to customers, are shown in the table below:



PMI Net Revenues by Product Category
	For the Three Months Ended March 31,
(in millions)	2017		2016
Combustible Products
European Union	$	5,852	$	6,134
Eastern Europe, Middle East & Africa	3,687		3,998
Asia	4,442		4,642
Latin America & Canada	2,134		1,958
Total Combustible Products	$	16,116	$	16,732
Reduced-Risk Products
European Union	$	36	$	9
Eastern Europe, Middle East & Africa	8		(1		)
Asia	396		47
Latin America & Canada	—		1
Total Reduced-Risk Products	$	440	$	56

Total PMI Net Revenues	$	16,556	$	16,788

Note: Sum of product categories or Regions might not foot to total PMI due to rounding.

Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, net of sales and promotion incentives. These net revenue amounts consist of the sale of our cigarettes and other tobacco products combined. Other tobacco products primarily include roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos and do not include reduced-risk products.

Net revenues related to reduced-risk products refer to the operating revenues generated from the sale of these products, net of sales and promotion incentives. These net revenue amounts consist of the sale of our heated tobacco units, IQOS devices and related accessories, and other nicotine-containing products, which primarily include our e-vapor products.

References to total international market, defined as worldwide cigarette and our heated tobacco unit volume excluding the United States, total industry, total market and market shares throughout this "Discussion and Analysis" are our tax-paid estimates based on the latest available data from a number of internal and external sources.

Consolidated Operating Results for the Three Months Ended March 31, 2017

The following discussion compares our consolidated operating results for the three months ended March 31, 2017, with the three months ended March 31, 2016.

Our total shipment volume for cigarettes and heated tobacco units decreased by 9.4%, or by 7.8% excluding net estimated inventory movements, reflecting a challenging comparison with the first quarter of 2016, which declined by a more modest 1.1%, as well as ongoing declines of primarily low-price volumes in specific markets, such as Pakistan and the Philippines. The first quarter of 2016 also benefited from the favorable estimated impact of the leap year.

Our cigarette volume decreased by 11.5% due to:


•	European Union, principally Italy and Spain, partly offset by Poland;


•	EEMA, mainly North Africa, primarily Egypt and Tunisia, as well as Russia and Ukraine;


•	Asia, principally Indonesia, Japan, Korea, Pakistan and the Philippines; and


•	Latin America & Canada, principally Argentina, Canada and Mexico.

- 39-

Table of Contents

Our cigarette shipment volume by brand and heated tobacco unit shipment volume are shown in the table below:



PMI Shipment Volume by Brand (Million Units)
	First-Quarter
	2017	2016	Change
Cigarettes
Marlboro	62,399	67,985	(8.2	)%
L&M	21,913	23,690	(7.5	)%
Chesterfield	11,544	10,176	13.4	%
Parliament	9,199	10,137	(9.3	)%
Bond Street	8,485	9,721	(12.7	)%
Philip Morris	10,608	9,209	15.2	%
Lark	6,526	6,501	0.4	%
Others	42,878	58,622	(26.9	)%
Total Cigarettes	173,552	196,041	(11.5	)%
Heated Tobacco Units	4,435	453	+100%
Total Cigarettes and Heated Tobacco Units	177,987	196,494	(9.4	)%

Cigarette shipment volume of Marlboro decreased in: the European Union, mainly due to Italy and Spain; EEMA, mainly due to Saudi Arabia and Tunisia, partly offset by Algeria; Asia, mainly due to Japan, principally reflecting out-switching to Marlboro HeatSticks; and Latin America & Canada, mainly due to Argentina and Mexico.

Cigarette shipment volume of L&M decreased, mainly due to Egypt, as well as Russia, Turkey and Ukraine, partly offset by Kazakhstan and Saudi Arabia.

Cigarette shipment volume of Chesterfield increased, mainly driven by Argentina and Turkey, partly offset by Italy and Russia. Cigarette shipment volume of Parliament decreased, mainly due to Russia. Cigarette shipment volume of Bond Street decreased, mainly due to Russia and Ukraine. Cigarette shipment volume of Philip Morris increased, driven by Russia and Ukraine, partly offset by Argentina and Italy. Cigarette shipment volume of Lark increased, principally driven by Japan and Korea, partly offset by Turkey. Cigarette shipment volume of "Others" decreased, mainly due to local, low-margin brands in Pakistan, the Philippines, Russia and Ukraine.

The decline in our cigarette shipment volume was partly offset by higher heated tobacco unit shipment volume of 4.4 billion units, up from 453 million units in the first quarter of 2016, driven by Japan.

Our market share increased in a number of markets, including Algeria, Belgium, France, Germany, Hong Kong, Japan, Kazakhstan, Kuwait, Poland, Saudi Arabia, Switzerland and the United Arab Emirates.

Our net revenues and excise taxes on products were as follows:



	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Net revenues	$	16,556	$	16,788	$	(232	)	(1.4	)%
Excise taxes on products	10,492		10,705		(213		)	(2.0	)%
Net revenues, excluding excise taxes on products	$	6,064	$	6,083	$	(19	)	(0.3	)%

Net revenues, which include excise taxes billed to customers, decreased by $232 million. Excluding excise taxes, net revenues decreased by $19 million due to:


•	unfavorable volume/mix ($307 million) and


•	unfavorable currency ($120 million), partly offset by

- 40-

Table of Contents


•	price increases ($408 million).

The unfavorable currency was due primarily to the Egyptian pound, Euro and Turkish lira, partially offset by the Japanese yen and Russian ruble.

Net revenues include $440 million in 2017 and $56 million in 2016 related to sale of RRPs, mainly driven by Japan. These amounts include excise taxes billed to customers. Excluding excise taxes, net revenues for RRPs were $435 million in 2017 and $55 million in 2016. In some jurisdictions, including Japan, we are not responsible for collecting excise taxes.

Excise taxes on products decreased by $213 million due to:


•	lower excise taxes resulting from volume/mix ($881 million) and


•	favorable currency ($666 million), partly offset by


•	higher excise taxes resulting from changes in retail prices and tax rates ($1.3 billion).

Our cost of sales; marketing, administration and research costs; and operating income were as follows:



	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Cost of sales	$	2,177	$	2,096	$	81		3.9	%
Marketing, administration and research costs	1,469		1,496		(27		)	(1.8	)%
Operating income	2,396		2,473		(77		)	(3.1	)%

Cost of sales increased by $81 million due to:


•	higher cost of sales resulting from volume/mix ($68 million) and


•	higher manufacturing costs ($36 million), partly offset by


•	favorable currency ($23 million).

Marketing, administration and research costs decreased by $27 million due to:


•	favorable currency ($86 million), partly offset by


•	higher expenses ($59 million, largely reflecting increased support behind reduced-risk products).

Operating income decreased by $77 million due primarily to:


•	unfavorable volume/mix ($375 million),


•	higher marketing, administration and research costs ($59 million),


•	higher manufacturing costs ($36 million) and


•	unfavorable currency ($11 million), partly offset by


•	price increases ($408 million).

Our effective tax rate decreased by 3.4 percentage points to 24.9%. We estimate that our full-year 2017 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2017, was favorably impacted by a legal entity restructuring ($61 million). The effective tax rate is based on our full-year earnings mix by taxing jurisdiction and cash repatriation plans. Changes in currency exchange rates, earnings mix by taxing jurisdiction, or cash repatriation plans could have an impact on the effective tax rate, which we monitor each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.

We are regularly examined by tax authorities around the world, and we are currently under examination in a number of jurisdictions. It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in

- 41-

Table of Contents

unrecognized tax benefits along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Interest expense, net, of $219 million decreased by $28 million (11.3%), due primarily to lower effective interest rates on debt and higher interest income.

Net earnings attributable to PMI of $1.6 billion increased by $60 million (3.9%). This increase was primarily due to a lower effective tax rate and lower interest expense, net, partially offset by lower operating income as discussed above. Diluted and basic EPS of $1.02 increased by 4.1%.

Operating Results by Business Segment

Business Environment

Taxes, Legislation, Regulation and Other Matters Regarding the Manufacture, Marketing, Sale and Use of Tobacco Products

The tobacco industry and our business face a number of challenges that may adversely affect our business, volume, results of operations, cash flows and financial position. These challenges, which are discussed below and in “Cautionary Factors That May Affect Future Results,” include:


•	regulatory restrictions on our products, including restrictions on the packaging, marketing, and sale of tobacco or other nicotine-containing products that could reduce our competitiveness, eliminate our ability to communicate with adult smokers, or even ban certain of our products;


•	fiscal challenges, such as excise tax increases and discriminatory tax structures;


•	illicit trade in cigarettes and other tobacco products, including counterfeit, contraband and so-called “illicit whites”;


•	intense competition, including from non-tax paid volume by certain local manufacturers;


•	pending and threatened litigation as discussed in Note 8. Contingencies; and


•	governmental investigations.

Regulatory Restrictions: The tobacco industry operates in a highly regulated environment. The well-known risks of smoking have led regulators to impose significant restrictions and high excise taxes on cigarettes.

We support a comprehensive regulatory framework for tobacco products based on the principle of harm reduction, including mandated health warnings, minimum age laws, restrictions on advertising, and public place smoking restrictions. We also support regulatory measures that help reduce illicit trade.

Much of the regulation that shapes the business environment in which we operate is driven by the World Health Organization's (“WHO”) Framework Convention on Tobacco Control (“FCTC”), which entered into force in 2005. The FCTC is the first international public health treaty and has as its main objective to establish a global agenda for tobacco regulation, with the purpose of reducing tobacco use. To date, 179 countries and the European Union are Parties to the FCTC. The treaty requires Parties to have in place various tobacco control measures and recommends others. The FCTC governing body, the Conference of the Parties (“CoP”), has also adopted non-binding guidelines and policy recommendations related to certain articles of the FCTC that go beyond the text of the treaty.

We have opposed certain measures and continue to engage in a dialogue with regulators with respect to those measures that we do not believe would protect public health and, if implemented, could disrupt competition, severely limit our ability to market and sell our products to adult smokers, or increase illicit trade. Certain measures are discussed in more detail below. It is not possible to predict whether or to what extent measures recommended in the FCTC guidelines will be implemented.

Fiscal Challenges: Excessive and disruptive excise, sales and other tax increases and discriminatory tax structures are expected to continue to have an adverse impact on our profitability, due to lower consumption and consumer down-trading to non-premium, discount, other low-price or low-taxed combustible tobacco products such as fine cut tobacco and illicit cigarettes. In addition, in certain jurisdictions, some of our combustible products are subject to tax structures that discriminate against premium-price products and manufactured cigarettes. We believe that such tax policies undermine public health by encouraging consumers to turn to the illicit trade, and ultimately undercut government revenue objectives, disrupt the competitive environment, and encourage

- 42-

Table of Contents

criminal activity. Other jurisdictions have imposed, or are seeking to impose, levies or other taxes specifically on tobacco companies, such as taxes on revenues and/or profits.

EU Tobacco Products Directive: In April 2014, the EU adopted the text of a significantly revised EU Tobacco Products Directive (TPD), which entered into force in May 2016. To date, 25 Member States and Norway have adopted laws transposing the TPD, while the remaining ones are concluding the national transposition. The TPD sets forth a comprehensive set of regulatory requirements for tobacco products, including:


•	health warnings covering 65% of the front and back panels of cigarette packs, with an option for Member States to further standardize tobacco packaging, including the introduction of plain packaging;


•	a ban on characterizing flavors in some tobacco products, with a transition period for menthol expiring in May 2020;


•	security features and tracking and tracing measures some of which could increase operational expenses depending on the scope of the implementing regulation; and


•	a framework for the regulation of novel tobacco products and e-cigarettes, including requirements for health warnings and information leaflets, a prohibition on product packaging text related to reduced risk, and the introduction of notification requirements or authorization procedures in advance of commercialization.

Plain Packaging and Other Packaging Restrictions: Plain packaging legislation bans the use of branding, logos and colors on packaging other than the brand name and variant that may be printed only in specified locations and in a uniform font. To date, Australia, France, Hungary, Ireland, New Zealand, Norway, Slovenia and the U.K., have adopted plain packaging legislation. In Australia, plain packaging has been implemented since December 2012. In France, plain packaging has been fully implemented since January 2017, and in the U.K., full compliance is required as of May 2017. In Hungary, full compliance is required immediately for new product launches and no later than May 2019 for other products. In Ireland, the law will go into effect in September 2017, and in Slovenia, full compliance is required as of January 2020. No implementation date has yet been set in New Zealand or Norway.

Several countries have initiated World Trade Organization (“WTO”) dispute settlement proceedings against Australia related to Australia's plain packaging legislation. The matter is still pending before the WTO panel.

Other countries are also considering adopting plain packaging legislation, including, but not limited to, Canada, Turkey, Singapore and South Africa.

Some countries have adopted, or are considering adopting, packaging restrictions that could have an impact similar to plain packaging. Examples of such restrictions include standardizing the shape and size of packages, prohibiting certain colors or the use of certain descriptive phrases on packaging, and requiring very large graphic health warnings that leave little space for branding.

Restrictions and Bans on the Use of Ingredients: The WHO and others in the public health community have recommended restrictions or total bans on the use of some or all ingredients in tobacco products, including menthol. Broad restrictions and ingredient bans would require us to reformulate our American blend tobacco products and could reduce our ability to differentiate these products in the market in the long term. Menthol bans would eliminate the entire category of mentholated tobacco products. The European Union has banned flavored tobacco products, subject to an exemption until May 2020 for menthol. Other countries may follow the EU’s approach. For instance, Turkey has banned menthol as of May 2020. More sweeping ingredient bans have been adopted by Canada and Brazil. While the Canadian ingredient ban currently exempts menthol at the national level, the majority of Canadian provinces have adopted or are in the process of adopting menthol bans. The Canadian federal government also recently published draft regulations that would prohibit menthol in cigarettes. The Brazil ingredients ban, which would prohibit the use of virtually all ingredients with flavoring or aromatic properties, is not in force due to a legal challenge by a tobacco industry union, of which our Brazilian subsidiary is a member. Other lawsuits are also pending against the Brazil ingredients ban. It is not possible to predict the outcome of these legal proceedings.

Bans on Display of Tobacco Products at Retail: In a number of our markets, including, but not limited to, Australia, Canada, Norway, Russia, and Singapore, governments have banned the display of tobacco products at the point of sale. Other countries are also considering similar bans.

- 43-

Table of Contents

Bans and Restrictions on Advertising, Marketing, Promotions and Sponsorships: For many years, the FCTC has called for, and countries have imposed, partial or total bans on tobacco advertising, marketing, promotions and sponsorships, including bans and restrictions on advertising on radio and television, in print and on the Internet. The FCTC's non-binding guidelines recommend that governments prohibit all forms of communication with adult smokers.

Restrictions on Product Design: Some members of the public health community are calling for the further standardization of tobacco products by requiring, for example, that cigarettes have a certain minimum diameter, which would amount to a ban on slim cigarettes, or requiring the use of standardized filter and cigarette paper designs. In addition, at its meeting in November 2016, the CoP adopted non-binding guidelines recommending that countries regulate product design features that increase the attractiveness of tobacco products, such as the diameter of cigarettes and the use of flavor capsules. Reduced cigarette ignition propensity (“RCIP”) standards previously recommended by the FCTC guidelines have been adopted in several of our markets (e.g., Australia, Canada, South Africa, South Korea, and the EU), and are being considered in others.

Restrictions on Public Smoking: The pace and scope of public smoking restrictions have increased significantly in most of our markets. Many countries around the world have adopted, or are likely to adopt, regulations that restrict or ban smoking in public and/or work places, restaurants, bars and nightclubs. Some public health groups have called for, and some countries, regional governments and municipalities have adopted or proposed, bans on smoking in outdoor places, as well as bans on smoking in cars (typically, when minors are present) and private homes.

Other Regulatory Issues: Some regulators are considering, or in some cases have adopted, regulatory measures designed to reduce the supply of tobacco products. These include regulations intended to reduce the number of retailers selling tobacco products by, for example, reducing the overall number of tobacco retail licenses available or banning the sale of tobacco products within arbitrary distances of certain public facilities.

In a limited number of markets, most notably Japan, we are dependent on governmental approvals that may limit our pricing flexibility.

Illicit Trade: The illicit tobacco trade creates a cheap and unregulated supply of tobacco products, undermines efforts to reduce smoking, especially among youth, damages legitimate businesses, stimulates organized crime, increases corruption and reduces government tax revenue. Illicit trade may account for as much as 10% of global cigarette consumption; this includes counterfeit, contraband and the growing problem of “illicit whites,” which are cigarettes legally produced in one jurisdiction for the sole purpose of being exported and illegally sold in another jurisdiction where they have no legitimate market. We estimate that illicit trade in the European Union accounted for slightly less than 10% of total cigarette consumption in 2016.

A number of jurisdictions are considering actions to prevent illicit trade. In November 2012, the FCTC adopted the Protocol to Eliminate Illicit Trade in Tobacco Products (the “Protocol”), which includes supply chain control measures, such as licensing of manufacturers and distributors, enforcement in free trade zones, controls on duty free and Internet sales and the implementation of tracking and tracing technologies. To date, 54 Parties have signed the Protocol, and 26 Parties, including the European Union, have ratified it. The Protocol will come into force once the fortieth country ratifies it, after which countries must implement its measures via national legislation. We expect, and welcome, that other Parties will ratify the Protocol.

In 2009, our Colombian subsidiaries entered into an Investment and Cooperation Agreement with the national and regional governments of Colombia to promote investment in, and cooperation on, anti-contraband and anti-counterfeit efforts. The agreement provides $200 million in funding over a 20-year period to address issues such as combating the illegal cigarette trade and increasing the quality and quantity of locally-grown tobacco.

In May 2016, PMI launched PMI IMPACT, a new global initiative that supports third-party projects dedicated to fighting illegal trade and related crimes such as corruption, organized criminal networks and money laundering. The centerpiece of PMI IMPACT is a council of external independent experts with impeccable credentials in the fields of law, anti-corruption and law enforcement. The experts are responsible for evaluating and approving funding proposals for PMI IMPACT grants. PMI has pledged $100 million to fund projects within PMI IMPACT during a three-year period. We expect that the first round of grants will be awarded in the second quarter of 2017.

In November 2016, PMI signed a joint Declaration of Intent to Prevent the Maritime Transportation of Counterfeit Goods together with eight other global brand owners and five of the world’s largest shipping companies. This commitment was a result of a dialogue with the International Chamber of Commerce’s Business Action to Stop Counterfeiting and Piracy. The signatories aim to tackle the infiltration of shipping services by criminal networks that exploit vessels to transport counterfeit goods, including “illicit whites,” across the oceans.

- 44-

Table of Contents

Reduced-Risk Products

Our Approach to RRPs: We recognize that smoking cigarettes causes serious diseases and that the best way to avoid the harms of smoking is never to start, or to quit. Nevertheless, it is predicted that over the next decade the number of smokers will remain largely unchanged from the current estimate of 1.1 billion, despite the considerable efforts to discourage smoking.

Cigarettes burn tobacco, which produces smoke. As a result of the combustion process, the smoker inhales various toxic substances. In contrast, RRPs do not burn tobacco and produce significantly lower levels of harmful or potentially harmful constituents (“HPHCs”) than found in cigarette smoke.

For smokers who would otherwise continue to smoke, we believe that RRPs offer a much better choice. Accordingly, our key strategic priorities are: to develop and commercialize products that present less risk of harm to adult smokers who switch to those products versus continued smoking; and to convince current adult smokers who would otherwise continue to smoke to switch to those products.

We recognize that this transformation from cigarettes to RRPs will take time and that the speed of transformation will depend in part upon factors beyond our control, such as the willingness of governments, regulators and other policy groups to embrace RRPs as a desired alternative to continued cigarette smoking. We also recognize that our part in this transformation must be funded from our existing cigarette business. For as long as a significant number of adult smokers continues to smoke, it is critical that the industry be led by responsible and ethical manufacturers. Therefore, during the transformation, we intend to remain the leading international cigarette manufacturer.

We have a range of RRPs in various stages of development, scientific assessment and commercialization. We conduct rigorous scientific assessments of our RRP platforms to substantiate that they reduce exposure to HPHCs and, ultimately, that these products present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to them versus continued smoking. We draw upon a team of expert scientists and engineers from a broad spectrum of scientific disciplines and our extensive learnings of adult consumer preferences to develop and assess our RRPs. Our efforts are guided by the following key objectives:


•	to develop RRPs that adult smokers who would otherwise continue to smoke find to be satisfying alternatives to smoking;


•	for those adult smokers, our goal is to offer RRPs with a scientifically substantiated risk-reduction profile that approaches as closely as possible that associated with smoking cessation;


•	to substantiate the reduction of risk for the individual adult smoker and the reduction of harm to the population as a whole, based on scientific evidence of the highest standard that is made available for scrutiny and review by external independent scientists and relevant regulatory bodies; and


•	to advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including the communication of scientifically substantiated information to enable adult consumers to make better health choices.

Our RRP Platforms: Our product development is based on the elimination of combustion via tobacco heating and other innovative systems for aerosol generation, which we believe is the most promising path to providing a better choice for those who would otherwise continue to smoke. We recognize that no single product will appeal to all adult smokers. Therefore, we are developing a portfolio of products intended to appeal to a variety of distinct adult consumer preferences.

Four RRP platforms are in various stages of development and commercialization readiness:

Platform 1 uses a precisely controlled heating device that we are commercializing under the IQOS brand name, into which a specially designed and proprietary tobacco unit is inserted and heated to generate an aerosol (collectively referred to as heated tobacco units). Eight clinical studies have been completed (including two with an exposure period of three months). The study results show a substantial reduction in relevant biomarkers of exposure to HPHCs in those adult smokers who switched completely to IQOS compared to those who continued to smoke cigarettes for the duration of the study. These reductions approached those that were observed in study participants who quit smoking for the duration of the study. While these reduced exposure clinical studies were primarily designed to focus on biomarkers of exposure, we also measured six clinical risk markers. These clinical risk markers are associated with disease mechanisms known to be affected by smoking and to reverse upon cessation. The results are generally consistent with the expected direction of change that is observed upon quitting and indicate that switching completely to IQOS led to an overall improvement of clinical risk markers affected by smoking after only three months. We also initiated a 6+6 month exposure response study in December 2014 and expect the results regarding the first six-month term in the third quarter of 2017. To further improve the consumer experience, we introduced a new version of IQOS in the first quarter of 2017.

- 45-

Table of Contents

Platform 2 uses a pressed carbon heat source, which when ignited, generates an aerosol by heating tobacco. A pharmacokinetic study and a five-day reduced-exposure study with Platform 2 have now been completed. In the pharmacokinetic study, we observed that the nicotine pharmacokinetic profile and the subjective effects are comparable to smoking cigarettes, indicating that this platform could be an acceptable substitute for adult smokers who want to continue to use tobacco products but seek an alternative to cigarettes. The results of the reduced exposure study show a substantial reduction in relevant biomarkers of exposure to HPHCs in those who switched completely to Platform 2 compared to those who continued to smoke cigarettes over a five-day period. The clinical phase of a three-month reduced-exposure study has also been completed, and we expect the results to be available by the end of 2017.

Platform 3 creates an aerosol of nicotine salt formed by the chemical reaction of nicotine with a weak organic acid. We are exploring two routes for this platform, one with electronics and one without. We have begun pre-clinical and clinical testing of this platform, and have completed a pharmacokinetic study in New Zealand for the electronic version. The study assessed the nicotine pharmacokinetic profile in comparison to a nicotine inhalator. The study showed that nicotine absorption with this product reached peak levels six times faster than with the inhalator. This is in line with the nicotine pharmacokinetic profile of a cigarette, suggesting a significantly higher potential for acceptance by adult smokers. We have also completed the clinical phase of a pharmacodynamics study in the U.S. and expect final results in the first half of 2017. We expect to commence a safety and efficacy study in the first half of 2017.

Platform 4 covers e-vapor products, which are battery-powered devices that produce an aerosol by vaporizing a nicotine-containing liquid solution. Our e-vapor products comprise devices using current generation technology, and we are well advanced in the development and commercialization of our new e-vapor mesh technology that addresses certain challenges presented by some e-vapor products currently on the market. Our MESH products are designed to ensure the consistency and quality of the generated aerosol. We have commenced non-clinical studies, and our planned clinical assessment includes a pharmacokinetic study scheduled to start in 2017 and a reduced-exposure study that we expect to start in 2018.

We are also developing other potential product platforms.

Commercialization of RRPs: In 2014, we introduced the IQOS system in pilot city launches in Nagoya, Japan, and in Milan, Italy. Since then, we have expanded our commercialization activities to include all of Japan, as well as multiple cities in Italy. To-date, IQOS is available for sale nationwide in Japan and in key cities — in a total of 24 markets, and approximately 1.8 million adult consumers have stopped smoking and converted to IQOS. We expect to expand IQOS nationally in many of these markets in 2017 as capacity for heated tobacco units increases. By the end of 2017, we expect IQOS to be in 30 to 35 key cities or nationwide as capacity permits.

On the basis of our experience in Japan and Italy, we estimate that only a very small percentage of adult smokers who convert to IQOS switch back to cigarettes.

In the first quarter of 2016, we started the large scale commercial production of heated tobacco units. To date, we have experienced supply shortages resulting from stronger-than-anticipated demand, primarily in Japan, and expect capacity limitations to ease as 2017 unfolds. Our 2016 year-end installed capacity was approximately 15 billion heated tobacco units, and we expect that our 2017 year-end installed capacity will reach approximately 50 billion units. This installed capacity is expected to allow us to produce approximately 32 billion units in 2017, up from 7 billion in 2016. For 2018, we are expecting to reach installed annual capacity

of 100 billion units at year end, translating to approximately 75 billion units in total capacity available for commercialization in 2018.

We are expanding our supplier base for IQOS devices. Our IQOS devices are subject to product warranties for a period of 12 months from the date of purchase or such other periods as required by law. Warranty claims for these devices have not had a material impact on our consolidated financial position, results of operations or cash flows in any of the periods presented, although they may become more significant as the number of devices sold increases.

We currently market our e-vapor products in several markets, including Ireland, Israel, Spain and the U.K. In November 2016, we began the city test of MESH, our Platform 4 product, in Birmingham, U.K. We also expect to conduct market tests of our Platform 2 and Platform 3 products in 2017.

RRP Regulation and Taxation: RRPs contain nicotine and are not risk-free. We therefore support science-based regulation and taxation of RRPs. Regulation and taxation should differentiate between cigarettes and products that present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to these products versus continued smoking. Regulation should provide minimum standards for RRPs and specific rules for, among other things, ingredients, labelling and

- 46-

Table of Contents

consumer communication, and should ensure that the public is informed about the health risks of all tobacco and nicotine-containing products. Regulation, as well as tobacco industry activities, should reflect the fact that youth should not consume nicotine in any form.

Some governments have banned or are seeking to ban or severely restrict emerging tobacco and nicotine-containing products such as our RRPs. These regulations might foreclose or unreasonably restrict adult consumer access even to products that might be shown to be a better health choice than continuing to smoke. We oppose such blanket bans and unreasonable restrictions of products that have the potential to present less risk of harm compared to continued smoking. By contrast, we support regulation that sets clear standards and propels innovation to benefit adult smokers.

In the United States, an established regulatory framework for assessing “Modified Risk Tobacco Products” and “New Tobacco Products” exists under the jurisdiction of the Food and Drug Administration (“FDA”). Future FDA actions may influence the regulatory approach of other interested governments. We submitted to the FDA a Modified Risk Tobacco Product Application for Platform 1 in December 2016, and a Premarket Tobacco Product Application for Platform 1 in March 2017.

In the EU, a majority of Member States have transposed the EU Tobacco Products Directive, including the provisions on Novel Tobacco Products, such as heated tobacco units and e-cigarettes. Most of the EU Member States require a notification submitted six months before the intended placing on the market of a Novel Tobacco Product, while some require pre-market authorizations for the introduction of such products. To date, we have filed a comprehensive dossier summarizing our scientific assessment of Platform 1 in 16 Member States.

There can be no assurance that we will succeed in our efforts to replace cigarettes with RRPs or that regulation will allow us to commercialize RRPs in all markets or treat RRPs differently from combustible tobacco products such as cigarettes.

Our RRP Business Development Initiatives: In December 2013, we established a strategic framework with Altria Group, Inc. (“Altria”) under which Altria will make available its e-vapor products exclusively to us for commercialization outside the United States, and we will make available two of our RRPs exclusively to Altria for commercialization in the United States. In March 2015, we launched Solaris, a Platform 4 e-vapor product licensed from Altria, in Spain. In December 2015, we introduced Solaris in Israel.

In July 2015, we extended the strategic framework with Altria to include a Joint Research, Development and Technology Sharing Agreement. The additional agreement provides the framework under which PMI and Altria will collaborate to develop the next generation of e-vapor products for commercialization in the United States by Altria and in markets outside the United States by PMI. The collaboration between PMI and Altria in this endeavor is enabled by exclusive technology cross licenses and technical information sharing. The agreements also provide for cooperation on the scientific assessment of, and for the sharing of improvements to, the existing generation of licensed products.

Governmental Investigations

From time to time, we are subject to governmental investigations on a range of matters. We describe certain matters pending in Thailand and South Korea in Note 8. Contingencies.

In November 2010, a WTO panel issued its decision in a dispute relating to facts that arose from August 2006 between the Philippines and Thailand concerning a series of Thai customs and tax measures affecting cigarettes imported by PM Thailand into Thailand from the Philippines (see Note 8. Contingencies for additional information). The WTO panel decision, which was upheld by the WTO Appellate Body, concluded that Thailand had no basis to find that PM Thailand's declared customs values and taxes paid were too low, as alleged by the DSI in 2009. The decision also created obligations for Thailand to revise its laws, regulations, or practices affecting the customs valuation and tax treatment of future cigarette imports. Thailand agreed in September 2011 to fully comply with the decision by October 2012. The Philippines contends that to date Thailand has not fully complied and commenced formal proceedings at the WTO to address the outstanding issues. The Philippines has repeatedly expressed concerns with ongoing investigations by Thailand of PM Thailand, including those that led to the criminal charges described in Note 8. Contingencies, noting that these investigations appear to be based on grounds not supported by WTO customs valuation rules and inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.

Investments in Unconsolidated Subsidiaries

We discuss our investments in unconsolidated subsidiaries in Note 14. Investments in Unconsolidated Subsidiaries to our condensed consolidated financial statements.

- 47-

Table of Contents

Trade Policy

We are subject to various trade restrictions imposed by the United States of America and countries in which we do business (“Trade Sanctions”), including the trade and economic sanctions administered by the U.S. Department of the Treasury's Office of Foreign Assets Control and the U.S. Department of State. It is our policy to comply fully with these Trade Sanctions.

Tobacco products are agricultural products under U.S. law and are not technological or strategic in nature. From time to time we make sales in countries subject to Trade Sanctions, either where such sanctions do not apply to our business or pursuant to exemptions or licenses.

To our knowledge, none of our commercial arrangements results in the governments of any country identified by the U.S. government as a state sponsor of terrorism, nor entities controlled by those governments, receiving cash or acting as intermediaries in violation of U.S. laws.

Currently, we do not sell products in Iran, Sudan, North Korea, Cuba and Syria. We are exploring opportunities to sell our products in Cuba, as permitted by law.

Certain states within the U.S. have enacted legislation permitting state pension funds to divest or abstain from future investment in stocks of companies that do business with certain countries that are sanctioned by the U.S. We do not believe such legislation has had a material effect on the price of our shares.

Operating Results – For the Three Months Ended March 31, 2017

The following discussion compares operating results within each of our reportable segments for the three months ended March 31, 2017, with the three months ended March 31, 2016.

Unless otherwise stated, references to total industry, total market, our shipment volume and our market share performance reflect cigarettes and our heated tobacco units for those markets that have commercial sales of IQOS.

European Union:



European Union	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Net revenues	$	5,889	$	6,143	$	(254	)	(4.1	)%
Excise taxes on products	4,149		4,280		(131		)	(3.1	)%
Net revenues, excluding excise taxes on products	1,740		1,863		(123		)	(6.6	)%
Operating companies income	772		906		(134		)	(14.8	)%

For the three months ended March 31, 2017, net revenues decreased by $254 million. Excluding excise taxes, net revenues decreased by $123 million due to:


•	unfavorable volume/mix ($115 million) and


•	unfavorable currency ($55 million), partly offset by


•	price increases ($47 million).

The net revenues of the European Union segment include $36 million in 2017 and $9 million in 2016 related to the sale of RRPs. Excluding excise taxes, net revenues for RRPs were $31 million in 2017 and $9 million in 2016.

Operating companies income decreased by $134 million during the three months ended March 31, 2017. This decrease was due primarily to:


•	unfavorable volume/mix ($109 million),


•	higher marketing, administration and research costs ($41 million, primarily related to increased investment behind reduced-risk products) and

- 48-

Table of Contents


•	unfavorable currency ($28 million), partially offset by


•	price increases ($47 million).

European Union - Total Market

The estimated total market in the European Union decreased by 2.8% to 112.1 billion units, partly reflecting a challenging comparison to the first quarter of 2016, which increased by 0.8%, benefiting from a lower prevalence of illicit trade and e-vapor products and, in certain geographies, the estimated favorable impact of immigration. The decline of the estimated total market also reflected the impact of price increases and the implementation of elements of the Tobacco Products Directive, notably in Italy and the United Kingdom. The net impact of inventory movements on the estimated total market was immaterial.

European Union - PMI Shipment Volume and Market Share Commentaries

Shipment volume and market share performance by brand for cigarettes and heated tobacco units are shown in the tables below:



European Union PMI Shipment Volume (Million Units)
	First-Quarter

	2017	2016	Change

Cigarettes	42,540	45,993	(7.5	)%
Heated Tobacco Units	184	16	+100%
Total European Union	42,724	46,009	(7.1	)%



European Union Shipment Volume by Brand (Million Units)
	First-Quarter
Cigarettes:	2017	2016	Change
Marlboro	20,924	22,700	(7.8	)%
L&M	7,933	8,188	(3.1	)%
Chesterfield	6,496	7,148	(9.1	)%
Philip Morris	3,696	4,054	(8.8	)%
Others	3,491	3,903	(10.6	)%
Total Cigarettes	42,540	45,993	(7.5	)%
Heated Tobacco Units	184	16	+100%
Total European Union	42,724	46,009	(7.1	)%



European Union Market Shares by Brand
	First-Quarter
					Change
	2017		2016		p.p.
Marlboro	18.8	%	19.0	%	(0.2	)
L&M	7.0	%	6.9	%	0.1
Chesterfield	6.1	%	5.9	%	0.2
Philip Morris	3.2	%	3.3	%	(0.1	)
Others*	3.4	%	3.5	%	(0.1	)
Total European Union	38.5	%	38.6	%	(0.1	)

*Includes heated tobacco units.

- 49-

Table of Contents

Our total shipment volume decreased by 7.1% to 42.7 billion units, mainly due to cigarette volume declines in Italy and Spain, partly offset by Poland. Excluding estimated inventory movements, principally associated with distributor cigarette inventory movements in Italy and Spain, our total shipment volume decreased by 2.9%. The decrease in cigarette shipment volume of Marlboro was mainly due to Italy and Spain. The decrease in cigarette shipment volume of L&M was mainly due to Romania and Spain. The decrease in cigarette shipment volume of Chesterfield was mainly due to Italy and Spain, partly offset by Poland and the United Kingdom. The decrease in cigarette shipment volume of Philip Morris was mainly due to Italy. The decrease in cigarette shipment volume of "Others" was mainly due to Merit and Muratti in Italy.

Our total market share decreased by 0.1 point to 38.5%, with declines, mainly in Italy and Spain, partly offset by gains, notably in France, Germany and Poland.

European Union - Key Market Commentaries

In France, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	France Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	10.8		10.7		1.4	%

PMI Shipments (million units)	4,726		4,779		(1.1	)%

PMI Market Share
Marlboro	26.6	%	26.1	%	0.5
Philip Morris	10.3	%	10.1	%	0.2
Chesterfield	3.1	%	3.1	%	—
Others*	2.8	%	2.8	%	—
Total	42.8	%	42.1	%	0.7

*Includes heated tobacco units (in Monaco).

The estimated total market increased by 1.4%. Excluding net estimated distributor cigarette inventory movements largely associated with the implementation of the Tobacco Products Directive at the beginning of 2016, our shipment volume increased by 2.8%, reflecting the higher total market, as well as higher market share.

- 50-

Table of Contents

In Germany, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	Germany Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	17.5		17.8		(2.2	)%

PMI Shipments (million units)	6,662		6,767		(1.6	)%

PMI Market Share
Marlboro	23.4	%	22.9	%	0.5
L&M	11.7	%	11.8	%	(0.1	)
Chesterfield	1.6	%	1.6	%	—
Others*	1.5	%	1.6	%	(0.1	)
Total	38.2	%	37.9	%	0.3

*Includes heated tobacco units.

The estimated total market decreased by 2.2%, partly reflecting the lapsed contribution of favorable factors in 2016, including a lower prevalence of illicit trade. The decrease in our shipment volume was mainly due to the lower total market. The increase in our market share was driven by Marlboro.

In Italy, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	Italy Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	16.2		17.1		(5.2	)%

PMI Shipments (million units)	7,801		9,853		(20.8	)%

PMI Market Share
Marlboro	23.5	%	24.4	%	(0.9	)
Chesterfield	11.3	%	11.6	%	(0.3	)
Philip Morris	7.9	%	9.0	%	(1.1	)
HEETS	0.5	%	—	%	0.5
Others	8.5	%	8.5	%	—
Total	51.7	%	53.5	%	(1.8	)

The estimated total market decreased by 5.2%, or by 6.5% excluding the net impact of trade inventory movements, mainly due to the implementation of elements of the Tobacco Products Directive, notably the ban on pack sizes of ten cigarettes, which fueled growth in cheaper alternatives such as fine cut, cigarillos, e-vapor and illicit products. The decline of the total market also reflected a challenging comparison with the first quarter of 2016, which grew by 3.9%. The decline of our shipments, down by 7.9% excluding the net impact of distributor inventory movements, mainly reflected the lower total market, as well as lower cigarette market share, notably due to: Marlboro, as a result of its price increase in the second quarter of 2016, the ban on pack sizes of ten cigarettes, and out-switching to HEETS; and low-price Philip Morris, impacted by the growth of the super-low price segment.

- 51-

Table of Contents

In Poland, estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	Poland Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	10.2		10.1		1.5	%

PMI Cigarette Shipments (million units)	4,302		4,145		3.8	%

PMI Cigarette Market Share
Marlboro	10.2	%	11.2	%	(1.0	)
L&M	18.8	%	18.5	%	0.3
Chesterfield	9.9	%	8.6	%	1.3
Others	3.2	%	2.9	%	0.3
Total	42.1	%	41.2	%	0.9

The estimated total cigarette market increased by 1.5%, despite a challenging comparison with the first quarter of 2016, which grew by 3.1%. The increase in our cigarette shipment volume primarily reflected the higher total cigarette market, as well as higher cigarette market share, mainly reflecting higher share of Chesterfield, driven by brand support, partly offset by Marlboro, unfavorably impacted by the estimated trade inventory movements.

In Spain, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	Spain Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	9.9		10.4		(4.7	)%

PMI Shipments (million units)	3,185		4,022		(20.8	)%

PMI Market Share
Marlboro	16.2	%	17.7	%	(1.5	)
L&M	5.5	%	5.6	%	(0.1	)
Chesterfield	8.7	%	8.9	%	(0.2	)
Others*	1.8	%	1.9	%	(0.1	)
Total	32.2	%	34.1	%	(1.9	)

*Includes heated tobacco units.

The estimated total market decreased by 4.7%, or by 0.3% excluding the impact of estimated inventory reductions following increases ahead of retail price increases in December 2016. The decline of our shipments, down by 8.8% excluding the net impact of distributor inventory movements, mainly associated with the replenishment in the first quarter of 2016 of low inventory levels at the end of 2015, was mainly due to the lower total market and lower market share, principally due to Marlboro, reflecting the impact of price increases, particularly past the round €5.00 per pack price point in the vending channel, as well as a challenging comparison with the first quarter of 2016 in which the market share of Marlboro grew by 1.6 points.

- 52-

Table of Contents

Eastern Europe, Middle East & Africa:



Eastern Europe, Middle East & Africa	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Net revenues	$	3,695	$	3,997	$	(302	)	(7.6	)%
Excise taxes on products	2,218		2,395		(177		)	(7.4	)%
Net revenues, excluding excise taxes on products	1,477		1,602		(125		)	(7.8	)%
Operating companies income	690		633		57			9.0	%

For the three months ended March 31, 2017, net revenues decreased by $302 million. Excluding excise taxes, net revenues decreased by $125 million due to:


•	unfavorable volume/mix ($179 million) and


•	unfavorable currency ($99 million), partly offset by


•	price increases ($153 million).

Operating companies income increased by $57 million during the three months ended March 31, 2017. This increase was primarily due to:


•	price increases ($153 million) and


•	lower marketing, administration and research costs ($30 million), partly offset by


•	unfavorable volume/mix ($135 million).

Eastern Europe, Middle East & Africa - PMI Shipment Volume Commentaries



EEMA PMI Shipment Volume (Million Units)
	First-Quarter

	2017	2016	Change

Cigarettes	56,574	63,126	(10.4	)%
Heated Tobacco Units	105	2	+100%
Total EEMA	56,679	63,128	(10.2	)%

- 53-

Table of Contents



EEMA PMI Shipment Volume by Brand (Million Units)
	First-Quarter

	2017		2016	Change
Cigarettes
Marlboro	16,116		17,532	(8.1	)%
L&M	11,489		12,865	(10.7	)%
Bond Street	8,133	8,132.531537	9,250	(12.1	)%
Parliament	6,542		7,302	(10.4	)%
Others	14,294		16,177	(11.6	)%
Total Cigarettes	56,574		63,126	(10.4	)%
Heated Tobacco Units	105		2	+100%
Total EEMA	56,679		63,128	(10.2	)%

As shown in the table above, our total shipment volume decreased by 10.2% to 56.7 billion units, mainly due to cigarette volume declines in North Africa, primarily Egypt associated with continuity of supply, Tunisia associated with the timing of shipments, Russia and Ukraine.

The decrease in cigarette shipment volume of Marlboro was mainly due to Saudi Arabia and Tunisia, partly offset by Algeria. The decrease in cigarette shipment volume of L&M was mainly due to Egypt, Russia, Turkey and Ukraine, partly offset by Kazakhstan and Saudi Arabia. The decrease in cigarette shipment volume of Bond Street was mainly due to Russia and Ukraine. The decrease in cigarette shipment volume of Parliament was mainly due to Russia. The decrease in cigarette shipment volume of "Others" was mainly due to largely local, lower-margin brands in Russia and Ukraine.

Eastern Europe, Middle East & Africa - Key Market Commentaries

In North Africa (defined as Algeria, Egypt, Libya, Morocco and Tunisia), estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	North Africa Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	33.1		34.4		(3.5	)%

PMI Cigarette Shipments (million units)	8,780		10,230		(14.2	)%

PMI Cigarette Market Share
Marlboro	8.3	%	7.3	%	1.0
L&M	12.1	%	14.1	%	(2.0	)
Others	2.7	%	3.1	%	(0.4	)
Total	23.1	%	24.5	%	(1.4	)

The estimated total cigarette market decreased by 3.5%, mainly due to Egypt, reflecting the impact of price increases since the third quarter of 2016. The decrease in our cigarette shipment volume, down by 7.9% excluding estimated distributor inventory movements, was mainly due to the lower total cigarette market, as well as lower cigarette market share, notably of L&M in Egypt as a result of widening price gaps with competitors' brands, partly offset by the recovery of Marlboro in Algeria following the lower-than-anticipated acceptance of Architecture 2.0 in 2016.

- 54-

Table of Contents

In Russia, estimated industry size and our shipment volume, shown in the table below, include cigarettes and our heated tobacco units. Our February quarter-to-date market share performance, as measured by Nielsen and shown in the table below, reflects that of cigarettes.



	Russia Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	54.7		59.4		(7.9	)%

PMI Shipments (million units)	14,839		17,811		(16.7	)%

PMI Cigarette Market Share
Marlboro	1.3	%	1.4	%	(0.1	)
Parliament	3.6	%	3.9	%	(0.3	)
Bond Street	9.3	%	8.4	%	0.9
Others	13.2	%	14.1	%	(0.9	)
Total	27.4	%	27.8	%	(0.4	)

The estimated total market decreased by 7.9%, reflecting the impact of excise tax-driven price increases. Excluding the net impact of estimated distributor inventory movements, mainly associated with the replenishment in the first quarter of 2016 of low inventory levels at the end of 2015, our shipment volume decreased by 7.5%, mainly due to the lower total market. The decrease of our cigarette market share was mainly due to: Parliament, reflecting the impact of price increases; Chesterfield, L&M and Next/Dubliss in "Others," primarily reflecting slower-than-anticipated retail price penetration of competitors' brands; partly offset by Bond Street; and the growth of recently-launched Philip Morris in "Others," reflecting the successful ongoing morphing of super-low price Optima and Apollo Soyuz.

In Turkey, estimated cigarette industry size, our cigarette shipment volume and February quarter-to-date cigarette market share performance, as measured by Nielsen, are shown in the table below.



	Turkey Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	22.6		22.4		0.8	%

PMI Cigarette Shipments (million units)	9,830		10,345		(5.0	)%

PMI Cigarette Market Share
Marlboro	9.9	%	10.0	%	(0.1	)
Parliament	11.3	%	11.5	%	(0.2	)
Lark	6.8	%	7.8	%	(1.0	)
Others	14.9	%	14.6	%	0.3
Total	42.9	%	43.9	%	(1.0	)

The estimated total cigarette market increased by 0.8%. Excluding the impact of estimated trade inventory movements associated with the comparative timing of purchases ahead of anticipated price increases, the estimated total cigarette market declined by 5.4%, mainly reflecting the impact of price increases and a higher prevalence of illicit trade. The decrease in our shipments was mainly due to lower cigarette market share, reflecting the impact of price increases and, in the case of low-price Lark, competitive pressure from super-low price alternatives.

- 55-

Table of Contents

In Ukraine, estimated industry size and our shipment volume, shown in the table below, include cigarettes and our heated tobacco units. Our February quarter-to-date market share performance, as measured by Nielsen and shown in the table below, reflects that of cigarettes.



	Ukraine Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	14.9		17.3		(14.2	)%

PMI Shipments (million units)	4,110		5,648		(27.2	)%

PMI Cigarette Market Share
Marlboro	3.1	%	3.3	%	(0.2	)
Parliament	3.1	%	2.8	%	0.3
Bond Street	9.2	%	10.1	%	(0.9	)
Others	12.0	%	13.4	%	(1.4	)
Total	27.4	%	29.6	%	(2.2	)

The estimated total market decreased by 14.2%, mainly due to the impact of price increases and a challenging comparison with the first quarter of 2016, which grew by 17.3%. The decrease in our shipment volume was mainly due to the lower total market, as well as lower cigarette market share, primarily of low-price Bond Street, as well as President, down by 3.0 points to 1.4%, and Chesterfield, down by 0.7 points to 2.1%, in "Others," largely reflecting the impact of price increases. The decline in our cigarette market share was partly offset by Parliament, as well as L&M, up by 1.9 points to 6.5%, in "Others."

Asia:



Asia	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Net revenues	$	4,838	$	4,689	$	149		3.2	%
Excise taxes on products	2,597		2,721		(124		)	(4.6	)%
Net revenues, excluding excise taxes on products	2,241		1,968		273			13.9	%
Operating companies income	852		778		74			9.5	%

For the three months ended March 31, 2017, net revenues increased by $149 million. Excluding excise taxes, net revenues increased by $273 million due to:


•	price increases ($143 million),


•	favorable volume/mix ($74 million) and


•	favorable currency ($56 million).

The net revenues of the Asia segment include $396 million in 2017 and $47 million in 2016 related to sale of RRPs, mainly driven by Japan. Excluding excise taxes, net revenues for RRPs were $396 million in 2017 and $47 million in 2016. In some jurisdictions, including Japan, we are not responsible for collecting excise taxes.

- 56-

Table of Contents

Operating companies income increased by $74 million during the three months ended March 31, 2017. This increase was due primarily to:


•	price increases ($143 million) and


•	favorable currency ($54 million), partly offset by


•	unfavorable volume/mix ($56 million),


•	higher marketing, administration and research costs ($45 million, primarily related to increased investment behind reduced-risk products, notably in Japan) and


•	higher manufacturing costs ($23 million).

Asia - PMI Shipment Volume Commentaries



Asia PMI Shipment Volume (Million Units)
	First-Quarter

	2017	2016	Change

Cigarettes	55,142	65,222	(15.5	)%
Heated Tobacco Units	4,145	435	+100%
Total Asia	59,287	65,657	(9.7	)%



Asia PMI Shipment Volume by Brand (Million Units)
	First-Quarter

	2017	2016	Change
Cigarettes
Marlboro	17,734	18,873	(6.0	)%
Lark	4,566	4,302	6.1	%
Parliament	2,326	2,410	(3.5	)%
Others	30,516	39,637	(23.0	)%
Total Cigarettes	55,142	65,222	(15.5	)%
Heated Tobacco Units	4,145	435	+100%
Total Asia	59,287	65,657	(9.7	)%

As shown in the table above, our total shipment volume decreased by 9.7% to 59.3 billion units, mainly due to cigarette volume declines in: Indonesia; Japan; Korea; Pakistan, reflecting the impact of excise tax-driven price increases and an increase in the prevalence of illicit trade; and the Philippines; partly offset by higher heated tobacco units volume in Japan.

The decrease in cigarette shipment volume of Marlboro was mainly due to Japan, primarily reflecting out-switching to Marlboro HeatSticks. The increase in cigarette shipment volume of Lark was driven by Japan and Korea. The decrease in cigarette shipment volume of Parliament was mainly due to Japan. The decrease in cigarette shipment volume of "Others" was mainly due to local, low-margin brands in Pakistan and the Philippines.

- 57-

Table of Contents

Asia - Key Market Commentaries

In Indonesia, estimated cigarette industry size, our cigarette shipment volume, cigarette market share and segmentation performance are shown in the tables below.



	Indonesia Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	71.0		75.2		(5.5	)%

PMI Cigarette Shipments (million units)	23,399		25,142		(6.9	)%

PMI Cigarette Market Share
Sampoerna A	13.9	%	14.3	%	(0.4	)
Dji Sam Soe	6.3	%	6.6	%	(0.3	)
Sampoerna U	5.0	%	4.5	%	0.5
Others	7.8	%	8.1	%	(0.3	)
Total	33.0	%	33.5	%	(0.5	)



	Indonesia Segmentation Data
	First-Quarter
					Change
	2017		2016		p.p.
Segment % of Total Market
Hand-Rolled Kretek (SKT)	18.2	%	18.8	%	(0.6	)
Machine-Made Kretek (SKM)	76.3	%	75.2	%	1.1
Whites (SPM)	5.5	%	6.0	%	(0.5	)
Total	100.0	%	100.0	%	—

PMI % Share of Segment
Hand-Rolled Kretek (SKT)	38.0	%	38.1	%	(0.1	)
Machine-Made Kretek (SKM)	28.6	%	28.5	%	0.1
Whites (SPM)	76.5	%	81.3	%	(4.8	)

The estimated total cigarette market decreased by 5.5%, primarily reflecting the impact of tax-driven price increases. The decrease in our cigarette shipments was mainly due to the lower estimated total market. The decline of our cigarette market share mainly reflected the decline of our share of the SPM segment and the soft performance of our SKT portfolio, broadly in line with industry trends.

- 58-

Table of Contents

In Japan, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	Japan Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	40.6		43.9		(7.4	)%

PMI Shipments (million units)
Cigarettes	10,701		11,551		(7.4	)%
Heated Tobacco Units	4,145		435		+100%
Total	14,846		11,986		23.9	%

PMI Market Share
Marlboro	10.0	%	10.6	%	(0.6	)
Marlboro HeatSticks	7.1	%	0.8	%	6.3
Parliament	2.2	%	2.3	%	(0.1	)
Lark	9.2	%	9.2	%	—
Others	1.5	%	1.7	%	(0.2	)
Total	30.0	%	24.6	%	5.4

The estimated total market decreased by 7.4%, or by 4.3% excluding the net impact of estimated trade inventory movements mainly associated with our principal competitor's products in the first quarter of 2016 ahead of its retail price increases. Our shipment volume increased by 11.6%, excluding the net impact of distributor inventory movements primarily associated with the timing of Marlboro HeatSticks in transit to Japan, mainly reflecting higher share driven by Marlboro HeatSticks.

In Korea, estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	Korea Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	16.1		17.0		(5.2	)%

PMI Cigarette Shipments (million units)	3,049		3,543		(13.9	)%

PMI Cigarette Market Share
Marlboro	8.7	%	9.4	%	(0.7	)
Parliament	8.0	%	7.5	%	0.5
Virginia S.	2.0	%	3.4	%	(1.4	)
Others	0.4	%	0.6	%	(0.2	)
Total	19.1	%	20.9	%	(1.8	)

The estimated total cigarette market decreased by 5.2%, primarily reflecting a challenging comparison with the first quarter of 2016 which increased by 40.9%. The decrease in our cigarette shipment volume was due to the lower total market, as well as lower cigarette market share, which was unfavorably impacted by the estimated trade inventory movements.

- 59-

Table of Contents

In the Philippines, estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	Philippines Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	16.6		19.6		(15.6	)%

PMI Cigarette Shipments (million units)	10,955		14,474		(24.3	)%

PMI Cigarette Market Share
Marlboro	32.5	%	27.5	%	5.0
Fortune	17.4	%	25.0	%	(7.6	)
Jackpot	5.9	%	9.0	%	(3.1	)
Others	10.3	%	12.2	%	(1.9	)
Total	66.1	%	73.7	%	(7.6	)

The estimated total cigarette market decreased by 15.6%, mainly due to the impact of excise tax-driven price increases, including those on our full brand portfolio in the fourth quarter of 2016, as well as a high prevalence of illicit trade. The decline in our cigarette shipment volume was due to the lower total cigarette market, as well as lower cigarette market share, particularly of our low and super-low price brands as a result of the timing of competitors' price increases, and widened price gaps to our principal competitor's discounted brands, partly offset by Marlboro, which benefited from in-switching from lower-priced brands.

Latin America & Canada:



Latin America & Canada	For the Three Months Ended March 31,
(in millions)	2017		2016		Variance			%
Net revenues	$	2,134	$	1,959	$	175		8.9	%
Excise taxes on products	1,528		1,309		219			16.7	%
Net revenues, excluding excise taxes on products	606		650		(44		)	(6.8	)%
Operating companies income	177		229		(52		)	(22.7	)%

For the three months ended March 31, 2017, net revenues increased by $175 million. Excluding excise taxes, net revenues decreased by $44 million due to:


•	unfavorable volume/mix ($87 million) and


•	unfavorable currency ($22 million), partly offset by


•	price increases ($65 million).

Operating companies income decreased by $52 million during the three months ended March 31, 2017 due primarily to:


•	unfavorable volume/mix ($75 million),


•	unfavorable currency ($26 million) and


•	higher manufacturing costs ($17 million), partly offset by


•	price increases ($65 million).

- 60-

Table of Contents

Latin America & Canada - PMI Shipment Volume Commentaries



Latin America & Canada PMI Shipment Volume (Million Units)
	First-Quarter

	2017	2016	Change

Cigarettes	19,296	21,700	(11.1	)%
Heated Tobacco Units	1	—	—	%
Total Latin America & Canada	19,297	21,700	(11.1	)%



Latin America & Canada PMI Shipment Volume by Brand (Million Units)
	First-Quarter

	2017	2016	Change
Cigarettes
Marlboro	7,625	8,880	(14.1	)%
Philip Morris	3,440	4,631	(25.7	)%
Chesterfield	1,887	171	+100.0%
Others	6,344	8,018	(20.9	)%
Total Cigarettes	19,296	21,700	(11.1	)%
Heated Tobacco Units	1	—	—	%
Total Latin America & Canada	19,297	21,700	(11.1	)%

As shown in the table above, our total shipment volume decreased by 11.1% to 19.3 billion units, mainly due to cigarette volume declines in Argentina, Canada and Mexico.

The decrease in cigarette shipment volume of Marlboro was mainly due to Argentina and Mexico. The decrease in cigarette shipment volume of Philip Morris was mainly due to Argentina. The increase in cigarette shipment volume of Chesterfield was driven by Argentina, Colombia and Venezuela. The decrease in cigarette shipment volume of "Others" was mainly due to largely local, lower-margin brands in Canada, Colombia and Mexico.

- 61-

Table of Contents

Latin America & Canada - Key Market Commentaries

In Argentina, estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	Argentina Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	9.3		9.8		(4.3	)%

PMI Cigarette Shipments (million units)	6,948		7,526		(7.7	)%

PMI Cigarette Market Share
Marlboro	20.2	%	24.0	%	(3.8	)
Chesterfield	14.5	%	1.6	%	12.9
Philip Morris	33.9	%	44.6	%	(10.7	)
Others	5.9	%	7.0	%	(1.1	)
Total	74.5	%	77.2	%	(2.7	)

The estimated total cigarette market decreased by 4.3%, primarily reflecting the impact of excise tax increases in May 2016, which drove a more than 50% increase in average industry retail prices, as well as retail price increases in the first quarter of 2017. The decrease in our cigarette shipment volume was mainly due to the lower total market, as well as lower cigarette market share, impacted by down-trading of Marlboro and mid-price Philip Morris, partly offset by low-price Chesterfield that also benefited from its successful morphing from Next.

In Canada, estimated industry size, our shipment volume and market share performance, shown in the table below, include cigarettes and our heated tobacco units.



	Canada Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Market (billion units)	4.9		5.6		(12.4	)%

PMI Shipments (million units)	1,776		2,184		(18.7	)%

PMI Market Share
Belmont	3.6	%	3.7	%	(0.1	)
Canadian Classics	8.9	%	10.7	%	(1.8	)
Next	10.9	%	11.6	%	(0.7	)
Others*	11.5	%	13.2	%	(1.7	)
Total	34.9	%	39.2	%	(4.3	)

*Includes heated tobacco units.

The estimated total market decreased by 12.4%, mainly reflecting a difficult comparison with the first quarter of 2016, which grew by 1.4%. Excluding the impact of estimated trade inventory movements associated with retail price increases in January 2017, the total market decreased by 8.8%. The decrease in our shipment volume was mainly due to the lower total market, as well as lower cigarette market share, which largely reflected the unfavorable impact of the estimated trade inventory movements.

- 62-

Table of Contents

In Mexico, estimated cigarette industry size, our cigarette shipment volume and cigarette market share performance are shown in the table below.



	Mexico Key Market Data
	First-Quarter
					Change
	2017		2016		% / p.p.
Total Cigarette Market (billion units)	7.9		8.9		(11.3	)%

PMI Cigarette Shipments (million units)	5,059		5,982		(15.4	)%

PMI Cigarette Market Share
Marlboro	46.0	%	47.5	%	(1.5	)
Delicados	8.2	%	9.9	%	(1.7	)
Benson & Hedges	4.9	%	4.2	%	0.7
Others	5.2	%	5.9	%	(0.7	)
Total	64.3	%	67.5	%	(3.2	)

The estimated total cigarette market decreased by 11.3%. Excluding the impact of estimated trade inventory movements associated with industry retail price increases in January 2017, the estimated total cigarette market increased by 1.8%. The decrease in our cigarette shipment volume mainly reflected the lower total cigarette market. The decline of our cigarette market share largely reflected the unfavorable impact of the estimated trade inventory movements.

Financial Review

Net Cash Provided by Operating Activities

During the first quarter of 2017, net cash provided by operating activities of $843 million increased by $381 million compared with the first quarter of 2016. Excluding unfavorable currency movements of $118 million, the change was primarily due to lower working capital requirements, partially offset by the 2017 payment in the South Korean tax matter (see Note 8. Contingencies for additional information).

Excluding currency, the favorable variance in working capital was due primarily to the following:


•	more cash provided by inventories, primarily due to lower finished goods inventories and lower leaf purchases; and


•	more cash provided by accounts receivable, primarily due to the timing of sales and cash collections; partially offset by


•	more cash used for accrued liabilities and other current assets, primarily due to the timing of payments for excise taxes.

Net Cash Used in Investing Activities

During the first quarter of 2017, net cash used in investing activities was $579 million, compared with net cash used in investing activities of $419 million during the first quarter of 2016. This change was due principally to cash collateral movements, primarily from derivatives designated as net investment hedges, and higher capital expenditures.

Our capital expenditures were $292 million and $226 million during the three months ended March 31, 2017 and 2016, respectively. The 2017 expenditures were primarily related to our ongoing investments in RRPs to support capacity expansion (notably for heated tobacco units). In support of our plans to increase heated tobacco unit production, we announced on April 20, 2017 that we are increasing our planned capital expenditures in 2017 to $1.6 billion, from the $1.5 billion previously communicated.

Net Cash Provided by (Used in) Financing Activities

During the first quarter of 2017, net cash provided by financing activities was $341 million, compared with net cash used of $593 million during the first quarter of 2016. The change was due primarily to higher proceeds from long-term debt (primarily the $2.5 billion proceeds in the first quarter of 2017 versus the $2.0 billion proceeds in the first quarter of 2016 from our U.S. dollar debt issuances) and higher net proceeds from short-term borrowings.

Dividends paid in the first quarter of 2017 and 2016 were $1,618 million and $1,585 million, respectively.

- 63-

Table of Contents

Debt and Liquidity

We define cash and cash equivalents as short-term, highly liquid investments, readily convertible to known amounts of cash that mature within a maximum of three months and have an insignificant risk of change in value due to interest rate or credit risk changes. As a policy, we do not hold any investments in structured or equity-linked products. Our cash and cash equivalents are predominantly held in demand deposits with institutions that have investment-grade long-term credit rating.

Credit Ratings – The cost and terms of our financing arrangements as well as our access to commercial paper markets may be affected by applicable credit ratings. At March 31, 2017, our credit ratings and outlook by major credit rating agencies were as follows:



	Short-term	Long-term	Outlook
Moody’s	P-1	A2	Stable
Standard & Poor’s	A-1	A	Negative
Fitch	F1	A	Negative

Credit Facilities – On January 27, 2017, we entered into an agreement to extend our $2.0 billion 364-day revolving credit facility from February 7, 2017 to February 6, 2018.

At March 31, 2017, our committed credit facilities and commercial paper outstanding were as follows:



(in billions)
Type	Committed Credit Facilities		Commercial Paper
364-day revolving credit, expiring February 6, 2018	$	2.0
Multi-year revolving credit, expiring February 28, 2021	2.5
Multi-year revolving credit, expiring October 1, 2020 ⁽¹⁾	3.5
Total facilities	$	8.0
Commercial paper outstanding			$	—

⁽¹⁾ On August 30, 2016, we entered into an agreement, effective October 1, 2016, to extend the term of our multi-year revolving credit facility, for an additional year covering the period October 1, 2020 to October 1, 2021 in the amount of $3.35 billion.

At March 31, 2017, there were no borrowings under the committed credit facilities, and the entire committed amounts were available for borrowing.

All banks participating in our committed credit facilities have an investment-grade long-term credit rating from the credit rating agencies. We continuously monitor the credit quality of our banking group, and at this time we are not aware of any potential non-performing credit provider.

Each of these facilities requires us to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization (“consolidated EBITDA”) to consolidated interest expense of not less than 3.5 to 1.0 on a rolling four-quarter basis. At March 31, 2017, our ratio calculated in accordance with the agreements was 10.6 to 1.0. These facilities do not include any credit rating triggers, material adverse change clauses or any provisions that could require us to post collateral. We expect to continue to meet our covenants. The terms “consolidated EBITDA” and “consolidated interest expense,” both of which include certain adjustments, are defined in the facility agreements previously filed with the U.S. Securities and Exchange Commission.

In addition to the committed credit facilities discussed above, certain of our subsidiaries maintain short-term credit arrangements to meet their respective working capital needs. These credit arrangements, which amounted to approximately $3.2 billion at March 31, 2017 and $2.9 billion at December 31, 2016, are for the sole use of our subsidiaries. Borrowings under these arrangements amounted to $1.0 billion at March 31, 2017, and $643 million at December 31, 2016.

- 64-

Table of Contents

Commercial Paper Program – We have commercial paper programs in place in the U.S. and in Europe. Our commercial paper programs in place in the U.S. and in Europe currently have an aggregate issuance capacity of $8.0 billion. At March 31, 2017 and December 31, 2016, we had no commercial paper outstanding.

We expect that the existence of the commercial paper program and the committed credit facilities, coupled with our operating cash flows, will enable us to meet our liquidity requirements.

Sale of Accounts Receivable – To mitigate credit risk and enhance cash and liquidity management we sell trade receivables to unaffiliated financial institutions. These arrangements allow us to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. We sell trade receivables under two types of arrangements, servicing and nonservicing.

Our operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2017, and March 31, 2016 were $561 million and $589 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows.

For further details, see Note 15. Sale of Accounts Receivable to our condensed consolidated financial statements.

Debt – Our total debt was $31.3 billion at March 31, 2017 and $29.1 billion at December 31, 2016.

On February 14, 2017, we filed a shelf registration statement with the U.S. Securities and Exchange Commission, under which we may from time to time sell debt securities and/or warrants to purchase debt securities over a three-year period.

Our debt issuances in the first quarter of 2017 were as follows:



(in millions)
Type		Face Value	Interest Rate	Issuance	Maturity

U.S. dollar notes	^(a)	$700	1.625%	February 2017	February 2019
U.S. dollar notes	^(b)	$300	Floating	February 2017	February 2020
U.S. dollar notes	^(a)	$1,000	2.000%	February 2017	February 2020
U.S. dollar notes	^(a)	$500	2.625%	February 2017	February 2022

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2017.

^(b) Interest on these notes is payable quarterly in arrears beginning in May 2017.

The net proceeds from the sale of the securities listed in the table above have been and will be used for general corporate purposes.

Guarantees – At March 31, 2017, we were contingently liable for $0.7 billion of guarantees of our own performance, which were primarily related to excise taxes on the shipment of our products. There is no liability in the condensed consolidated financial statements associated with these guarantees. At March 31, 2017, our third-party guarantees were insignificant.

Equity and Dividends

We discuss our stock awards as of March 31, 2017 in Note 2. Stock Plans to our condensed consolidated financial statements.

During 2016, we did not repurchase any shares under a share repurchase program and we do not presently intend to repurchase shares of our common stock in 2017.

Dividends paid in the first three months of 2017 were $1.6 billion. During the third quarter of 2016, our Board of Directors approved a 2.0% increase in the quarterly dividend to $1.04 per common share. As a result, the present annualized dividend rate is $4.16 per common share.

- 65-

Table of Contents

Market Risk

Counterparty Risk - We predominantly work with financial institutions with strong short- and long-term credit ratings as assigned by Standard & Poor’s and Moody’s. These banks are also part of a defined group of relationship banks. Non-investment grade institutions are only used in certain emerging markets to the extent required by local business needs. We have a conservative approach when it comes to choosing financial counterparties and financial instruments. As such, we do not invest or hold investments in any structured or equity-linked products. The majority of our cash and cash equivalents is currently invested in demand deposits maturing within less than 30 days.

We continuously monitor and assess the credit worthiness of all our counterparties.

Derivative Financial Instruments - We operate in markets outside of the United States of America, with manufacturing and sales facilities in various locations throughout the world. Consequently, we use certain financial instruments to manage our foreign currency and interest rate exposure. We use derivative financial instruments principally to reduce our exposure to market risks resulting from fluctuations in foreign exchange rates by creating offsetting exposures. We are not a party to leveraged derivatives and, by policy, do not use derivative financial instruments for speculative purposes.

See Note 5. Financial Instruments, Note 11. Fair Value Measurements, and Note 13. Balance Sheet Offsetting to our condensed consolidated financial statements for further details on our derivative financial instruments and the related collateral arrangements.

Contingencies

See Note 8. Contingencies to our condensed consolidated financial statements for a discussion of contingencies.

Cautionary Factors That May Affect Future Results

Forward-Looking and Cautionary Statements

We may from time to time make written or oral forward-looking statements, including statements contained in filings with the SEC, in reports to stockholders and in press releases and investor webcasts. You can identify these forward-looking statements by use of words such as "strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets" and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.

We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially from those anticipated, estimated or projected. Investors should bear this in mind as they consider forward-looking statements and whether to invest in or remain invested in our securities. In connection with the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, we are identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made by us; any such statement is qualified by reference to the following cautionary statements. We elaborate on these and other risks we face throughout this document, particularly in the “Business Environment” section. You should understand that it is not possible to predict or identify all risk factors. Consequently, you should not consider the following to be a complete discussion of all potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time, except in the normal course of our public disclosure obligations.

- 66-

Table of Contents

Risks Related to Our Business and Industry

Consumption of tax-paid cigarettes continues to decline in many of our markets.

This decline is due to multiple factors, including increased taxes and pricing, governmental actions, the diminishing social acceptance of smoking, continuing economic and geopolitical uncertainty, and the continuing prevalence of illicit products. These factors and their potential consequences are discussed more fully below and in the "Business Environment" section.

Cigarettes are subject to substantial taxes. Significant increases in cigarette-related taxes have been proposed or enacted and are likely to continue to be proposed or enacted in numerous jurisdictions. These tax increases may disproportionately affect our profitability and make us less competitive versus certain of our competitors.

Tax regimes, including excise taxes, sales taxes and import duties, can disproportionately affect the retail price of cigarettes versus other tobacco products, or disproportionately affect the relative retail price of our cigarette brands versus cigarette brands manufactured by certain of our competitors. Because our portfolio is weighted toward the premium-price cigarette category, tax regimes based on sales price can place us at a competitive disadvantage in certain markets. As a result, our volume and profitability may be adversely affected in these markets.

Increases in cigarette taxes are expected to continue to have an adverse impact on our sales of cigarettes, due to resulting lower consumption levels, a shift in sales from manufactured cigarettes to other tobacco products and from the premium-price to the mid-price or low-price cigarette categories, where we may be under-represented, from local sales to legal cross-border purchases of lower price products, or to illicit products such as contraband, counterfeit and "illicit whites."

Our business faces significant governmental action aimed at increasing regulatory requirements with the goal of reducing or preventing the use of tobacco products.

Governmental actions, combined with the diminishing social acceptance of smoking and private actions to restrict smoking, have resulted in reduced industry volume in many of our markets, and we expect that such factors will continue to reduce consumption levels and will increase down-trading and the risk of counterfeiting, contraband, "illicit whites" and legal cross-border purchases. Significant regulatory developments will take place over the next few years in most of our markets, driven principally by the World Health Organization's Framework Convention on Tobacco Control ("FCTC"). The FCTC is the first international public health treaty on tobacco, and its objective is to establish a global agenda for tobacco regulation. The FCTC has led to increased efforts by tobacco control advocates and public health organizations to promote increasingly restrictive regulatory measures on the marketing and sale of tobacco products to adult smokers. Regulatory initiatives that have been proposed, introduced or enacted include:


•	restrictions on, or licensing of, outlets permitted to sell cigarettes;


•	the levying of substantial and increasing tax and duty charges;


•	restrictions or bans on advertising, marketing and sponsorship;


•	the display of larger health warnings, graphic health warnings and other labeling requirements;


•	restrictions on packaging design, including the use of colors, and plain packaging;


•	restrictions on packaging and cigarette formats and dimensions;


•	restrictions or bans on the display of tobacco product packaging at the point of sale and restrictions or bans on cigarette vending machines;


•	requirements regarding testing, disclosure and performance standards for tar, nicotine, carbon monoxide and other smoke constituents;


•	disclosure, restrictions, or bans of tobacco product ingredients;


•	increased restrictions on smoking in public and work places and, in some instances, in private places and outdoors;


•	restrictions on the sale of novel tobacco or nicotine-containing products;


•	elimination of duty free sales and duty free allowances for travelers; and


•	encouraging litigation against tobacco companies.

- 67-

Table of Contents

Our operating income could be significantly affected by regulatory initiatives resulting in a significant decrease in demand for our brands, in particular requirements that lead to a commoditization of tobacco products, as well as any significant increase in the cost of complying with new regulatory requirements.

Litigation related to tobacco use and exposure to environmental tobacco smoke could substantially reduce our profitability and could severely impair our liquidity.

There is litigation related to tobacco products pending in certain jurisdictions. Damages claimed in some tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. We anticipate that new cases will continue to be filed. The FCTC encourages litigation against tobacco product manufacturers. It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Please see Note 8. Contingencies to our condensed consolidated financial statements for a discussion of pending litigation.

We face intense competition, and our failure to compete effectively could have a material adverse effect on our profitability and results of operations.

We compete primarily on the basis of product quality, brand recognition, brand loyalty, taste, innovation, packaging, service, marketing, advertising and price. We are subject to highly competitive conditions in all aspects of our business. The competitive environment and our competitive position can be significantly influenced by weak economic conditions, erosion of consumer confidence, competitors' introduction of lower-price products or innovative products, higher tobacco product taxes, higher absolute prices and larger gaps between retail price categories, and product regulation that diminishes the ability to differentiate tobacco products. Competitors include three large international tobacco companies and several regional and local tobacco companies and, in some instances, state-owned tobacco enterprises, principally in Algeria, the PRC, Egypt, Taiwan, Thailand and Vietnam. Industry consolidation and privatizations of state-owned enterprises have led to an overall increase in competitive pressures. Some competitors have different profit and volume objectives, and some international competitors are susceptible to changes in different currency exchange rates.

Because we have operations in numerous countries, our results may be influenced by economic, regulatory and political developments, natural disasters or conflicts.

Some of the countries in which we operate face the threat of civil unrest and can be subject to regime changes. In others, nationalization, terrorism, conflict and the threat of war may have a significant impact on the business environment. Economic, political, regulatory or other developments or natural disasters could disrupt our supply chain, manufacturing capabilities or distribution capabilities. In addition, such developments could lead to loss of property or equipment that are critical to our business in certain markets and difficulty in staffing and managing our operations, which could reduce our volumes, revenues and net earnings.

In certain markets, we are dependent on governmental approvals of various actions such as price changes, and failure to obtain such approvals could impair growth in our profitability.

In addition, despite our high ethical standards and rigorous control and compliance procedures aimed at preventing and detecting unlawful conduct, given the breadth and scope of our international operations, we may not be able to detect all potential improper or unlawful conduct by our employees and international partners.

We may be unable to anticipate changes in consumer preferences or to respond to consumer behavior influenced by economic downturns.

Our business is subject to changes in adult consumer preferences, which may be influenced by local economic conditions. To be successful, we must:


•	promote brand equity successfully;


•	anticipate and respond to new adult consumer trends;


•	develop new products and markets and broaden brand portfolios;


•	improve productivity;


•	ensure adequate production capacity to meet demand for our products; and


•	be able to protect or enhance margins through price increases.

- 68-

Table of Contents

In periods of economic uncertainty, adult consumers may tend to purchase lower-price brands, and the volume of our premium-price and mid-price brands and our profitability could suffer accordingly. Such down-trading trends may be reinforced by regulation that limits branding, communication and product differentiation.

We lose revenues as a result of counterfeiting, contraband, cross-border purchases and non-tax-paid volume produced by local manufacturers.

Large quantities of counterfeit cigarettes are sold in the international market. We believe that Marlboro is the most heavily counterfeited international cigarette brand, although we cannot quantify the revenues we lose as a result of this activity. In addition, our revenues are reduced by contraband, legal cross-border purchases and non-tax-paid volume produced by local manufacturers.

From time to time, we are subject to governmental investigations on a range of matters.

Investigations include allegations of contraband shipments of cigarettes, allegations of unlawful pricing activities within certain markets, allegations of underpayment of customs duties and/or excise taxes, allegations of false and misleading usage of descriptors and allegations of unlawful advertising. We cannot predict the outcome of those investigations or whether additional investigations may be commenced, and it is possible that our business could be materially affected by an unfavorable outcome of pending or future investigations. See “Management's Discussion and Analysis of Financial Condition and Results of Operations-Operating Results by Business Segment-Business Environment-Governmental Investigations” for a description of certain governmental investigations to which we are subject.

We may be unsuccessful in our attempts to introduce Reduced-Risk Products, and regulators may not permit the commercialization of these products or health-related claims.

Our key strategic priorities are: to develop and commercialize products that present less risk of harm to adult smokers who switch to those products versus continued smoking; and to convince current adult smokers who would otherwise continue to smoke to switch to those RRPs. For our efforts to be successful, we must: develop RRPs that such adult smokers find acceptable alternatives to smoking; conduct rigorous scientific studies to substantiate that they reduce exposure to harmful and potentially harmful constituents in smoke and, ultimately, that these products present, are likely to present, or have the potential to present less risk of harm to adult smokers who switch to them versus continued smoking; and effectively advocate for the development of science-based regulatory frameworks for the development and commercialization of RRPs, including communication of scientifically substantiated information to enable adult consumers to make better health choices. We might not succeed in our efforts. If we do not succeed, but others do, we may be at a competitive disadvantage. Furthermore, we cannot predict whether regulators will permit the sale and/or marketing of RRPs with health-related claims. Such restrictions could limit the success of our RRPs.

Our reported results could be adversely affected by unfavorable currency exchange rates, and currency devaluations could impair our competitiveness.

We conduct our business primarily in local currency and, for purposes of financial reporting, the local currency results are translated into U.S. dollars based on average exchange rates prevailing during a reporting period. During times of a strengthening U.S. dollar, our reported net revenues and operating income will be reduced because the local currency translates into fewer U.S. dollars. During periods of local economic crises, foreign currencies may be devalued significantly against the U.S. dollar, reducing our margins. Actions to recover margins may result in lower volume and a weaker competitive position.

The repatriation of our foreign earnings, changes in the earnings mix, and changes in tax laws may increase our effective tax rate. Our ability to receive payments from foreign subsidiaries or to repatriate royalties and dividends could be restricted by local country currency exchange controls.

Because we are a U.S. holding company, our most significant source of funds is distributions from our non-U.S. subsidiaries. Under current U.S. tax law, in general we do not pay U.S. taxes on our foreign earnings until they are repatriated to the U.S. as distributions from our non-U.S. subsidiaries. These distributions may result in a residual U.S. tax cost. It may be advantageous to us in certain circumstances to significantly increase the amount of such distributions, which could result in a material increase in our overall effective tax rate under current U.S. tax law. Furthermore, our effective tax rate could be increased due to changes in the earnings mix or applicable tax laws. In addition, certain countries in which we operate have adopted or could institute currency exchange controls that limit or prohibit our local subsidiaries' ability to convert local currency into U.S. dollars or to make payments outside the country. This could subject us to the risks of local currency devaluation and business disruption.

- 69-

Table of Contents

Our ability to grow profitability may be limited by our inability to introduce new products, enter new markets or improve our margins through higher pricing and improvements in our brand and geographic mix.

Our profit growth may suffer if we are unable to introduce new products or enter new markets successfully, to raise prices or to improve the proportion of our sales of higher margin products and in higher margin geographies.

We may be unable to expand our brand portfolio through successful acquisitions or the development of strategic business relationships.

One element of our growth strategy is to strengthen our brand portfolio and market positions through selective acquisitions and the development of strategic business relationships. Acquisition and strategic business development opportunities are limited and present risks of failing to achieve efficient and effective integration, strategic objectives and anticipated revenue improvements and cost savings. There is no assurance that we will be able to acquire attractive businesses on favorable terms, or that future acquisitions or strategic business developments will be accretive to earnings.

Government mandated prices, production control programs, shifts in crops driven by economic conditions and the impact of climate change may increase the cost or reduce the quality of the tobacco and other agricultural products used to manufacture our products.

As with other agricultural commodities, the price of tobacco leaf and cloves can be influenced by imbalances in supply and demand, and crop quality can be influenced by variations in weather patterns, including those caused by climate change. Tobacco production in certain countries is subject to a variety of controls, including government mandated prices and production control programs. Changes in the patterns of demand for agricultural products could cause farmers to produce less tobacco or cloves. Any significant change in tobacco leaf and clove prices, quality and quantity could affect our profitability and our business.

Our ability to implement our strategy of attracting and retaining the best global talent may be impaired by the decreasing social acceptance of cigarette smoking.

The tobacco industry competes for talent with consumer products and other companies that enjoy greater societal acceptance. As a result, we may be unable to attract and retain the best global talent.

The failure of our information systems to function as intended or their penetration by outside parties with the intent to corrupt them could result in business disruption, litigation and regulatory action, and loss of revenue, assets or personal or other sensitive data.

We use information systems to help manage business processes, collect and interpret business data and communicate internally and externally with employees, suppliers, customers and others. Some of these information systems are managed by third-party service providers. We have backup systems and business continuity plans in place, and we take care to protect our systems and data from unauthorized access. Nevertheless, failure of our systems to function as intended, or penetration of our systems by outside parties intent on extracting or corrupting information or otherwise disrupting business processes, could place us at a competitive disadvantage, result in a loss of revenue, assets or personal or other sensitive data, litigation and regulatory action, cause damage to our reputation and that of our brands and result in significant remediation and other costs to us.

We may be required to replace third-party contract manufacturers or service providers with our own resources.

In certain instances, we contract with third parties to manufacture some of our products or product parts or to provide other services. We may be unable to renew these agreements on satisfactory terms for numerous reasons, including government regulations. Accordingly, our costs may increase significantly if we must replace such third parties with our own resources.

- 70-

Table of Contents

Item 4. Controls and Procedures.

PMI carried out an evaluation, with the participation of PMI’s management, including PMI’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of PMI’s disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based upon that evaluation, PMI’s Chief Executive Officer and Chief Financial Officer concluded that PMI’s disclosure controls and procedures are effective. There have been no changes in PMI’s internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, PMI’s internal control over financial reporting.

- 71-

Table of Contents

Part II - OTHER INFORMATION


Item 1.	Legal Proceedings.

See Note 8. Contingencies of the Notes to the Condensed Consolidated Financial Statements included in Part I – Item 1 of this report for a discussion of legal proceedings pending against Philip Morris International Inc. and its subsidiaries.


Item 1A.	Risk Factors.

Information regarding Risk Factors appears in “MD&A – Cautionary Factors That May Affect Future Results,” in Part I – Item 2 of this Form 10-Q and in Part I – Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2016. There have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K.

- 72-

Table of Contents


Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.

Our share repurchase activity for each of the three months in the quarter ended March 31, 2017 was as follows:



Period	Total Number of Shares Repurchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs
January 1, 2017 – January 31, 2017 (1)	—	$	—	—	$	—
February 1, 2017 – February 28, 2017 (1)	—	$	—	—	$	—
March 1, 2017 – March 31, 2017 (1)	—	$	—	—	$	—
Pursuant to Publicly Announced Plans or Programs	—	$	—
January 1, 2017 – January 31, 2017 (2)	234	$	91.48
February 1, 2017 – February 28, 2017 (2)	181,890	$	102.24
March 1, 2017 – March 31, 2017 (2)	1,394	$	108.10
For the Quarter Ended March 31, 2017	183,518	$	102.27


(1)	During this reporting period, we did not have an authorized share repurchase program.


(2)	Shares repurchased represent shares tendered to us by employees who vested in restricted share unit awards and used shares to pay all, or a portion of, the related taxes.

- 73-

Table of Contents


Item 6.	Exhibits.




3.1		Amended and Restated By-Laws of Philip Morris International Inc. (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed December 9, 2016).

10.1		Extension Agreement, effective February 7, 2017, to the Credit Agreement, dated as of February 12, 2013, among Philip Morris International Inc., the lenders named therein, Citibank Europe PLC, UK Branch (formerly, Citibank International Limited), as Administrative Agent (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed January 30, 2017).

10.2		Form of Restricted Stock Unit Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed February 7, 2017).

10.3		Form of Performance Share Unit Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed February 7, 2017).

10.4		Amendment to Employment Agreement with André Calantzopoulos.

10.5		Amendment to Employment Agreement with Marc S. Firestone.

10.6		Amendment to Employment Agreement with Martin King.

10.7		Amendment to Employment Agreement with Jacek Olczak.

10.8		Amendment to Employment Agreement with Miroslaw Zielinski.

12		Statement regarding computation of ratios of earnings to fixed charges.

31.1		Certification of the Registrant's Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2		Certification of the Registrant's Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1		Certification of the Registrant's Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Certification of the Registrant's Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document.

101.SCH		XBRL Taxonomy Extension Schema.

101.CAL		XBRL Taxonomy Extension Calculation Linkbase.

101.DEF		XBRL Taxonomy Extension Definition Linkbase.

101.LAB		XBRL Taxonomy Extension Label Linkbase.

101.PRE		XBRL Taxonomy Extension Presentation Linkbase.

- 74-

Table of Contents

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

PHILIP MORRIS INTERNATIONAL INC.

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

April 27, 2017

- 75-

EX-10.4 2 a01042017_andrexcalantzopo.htm EXHIBIT 10.4 Exhibit

Exhibit 10.4

PERSONAL AND CONFIDENTIAL

To: Mr. André CALANTZOPOULOS Lausanne, February 27, 2017

Subject: Merit Increase

Dear André,

Further to your annual performance assessment we confirm that your 2017 merit increase amounts to 2.5%.

As a result of this increase, effective April 1, 2017, the following conditions of your employment have been modified according to the information detailed below:

Gross Base Salary: CHF 1’513’057.-- annually, CHF 116’389.-- monthly

All other conditions relating to your employment with Philip Morris International Management SA remain as stated in your employment contract and in any subsequent amendments.

We would like to take this opportunity to wish you continued success and satisfaction.

Yours sincerely,

/S/ RALF ZYSK

Ralf Zysk

Vice President Compensation & Benefits
and International Assignments

Avenue de Rhodanie 50, 1007 Lausanne, Switzerland T:+41 (58) 242 00 00, F: +41 (58) 242 01 11

EX-10.5 3 a01042017_marcxfirestone.htm EXHIBIT 10.5 Exhibit

Exhibit 10.5

PERSONAL AND CONFIDENTIAL

To: Mr. Marc FIRESTONE Lausanne, February 27, 2017

Subject: Merit Increase

Dear Marc,

Further to your annual performance assessment we confirm that your 2017 merit increase amounts to 2%.

As a result of this increase, effective April 1, 2017, the following conditions of your employment have been modified according to the information detailed below:

Gross Base Salary: CHF 1’020’006.-- annually, CHF 78’462.-- monthly

Comparatio: 100%

All other conditions relating to your employment with Philip Morris International Management SA remain as stated in your employment contract and in any subsequent amendments.

We would like to take this opportunity to wish you continued success and satisfaction.

Yours sincerely,

/S/ RALF ZYSK

Ralf Zysk

Vice President Compensation & Benefits
and International Assignments

Avenue de Rhodanie 50, 1007 Lausanne, Switzerland T:+41 (58) 242 00 00, F: +41 (58) 242 01 11

EX-10.6 4 a01042017_martinxking.htm EXHIBIT 10.6 Exhibit

Exhibit 10.6

PERSONAL AND CONFIDENTIAL

To: Mr. Martin KING Lausanne, February 27, 2017

Subject: Merit Increase

Dear Martin,

Further to your annual performance assessment we confirm that your 2017 merit increase amounts to 2.42%.

As a result of this increase, effective April 1, 2017, the following conditions of your employment have been modified according to the information detailed below:

Gross Base Salary: CHF 845’004.-- annually, CHF 70’417.-- monthly

Comparatio: 94%

All other conditions relating to your employment with Philip Morris Services S.A. remain as stated in your employment contract and in any subsequent amendments.

We would like to take this opportunity to wish you continued success and satisfaction.

Yours sincerely,

/S/ RALF ZYSK

Ralf Zysk

Vice President Compensation & Benefits
and International Assignments

Avenue de Cour 107, 1001 Lausanne, Switzerland T:+41 (58) 242 00 00, F: +41 (58) 242 01 11

EX-10.7 5 a01042017_jacekxolczak.htm EXHIBIT 10.7 Exhibit

Exhibit 10.7

PERSONAL AND CONFIDENTIAL

To: Mr. Jacek OLCZAK Lausanne, February 27, 2017

Subject: Merit Increase

Dear Jacek,

Further to your annual performance assessment we confirm that your 2017 merit increase amounts to 2.10%.

As a result of this increase, effective April 1, 2017, the following conditions of your employment have been modified according to the information detailed below:

Gross Base Salary: CHF 974’012.-- annually, CHF 74’924.-- monthly

Comparatio: 96%

All other conditions relating to your employment with Philip Morris International Management SA remain as stated in your employment contract and in any subsequent amendments.

We would like to take this opportunity to wish you continued success and satisfaction.

Yours sincerely,

/S/ RALF ZYSK

Ralf Zysk

Vice President Compensation & Benefits
and International Assignments

Avenue de Rhodanie 50, 1007 Lausanne, Switzerland T:+41 (58) 242 00 00, F: +41 (58) 242 01 11

EX-10.8 6 a01042017_miroslawxzielins.htm EXHIBIT 10.8 Exhibit

Exhibit 10.8

PERSONAL AND CONFIDENTIAL

To: Mr. Miroslaw ZIELINSKI Lausanne, February 27, 2017

Subject: Merit Increase

Dear Miroslaw,

Further to your annual performance assessment we confirm that your 2017 merit increase amounts to 2.16%.

As a result of this increase, effective April 1, 2017, the following conditions of your employment have been modified according to the information detailed below:

Gross Base Salary: CHF 945’009.-- annually, CHF 72’693.-- monthly

Comparatio: 105%

All other conditions relating to your employment with Philip Morris International Management SA remain as stated in your employment contract and in any subsequent amendments.

We would like to take this opportunity to wish you continued success and satisfaction.

Yours sincerely,

/S/ RALF ZYSK

Ralf Zysk

Vice President Compensation & Benefits

and International Assignments

Avenue de Rhodanie 50, 1007 Lausanne, Switzerland T:+41 (58) 242 00 00, F: +41 (58) 242 01 11

EX-12 7 pm-ex12_033117xq1.htm EXHIBIT 12 Exhibit

Exhibit 12

PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES

Computation of Ratios of Earnings to Fixed Charges

(in millions of dollars)



	Three Months Ended March 31, 2017
Earnings before income taxes	$	2,177
Add (deduct):
Dividends from less than 50% owned affiliates	—
Fixed charges	284
Interest capitalized, net of amortization	—
Earnings available for fixed charges	$	2,461
Fixed charges:
Interest incurred	$	260
Portion of rent expense deemed to represent interest factor	24
Fixed charges	$	284
Ratio of earnings to fixed charges	8.7

- 1 -

Exhibit 12

PHILIP MORRIS INTERNATIONAL INC. AND SUBSIDIARIES

Computation of Ratios of Earnings to Fixed Charges

(in millions of dollars)



	For the Years Ended December 31,
	2016		2015			2014		2013		2012
Earnings before income taxes	$	9,924	$	9,615		$	10,650	$	12,542	$	13,004
Add (deduct):
Dividends from less than 50% owned affiliates	117		127			107		1		—
Fixed charges	1,166		1,232			1,284		1,216		1,115
Interest capitalized, net of amortization	—		(3		)	1		4		2
Earnings available for fixed charges	$	11,207	$	10,971		$	12,042	$	13,763	$	14,121
Fixed charges:
Interest incurred	$	1,071	$	1,137		$	1,172	$	1,105	$	1,009
Portion of rent expense deemed to represent interest factor	95		95			112		111		106
Fixed charges	$	1,166	$	1,232		$	1,284	$	1,216	$	1,115
Ratio of earnings to fixed charges	9.6		8.9			9.4		11.3		12.7

- 2 -

EX-31.1 8 pm-ex311_033117xq1.htm EXHIBIT 31.1 Exhibit

Exhibit 31.1

Certifications

I, André Calantzopoulos, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2017

/s/ ANDRÉ CALANTZOPOULOS

André Calantzopoulos

Chief Executive Officer

-1-

EX-31.2 9 pm-ex312_033117xq1.htm EXHIBIT 31.2 Exhibit

Exhibit 31.2

Certifications

I, Jacek Olczak, certify that:


1.	I have reviewed this quarterly report on Form 10-Q of Philip Morris International Inc.;


2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;


3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;


4.	The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:


a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;


b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;


c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and


d.	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):


a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and


b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: April 27, 2017

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

- 1 -

EX-32.1 10 pm-ex321_033117xq1.htm EXHIBIT 32.1 Exhibit

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, André Calantzopoulos, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ ANDRÉ CALANTZOPOULOS

André Calantzopoulos

Chief Executive Officer

April 27, 2017

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Philip Morris International Inc. and will be retained by Philip Morris International Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

-1-

EX-32.2 11 pm-ex322_033117xq1.htm EXHIBIT 32.2 Exhibit

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Philip Morris International Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jacek Olczak, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JACEK OLCZAK

Jacek Olczak

Chief Financial Officer

April 27, 2017

-1-

EX-101.INS 12 pm-20170331.xml XBRL INSTANCE DOCUMENT 0001413329 2017-01-01 2017-03-31 0001413329 2017-04-24 0001413329 2017-03-31 0001413329 2016-12-31 0001413329 2016-01-01 2016-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0001413329 us-gaap:TreasuryStockMember 2016-01-01 2016-03-31 0001413329 us-gaap:TreasuryStockMember 2017-01-01 2017-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2017-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-03-31 0001413329 2016-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2015-12-31 0001413329 us-gaap:RetainedEarningsMember 2017-03-31 0001413329 us-gaap:TreasuryStockMember 2016-12-31 0001413329 us-gaap:CommonStockMember 2015-12-31 0001413329 us-gaap:RetainedEarningsMember 2016-01-01 2016-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0001413329 us-gaap:NoncontrollingInterestMember 2016-12-31 0001413329 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0001413329 us-gaap:TreasuryStockMember 2017-03-31 0001413329 us-gaap:RetainedEarningsMember 2016-03-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001413329 2015-12-31 0001413329 us-gaap:TreasuryStockMember 2015-12-31 0001413329 us-gaap:CommonStockMember 2017-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001413329 us-gaap:TreasuryStockMember 2016-03-31 0001413329 us-gaap:CommonStockMember 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0001413329 us-gaap:CommonStockMember 2016-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-03-31 0001413329 us-gaap:RetainedEarningsMember 2015-12-31 0001413329 us-gaap:RetainedEarningsMember 2016-12-31 0001413329 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001413329 us-gaap:AdditionalPaidInCapitalMember 2016-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0001413329 pm:A2008NonEmployeeDirectorsPlanMember 2017-03-31 0001413329 pm:FairValueMember us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0001413329 pm:A2012PerformanceIncentivePlanMember 2012-05-31 0001413329 us-gaap:PerformanceSharesMember 2017-01-01 2017-03-31 0001413329 pm:A2008NonEmployeeDirectorsPlanMember 2008-12-31 0001413329 pm:A2012PerformanceIncentivePlanMember 2017-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001413329 pm:GrantDateFairValueMember us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2017-03-31 0001413329 us-gaap:PerformanceSharesMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:PerformanceSharesMember 2017-03-31 0001413329 pm:PerformanceShareUnitsOtherPerformanceFactorsMember 2017-01-01 2017-03-31 0001413329 us-gaap:PerformanceSharesMember 2016-01-01 2016-03-31 0001413329 pm:PerformanceShareUnitsOtherPerformanceFactorsMember 2016-01-01 2016-03-31 0001413329 pm:PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember 2016-01-01 2016-03-31 0001413329 pm:PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember 2017-01-01 2017-03-31 0001413329 us-gaap:RestrictedStockUnitsRSUMember 2016-01-01 2016-03-31 0001413329 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignPensionPlansDefinedBenefitMember 2017-01-01 2017-03-31 0001413329 us-gaap:UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignPensionPlansDefinedBenefitMember 2016-01-01 2016-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2016-12-31 0001413329 us-gaap:AsiaMember 2016-12-31 0001413329 us-gaap:AsiaMember 2017-01-01 2017-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2017-01-01 2017-03-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 us-gaap:AsiaMember 2017-03-31 0001413329 pm:LatinAmericaAndCanadaMember 2017-03-31 0001413329 us-gaap:EuropeanUnionMember 2017-03-31 0001413329 us-gaap:EuropeanUnionMember 2017-01-01 2017-03-31 0001413329 us-gaap:EuropeanUnionMember 2016-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2016-12-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2017-03-31 0001413329 us-gaap:TrademarksMember 2017-01-01 2017-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2017-03-31 0001413329 us-gaap:DistributionRightsMember 2017-03-31 0001413329 us-gaap:TrademarksMember 2017-03-31 0001413329 us-gaap:TrademarksMember 2017-01-01 2017-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:TrademarksMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001413329 us-gaap:DistributionRightsMember 2017-01-01 2017-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember 2017-01-01 2017-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001413329 pm:OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0001413329 us-gaap:DistributionRightsMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember pm:MarketingAdministrationAndResearchCostsMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:CostOfSalesMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:InterestExpenseMember 2017-01-01 2017-03-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-03-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-12-31 0001413329 us-gaap:OtherAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember 2017-03-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2016-12-31 0001413329 us-gaap:ForeignExchangeContractMember 2016-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-12-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-03-31 0001413329 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-12-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-03-31 0001413329 us-gaap:OtherLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-12-31 0001413329 pm:OtherAccruedLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-03-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2015-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2016-12-31 0001413329 us-gaap:ForeignExchangeContractMember us-gaap:OtherComprehensiveIncomeMember 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:AsiaMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:AsiaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:EasternEuropeMiddleEastAndAfricaMember 2017-01-01 2017-03-31 0001413329 us-gaap:OperatingSegmentsMember pm:LatinAmericaAndCanadaMember 2016-01-01 2016-03-31 0001413329 us-gaap:OperatingSegmentsMember us-gaap:EuropeanUnionMember 2017-01-01 2017-03-31 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2017-01-01 2017-03-31 0001413329 pm:PublicCivilActionsMember 2016-04-22 0001413329 pm:IndividualLightsCasesMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:HealthCareCostRecoveryActionsMember 2016-04-22 0001413329 pm:HealthCareCostRecoveryActionsMember 2015-04-30 0001413329 pm:IndividualLightsCasesMember 2016-04-22 0001413329 pm:IndividualLightsCasesMember 2015-04-30 0001413329 pm:SmokingAndHealthClassActionsMember 2015-04-30 0001413329 pm:PublicCivilActionsMember 2015-04-30 0001413329 pm:IndividualSmokingAndHealthCasesMember 2016-04-22 0001413329 pm:SmokingAndHealthClassActionsMember 2016-04-22 0001413329 pm:SmokingAndHealthClassActionsMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:IndividualSmokingAndHealthCasesMember 2015-04-30 0001413329 pm:LightsClassActionsMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:LightsClassActionsMember 2016-04-22 0001413329 pm:HealthCareCostRecoveryActionsMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:IndividualSmokingAndHealthCasesMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:PublicCivilActionsMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:LightsClassActionsMember 2015-04-30 0001413329 pm:CeciliaLetourneauMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:CA 2017-01-01 2017-03-31 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2015-10-01 2015-10-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2016-11-01 2017-03-31 0001413329 pm:TheAttorneyGeneralOfLagosStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-03-13 2008-03-13 0001413329 pm:TheAttorneyGeneralOfKanoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-09 2007-05-09 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CL us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2015-10-01 2015-10-31 0001413329 pm:IndividualSmokingAndHealthCasesMember country:IT us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:CaseDecidedInFavorOfPlaintiffMember 2017-03-31 0001413329 pm:TheAttorneyGeneralOfOyoStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2007-05-25 2007-05-25 0001413329 pm:CeciliaLetourneauMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember country:CA 2015-05-27 2015-05-27 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2017-01-01 2017-03-31 0001413329 pm:TheSouthKoreanBoardOfAuditAndInspectionMember pm:OtherLitigationMember country:KR 2016-01-01 2016-12-31 0001413329 pm:CasesRemainingOnAppealMember 2017-03-31 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember country:CA 2017-03-01 2017-03-31 0001413329 pm:HealthCareCostRecoveryActionsMember country:NG us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:SubsidiaryAndOtherKoreanManufacturersMember pm:HealthCareCostRecoveryActionsMember country:KR 2014-04-14 2014-04-14 0001413329 pm:HealthCareCostRecoveryActionsMember country:CA us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember us-gaap:PendingLitigationMember pm:OtherLitigationMember country:TH 2016-01-18 2016-01-18 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA 2015-10-01 2015-10-31 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember country:CA 2015-05-27 2015-05-27 0001413329 pm:TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember pm:OtherLitigationMember country:TH 2017-01-26 2017-01-26 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:RothmansBensonHedgesInc.andImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:UnderAdvisementMember country:CA 2015-08-01 2015-08-31 0001413329 pm:ImperialTobaccoLtd.Member pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember country:CA 2015-10-01 2015-10-31 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember pm:AppellateRulingMember country:CA 2015-07-01 2015-07-31 0001413329 pm:IndividualSmokingAndHealthCasesMember country:BR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:IndividualSmokingAndHealthCasesMember country:AR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR 2014-04-14 2014-04-14 0001413329 pm:IndividualSmokingAndHealthCasesMember pm:ScotlandMember us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:IndividualSmokingAndHealthCasesMember country:PH us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:SmokingAndHealthClassActionsMember country:CA us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:SuzanneJacklinMember us-gaap:PendingLitigationMember country:CA 2012-06-20 2012-06-20 0001413329 pm:IndividualSmokingAndHealthCasesMember country:CA us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:TheAttorneyGeneralOfOgunStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-02-26 2008-02-26 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:AwardpersmokerperyearMember pm:SmokingAndHealthClassActionsMember 2004-01-01 2004-12-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:SmokingAndHealthClassActionsMember 2004-12-31 0001413329 pm:PublicCivilActionsMember country:AR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:TheAttorneyGeneralOfGombeStateMember us-gaap:PendingLitigationMember pm:HealthCareCostRecoveryActionsMember country:NG 2008-10-17 2008-10-17 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember country:CA 2015-06-01 2015-06-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember country:CA 2015-05-27 2015-05-27 0001413329 pm:PublicCivilActionsMember country:VE us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:HealthCareCostRecoveryActionsMember country:KR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:PendingLitigationMember country:CA 2015-06-01 2015-06-30 0001413329 pm:SmokingAndHealthClassActionsMember country:BR us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember pm:AppellateRulingMember country:CA 2015-07-01 2015-07-31 0001413329 pm:IndividualLightsCasesMember country:IT us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:AdamsMember us-gaap:PendingLitigationMember country:CA 2009-07-10 2009-07-10 0001413329 pm:IndividualSmokingAndHealthCasesMember country:RU us-gaap:SubsequentEventMember 2017-04-25 0001413329 pm:HugoLespadaMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthIndividualActionsMember country:AR 2017-01-01 2017-03-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:CasesWithVerdictsAndPostTrialDevelopmentsMember pm:SmokingAndHealthClassActionsMember country:BR 2017-01-01 2017-03-31 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-30 0001413329 pm:SmokerHealthDefenseAssociationadesfMember pm:AwardpersmokerperyearMember pm:SmokingAndHealthClassActionsMember country:BR 2004-04-01 2004-04-30 0001413329 pm:HugoLespadaMember us-gaap:JudicialRulingMember pm:SmokingAndHealthIndividualActionsMember country:AR 2016-08-05 2016-08-05 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauMember us-gaap:PendingLitigationMember pm:SmokingAndHealthClassActionsMember country:CA 2015-06-01 2015-06-30 0001413329 pm:RothmansBensonAndHedgesInc.RBHMember pm:CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember pm:AppellateRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-10-01 2015-10-30 0001413329 pm:ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember us-gaap:JudicialRulingMember pm:SmokingAndHealthClassActionsMember country:CA 2015-05-27 2015-05-27 0001413329 country:US 2017-01-01 2017-03-31 0001413329 us-gaap:ScenarioForecastMember 2017-01-01 2017-12-31 0001413329 pm:RevolvingCreditExpiringFebruarySixthTwoThousandEighteenMember 2017-01-27 0001413329 pm:MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyOneMember us-gaap:ScenarioForecastMember 2020-10-01 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2016-12-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2017-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2016-12-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2017-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2017-03-31 0001413329 pm:UsDollarNotesMember 2017-03-31 0001413329 pm:UsDollarNotesMember 2016-12-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2016-12-31 0001413329 pm:MultiYearRevolvingCreditExpiringFebruaryTwentyEighthTwoThousandTwentyOneMember 2017-03-31 0001413329 pm:RevolvingCreditExpiringFebruarySixthTwoThousandEighteenMember 2017-03-31 0001413329 pm:MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyMember 2017-03-31 0001413329 pm:FloatingRateUSDollarNotesDueFebruary2020Member pm:UsDollarNotesMember 2017-03-31 0001413329 pm:FloatingRateUSDollarNotesDueFebruary2020Member pm:UsDollarNotesMember 2017-01-01 2017-03-31 0001413329 pm:TwoPointSixTwoFivePercentUSDollarNotesDueFebruary2022Member pm:UsDollarNotesMember 2017-01-01 2017-03-31 0001413329 pm:OnePointSixTwoFivePercentUSDollarNotesDueFebruary2019Member pm:UsDollarNotesMember 2017-03-31 0001413329 pm:OnePointSixTwoFivePercentUSDollarNotesDueFebruary2019Member pm:UsDollarNotesMember 2017-01-01 2017-03-31 0001413329 pm:TwoPointZeroPercentUSDollarNotesDueFebruary2020Member pm:UsDollarNotesMember 2017-03-31 0001413329 pm:TwoPointZeroPercentUSDollarNotesDueFebruary2020Member pm:UsDollarNotesMember 2017-01-01 2017-03-31 0001413329 pm:TwoPointSixTwoFivePercentUSDollarNotesDueFebruary2022Member pm:UsDollarNotesMember 2017-03-31 0001413329 pm:UsDollarNotesMember 2017-01-01 2017-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember us-gaap:MaximumMember 2017-03-31 0001413329 us-gaap:NotesPayableOtherPayablesMember pm:ForeignCurrencyObligationsMember 2017-01-01 2017-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember us-gaap:MinimumMember 2017-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember us-gaap:MinimumMember 2017-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember us-gaap:MaximumMember 2017-03-31 0001413329 pm:EuroNotesPayableMember pm:ForeignCurrencyObligationsMember 2017-01-01 2017-03-31 0001413329 pm:UsDollarNotesMember us-gaap:MaximumMember 2017-03-31 0001413329 pm:UsDollarNotesMember us-gaap:MinimumMember 2017-03-31 0001413329 pm:SwissFrancNotesMember pm:ForeignCurrencyObligationsMember 2017-01-01 2017-03-31 0001413329 us-gaap:FairValueInputsLevel2Member 2017-03-31 0001413329 us-gaap:FairValueInputsLevel3Member 2017-03-31 0001413329 us-gaap:FairValueInputsLevel1Member 2017-03-31 0001413329 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-03-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-12-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-03-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-03-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2017-03-31 0001413329 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-03-31 0001413329 us-gaap:AccumulatedTranslationAdjustmentMember 2016-03-31 0001413329 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-03-31 0001413329 us-gaap:MaximumMember 2017-01-01 2017-03-31 0001413329 us-gaap:CorporateJointVentureMember pm:EITAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember 2017-03-31 0001413329 us-gaap:CorporateJointVentureMember pm:SocieteNationaledesTabacsetAllumettesSpAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember 2017-03-31 0001413329 pm:STAEMMember 2017-03-31 0001413329 pm:MegapolisMember 2017-03-31 0001413329 pm:EITAMember 2017-03-31 0001413329 2016-01-01 2016-12-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2016-12-31 0001413329 us-gaap:MinimumMember 2017-01-01 2017-03-31 0001413329 pm:EquityMethodInvestmentGoodwillMember 2017-03-31 0001413329 pm:EasternEuropeMiddleEastAndAfricaMember 2016-01-01 2016-03-31 iso4217:ARS iso4217:BRL xbrli:pure iso4217:CAD pm:cigarette pm:import_entry xbrli:shares iso4217:THB iso4217:USD xbrli:shares iso4217:KRW pm:performance_metric pm:intangible_asset pm:litigation_case pm:plaintiff pm:defendant pm:patient pm:manufacturer pm:year pm:installment iso4217:USD false --12-31 Q1 2017 2017-03-31 10-Q 0001413329 1553143195 Large Accelerated Filer Philip Morris International Inc. 31000000000 4600000000 11100000000 15300000000 -14000000 -2000000 16 2 61 0 2 11 16 3 66 0 3 11 10 1 5 16 1 1 35 14 2 5 2 2 1 1 1 63 0 1 1 2 2 9 11 May 27, 2015 May 27, 2015 August 5, 2016 February 2004 P20Y P4Y 922000000 2207000000 153000000 -153000000 2498000000 2683000000 13 4 9 459 147000000 200000000 737000000 1000000000 1000000000 737000000 147000000 200000000 200000000 147000000 P60D P60D 11400000000 15500000000 11400000000 15500000000 3100000000 2300000000 3100000000 2300000000 7100 110000 P60D 0.2 0.2 P60D P60D P60D P60D P60D 46000000 34000000 97000000 131000000 97000000 131000000 66300 90000 66300 90000 34000000 46000000 34000000 46000000 22100 30000 30000 22100 P20Y P20Y P20Y P20Y P20Y 3484 P20Y P20Y P20Y P20Y P20Y 918000 99957 575000000 19800000000 5000000000 3700000000 108000000 80000000 37600000 27700000 37600000 27700000 758000000 559000000 167000000 226000000 167000000 226000000 2 2 7 6 272 780 P3Y 25000 25000 In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.) In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.) On August 23, 2016, our subsidiary filed its notice of appeal. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending. 1496000000 1469000000 58 58 1525000000 1587000000 0.5 3 2013 and onward 633000000 229000000 778000000 906000000 690000000 177000000 852000000 772000000 3000000 0 240000000 272000000000 100000000000 88000000 172000000000 152000000 3 P3Y 1 0.01 0.01 1 30329000000 1946000000 2092000000 589000000 561000000

1666000000

1746000000

3499000000

3090000000

289000000

394000000

832000000

330000000

575000000

576000000

6296000000

6598000000

59000000

-10000000

97000000

27000000

-9559000000

-9265000000

P19Y

P9Y

P10Y

1964000000

1892000000

12000000

41000000

17000000

35000000

42000000

18000000

22000000

36851000000

36627000000

17608000000

16884000000

480000000

13000000

3417000000

2944000000

4239000000

5076000000

-473000000

837000000

1.02

1.04

2109316331

2018000000

1884000000

101000000

63000000

2119000000

1947000000

2096000000

2177000000

300000000

700000000

500000000

1000000000

31834000000

171000000

32005000000

0.02402

0.01269

0.03520

0.03586

0.03125

0.01750

0.01625

0.02

0.0075

0.02625

0.02

0.06375

0.01125

2017-02-01

2020-02-29

2019-02-28

2022-02-28

2020-02-29

2036

2024

2044

2024

859000000

834000000

10000000

27000000

1897000000

1739000000

-44000000

-1000000

-44000000

1000000

2000000

18000000

81000000

3000000

76000000

3000000

31000000

4000000

23000000

3000000

45000000

4000000

42000000

3000000

50000000

1000000

50000000

1000000

50000000

175000000

197000000

126000000

170000000

813000000

480000000

607000000

258000000

31000000

11000000

436000000

9000000

207000000

161000000

813000000

291000000

1000000

82000000

106000000

480000000

80000000

52000000

66000000

61000000

36000000

163000000

10000000

96000000

101000000

207000000

6000000

26000000

6000000

4000000

14000000

-17000000

5000000

7000000

-3000000

-9000000

-3000000

9000000

-5000000

-276000000

-79000000

-197000000

-62000000

-335000000

-86000000

-249000000

-75000000

163000000

207000000

126000000

170000000

P021M

1587000000

1620000000

1621000000

1622000000

0.98

1.02

0.98

1.02

77000000

232000000

0.28

0.283

0.249

800000000

719000000

52000000

186000000

867000000

900000000

117000000

0.51

0.49

0.20

0.25

10705000000

10492000000

P17Y

P4Y

P30Y

P5Y

P40Y

P2Y

583000000

612000000

86000000

1598000000

1773000000

88000000

150000000

1535000000

9000000

91000000

-39000000

46000000

51000000

7324000000

372000000

2118000000

3596000000

1238000000

7485000000

388000000

2193000000

3626000000

1278000000

161000000

16000000

75000000

30000000

40000000

3987000000

3887000000

2226000000

2177000000

9000000

22000000

630000000

541000000

223000000

84000000

-485000000

-510000000

-49000000

-1243000000

-48000000

133000000

175000000

-504000000

1000000

1455000000

1356000000

3053000000

3129000000

2470000000

200000000

717000000

1074000000

479000000

2517000000

199000000

766000000

1079000000

473000000

-247000000

-219000000

4950000000

3793000000

9017000000

8007000000

1569000000

1531000000

1011000000

810000000

1079000000

844000000

47751000000

47184000000

36851000000

36627000000

16467000000

13355000000

31834000000

378000000

32212000000

8000000000

2500000000

3500000000

2000000000

3350000000.00

25851000000

28588000000

2573000000

1754000000

28424000000

6828000000

1312000000

19857000000

427000000

30342000000

7032000000

1354000000

21796000000

160000000

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.

On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages. The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.

The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.

318

1000

318

53700000

2350000000

80800000000

2024-05-31

1788000000

1835000000

12000000

17000000

-593000000

341000000

-419000000

-579000000

462000000

843000000

1530000000

1590000000

75000000

68000000

2473000000

2396000000

1553000000

1329000000

853000000

711000000

1515000000

1564000000

538000000

-267000000

-294000000

303000000

-162000000

-156000000

514000000

488000000

26000000

289000000

294000000

-5000000

10000000

7000000

-5000000

1000000

-2000000

55000000

56000000

-8000000

-9000000

-62000000

-75000000

-17000000

-11000000

736000000

662000000

-61000000

5000000

3000000

186000000

282000000

1585000000

1618000000

7000000

5000000

226000000

292000000

2800000000

2840000000

52000000

18000000

1978000000

2482000000

-29000000

-83000000

6000000

-136000000

374000000

1605000000

75000000

1530000000

1658000000

68000000

1590000000

12360000000

12862000000

6064000000

6264000000

827000000

814000000

30397000000

30367000000

777000000

840000000

6204000000

4275000000

16788000000

3997000000

1959000000

4689000000

6143000000

3695000000

2134000000

4838000000

5889000000

16556000000

P3Y

428400

1212050

393460

1202060

89.02

104.60

89.02

98.29

128.72

98.47

1938610

198000000

151000000

1000000

30000000

677539

19191050

643000000

1004000000

59000000

-56000000

115000000

33000000

-71000000

104000000

-12688000000

-12392000000

22802000000

22994000000

-11476000000

-9402000000

1929000000

1768000000

29842000000

-35613000000

-10894000000

-3287000000

-10000000

-8914000000

-5617000000

1874000000

1859000000

29785000000

-35498000000

-10900000000

-3565000000

97000000

-9559000000

-6091000000

1964000000

1788000000

30397000000

-35490000000

-10557000000

-3509000000

27000000

-9265000000

-5783000000

1892000000

1835000000

30367000000

-35386000000

-3000000

-1000000

-2000000

1000000

-1000000

557930784

556175692

35490000000

35386000000

1550000000

1553000000

1550000000

1552000000

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Sale of Accounts Receivable:</font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumulative trade receivables sold, including excise taxes, for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$2,092 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$1,946 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">March 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were </font><font style="font-family:inherit;font-size:10pt;">$561 million</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">$589 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, the loss on sale of trade receivables was immaterial.</font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's debt issuances in the </font><font style="font-family:inherit;font-size:10pt;">first three months</font><font style="font-family:inherit;font-size:10pt;"> of </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> were as follows: </font></div><div style="line-height:120%;padding-top:12px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.05847953216374%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:29%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Face Value </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest Rate</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Issuance</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Maturity</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$700</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1.625%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2019</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$300</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Floating</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2020</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$1,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.000%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2020</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$500</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.625%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2022</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font><font style="font-family:inherit;font-size:10pt;"> Interest on these notes is payable semi-annually in arrears beginning in August 2017. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font><font style="font-family:inherit;font-size:10pt;"> Interest on these notes is payable quarterly in arrears beginning in May 2017. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(335</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.88109161793372%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 25, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 22, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of<br clear="none"/>April 30, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lights Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Lights Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div> <div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia Létourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 5, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Argentina/Hugo Lespada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 23, 2016, our subsidiary filed its notice of appeal. </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Background and Basis of Presentation:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Background</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Basis of Presentation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Contingencies:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Tobacco-Related Litigation</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.    </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">To date, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">no</font><font style="font-family:inherit;font-size:10pt;"> tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of </font><font style="font-family:inherit;font-size:10pt;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:96.88109161793372%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:37%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 25, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of <br clear="none"/>April 22, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Number of Cases Pending as of<br clear="none"/>April 30, 2015</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Smoking and Health Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">63</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Smoking and Health Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">11</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Health Care Cost Recovery Actions</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Lights Class Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Lights Cases</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Public Civil Actions</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since 1995, when the first tobacco-related litigation was filed against a PMI entity, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">459</font><font style="font-family:inherit;font-size:10pt;"> Smoking and Health, Lights, Health Care Cost Recovery, and Public Civil Actions in which we and/or </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Thirteen</font><font style="font-family:inherit;font-size:10pt;"> cases have had decisions in favor of plaintiffs. </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">Nine</font><font style="font-family:inherit;font-size:10pt;"> of these cases have subsequently reached final resolution in our favor and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">four</font><font style="font-family:inherit;font-size:10pt;"> remain on appeal.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The table below lists the verdict and significant post-trial developments in the </font><font style="font-family:inherit;font-size:10pt;">four</font><font style="font-family:inherit;font-size:10pt;"> pending cases where a verdict was returned in favor of the plaintiff:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">February 2004</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Brazil/The Smoker Health Defense Association</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Cecilia Létourneau<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.<br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">May 27, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Location of<br clear="none"/>Court/Name of<br clear="none"/>Plaintiff</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type of<br clear="none"/>Case</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Verdict</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">  </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Post-Trial<br clear="none"/>Developments</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">August 5, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Argentina/Hugo Lespada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Individual Action</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes. </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On August 23, 2016, our subsidiary filed its notice of appeal. </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pending claims related to tobacco products generally fall within the following categories:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Smoking and Health Litigation:</font><font style="font-family:inherit;font-size:10pt;"> These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;padding-left:24px;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;text-indent:-24px;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">63</font><font style="font-family:inherit;font-size:10pt;"> cases brought by individual plaintiffs in Argentina (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">35</font><font style="font-family:inherit;font-size:10pt;">), Brazil (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">14</font><font style="font-family:inherit;font-size:10pt;">), Canada (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">), Chile (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">5</font><font style="font-family:inherit;font-size:10pt;">), Costa Rica (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">), Italy (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">), the Philippines (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), Russia (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">) and Scotland (</font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">66</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">61</font><font style="font-family:inherit;font-size:10pt;"> cases on </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">•</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> cases brought on behalf of classes of individual plaintiffs in Brazil (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;">) and Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">9</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">11</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Brazil, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil</font><font style="font-family:inherit;font-size:10pt;">, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of </font><font style="font-family:inherit;font-size:10pt;">R$1,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$318</font><font style="font-family:inherit;font-size:10pt;">) per smoker per full year of smoking plus interest at the rate of </font><font style="font-family:inherit;font-size:10pt;">1%</font><font style="font-family:inherit;font-size:10pt;"> per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">en banc</font><font style="font-family:inherit;font-size:10pt;"> appeal to the Supreme Court of Justice. In addition, the defendants previously filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Brazil</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil,</font><font style="font-family:inherit;font-size:10pt;"> filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ADESF</font><font style="font-family:inherit;font-size:10pt;"> case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005.  Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and awarded a total of CAD </font><font style="font-family:inherit;font-size:10pt;">131 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$97 million</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">46 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$34 million</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at </font><font style="font-family:inherit;font-size:10pt;">918,000</font><font style="font-family:inherit;font-size:10pt;"> members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau </font><font style="font-family:inherit;font-size:10pt;">case and the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$167 million</font><font style="font-family:inherit;font-size:10pt;">), in the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$27.7 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. See the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais </font><font style="font-family:inherit;font-size:10pt;">description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than </font><font style="font-family:inherit;font-size:10pt;">three years</font><font style="font-family:inherit;font-size:10pt;"> after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD </font><font style="font-family:inherit;font-size:10pt;">15.5 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$11.4 billion</font><font style="font-family:inherit;font-size:10pt;">). The trial court awarded compensatory damages on a joint and several liability basis, allocating </font><font style="font-family:inherit;font-size:10pt;">20%</font><font style="font-family:inherit;font-size:10pt;"> to our subsidiary (approximately CAD </font><font style="font-family:inherit;font-size:10pt;">3.1 billion</font><font style="font-family:inherit;font-size:10pt;">, including pre-judgment interest (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.3 billion</font><font style="font-family:inherit;font-size:10pt;">)). In addition, the trial court awarded CAD </font><font style="font-family:inherit;font-size:10pt;">90,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$66,300</font><font style="font-family:inherit;font-size:10pt;">) in punitive damages, allocating CAD </font><font style="font-family:inherit;font-size:10pt;">30,000</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$22,100</font><font style="font-family:inherit;font-size:10pt;">) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at </font><font style="font-family:inherit;font-size:10pt;">99,957</font><font style="font-family:inherit;font-size:10pt;"> members. The trial court ordered defendants to pay CAD </font><font style="font-family:inherit;font-size:10pt;">1 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$737 million</font><font style="font-family:inherit;font-size:10pt;">) of the compensatory damage award into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">, CAD </font><font style="font-family:inherit;font-size:10pt;">200 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$147 million</font><font style="font-family:inherit;font-size:10pt;">) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;"> notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within </font><font style="font-family:inherit;font-size:10pt;">60 days</font><font style="font-family:inherit;font-size:10pt;">. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD </font><font style="font-family:inherit;font-size:10pt;">5 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$3.7 billion</font><font style="font-family:inherit;font-size:10pt;">) into trust, to secure the judgments in both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau </font><font style="font-family:inherit;font-size:10pt;">and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">226 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$167 million</font><font style="font-family:inherit;font-size:10pt;">) to cover both the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Létourneau</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Blais</font><font style="font-family:inherit;font-size:10pt;"> cases. Such security may take the form of cash into a court trust or letters of credit, in </font><font style="font-family:inherit;font-size:10pt;">six</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$27.7 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD </font><font style="font-family:inherit;font-size:10pt;">758 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$559 million</font><font style="font-family:inherit;font-size:10pt;">) in </font><font style="font-family:inherit;font-size:10pt;">seven</font><font style="font-family:inherit;font-size:10pt;"> equal consecutive quarterly installments of approximately CAD </font><font style="font-family:inherit;font-size:10pt;">108 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$80 million</font><font style="font-family:inherit;font-size:10pt;">) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD </font><font style="font-family:inherit;font-size:10pt;">37.6 million</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$27.7 million</font><font style="font-family:inherit;font-size:10pt;">) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, below).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Queen's Bench, Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Semple v. Canadian Tobacco Manufacturers' Council, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Supreme Court (trial court), Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Adams</font><font style="font-family:inherit;font-size:10pt;">, above).</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">McDermid v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Bourassa v. Imperial Tobacco Canada Limited, et al.,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Supreme Court, British Columbia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth class action pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, </font><font style="font-family:inherit;font-size:10pt;">filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of </font><font style="font-family:inherit;font-size:10pt;">25,000</font><font style="font-family:inherit;font-size:10pt;"> cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Health Care Cost Recovery Litigation:</font><font style="font-family:inherit;font-size:10pt;"> These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">10</font><font style="font-family:inherit;font-size:10pt;">), Korea (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Nigeria (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">5</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">16</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case pending in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada,</font><font style="font-family:inherit;font-size:10pt;"> filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. In September 2016,  the trial court entered a consent order establishing a discovery timetable that contemplates the province of New Brunswick applying by September 2017 for a trial date.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the sixth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the seventh health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the eighth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the ninth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada</font><font style="font-family:inherit;font-size:10pt;">, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the tenth health care cost recovery case filed in Canada, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada</font><font style="font-family:inherit;font-size:10pt;">, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Discovery is scheduled to begin in 2017.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the first health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections. </font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the second health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the third health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed October 17, 2008, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fourth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria,</font><font style="font-family:inherit;font-size:10pt;"> filed May 25, 2007, we and other members of the industry are defendants</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">.</font><font style="font-family:inherit;font-size:10pt;"> Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the fifth health care cost recovery case in Nigeria, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria</font><font style="font-family:inherit;font-size:10pt;">, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, payment of anticipated costs of treating alleged smoking-related diseases for the next </font><font style="font-family:inherit;font-size:10pt;">20 years</font><font style="font-family:inherit;font-size:10pt;">, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the health care cost recovery case in Korea, the </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">National Health Insurance Service v. KT&G, et. al.,</font><font style="font-family:inherit;font-size:10pt;"> filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lights</font><font style="font-family:inherit;font-size:10pt;"> cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately </font><font style="font-family:inherit;font-size:10pt;">$53.7 million</font><font style="font-family:inherit;font-size:10pt;"> allegedly incurred in treating </font><font style="font-family:inherit;font-size:10pt;">3,484</font><font style="font-family:inherit;font-size:10pt;"> patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Lights Cases:</font><font style="font-family:inherit;font-size:10pt;"> These cases, brought by individual plaintiffs, allege that the use of the term “lights” constitutes fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, there was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;"> lights case brought by an individual plaintiff pending against our subsidiaries or indemnitees in Italy (</font><font style="font-family:inherit;font-size:10pt;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">3</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Public Civil Actions:</font><font style="font-family:inherit;font-size:10pt;"> Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 25, 2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2</font><font style="font-family:inherit;font-size:10pt;"> public civil actions pending against our subsidiaries in Argentina (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">) and Venezuela (</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">1</font><font style="font-family:inherit;font-size:10pt;">), compared with </font><font style="font-family:inherit;font-size:10pt;">3</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April 22, 2016</font><font style="font-family:inherit;font-size:10pt;">, and </font><font style="font-family:inherit;font-size:10pt;">2</font><font style="font-family:inherit;font-size:10pt;"> such cases on </font><font style="font-family:inherit;font-size:10pt;">April 30, 2015</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Argentina, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina,</font><font style="font-family:inherit;font-size:10pt;"> filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In the public civil action in Venezuela, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court</font><font style="font-family:inherit;font-size:10pt;">, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Other Litigation</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">in the</font><font style="font-family:inherit;font-size:10pt;font-style:italic;"> </font><font style="font-family:inherit;font-size:10pt;">Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with </font><font style="font-family:inherit;font-size:10pt;">272</font><font style="font-family:inherit;font-size:10pt;"> import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB </font><font style="font-family:inherit;font-size:10pt;">80.8 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$2.35 billion</font><font style="font-family:inherit;font-size:10pt;">). The case is in the pre-trial evidentiary phase. Trial is scheduled to begin during the last quarter of 2017. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with </font><font style="font-family:inherit;font-size:10pt;">780</font><font style="font-family:inherit;font-size:10pt;"> import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB </font><font style="font-family:inherit;font-size:10pt;">19.8 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$575 million</font><font style="font-family:inherit;font-size:10pt;">). The case is in pre-trial proceedings and has not yet been set for trial. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws.  In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties.  In order to avoid nonpayment financial costs, PM Korea paid approximately KRW </font><font style="font-family:inherit;font-size:10pt;">272 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$240 million</font><font style="font-family:inherit;font-size:10pt;">), of which KRW </font><font style="font-family:inherit;font-size:10pt;">100 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$88 million</font><font style="font-family:inherit;font-size:10pt;">) was paid in 2016 and KRW </font><font style="font-family:inherit;font-size:10pt;">172 billion</font><font style="font-family:inherit;font-size:10pt;"> (approximately </font><font style="font-family:inherit;font-size:10pt;">$152 million</font><font style="font-family:inherit;font-size:10pt;">) was paid in 2017.  These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows.  PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (“MOSF”) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF’s criminal complaint and decide whether to prosecute.  PM Korea disagrees with the MOSF’s allegations.</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Accumulated Other Comprehensive Losses:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.38011695906432%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,509</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,565</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,287</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,559</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,914</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Reclassifications from Other Comprehensive Earnings </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">. For additional information, see Note 3. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Benefit Plans</font><font style="font-family:inherit;font-size:10pt;"> and Note 5. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Financial Instruments:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Overview</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. PMI reports its net transaction gains or losses in marketing, administration and research costs on the condensed consolidated statements of earnings.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Russian ruble, Swiss franc and Turkish lira. At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI had contracts with aggregate notional amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$31.0 billion</font><font style="font-family:inherit;font-size:10pt;"> of which </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$4.6 billion</font><font style="font-family:inherit;font-size:10pt;"> related to cash flow hedges, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$11.1 billion</font><font style="font-family:inherit;font-size:10pt;"> related to hedges of net investments in foreign operations and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$15.3 billion</font><font style="font-family:inherit;font-size:10pt;"> related to other derivatives that primarily offset currency exposures on intercompany financing.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="10" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.22027290448344%;border-collapse:collapse;text-align:left;"><tr><td colspan="18" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:8%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(pre-tax, millions)</font></div></td><td colspan="17" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Statement of Earnings </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Classification of Gain/(Loss) </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Reclassified from Other </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Comprehensive </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings/(Losses) into </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-right:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Cash Flow Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(86</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cost of sales</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">14</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Marketing, administration and research costs</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives in Net Investment Hedging Relationship</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(249</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(197</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(335</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(276</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Cash Flow Hedges</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. The effective portion of gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, ineffectiveness related to cash flow hedges was not material. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI has hedged forecasted transactions for periods not exceeding the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">twenty-one</font><font style="font-family:inherit;font-size:10pt;"> months with the exception of </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> foreign exchange contract that expires in </font><font style="font-family:inherit;font-size:10pt;">May 2024</font><font style="font-family:inherit;font-size:10pt;">. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hedges of Net Investments in Foreign Operations</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges of its foreign operations. For the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, these hedges of net investments resulted in losses, net of income taxes, of </font><font style="font-family:inherit;font-size:10pt;">$294 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$267 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, ineffectiveness related to net investment hedges was not material. Other investing cash flows on PMI’s condensed consolidated statements of cash flows include the premiums paid for, and settlements of, net investment hedges.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Other Derivatives</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, the gains (losses) from contracts for which PMI did not apply hedge accounting were </font><font style="font-family:inherit;font-size:10pt;">$(39) million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$91 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, the net impact of these contracts on the condensed consolidated statements of earnings was not material.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11" rowspan="1"></td></tr><tr><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative (gains)/losses transferred to earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI expects </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$9 million</font><font style="font-family:inherit;font-size:10pt;"> of derivative </font><font style="font-family:inherit;font-size:10pt;">gains</font><font style="font-family:inherit;font-size:10pt;"> that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These </font><font style="font-family:inherit;font-size:10pt;">gains</font><font style="font-family:inherit;font-size:10pt;"> are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingent Features</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s derivative instruments do not contain contingent features.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Credit Exposure and Credit Risk</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">See Note 11. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurements</font><font style="font-family:inherit;font-size:10pt;"> and Note 13. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Balance Sheet Offsetting</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion of derivative financial instruments.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:174%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Stock Plans:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to </font><font style="font-family:inherit;font-size:10pt;">30 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI’s common stock may be issued under the 2012 Plan. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the 2012 Plan were </font><font style="font-family:inherit;font-size:10pt;">19,191,050</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least </font><font style="font-family:inherit;font-size:10pt;">50%</font><font style="font-family:inherit;font-size:10pt;"> of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to </font><font style="font-family:inherit;font-size:10pt;">1 million</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, shares available for grant under the plan were </font><font style="font-family:inherit;font-size:10pt;">677,539</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s accounting policy is to estimate the number of awards expected to be forfeited and adjust the expense when it is no longer probable that the employee will fulfill the service condition.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Restricted share unit (RSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the weighted-average grant date fair value per share and the recorded compensation expense related to RSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average Grant Date Fair Value Per RSU Award Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Expense Related to RSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202,060</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,212,050</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.02</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$186 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> years after the date of the award, or upon death, disability or reaching the age of </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;">1,938,610</font><font style="font-family:inherit;font-size:10pt;"> shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately </font><font style="font-family:inherit;font-size:10pt;">$151 million</font><font style="font-family:inherit;font-size:10pt;">. The total fair value of RSU awards that vested during the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> was approximately </font><font style="font-family:inherit;font-size:10pt;">$198 million</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Performance share unit (PSU) awards</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2016</font><font style="font-family:inherit;font-size:10pt;">, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency-neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation and transformation. The aggregate of the weighted performance factors for the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> metrics determines the percentage of PSUs that will vest at the end of the </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;">-year performance cycle. Each vested PSU entitles the participant to </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;"> share of common stock. An aggregate weighted PSU performance factor of </font><font style="font-family:inherit;font-size:10pt;">100</font><font style="font-family:inherit;font-size:10pt;"> will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is </font><font style="font-family:inherit;font-size:10pt;">zero</font><font style="font-family:inherit;font-size:10pt;">, with a maximum percentage of </font><font style="font-family:inherit;font-size:10pt;">200</font><font style="font-family:inherit;font-size:10pt;">. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the grant date fair value per share and the recorded compensation expense related to PSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.6953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date Fair Value Subject to TSR Performance Factor Per Share </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date Fair Value Subject to Other Performance Factors Per Share </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Expense Related to PSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,460</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428,400</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.60</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.02</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.</font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI had </font><font style="font-family:inherit;font-size:10pt;">$52 million</font><font style="font-family:inherit;font-size:10pt;"> of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of </font><font style="font-family:inherit;font-size:10pt;">58</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2017</font><font style="font-family:inherit;font-size:10pt;">, there were </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> PSU awards that vested.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the grant date fair value per share and the recorded compensation expense related to PSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.6953125%;border-collapse:collapse;text-align:left;"><tr><td colspan="12" rowspan="1"></td></tr><tr><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date Fair Value Subject to TSR Performance Factor Per Share </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(a)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Grant Date Fair Value Subject to Other Performance Factors Per Share </font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(b)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Expense Related to PSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">393,460</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">128.72</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.29</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">17</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">428,400</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">104.60</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.02</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">12</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(a)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.</font></div><div style="line-height:120%;text-align:justify;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(b)</sup></font><font style="font-family:inherit;font-size:9pt;"> The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.</font></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">During the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, shares granted to eligible employees, the weighted-average grant date fair value per share and the recorded compensation expense related to RSU awards were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:74.0234375%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:33%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:20%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Number of Shares Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Weighted-Average Grant Date Fair Value Per RSU Award Granted</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Compensation Expense Related to RSU Awards (in millions)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,202,060</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">98.47</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">35</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,212,050</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">89.02</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">41</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s earnings activity from unconsolidated subsidiaries was as follows: </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:61%;" rowspan="1" colspan="1"></td><td style="width:3%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">840</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">777</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-bottom:13px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:41%;" rowspan="1" colspan="1"></td><td style="width:21%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:16%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Receivables</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">394</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">289</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI’s derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value<br clear="none"/>at March 31,<br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,212</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,834</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Fair Value Measurements:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:20px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 1 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted prices in active markets for identical assets or liabilities;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 2 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:84px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;">Level 3 -</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period. </font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Derivative Financial Instruments</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments</font><font style="font-family:inherit;font-size:10pt;"> for additional discussion of derivative financial instruments.</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Debt</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$13 million</font><font style="font-family:inherit;font-size:10pt;"> of capital lease obligations, was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$30,329 million</font><font style="font-family:inherit;font-size:10pt;"> at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The aggregate fair values of PMI’s derivative financial instruments and debt as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"> </font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:93.76218323586744%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:28%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:18%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value<br clear="none"/>at March 31,<br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Quoted Prices<br clear="none"/>in Active<br clear="none"/>Markets for<br clear="none"/>Identical<br clear="none"/>Assets/Liabilities<br clear="none"/>(Level 1)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Other<br clear="none"/>Observable<br clear="none"/>Inputs<br clear="none"/>(Level 2)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Significant<br clear="none"/>Unobservable<br clear="none"/>Inputs<br clear="none"/>(Level 3)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Assets:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liabilities:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Debt</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,005</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,834</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">171</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32,212</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31,834</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">378</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Goodwill and Other Intangible Assets, net:</font></div><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">479</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">388</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,626</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,074</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,118</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,485</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,517</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,470</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European<br clear="none"/>Union</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern<br clear="none"/>Europe,<br clear="none"/>Middle East<br clear="none"/>&<br clear="none"/>Africa</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin<br clear="none"/>America &<br clear="none"/>Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,278</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">388</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,626</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,193</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,485</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,356</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">583</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,129</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,053</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">583</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. During the first quarter of </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, PMI reclassified </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> trademarks with a gross carrying amount of </font><font style="font-family:inherit;font-size:10pt;">$153 million</font><font style="font-family:inherit;font-size:10pt;"> from non-amortizable intangible assets to amortizable intangible assets. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining Useful Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,535</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer<br clear="none"/>  contracts and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-tax amortization expense for intangible assets during the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> was </font><font style="font-family:inherit;font-size:10pt;">$22 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">$18 million</font><font style="font-family:inherit;font-size:10pt;">, respectively. Amortization expense for each of the next </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">five</font><font style="font-family:inherit;font-size:10pt;"> years is estimated to be </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$86 million</font><font style="font-family:inherit;font-size:10pt;"> or less, assuming no additional transactions occur that require the amortization of intangible assets.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The increase in the gross carrying amount of other intangible assets from </font><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, was due to currency movements.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Income Taxes:</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s effective tax rates for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;"> were </font><font style="font-family:inherit;font-size:10pt;">24.9%</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;">28.3%</font><font style="font-family:inherit;font-size:10pt;">, respectively. PMI estimates that its full-year </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> effective tax rate will be approximately </font><font style="font-family:inherit;font-size:10pt;">28%</font><font style="font-family:inherit;font-size:10pt;">. The effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, was favorably impacted by the tax benefit of a legal entity restructuring (</font><font style="font-family:inherit;font-size:10pt;">$61 million</font><font style="font-family:inherit;font-size:10pt;">). Excluding the effect of the legal entity restructuring, the change in the effective tax rate for the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, as compared to the </font><font style="font-family:inherit;font-size:10pt;">three months ended March 31,</font><font style="font-family:inherit;font-size:10pt;"> </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in currency exchange rates, earnings mix by taxing jurisdiction, or cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2013 and onward</font><font style="font-family:inherit;font-size:10pt;">. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">New Accounting Standards:</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing its cost method investments and the impact that the adoption of ASU 2016-01 will have on its financial position and results of operations.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Entities can apply the final standard using one of the following two methods:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">1.</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">retrospectively to each prior period presented; or </font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">2.</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.</font></div></td></tr></table><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI plans to adopt ASU 2014-09 on January 1, 2018, and does not expect the adoption to have a material impact on its consolidated financial position or results of operations. Following the release of ASU 2016-12 in May 2016, which provided some practical expedients to the original standard, PMI is continuing to assess the standard’s policy election for gross versus net presentation of excise taxes and, related to this assessment, the method of adoption.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.635477582846%;border-collapse:collapse;text-align:left;"><tr><td colspan="20" rowspan="1"></td></tr><tr><td style="width:0%;" rowspan="1" colspan="1"></td><td style="width:23%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:9%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Recognized</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amount Offset in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="3" rowspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amounts Presented in the Condensed Consolidated Balance Sheet</font></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Amounts Not Offset in the</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Condensed Consolidated </font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial Instruments</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cash Collateral Received/Pledged</font></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net Amount</font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">At March 31, 2017</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(258</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">52</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(170</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(11</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">At December 31, 2016</font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Assets</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(607</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">80</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Liabilities</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td rowspan="1" colspan="1"><font> </font></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(126</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(31</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;"> </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:85.38011695906432%;border-collapse:collapse;text-align:left;"><tr><td colspan="13" rowspan="1"></td></tr><tr><td style="width:49%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency translation adjustments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,783</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(6,091</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(5,617</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pension and other benefits</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,509</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,565</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3,287</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivatives accounted for as hedges</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total accumulated other comprehensive losses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,265</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9,559</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(8,914</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, PMI’s long-term debt consisted of the following: </font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:57%;" rowspan="1" colspan="1"></td><td style="width:4%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.520%), due through 2044</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21,796</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19,857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign currency obligations:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Euro notes, 1.750% to 3.125% (average interest rate 2.402%), due through 2036</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,032</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,828</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:24px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,354</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,312</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (average interest rate 3.586%), due through 2024</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">160</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">427</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30,342</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,424</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less current portion of long-term debt</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,754</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,573</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28,588</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25,851</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain as of January 1,</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">97</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">59</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Derivative (gains)/losses transferred to earnings</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(7</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Change in fair value</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(62</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gain/(loss) as of March 31,</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(10</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Basic and diluted earnings per share (“EPS”) were calculated using the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.41520467836257%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:74%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings attributable to PMI</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,590</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,530</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less distributed and undistributed earnings attributable to share-based payment awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net earnings for basic and diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,587</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,525</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for basic EPS</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,552</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Plus contingently issuable performance stock units (PSUs)<br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-average shares for diluted EPS</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,553</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,550</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:90.8203125%;border-collapse:collapse;text-align:left;"><tr><td colspan="7" rowspan="1"></td></tr><tr><td style="width:38%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:17%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:19%;" rowspan="1" colspan="1"></td><td style="width:2%;" rowspan="1" colspan="1"></td><td style="width:22%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(dollars in millions) </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross Carrying Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Initial Estimated<br clear="none"/>Useful Lives</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Weighted-Average<br clear="none"/>Remaining Useful Life</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Trademarks</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,535</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2 - 40 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">19 years</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Distribution networks</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">150</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5 - 30 years</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10 years</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other (including farmer<br clear="none"/>  contracts and intellectual property rights)</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4 - 17 years</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">    </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9 years</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99.61013645224172%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:13%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asset Derivatives</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="9" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Liability Derivatives</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fair Value</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balance Sheet Classification</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At December 31, 2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts designated as hedging instruments</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">82</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">10</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">66</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">291</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">436</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">101</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">36</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Foreign exchange contracts not designated as hedging instruments </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other current assets </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">106</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other accrued liabilities</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">96</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">61</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other assets</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other liabilities</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total derivatives</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">480</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">813</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">207</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">163</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The movements in goodwill from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2016</font><font style="font-family:inherit;font-size:10pt;">, were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="21" rowspan="1"></td></tr><tr><td style="width:30%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European<br clear="none"/>Union</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern<br clear="none"/>Europe,<br clear="none"/>Middle East<br clear="none"/>&<br clear="none"/>Africa</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin<br clear="none"/>America &<br clear="none"/>Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, December 31, 2016</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,118</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Changes due to:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Currency</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">75</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">161</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Balances, March 31, 2017</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,278</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">388</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,626</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,193</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,485</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill and other intangible assets, net, by segment were as follows:</font></div><div style="line-height:120%;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Goodwill</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other Intangible Assets, net</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, <br clear="none"/>2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, <br clear="none"/>2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,278</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,238</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">479</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">388</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">372</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">199</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">200</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,626</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,596</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,079</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,074</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,193</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,118</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">766</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">717</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,485</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">7,324</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,517</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,470</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div><div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Additional details of other intangible assets were as follows: </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:44%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">December 31, 2016</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Gross<br clear="none"/>Carrying<br clear="none"/>Amount</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accumulated<br clear="none"/>Amortization</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-amortizable intangible assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,356</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,455</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortizable intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,773</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,598</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">583</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total other intangible assets</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,129</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">612</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,053</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">583</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">At </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, PMI's total committed credit facilities were as follows:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;padding-left:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in billions)</font></div><div style="line-height:120%;padding-left:6px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:84.21052631578947%;border-collapse:collapse;text-align:left;"><tr><td colspan="5" rowspan="1"></td></tr><tr><td style="width:78%;" rowspan="1" colspan="1"></td><td style="width:5%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:15%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Type</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Committed</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Credit</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-align:center;">Facilities</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">364-day revolving credit, expiring February 6, 2018</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.0</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring February 28, 2021</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2.5</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="padding-bottom:8px;padding-left:18px;text-indent:-18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Multi-year revolving credit, expiring October 1, 2020 </font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3.5</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="padding-bottom:8px;text-align:left;text-indent:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Total facilities</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">8.0</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></font><font style="font-family:inherit;font-size:10pt;"> On August 30, 2016, PMI entered into an agreement, effective October 1, 2016, to extend the term of its multi-year revolving credit facility, for an additional year covering the period October 1, 2020 to October 1, 2021 in the amount of </font><font style="font-family:inherit;font-size:10pt;">$3.35 billion</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost consisted of the following:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:12%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;height:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="17" rowspan="1"></td></tr><tr><td style="width:48%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:10%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">U.S. Plans</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Non-U.S. Plans</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Service cost</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Expected return on plan assets</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(3</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(76</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(81</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net loss</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">—</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">44</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Prior service cost</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net periodic pension cost</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">42</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">45</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;border-top:1.5px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,889</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,838</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,689</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,556</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating companies income:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">772</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">690</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity (income)/loss in unconsolidated subsidiaries, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,177</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Segment Reporting:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Reportable segments for PMI are organized and managed by geographic region. PMI’s reportable segments are the European Union; Eastern Europe, Middle East & Africa; Asia; and Latin America & Canada. PMI records net revenues and operating companies income to its segments based upon the geographic area in which the customer resides.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">PMI’s management evaluates segment performance and allocates resources based on operating companies income, which PMI defines as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. Interest expense, net, and provision for income taxes are centrally managed and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by management.</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Segment data were as follows:</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="9" rowspan="1"></td></tr><tr><td style="width:66%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:14%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(in millions)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">For the Three Months Ended March 31,</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2017</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2016</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">5,889</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">6,143</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,695</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">3,997</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,838</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">4,689</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,134</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,959</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Net revenues</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,556</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">16,788</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating companies income:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">European Union</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">772</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">906</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Eastern Europe, Middle East & Africa</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">690</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">633</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Asia</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">852</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">778</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Latin America & Canada</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">177</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">229</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Amortization of intangibles</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(18</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">General corporate expenses</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(51</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(46</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Less:</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Equity (income)/loss in unconsolidated subsidiaries, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(22</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(9</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Operating income</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,396</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,473</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;border-bottom:1px solid #000000;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Interest expense, net</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(219</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(247</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">)</font></div></td></tr><tr><td style="vertical-align:top;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:28px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Earnings before income taxes</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,177</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">2,226</font></div></td><td style="vertical-align:bottom;border-bottom:2px solid #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

EX-101.SCH 13 pm-20170331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2115100 - Disclosure - Accumulated Other Comprehensive Losses link:presentationLink link:calculationLink link:definitionLink 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) link:presentationLink link:calculationLink link:definitionLink 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - Background and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 2116100 - Disclosure - Balance Sheet Offsetting link:presentationLink link:calculationLink link:definitionLink 2416402 - Disclosure - Balance Sheet Offsetting (Details) link:presentationLink link:calculationLink link:definitionLink 2316301 - Disclosure - Balance Sheet Offsetting (Tables) link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - Benefit Plans link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - Benefit Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - Benefit Plans (Tables) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Condensed Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings link:presentationLink link:calculationLink link:definitionLink 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Condensed Consolidated Statements of Earnings link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411407 - Disclosure - Contingencies (Lights Cases) (Details) link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) link:presentationLink link:calculationLink link:definitionLink 2411409 - Disclosure - Contingencies (Other Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411408 - Disclosure - Contingencies (Public Civil Actions) (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Contingencies (Tables) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Financial Instruments link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Financial Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - Goodwill and Other Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) link:presentationLink link:calculationLink link:definitionLink 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2412401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2113100 - Disclosure - Indebtedness link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Indebtedness (Credit Facilities) (Details) link:presentationLink link:calculationLink link:definitionLink 2413404 - Disclosure - Indebtedness (Debt Issuances During Current Period) (Details) link:presentationLink link:calculationLink link:definitionLink 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) link:presentationLink link:calculationLink link:definitionLink 2413402 - Disclosure - Indebtedness (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2313301 - Disclosure - Indebtedness (Tables) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries link:presentationLink link:calculationLink link:definitionLink 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) link:presentationLink link:calculationLink link:definitionLink 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) link:presentationLink link:calculationLink link:definitionLink 2119100 - Disclosure - New Accounting Standards link:presentationLink link:calculationLink link:definitionLink 2219201 - Disclosure - New Accounting Standards (Policies) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Sale of Accounts Receivable link:presentationLink link:calculationLink link:definitionLink 2418401 - Disclosure - Sale of Accounts Receivable (Details) link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - Segment Reporting link:presentationLink link:calculationLink link:definitionLink 2410402 - Disclosure - Segment Reporting (Details) link:presentationLink link:calculationLink link:definitionLink 2310301 - Disclosure - Segment Reporting (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Stock Plans link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Stock Plans (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - Stock Plans (PSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Stock Plans (RSU Awards) (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Stock Plans (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 14 pm-20170331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 15 pm-20170331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 16 pm-20170331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Debt Disclosure [Abstract] Line of Credit Facility [Table] Line of Credit Facility [Table] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario, Forecast [Member] Lender Name [Axis] Lender Name [Axis] Line of Credit Facility, Lender [Domain] Line of Credit Facility, Lender [Domain] Revolving Credit Expiring February 6, 2018 [Member] Revolving Credit Expiring February Sixth Two Thousand Eighteen [Member] Revolving Credit Expiring February Sixth Two Thousand Eighteen Multi-year revolving credit, expiring October 1, 2021 [Member] Multi Year Revolving Credit Expiring October First Two Thousand Twenty One [Member] Multi Year Revolving Credit Expiring October First Two Thousand Twenty One [Member] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Short-term borrowings, carrying value Short-term Debt Committed credit facilities Line of Credit Facility, Maximum Borrowing Capacity Borrowings under committed credit facilities Long-term Line of Credit Segment Reporting [Abstract] Segment Reporting Segment Reporting Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class Schedule of Intangible Assets and Goodwill [Table Text Block] Movements in Goodwill Schedule of Goodwill [Table Text Block] Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Axis] Other Comprehensive Income Location [Domain] Other Comprehensive Income Location [Domain] Other Comprehensive Income (Loss) [Member] Other Comprehensive Income (Loss) [Member] Derivative Instrument Risk [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward] Gain as of January 1, Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax Derivative (gains)/losses transferred to earnings Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Change in fair value Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net Gain/(loss) as of March 31, Offsetting [Abstract] Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Table] Offsetting Assets and Liabilities [Line Items] Offsetting Assets and Liabilities [Line Items] [Line Items] for Offsetting Assets and Liabilities [Table] Assets Offsetting Derivative Assets [Abstract] Gross Amounts Recognized Derivative Asset, Fair Value, Gross Asset Gross Amount Offset in the Condensed Consolidated Balance Sheet Derivative Asset, Fair Value, Gross Liability Net Amounts Presented in the Condensed Consolidated Balance Sheet Derivative Asset Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments Derivative Asset, Not Offset, Policy Election Deduction Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged Derivative, Collateral, Obligation to Return Cash Net Amount Derivative Asset, Fair Value, Amount Offset Against Collateral Liabilities Offsetting Derivative Liabilities [Abstract] Gross Amounts Recognized Derivative Liability, Fair Value, Gross Liability Gross Amount Offset in the Condensed Consolidated Balance Sheet Derivative Liability, Fair Value, Gross Asset Net Amounts Presented in the Condensed Consolidated Balance Sheet Derivative Liability Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments Derivative Liability, Not Offset, Policy Election Deduction Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged Derivative, Collateral, Right to Reclaim Cash Net Amount Derivative Liability, Fair Value, Amount Offset Against Collateral Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] US Dollar Notes [Member] US Dollar Notes [Member] U.S. Dollar Notes Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 1.625% US Dollar Notes Due February 2019 [Member] One Point Six Two Five Percent US Dollar Notes Due February 2019 [Member] One Point Six Two Five Percent US Dollar Notes Due February 2019 [Member] Floating Rate US Dollar Notes Due February 2020 [Member] Floating Rate US Dollar Notes Due February 2020 [Member] Floating Rate US Dollar Notes Due February 2020 [Member] 2.000% US Dollar Notes Due February 2020 [Member] Two Point Zero Percent US Dollar Notes Due February 2020 [Member] Two Point Zero Percent US Dollar Notes Due February 2020 [Member] 2.625% US Dollar Notes Due February 2022 [Member] Two Point Six Two Five Percent US Dollar Notes Due February 2022 [Member] Two Point Six Two Five Percent US Dollar Notes Due February 2022 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Face Value Debt Instrument, Face Amount Interest Rate Debt Instrument, Interest Rate, Stated Percentage Issuance Debt Instrument, Issuance Date Maturity Debt Instrument, Maturity Date Income Tax Disclosure [Abstract] Income Taxes [Table] Income Taxes [Table] Income Taxes [Table] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States [Member] UNITED STATES Income Taxes [Line Items] Income Taxes [Line Items] Income Taxes [Line Items] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Tax benefit from legal entity restructuring Other Tax Expense (Benefit) Open Tax Year Open Tax Years By Major Jurisdiction Open Tax Years By Major Jurisdiction Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingencies Nature [Axis] Loss Contingency Nature [Axis] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Individual Lights Cases [Member] Individual Lights Cases [Member] Individual Lights Cases [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] Italy [Member] ITALY Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cases brought against PM Cases Brought Against Company Cases Brought Against Company Organization, Consolidation and Presentation of Financial Statements [Abstract] Background and Basis of Presentation Business Description and Basis of Presentation [Text Block] Earnings Per Share [Abstract] Calculation of Basic and Diluted EPS Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Statement of Cash Flows [Abstract] CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Adjustments to reconcile net earnings to operating cash flows: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Deferred income tax provision Deferred Income Tax Expense (Benefit) Asset impairment and exit costs, net of cash paid Asset Impairment And Exit Costs, Net Of Cash Paid Adjustment to remove provision for asset impairment and exit costs, net of the related cash payments. Cash effects of changes: Increase (Decrease) in Operating Capital [Abstract] Receivables, net Increase (Decrease) in Receivables Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable Income taxes Increase (Decrease) in Income Taxes Payable Accrued liabilities and other current assets Increase Decrease In Accrued Liabilities And Other Current Assets The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities Pension plan contributions Pension Contributions Other Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES Net Cash Provided by (Used in) Investing Activities [Abstract] Capital expenditures Payments to Acquire Property, Plant, and Equipment Investments in unconsolidated subsidiaries Payments to Acquire Interest in Subsidiaries and Affiliates Other Payments for (Proceeds from) Other Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Net Cash Provided by (Used in) Financing Activities [Abstract] Short-term borrowing activity by original maturity: Proceeds from (Repayments of) Debt [Abstract] Net issuances (repayments) - maturities of 90 days or less Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Long-term debt proceeds Proceeds from Issuance of Long-term Debt Long-term debt repaid Repayments of Long-term Debt Dividends paid Payments of Dividends Sale (purchase) of subsidiary shares to/(from) noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Other Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash and Cash Equivalents Cash and cash equivalents: Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Increase (Decrease) Cash and Cash Equivalents, Period Increase (Decrease) Balance at beginning of period Cash and Cash Equivalents, at Carrying Value Balance at end of period Individual Smoking And Health Cases [Member] Individual Smoking And Health Cases [Member] Individual Smoking And Health Cases Smoking And Health Class Actions [Member] Smoking And Health Class Actions [Member] Smoking And Health Class Actions Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions [Member] Health Care Cost Recovery Actions Lights Class Actions [Member] Lights Class Actions [Member] Lights Class Actions Public Civil Actions [Member] Public Civil Actions [Member] Public Civil Actions Schedule of Tobacco Related Cases Pending Against Company Schedule Of Tobacco Related Cases Pending Against Company [Table Text Block] Schedule of tobacco related cases pending against company and/or subsidiaries or indemnitees Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s) Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Schedule Of Verdicts And Post Trial Developments1 [Table Text Block] Argentina [Member] ARGENTINA Brazil [Member] BRAZIL Canada [Member] CANADA Chile [Member] CHILE Costa Rica [Member] COSTA RICA Philippines [Member] PHILIPPINES Russia [Member] RUSSIAN FEDERATION Scotland [Member] Scotland [Member] Scotland Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Axis] Loss Contingencies by Name of Plaintiff [Domain] Loss Contingencies By Name Of Plaintiff [Domain] Loss Contingencies by Name of Plaintiff [Domain] The Smoker Health Defense Association (ADESF) [Member] The Smoker Health Defense AssociationADESF [Member] The Smoker Health Defense Association (ADESF) Litigation Case [Axis] Litigation Case [Axis] Litigation Case Type [Domain] Litigation Case [Domain] Award per smoker per year [Member] Award per smoker per year [Member] Award per smoker per year [Member] Cecilia Letourneau [Member] Cecilia Letourneau [Member] Cecilia Letourneau [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Cecilia Letourneau &Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] Adams [Member] Adams [Member] Adams [Member] Suzanne Jacklin [Member] Suzanne Jacklin [Member] Suzanne Jacklin [Member] Litigation Status [Axis] Litigation Status [Axis] Litigation Status [Domain] Litigation Status [Domain] Judicial Ruling [Member] Judicial Ruling [Member] Appellate Ruling [Member] Appellate Ruling [Member] Appellate Ruling [Member] Pending Litigation [Member] Pending Litigation [Member] Under Advisement [Member] Under Advisement [Member] Under Advisement [Member] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson, And Hedges Inc. (RBH) [Member] Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member] Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member] Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Imperial Tobacco Ltd. [Member] Damages awarded Loss Contingency, Damages Awarded, Value Smoking and health loss contingency interest rate Smoking And Health Loss Contingency Interest Rate Interest rate applied on damages awarded Number of additional manufacturers found liable Loss Contingency, Number Of Additional Manufacturers Found Liable Loss Contingency, Number Of Additional Manufacturers Found Liable Punitive damages awarded Loss Contingency, Damages Awarded, Punitive Damages, Value Loss Contingency, Damages Awarded, Punitive Damages, Value Estimated number of members in class Loss Contingency, Estimated Number Of Members In Class Loss Contingency, Estimated Number Of Members In Class Payment period for awarded punitive damages to be deposited into trust Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Loss Contingency, Damages Awarded, Punitive Damages, Payment Period Amount of security ordered to be furnished Loss Contingency, Motion for Security Ordered by Appeals Court, to be Furnished by Defendants Loss Contingency, Motion for Security Ordered by an Appeals Court, to be Furnished by Defendants in Equal Consecutive Quarterly Installments in the Form of Cash to a Court Trust or Letters of Credit. Number of consecutive quarterly installment Loss Contingency, Number of Equal Consecutive Quarterly Installments Ordered by Court of Appeals Loss Contingency, Number of Equal Consecutive Quarterly Installments Ordered by Court of Appeals Amount of security to be furnished in each consecutive quarterly installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished By Defendants, Amount Of Each Consecutive Quarterly Equal Installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished By Defendants, Amount Of Each Consecutive Quarterly Equal Installment Amount of security furnished by defendants in quarterly installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished Quarterly By Defendants, Amount Of Quarterly Installment Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished Quarterly By Defendants, Amount Of Quarterly Installment Period between addiction warning and claim Loss Contingency, Period Between Addiction Warning And Claim Loss Contingency, Period Between Addiction Warning And Claim Compensatory damages awarded Loss Contingency, Damages Awarded, Compensatory Damages, Value Loss Contingency, Damages Awarded, Compensatory Damages, Value Damages allocated to subsidiary (percent) Loss Contingency, Damages Awarded, Percentage Allocated Loss Contingency, Damages Awarded, Percentage Allocated Awarded compensatory damages that are to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust Payment period for compensatory damages to be deposited into trust Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period Payment period for compensatory damages to be deposited into trust Loss Contingency, Damages Awarded, Payment Period Loss Contingency, Damages Awarded, Payment Period Motion to secure judgment, Letters of credit to be placed into trust, option 1 Loss Contingency, Motion Filed by Plaintiffs to Secure Judgment, Letters of Credit Amount to be Placed in Trust, Option One Loss Contingency, Motion Filed by Plaintiffs to Secure Judgment, Letters of Credit Amount to be Placed in Trust, Option One Plaintiff requirement, Minimum number of cigarettes smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked Earnings Per Share Earnings Per Share [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Measurement Basis [Axis] Measurement Basis [Axis] Fair Value Measurement [Domain] Fair Value Measurement [Domain] Portion at Fair Value Measurement [Member] Portion at Fair Value Measurement [Member] Fair Value [Member] Estimate of Fair Value Measurement [Member] Fair Value, Hierarchy [Axis] Fair Value, Hierarchy [Axis] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Significant Other Observable Inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Significant Unobservable Inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] EX-101.PRE 17 pm-20170331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 18 a01042017andrecalantz_image1.jpg begin 644 a01042017andrecalantz_image1.jpg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end GRAPHIC 19 a01042017jacekolczakimage1.jpg begin 644 a01042017jacekolczakimage1.jpg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end GRAPHIC 20 a01042017marcfireston_image1.jpg begin 644 a01042017marcfireston_image1.jpg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end GRAPHIC 21 a01042017martinkingimage1.jpg begin 644 a01042017martinkingimage1.jpg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end GRAPHIC 22 a01042017miroslawziel_image1.jpg begin 644 a01042017miroslawziel_image1.jpg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end XML 23 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1

Document and Entity Information - shares
3 Months Ended

Mar. 31, 2017

Apr. 24, 2017

Document And Entity Information [Abstract]

Entity Registrant Name Philip Morris International Inc.

Entity Central Index Key 0001413329

Current Fiscal Year End Date --12-31

Entity Filer Category Large Accelerated Filer

Document Type 10-Q

Document Period End Date Mar. 31, 2017

Document Fiscal Year Focus 2017

Document Fiscal Period Focus Q1

Amendment Flag false

Entity Common Stock, Shares Outstanding 1,553,143,195

X

- Definition
If the value is true, then the document is an amendment to previously-filed/accepted document.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
End date of current fiscal year in the format --MM-DD.
+ References
No definition available.
+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.
+ References
No definition available.
+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
+ References
No definition available.
+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.
+ References
No definition available.
+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation 12B
-Number 240
-Section 12b
-Subsection 1
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Document And Entity Information [Abstract]
+ References
No definition available.
+ Details

Name: pm_DocumentAndEntityInformationAbstract

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 24 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Balance Sheets - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

ASSETS

Cash and cash equivalents $ 5,076 $ 4,239

Receivables (less allowances of $42 in 2017 and $42 in 2016) 3,090 3,499

Inventories:

Leaf tobacco 2,683 2,498

Other raw materials 1,531 1,569

Finished product 3,793 4,950

Total inventory, net 8,007 9,017

Other current assets 711 853

Total current assets 16,884 17,608

Property, plant and equipment, at cost 12,862 12,360

Less: accumulated depreciation 6,598 6,296

Total property, plant and equipment, net 6,264 6,064

Goodwill 7,485 7,324

Other intangible assets, net 2,517 2,470

Investments in unconsolidated subsidiaries 1,079 1,011

Deferred income taxes 834 859

Other assets 1,564 1,515

TOTAL ASSETS 36,627 36,851

LIABILITIES

Short-term borrowings 1,004 643

Current portion of long-term debt 1,754 2,573

Accounts payable 1,746 1,666

Accrued liabilities:

Marketing and selling 576 575

Taxes, except income taxes 4,275 6,204

Employment costs 719 800

Dividends payable 1,622 1,621

Other 1,329 1,553

Income taxes 330 832

Total current liabilities 13,355 16,467

Long-term debt 28,588 25,851

Deferred income taxes 1,739 1,897

Employment costs 2,840 2,800

Other liabilities 662 736

Total liabilities 47,184 47,751

Contingencies

STOCKHOLDERS’ (DEFICIT) EQUITY

Common stock, no par value (2,109,316,331 shares issued in 2017 and 2016) 0 0

Additional paid-in capital 1,892 1,964

Earnings reinvested in the business 30,367 30,397

Accumulated other comprehensive losses (9,265) (9,559)

Total stockholders' equity before treasury stock 22,994 22,802

Less: cost of repurchased stock (556,175,692 and 557,930,784 shares in 2017 and 2016, respectively) 35,386 35,490

Total PMI stockholders’ deficit (12,392) (12,688)

Noncontrolling interests 1,835 1,788

Total stockholders’ deficit (10,557) (10,900)

TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY $ 36,627 $ 36,851

X

- Definition
Carrying amount as of the balance sheet date of leaf tobacco inventory to be consumed in the manufacturing and production process.
+ References
No definition available.
+ Details

Name: pm_InventoryLeafTobacco

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccountsReceivableNetCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(15)(b)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(20))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(1))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_AccruedIncomeTaxesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AccruedLiabilitiesCurrentAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
No definition available.
+ Details

Name: us-gaap_AccruedMarketingCostsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.14)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_AdditionalPaidInCapitalCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(12))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(11))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_Assets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.9)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_AssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03.(a),19)
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.17)
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommitmentsAndContingencies

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_DeferredIncomeTaxAssetsNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=75116654&loc=d3e31931-109318
+ Details

Name: us-gaap_DeferredIncomeTaxLiabilitiesNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677
+ Details

Name: us-gaap_DividendsPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_EmployeeRelatedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryFinishedGoods

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 330
-SubTopic 10
-Section 35
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765
+ Details

Name: us-gaap_InventoryNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_InventoryNetAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.6(a)(4))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InventoryRawMaterials

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19-26)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_Liabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(23))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(25))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(32))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesAndStockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.21)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(22))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(24))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_MinorityInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAccruedLiabilitiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of current assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.8)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of noncurrent assets classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.17)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherAssetsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_OtherLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This represents the noncurrent liability recognized in the balance sheet that is associated with the defined benefit pension plans and other postretirement and postemployment benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.24)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e2410-114920

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e2417-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64852052&loc=d3e1703-114919
+ Details

Name: us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.13)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_PropertyPlantAndEquipmentGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(13))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(14))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(8))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229
+ Details

Name: us-gaap_PropertyPlantAndEquipmentNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(23)(a)(4))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30)(a)(3))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_RetainedEarningsAccumulatedDeficit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Current Liabilities
-URI http://asc.fasb.org/extlink&oid=6509677
+ Details

Name: us-gaap_SalesAndExciseTaxPayableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockholdersEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Total amount of stockholders' equity (deficit) items including stock value, paid in capital, retained earnings and including equity attributable to noncontrolling interests and before deducting the carrying value of treasury stock.
+ References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityBeforeTreasuryStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656
+ Details

Name: us-gaap_TreasuryStockValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

XML 25 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Statement of Financial Position [Abstract]

Receivables, allowances $ 42 $ 42

Common stock, no par value (in dollars per share)

Common stock, shares issued (in shares) 2,109,316,331 2,109,316,331

Repurchased stock, shares (in shares) 556,175,692 557,930,784

X

- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.4)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66008989&loc=d3e5074-111524
+ Details

Name: us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Face amount per share of no-par value common stock.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockNoParValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: instant

X

- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CommonStockSharesIssued

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfFinancialPositionAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29,30)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655
+ Details

Name: us-gaap_TreasuryStockShares

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

XML 26 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Earnings - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Income Statement [Abstract]

Net revenues $ 16,556 $ 16,788

Cost of sales 2,177 2,096

Excise taxes on products 10,492 10,705

Gross profit 3,887 3,987

Marketing, administration and research costs 1,469 1,496

Amortization of intangibles 22 18

Operating income 2,396 2,473

Interest expense, net 219 247

Earnings before income taxes 2,177 2,226

Provision for income taxes 541 630

Equity (income)/loss in unconsolidated subsidiaries, net (22) (9)

Net earnings 1,658 1,605

Net earnings attributable to noncontrolling interests 68 75

Net earnings attributable to PMI $ 1,590 $ 1,530

Per share data:

Basic earnings per share (in dollars per share) $ 1.02 $ 0.98

Diluted earnings per share (in dollars per share) 1.02 0.98

Dividends declared (in dollars per share) $ 1.04 $ 1.02

X

- Definition
The aggregate total costs related to selling a firm's product and services, as well as research and development costs and all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. Research and development costs represent the aggregate costs incurred during an accounting period to research and develop new products/technologies. General and administrative expenses include costs such as salaries of nonsales personnel, rent, utilities, communication and realized and unrealized gains and losses on foreign currency transactions.
+ References
No definition available.
+ Details

Name: pm_MarketingAdministrationAndResearchCosts

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Total costs related to goods produced and sold during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.2(a))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_CostOfGoodsSold

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareBasic

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(19))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(21))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(23))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_EarningsPerShareDiluted

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 605
-SubTopic 45
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=68080631&loc=d3e61097-111654
+ Details

Name: us-gaap_ExciseAndSalesTaxes

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GrossProfit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(13)(f))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeStatementAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (a),(b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Income Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=6515339
+ Details

Name: us-gaap_IncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.10)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of Net Income (Loss) attributable to noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_NetIncomeLossAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 27 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Comprehensive Earnings - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Statement of Comprehensive Income [Abstract]

Net earnings $ 1,658 $ 1,605

Change in currency translation adjustments:

Unrealized gains (losses), net of income taxes of $156 in 2017 and $162 in 2016 303 538

Change in net loss and prior service cost:

Net losses and prior service costs, net of income taxes of $- in 2017 and $3 in 2016 0 (10)

Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($9) in 2017 and ($8) in 2016 56 55

Change in fair value of derivatives accounted for as hedges:

Gains (losses) recognized, net of income taxes of $11 in 2017 and $17 in 2016 (75) (62)

(Gains) losses transferred to earnings, net of income taxes of $2 in 2017 and ($1) in 2016 5 (7)

Total other comprehensive earnings 289 514

Total comprehensive earnings 1,947 2,119

Less comprehensive earnings attributable to:

Noncontrolling interests 63 101

Comprehensive earnings attributable to PMI $ 1,884 $ 2,018

X

- Definition
Change in currency translation adjustment [Abstract]
+ References
No definition available.
+ Details

Name: pm_ChangeincurrencytranslationadjustmentAbstract

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831223

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e557-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4613674-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569643-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterestAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686
+ Details

Name: us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32157-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004921&loc=d3e1436-108581
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments, of (increase) decrease in accumulated other comprehensive (income) loss related to pension and other postretirement benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (i-k)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph c
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax of reclassification adjustment from accumulated other comprehensive (income) loss related to net period benefit cost (credit) for pension and other postretirement defined benefit plans.
+ References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount after tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 28 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Statement of Comprehensive Income [Abstract]

Income taxes on Currency translation adjustments $ 156 $ 162

Income taxes on net losses and prior service costs 0 3

Income taxes on Amortization of net losses, prior service costs and net transition costs (9) (8)

Income taxes on (loss)/gain recognized from fair value of derivatives accounted for as hedges 11 17

Income taxes on loss/(gain) transferred to earnings from fair value of derivatives accounted for as hedges $ 2 $ (1)

X

- Definition
Other Comprehensive Income Net Losses and Prior Service Costs, Tax Effect
+ References
No definition available.
+ Details

Name: pm_OtherComprehensiveIncomeNetLossesandPriorServiceCostsTaxEffect

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of tax expense (benefit), before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTranslationGainLossArisingDuringPeriodTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph c
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of tax (expense) benefit of reclassification adjustment from accumulated other comprehensive (income) loss related to pension and other postretirement defined benefit plans.
+ References
No definition available.
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of tax expense (benefit), before reclassification adjustments, related to increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580
+ Details

Name: us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 29 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($)
$ in Millions

Total

Common Stock [Member]

Additional Paid-in Capital [Member]

Earnings Reinvested in the Business [Member]

Accumulated Other Comprehensive Losses [Member]

Cost of Repurchased Stock [Member]

Noncontrolling Interests [Member]

Beginning balance at Dec. 31, 2015 $ (11,476) $ 0 $ 1,929 $ 29,842 $ (9,402) $ (35,613) $ 1,768

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net earnings 1,605 1,530 75

Other comprehensive earnings (losses), net of income taxes 514 488 26

Issuance of stock awards 59 (56) 115

Dividends declared ($1.02 and $1.04 per share for the three months ended March 31, 2016 and 2017, respectively) (1,587) (1,587)

Payments to noncontrolling interests (12) (12)

Other 3 1 2

Ending balance at Mar. 31, 2016 (10,894) 0 1,874 29,785 (8,914) (35,498) 1,859

Beginning balance at Dec. 31, 2016 (10,900) 0 1,964 30,397 (9,559) (35,490) 1,788

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net earnings 1,658 1,590 68

Other comprehensive earnings (losses), net of income taxes 289 294 (5)

Issuance of stock awards 33 (71) 104

Dividends declared ($1.02 and $1.04 per share for the three months ended March 31, 2016 and 2017, respectively) (1,620) (1,620)

Payments to noncontrolling interests (17) (17)

Other 0 (1) 1

Ending balance at Mar. 31, 2017 $ (10,557) $ 0 $ 1,892 $ 30,367 $ (9,265) $ (35,386) $ 1,835

X

- Definition
Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 405
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817
+ Details

Name: us-gaap_DividendsCommonStock

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInStockholdersEquityRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount after tax and reclassification adjustments of other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669625-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004921&loc=d3e1436-108581
+ Details

Name: us-gaap_OtherComprehensiveIncomeLossNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.
+ References
No definition available.
+ Details

Name: us-gaap_StockholdersEquityOther

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AdditionalPaidInCapitalMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_RetainedEarningsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_NoncontrollingInterestMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 30 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - $ / shares
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Statement of Stockholders' Equity [Abstract]

Dividends declared (in dollars per share) $ 1.04 $ 1.02

X

- Definition
Aggregate dividends declared during the period for each share of common stock outstanding.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770
+ Details

Name: us-gaap_CommonStockDividendsPerShareDeclared

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_StatementOfStockholdersEquityAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 31 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1

Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES

Net earnings $ 1,658 $ 1,605

Adjustments to reconcile net earnings to operating cash flows:

Depreciation and amortization 197 175

Deferred income tax provision 27 10

Asset impairment and exit costs, net of cash paid (2) (14)

Cash effects of changes:

Receivables, net 504 (175)

Inventories 1,243 49

Accounts payable 84 223

Income taxes (510) (485)

Accrued liabilities and other current assets (2,207) (922)

Pension plan contributions (18) (52)

Other (133) 48

Net cash provided by operating activities 843 462

CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES

Capital expenditures (292) (226)

Investments in unconsolidated subsidiaries (5) (7)

Other (282) (186)

Net cash used in investing activities (579) (419)

Short-term borrowing activity by original maturity:

Net issuances (repayments) - maturities of 90 days or less 374 (136)

Long-term debt proceeds 2,482 1,978

Long-term debt repaid (814) (827)

Dividends paid (1,618) (1,585)

Sale (purchase) of subsidiary shares to/(from) noncontrolling interests 0 6

Other (83) (29)

Net cash provided by (used in) financing activities 341 (593)

Effect of exchange rate changes on cash and cash equivalents 232 77

Cash and cash equivalents:

Increase (Decrease) 837 (473)

Balance at beginning of period 4,239 3,417

Balance at end of period $ 5,076 $ 2,944

X

- Definition
Adjustment to remove provision for asset impairment and exit costs, net of the related cash payments.
+ References
No definition available.
+ Details

Name: pm_AssetImpairmentAndExitCostsNetOfCashPaid

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The net change during the reporting period in the aggregate amount of expenses incurred but not yet paid, as well as the net change during the reporting period in the aggregate value of other current assets, associated with transactions that are classified as operating activities
+ References
No definition available.
+ Details

Name: pm_IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentAssets

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash
-URI http://asc.fasb.org/extlink&oid=6506951

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section 45
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3044-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Cash Equivalents
-URI http://asc.fasb.org/extlink&oid=6507016

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.1)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CashAndCashEquivalentsAtCarryingValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Deferred Tax Expense (or Benefit)
-URI http://asc.fasb.org/extlink&oid=63044130

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 6.I.7)
-URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817
+ Details

Name: us-gaap_DeferredIncomeTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_DepreciationAndAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 230
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49171198&loc=d3e33268-110906
+ Details

Name: us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccountsPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInInventories

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_IncreaseDecreaseInOperatingCapitalAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585
+ Details

Name: us-gaap_IncreaseDecreaseInReceivables

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3574-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 24
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3521-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of cash (inflow) outflow from investing activities classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3098-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3095-108585
+ Details

Name: us-gaap_PaymentsForProceedsFromOtherInvestingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_PaymentsOfDividends

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of or advances to an entity that is related to it but not strictly controlled (for example, an unconsolidated subsidiary, affiliate, and joint venture or equity method investment) or the acquisition of an additional interest in a subsidiary (controlled entity).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquireInterestInSubsidiariesAndAffiliates

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Investing Activities
-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3213-108585
+ Details

Name: us-gaap_PaymentsToAcquirePropertyPlantAndEquipment

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of cash or cash equivalents contributed by the entity to fund its pension plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3536-108585
+ Details

Name: us-gaap_PensionContributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_ProceedsFromIssuanceOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from financing activities classified as other.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3095-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3098-108585
+ Details

Name: us-gaap_ProceedsFromPaymentsForOtherFinancingActivities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585
+ Details

Name: us-gaap_ProceedsFromPaymentsToMinorityShareholders

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_ProceedsFromRepaymentsOfDebtAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3255-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3095-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 9
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3098-108585
+ Details

Name: us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591552-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4569616-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4591551-111686

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=64809438&loc=SL4573702-111684
+ Details

Name: us-gaap_ProfitLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3291-108585

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228
+ Details

Name: us-gaap_RepaymentsOfLongTermDebt

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

XML 32 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1

Background and Basis of Presentation
3 Months Ended

Mar. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Background and Basis of Presentation
Background and Basis of Presentation:

Background

Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries.

Basis of Presentation

The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year.
These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2016.

X

- Definition
The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).
+ References
No definition available.
+ Details

Name: us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 33 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock Plans
3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock Plans
Stock Plans:

In May 2012, PMI’s shareholders approved the Philip Morris International Inc. 2012 Performance Incentive Plan (the “2012 Plan”). Under the 2012 Plan, PMI may grant to eligible employees restricted stock, restricted stock units and deferred stock units (collectively referred to as restricted share units), performance-based cash incentive awards and performance-based equity awards. Up to 30 million shares of PMI’s common stock may be issued under the 2012 Plan. At March 31, 2017, shares available for grant under the 2012 Plan were 19,191,050.

In 2008, PMI adopted the Philip Morris International Inc. 2008 Stock Compensation Plan for Non-Employee Directors (the “Non-Employee Directors Plan”). A non-employee director is defined as a member of the PMI Board of Directors who is not a full-time employee of PMI or of any corporation in which PMI owns, directly or indirectly, stock possessing at least 50% of the total combined voting power of all classes of stock entitled to vote in the election of directors in such corporation. Up to 1 million shares of PMI common stock may be awarded under the Non-Employee Directors Plan. At March 31, 2017, shares available for grant under the plan were 677,539.

PMI’s accounting policy is to estimate the number of awards expected to be forfeited and adjust the expense when it is no longer probable that the employee will fulfill the service condition.

Restricted share unit (RSU) awards

During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the weighted-average grant date fair value per share and the recorded compensation expense related to RSU awards were as follows:

Number of Shares Granted
Weighted-Average Grant Date Fair Value Per RSU Award Granted
Compensation Expense Related to RSU Awards (in millions)
2017
1,202,060

$
98.47

$
35

2016
1,212,050

$
89.02

$
41

As of March 31, 2017, PMI had $186 million of total unrecognized compensation cost related to non-vested RSU awards. The cost is recognized over the original restriction period of the awards, which is typically three years after the date of the award, or upon death, disability or reaching the age of 58.

During the three months ended March 31, 2017, 1,938,610 shares of PMI RSU awards vested. The grant date fair value of all the vested shares was approximately $151 million. The total fair value of RSU awards that vested during the three months ended March 31, 2017 was approximately $198 million.

Performance share unit (PSU) awards

During the three months ended March 31, 2017 and 2016, PMI granted PSU awards to certain executives. The PSU awards require the achievement of certain performance factors, which are predetermined at the time of grant, over a three-year performance cycle. PMI’s performance metrics consist of PMI’s Total Shareholder Return (TSR) relative to a predetermined peer group, PMI’s currency-neutral compound annual adjusted operating companies income growth rate, excluding acquisitions, and PMI’s performance against specific measures of PMI’s innovation and transformation. The aggregate of the weighted performance factors for the three metrics determines the percentage of PSUs that will vest at the end of the three-year performance cycle. Each vested PSU entitles the participant to one share of common stock. An aggregate weighted PSU performance factor of 100 will result in the targeted number of PSUs being vested. The minimum percentage of PSUs that can vest is zero, with a maximum percentage of 200. At the end of the performance cycle, participants are entitled to an amount equivalent to the accumulated dividends paid on common stock during the performance cycle for the number of shares earned.

During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the grant date fair value per share and the recorded compensation expense related to PSU awards were as follows:

Number of Shares Granted
Grant Date Fair Value Subject to TSR Performance Factor Per Share ^(a)
Grant Date Fair Value Subject to Other Performance Factors Per Share ^(b)
Compensation Expense Related to PSU Awards (in millions)
2017
393,460

$
128.72

$
98.29

$
17

2016
428,400

$
104.60

$
89.02

$
12

^(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.
^(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.

As of March 31, 2017, PMI had $52 million of total unrecognized compensation cost related to non-vested PSU awards. The cost is recognized over the performance cycle of the awards, or upon death, disability or reaching the age of 58.
During the three months ended March 31, 2017, there were no PSU awards that vested.

X

- Definition
The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 34 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1

Benefit Plans
3 Months Ended

Mar. 31, 2017

Compensation and Retirement Disclosure [Abstract]

Benefit Plans
Benefit Plans:

Pension coverage for employees of PMI’s subsidiaries is provided, to the extent deemed appropriate, through separate plans, many of which are governed by local statutory requirements. In addition, PMI provides health care and other benefits to substantially all U.S. retired employees and certain non-U.S. retired employees. In general, health care benefits for non-U.S. retired employees are covered through local government plans.
Pension Plans
Components of Net Periodic Benefit Cost
Net periodic pension cost consisted of the following:

U.S. Plans

Non-U.S. Plans

For the Three Months Ended March 31,

For the Three Months Ended March 31,
(in millions)

2017

2016

2017

2016
Service cost

$
1

$
1

$
50

$
50

Interest cost

3

4

23

31

Expected return on plan assets

(3
)

(3
)

(76
)

(81
)
Amortization:

Net loss

—

1

44

44

Prior service cost

2

1

1

1

Net periodic pension cost

$
3

$
4

$
42

$
45

Employer Contributions
PMI makes, and plans to make, contributions, to the extent that they are tax deductible and to meet specific funding requirements of its funded U.S. and non-U.S. plans. Employer contributions of $18 million were made to the pension plans during the three months ended March 31, 2017. Currently, PMI anticipates making additional contributions during the remainder of 2017 of approximately $50 million to its pension plans, based on current tax and benefit laws. However, this estimate is subject to change as a result of changes in tax and other benefit laws, as well as asset performance significantly above or below the assumed long-term rate of return on pension assets, or changes in interest and currency rates.

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for pension and other postretirement benefits.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 80
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e2410-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6414203&loc=d3e39675-114964

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66047640&loc=d3e39622-114963
+ Details

Name: us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 35 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net
3 Months Ended

Mar. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets, net
Goodwill and Other Intangible Assets, net:
Goodwill and other intangible assets, net, by segment were as follows:

Goodwill

Other Intangible Assets, net
(in millions)

March 31,
2017

December 31,
2016

March 31,
2017

December 31,
2016
European Union

$
1,278

$
1,238

$
473

$
479

Eastern Europe, Middle East & Africa

388

372

199

200

Asia

3,626

3,596

1,079

1,074

Latin America & Canada

2,193

2,118

766

717

Total

$
7,485

$
7,324

$
2,517

$
2,470

Goodwill primarily reflects PMI’s acquisitions in Canada, Colombia, Greece, Indonesia, Mexico, Pakistan and Serbia, as well as the business combination in the Philippines. The movements in goodwill from December 31, 2016, were as follows:
(in millions)

European
Union

Eastern
Europe,
Middle East
&
Africa

Asia

Latin
America &
Canada

Total
Balances, December 31, 2016

$
1,238

$
372

$
3,596

$
2,118

$
7,324

Changes due to:

Currency

40

16

30

75

161

Balances, March 31, 2017

$
1,278

$
388

$
3,626

$
2,193

$
7,485

Additional details of other intangible assets were as follows:

March 31, 2017

December 31, 2016
(in millions)

Gross
Carrying
Amount

Accumulated
Amortization

Gross
Carrying
Amount

Accumulated
Amortization
Non-amortizable intangible assets

$
1,356

$
1,455

Amortizable intangible assets

1,773

$
612

1,598

$
583

Total other intangible assets

$
3,129

$
612

$
3,053

$
583

Non-amortizable intangible assets substantially consist of trademarks from PMI’s acquisitions in Indonesia in 2005 and Mexico in 2007. Amortizable intangible assets primarily consist of certain trademarks and distribution networks associated with business combinations. During the first quarter of 2017, PMI reclassified three trademarks with a gross carrying amount of $153 million from non-amortizable intangible assets to amortizable intangible assets. The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2017, were as follows:

(dollars in millions)
Gross Carrying Amount
Initial Estimated
Useful Lives

Weighted-Average
Remaining Useful Life
Trademarks
$
1,535

2 - 40 years

19 years
Distribution networks
150

5 - 30 years

10 years
Other (including farmer
  contracts and intellectual property rights)
88

4 - 17 years

9 years

$
1,773

Pre-tax amortization expense for intangible assets during the three months ended March 31, 2017 and 2016 was $22 million and $18 million, respectively. Amortization expense for each of the next five years is estimated to be $86 million or less, assuming no additional transactions occur that require the amortization of intangible assets.
The increase in the gross carrying amount of other intangible assets from December 31, 2016, was due to currency movements.

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 36 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments
3 Months Ended

Mar. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Financial Instruments
Financial Instruments:
Overview
PMI operates in markets outside of the United States of America, with manufacturing and sales facilities in various locations around the world. PMI utilizes certain financial instruments to manage foreign currency and interest rate exposure. Derivative financial instruments are used by PMI principally to reduce exposures to market risks resulting from fluctuations in foreign currency exchange and interest rates by creating offsetting exposures. PMI is not a party to leveraged derivatives and, by policy, does not use derivative financial instruments for speculative purposes. Financial instruments qualifying for hedge accounting must maintain a specified level of effectiveness between the hedging instrument and the item being hedged, both at inception and throughout the hedged period. PMI formally documents the nature and relationships between the hedging instruments and hedged items, as well as its risk-management objectives, strategies for undertaking the various hedge transactions and method of assessing hedge effectiveness. Additionally, for hedges of forecasted transactions, the significant characteristics and expected terms of the forecasted transaction must be specifically identified, and it must be probable that each forecasted transaction will occur. If it were deemed probable that the forecasted transaction would not occur, the gain or loss would be recognized in earnings. PMI reports its net transaction gains or losses in marketing, administration and research costs on the condensed consolidated statements of earnings.
PMI uses deliverable and non-deliverable forward foreign exchange contracts, foreign currency swaps and foreign currency options, collectively referred to as foreign exchange contracts ("foreign exchange contracts"), and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. The primary currencies to which PMI is exposed include the Australian dollar, Euro, Indonesian rupiah, Japanese yen, Mexican peso, Russian ruble, Swiss franc and Turkish lira. At March 31, 2017, PMI had contracts with aggregate notional amounts of $31.0 billion of which $4.6 billion related to cash flow hedges, $11.1 billion related to hedges of net investments in foreign operations and $15.3 billion related to other derivatives that primarily offset currency exposures on intercompany financing.
The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2017 and December 31, 2016, were as follows:

Asset Derivatives

Liability Derivatives

Fair Value

Fair Value
(in millions)

Balance Sheet Classification

At March 31, 2017

At December 31, 2016

Balance Sheet Classification

At March 31, 2017

At December 31, 2016
Foreign exchange contracts designated as hedging instruments

Other current assets

$
82

$
207

Other accrued liabilities

$
10

$
66

Other assets

291

436

Other liabilities

101

36

Foreign exchange contracts not designated as hedging instruments

Other current assets

106

161

Other accrued liabilities

96

61

Other assets

1

9

Other liabilities

—

—

Total derivatives

$
480

$
813

$
207

$
163

For the three months ended March 31, 2017 and 2016, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:

(pre-tax, millions)
For the Three Months Ended March 31,

Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives

Statement of Earnings
Classification of Gain/(Loss)
Reclassified from Other
Comprehensive
Earnings/(Losses) into
Earnings

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings

2017

2016

2017

2016
Derivatives in Cash Flow Hedging Relationship

Foreign exchange contracts
$
(86
)

$
(79
)

Net revenues

$
9

$
5

Cost of sales

—

14

Marketing, administration and research costs

(9
)

4

Interest expense, net

(3
)

(17
)
Derivatives in Net Investment Hedging Relationship

Foreign exchange contracts
(249
)

(197
)

Total
$
(335
)

$
(276
)

$
(3
)

$
6

Cash Flow Hedges
PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to certain forecasted transactions. The effective portion of gains and losses associated with qualifying cash flow hedge contracts is deferred as a component of accumulated other comprehensive losses until the underlying hedged transactions are reported in PMI’s condensed consolidated statements of earnings. During the three months ended March 31, 2017 and 2016, ineffectiveness related to cash flow hedges was not material. As of March 31, 2017, PMI has hedged forecasted transactions for periods not exceeding the next twenty-one months with the exception of one foreign exchange contract that expires in May 2024. The impact of these hedges is primarily included in operating cash flows on PMI’s condensed consolidated statements of cash flows.

Hedges of Net Investments in Foreign Operations
PMI designates certain foreign currency denominated debt and foreign exchange contracts as net investment hedges of its foreign operations. For the three months ended March 31, 2017 and 2016, these hedges of net investments resulted in losses, net of income taxes, of $294 million and $267 million, respectively. These losses were reported as a component of accumulated other comprehensive losses within currency translation adjustments. For the three months ended March 31, 2017 and 2016, ineffectiveness related to net investment hedges was not material. Other investing cash flows on PMI’s condensed consolidated statements of cash flows include the premiums paid for, and settlements of, net investment hedges.

Other Derivatives
PMI has entered into foreign exchange contracts to hedge the foreign currency exchange and interest rate risks related to intercompany loans between certain subsidiaries, and third-party loans. While effective as economic hedges, no hedge accounting is applied for these contracts; therefore, the unrealized gains (losses) relating to these contracts are reported in PMI’s condensed consolidated statements of earnings. For the three months ended March 31, 2017 and 2016, the gains (losses) from contracts for which PMI did not apply hedge accounting were $(39) million and $91 million, respectively. The gains (losses) from these contracts substantially offset the losses and gains generated by the underlying intercompany and third-party loans being hedged.

For the three months ended March 31, 2017 and 2016, the net impact of these contracts on the condensed consolidated statements of earnings was not material.

Qualifying Hedging Activities Reported in Accumulated Other Comprehensive Losses
Derivative gains or losses reported in accumulated other comprehensive losses are a result of qualifying hedging activity. Transfers of these gains or losses to earnings are offset by the corresponding gains or losses on the underlying hedged item. Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:

(in millions)

For the Three Months Ended March 31,

2017

2016
Gain as of January 1,

$
97

$
59

Derivative (gains)/losses transferred to earnings

5

(7
)
Change in fair value

(75
)

(62
)
Gain/(loss) as of March 31,

$
27

$
(10
)

At March 31, 2017, PMI expects $9 million of derivative gains that are included in accumulated other comprehensive losses to be reclassified to the condensed consolidated statement of earnings within the next 12 months. These gains are expected to be substantially offset by the statement of earnings impact of the respective hedged transactions.
Contingent Features
PMI’s derivative instruments do not contain contingent features.
Credit Exposure and Credit Risk
PMI is exposed to credit loss in the event of non-performance by counterparties. While PMI does not anticipate non-performance, its risk is limited to the fair value of the financial instruments less any cash collateral received or pledged. PMI actively monitors its exposure to credit risk through the use of credit approvals and credit limits, and by selecting and continuously monitoring a diverse group of major international banks and financial institutions as counterparties.
Fair Value
See Note 11. Fair Value Measurements and Note 13. Balance Sheet Offsetting for additional discussion of derivative financial instruments.

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41620-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579240-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41641-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5579245-113959

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4H
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624258-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708775-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5708773-113959

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 1B
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5580258-113959

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624181-113959

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 25
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41638-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(n))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 37 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1

Earnings Per Share
3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Earnings Per Share
Earnings Per Share:
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)

For the Three Months Ended March 31,

2017

2016
Net earnings attributable to PMI

$
1,590

$
1,530

Less distributed and undistributed earnings attributable to share-based payment awards

3

5

Net earnings for basic and diluted EPS

$
1,587

$
1,525

Weighted-average shares for basic EPS

1,552

1,550

Plus contingently issuable performance stock units (PSUs)

1

—

Weighted-average shares for diluted EPS

1,553

1,550

Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents are participating securities and therefore are included in PMI’s earnings per share calculation pursuant to the two-class method.
For the 2017 and 2016 computations, there were no antidilutive stock awards.

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for earnings per share.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1278-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1252-109256

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI http://asc.fasb.org/extlink&oid=65016374&loc=d3e4984-109258

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.21)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_EarningsPerShareTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 38 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1

Segment Reporting
3 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Segment Reporting
Segment Reporting:

PMI’s subsidiaries and affiliates are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Reportable segments for PMI are organized and managed by geographic region. PMI’s reportable segments are the European Union; Eastern Europe, Middle East & Africa; Asia; and Latin America & Canada. PMI records net revenues and operating companies income to its segments based upon the geographic area in which the customer resides.

PMI’s management evaluates segment performance and allocates resources based on operating companies income, which PMI defines as operating income, excluding general corporate expenses and amortization of intangibles, plus equity (income)/loss in unconsolidated subsidiaries, net. Interest expense, net, and provision for income taxes are centrally managed and, accordingly, such items are not presented by segment since they are excluded from the measure of segment profitability reviewed by management.

Segment data were as follows:
(in millions)

For the Three Months Ended March 31,

2017

2016
Net revenues:

European Union

$
5,889

$
6,143

Eastern Europe, Middle East & Africa

3,695

3,997

Asia

4,838

4,689

Latin America & Canada

2,134

1,959

Net revenues

$
16,556

$
16,788

Earnings before income taxes:

Operating companies income:

European Union

$
772

$
906

Eastern Europe, Middle East & Africa

690

633

Asia

852

778

Latin America & Canada

177

229

Amortization of intangibles

(22
)

(18
)
General corporate expenses

(51
)

(46
)
Less:

Equity (income)/loss in unconsolidated subsidiaries, net

(22
)

(9
)
Operating income

2,396

2,473

Interest expense, net

(219
)

(247
)
Earnings before income taxes

$
2,177

$
2,226

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 33
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 29
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599
+ Details

Name: us-gaap_SegmentReportingDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 39 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies
3 Months Ended

Mar. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Contingencies
Contingencies:
Tobacco-Related Litigation
Legal proceedings covering a wide range of matters are pending or threatened against us, and/or our subsidiaries, and/or our indemnitees in various jurisdictions. Our indemnitees include distributors, licensees, and others that have been named as parties in certain cases and that we have agreed to defend, as well as to pay costs and some or all of judgments, if any, that may be entered against them. Pursuant to the terms of the Distribution Agreement between Altria Group, Inc. ("Altria") and PMI, PMI will indemnify Altria and Philip Morris USA Inc. ("PM USA"), a U.S. tobacco subsidiary of Altria, for tobacco product claims based in substantial part on products manufactured by PMI or contract manufactured for PMI by PM USA, and PM USA will indemnify PMI for tobacco product claims based in substantial part on products manufactured by PM USA, excluding tobacco products contract manufactured for PMI.
It is possible that there could be adverse developments in pending cases against us and our subsidiaries. An unfavorable outcome or settlement of pending tobacco-related litigation could encourage the commencement of additional litigation.
Damages claimed in some of the tobacco-related litigation are significant and, in certain cases in Brazil, Canada and Nigeria, range into the billions of U.S. dollars. The variability in pleadings in multiple jurisdictions, together with the actual experience of management in litigating claims, demonstrate that the monetary relief that may be specified in a lawsuit bears little relevance to the ultimate outcome. Much of the tobacco-related litigation is in its early stages, and litigation is subject to uncertainty. However, as discussed below, we have to date been largely successful in defending tobacco-related litigation.
We and our subsidiaries record provisions in the consolidated financial statements for pending litigation when we determine that an unfavorable outcome is probable and the amount of the loss can be reasonably estimated. At the present time, while it is reasonably possible that an unfavorable outcome in a case may occur, after assessing the information available to it (i) management has not concluded that it is probable that a loss has been incurred in any of the pending tobacco-related cases; (ii) management is unable to estimate the possible loss or range of loss for any of the pending tobacco-related cases; and (iii) accordingly, no estimated loss has been accrued in the consolidated financial statements for unfavorable outcomes in these cases, if any. Legal defense costs are expensed as incurred.
It is possible that our consolidated results of operations, cash flows or financial position could be materially affected in a particular fiscal quarter or fiscal year by an unfavorable outcome or settlement of certain pending litigation. Nevertheless, although litigation is subject to uncertainty, we and each of our subsidiaries named as a defendant believe, and each has been so advised by counsel handling the respective cases, that we have valid defenses to the litigation pending against us, as well as valid bases for appeal of adverse verdicts. All such cases are, and will continue to be, vigorously defended. However, we and our subsidiaries may enter into settlement discussions in particular cases if we believe it is in our best interests to do so.
To date, no tobacco-related case has been finally resolved in favor of a plaintiff against us, our subsidiaries or indemnitees.
The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 25, 2017, April 22, 2016 and April 30, 2015:

Type of Case

Number of Cases Pending as of
April 25, 2017

Number of Cases Pending as of
April 22, 2016

Number of Cases Pending as of
April 30, 2015
Individual Smoking and Health Cases

63

66

61

Smoking and Health Class Actions

11

11

11

Health Care Cost Recovery Actions

16

16

16

Lights Class Actions

—

—

—

Individual Lights Cases

1

3

2

Public Civil Actions

2

3

2

Since 1995, when the first tobacco-related litigation was filed against a PMI entity, 459 Smoking and Health, Lights, Health Care Cost Recovery, and Public Civil Actions in which we and/or one of our subsidiaries and/or indemnitees were a defendant have been terminated in our favor. Thirteen cases have had decisions in favor of plaintiffs. Nine of these cases have subsequently reached final resolution in our favor and four remain on appeal.

The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
February 2004

Brazil/The Smoker Health Defense Association

Class Action

The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.

Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
May 27, 2015

Canada/Cecilia Létourneau

Class Action

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.

In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
May 27, 2015

Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais


Class Action

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.

In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
August 5, 2016

Argentina/Hugo Lespada

Individual Action

On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages.
The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.

On August 23, 2016, our subsidiary filed its notice of appeal.

Pending claims related to tobacco products generally fall within the following categories:
Smoking and Health Litigation: These cases primarily allege personal injury and are brought by individual plaintiffs or on behalf of a class or purported class of individual plaintiffs. Plaintiffs' allegations of liability in these cases are based on various theories of recovery, including negligence, gross negligence, strict liability, fraud, misrepresentation, design defect, failure to warn, breach of express and implied warranties, violations of deceptive trade practice laws and consumer protection statutes. Plaintiffs in these cases seek various forms of relief, including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include licit activity, failure to state a claim, lack of defect, lack of proximate cause, assumption of the risk, contributory negligence, and statute of limitations.
As of April 25, 2017, there were a number of smoking and health cases pending against us, our subsidiaries or indemnitees, as follows:

•
63 cases brought by individual plaintiffs in Argentina (35), Brazil (14), Canada (2), Chile (5), Costa Rica (2), Italy (2), the Philippines (1), Russia (1) and Scotland (1), compared with 66 such cases on April 22, 2016, and 61 cases on April 30, 2015; and
•
11 cases brought on behalf of classes of individual plaintiffs in Brazil (2) and Canada (9), compared with 11 such cases on April 22, 2016 and 11 such cases on April 30, 2015.

In the first class action pending in Brazil, The Smoker Health Defense Association (ADESF) v. Souza Cruz, S.A. and Philip Morris Marketing, S.A., Nineteenth Lower Civil Court of the Central Courts of the Judiciary District of São Paulo, Brazil, filed July 25, 1995, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer organization, is seeking damages for all addicted smokers and former smokers, and injunctive relief. In 2004, the trial court found defendants liable without hearing evidence and awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not award actual damages, which were to be assessed in the second phase of the case. The size of the class was not estimated. Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In February 2017, the Chief Justice of the Supreme Court of Justice denied plaintiff's appeal. In March 2017, plaintiff filed an en banc appeal to the Supreme Court of Justice. In addition, the defendants previously filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. Both appeals are still pending.

In the second class action pending in Brazil, Public Prosecutor of São Paulo v. Philip Morris Brasil Industria e Comercio Ltda., Civil Court of the City of São Paulo, Brazil, filed August 6, 2007, our subsidiary is a defendant. The plaintiff, the Public Prosecutor of the State of São Paulo, is seeking (i) damages on behalf of all smokers nationwide, former smokers, and their relatives; (ii) damages on behalf of people exposed to environmental tobacco smoke nationwide, and their relatives; and (iii) reimbursement of the health care costs allegedly incurred for the treatment of tobacco-related diseases by all Brazilian States and Municipalities, and the Federal District. In an interim ruling issued in December 2007, the trial court limited the scope of this claim to the State of São Paulo only. In December 2008, the Seventh Civil Court of São Paulo issued a decision declaring that it lacked jurisdiction because the case involved issues similar to the ADESF case discussed above and should be transferred to the Nineteenth Lower Civil Court in São Paulo where the ADESF case is pending. The court further stated that these cases should be consolidated for the purposes of judgment. In April 2010, the São Paulo Court of Appeals reversed the Seventh Civil Court's decision that consolidated the cases, finding that they are based on different legal claims and are progressing at different stages of proceedings. This case was returned to the Seventh Civil Court of São Paulo, and our subsidiary filed its closing arguments in December 2010. In March 2012, the trial court dismissed the case on the merits. In January 2014, the São Paulo Court of Appeals rejected plaintiff’s appeal and affirmed the trial court decision. In July 2014, plaintiff appealed to the Superior Court of Justice.

In the first class action pending in Canada, Cecilia Létourneau v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in September 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants.  The plaintiff, an individual smoker, sought compensatory and punitive damages for each member of the class who is deemed addicted to smoking. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ addiction. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the size of the addiction class at 918,000 members but declined to award compensatory damages to the addiction class because the evidence did not establish the claims with sufficient accuracy. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days and found that a claims process to allocate the awarded damages to individual class members would be too expensive and difficult to administer. The trial court ordered a briefing on the proposed process for the distribution of sums remaining from the punitive damage award after payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking security in both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million), in the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $27.7 million) beginning in December 2015 through March 2017. See the Blais description for further detail concerning the security order. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) holding that the addiction class members’ claims for punitive damages were not time-barred even though the case was filed more than three years after a prominent addiction warning appeared on all packages, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.

In the second class action pending in Canada, Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais v. Imperial Tobacco Ltd., Rothmans, Benson & Hedges Inc. and JTI Macdonald Corp., Quebec Superior Court, Canada, filed in November 1998, our subsidiary and other Canadian manufacturers (Imperial Tobacco Canada Ltd. and JTI-MacDonald Corp.) are defendants. The plaintiffs, an anti-smoking organization and an individual smoker, sought compensatory and punitive damages for each member of the class who allegedly suffers from certain smoking-related diseases. The class was certified in 2005. Trial began in March 2012 and concluded in December 2014. The trial court issued its judgment on May 27, 2015. The trial court found our subsidiary and two other Canadian manufacturers liable and found that the class members’ compensatory damages totaled approximately CAD 15.5 billion, including pre-judgment interest (approximately $11.4 billion). The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion, including pre-judgment interest (approximately $2.3 billion)). In addition, the trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary and found that defendants violated the Civil Code of Quebec, the Quebec Charter of Human Rights and Freedoms, and the Quebec Consumer Protection Act by failing to warn adequately of the dangers of smoking. The trial court also found that defendants conspired to prevent consumers from learning the dangers of smoking. The trial court further held that these civil faults were a cause of the class members’ diseases. The trial court rejected other grounds of fault advanced by the class, holding that: (i) the evidence was insufficient to show that defendants marketed to youth, (ii) defendants’ advertising did not convey false information about the characteristics of cigarettes, and (iii) defendants did not commit a fault by using the descriptors light or mild for cigarettes with a lower tar delivery. The trial court estimated the disease class at 99,957 members. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award into a trust within 60 days, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion and ordered briefing on a proposed claims process for the distribution of damages to individual class members and for payment of attorneys’ fees and legal costs. In June 2015, our subsidiary commenced the appellate process by filing its inscription of appeal of the trial court’s judgment with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust within 60 days notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make an initial payment within 60 days. In August 2015, plaintiffs filed a motion with the Court of Appeal seeking an order that defendants place irrevocable letters of credit totaling CAD 5 billion (approximately $3.7 billion) into trust, to secure the judgments in both the Létourneau and Blais cases. Plaintiffs subsequently withdrew their motion for security against JTI-MacDonald Corp. and proceeded only against our subsidiary and Imperial Tobacco Canada Ltd. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. Such security may take the form of cash into a court trust or letters of credit, in six equal consecutive quarterly installments of approximately CAD 37.6 million (approximately $27.7 million) beginning in December 2015 through March 2017. The Court of Appeal ordered Imperial Tobacco Canada Ltd. to furnish security totaling CAD 758 million (approximately $559 million) in seven equal consecutive quarterly installments of approximately CAD 108 million (approximately $80 million) beginning in December 2015 through June 2017. In March 2017, our subsidiary made its sixth and final quarterly installment of security for approximately CAD 37.6 million (approximately $27.7 million) into a court trust. This payment is included in other assets on the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. The Court of Appeal ordered that the security is payable upon a final judgment of the Court of Appeal affirming the trial court’s judgment or upon further order of the Court of Appeal. The Court of Appeal heard oral arguments on the merits appeal in November 2016. Our subsidiary and PMI believe that the findings of liability and damages were incorrect and should ultimately be set aside on any one of many grounds, including the following: (i) holding that defendants violated Quebec law by failing to warn class members of the risks of smoking even after the court found that class members knew, or should have known, of the risks, (ii) finding that plaintiffs were not required to prove that defendants’ alleged misconduct caused injury to each class member in direct contravention of binding precedent, (iii) creating a factual presumption, without any evidence from class members or otherwise, that defendants’ alleged misconduct caused all smoking by all class members, (iv) relying on epidemiological evidence that did not meet recognized scientific standards, and (v) awarding punitive damages to punish defendants without proper consideration as to whether punitive damages were necessary to deter future misconduct.
In the third class action pending in Canada, Kunta v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Winnipeg, Canada, filed June 12, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic obstructive pulmonary disease (“COPD”), severe asthma, and mild reversible lung disease resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. In September 2009, plaintiff's counsel informed defendants that he did not anticipate taking any action in this case while he pursues the class action filed in Saskatchewan (see description of Adams, below).
In the fourth class action pending in Canada, Adams v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Saskatchewan, Canada, filed July 10, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, emphysema, heart disease, or cancer, as well as restitution of profits. Preliminary motions are pending.
In the fifth class action pending in Canada, Semple v. Canadian Tobacco Manufacturers' Council, et al., The Supreme Court (trial court), Nova Scotia, Canada, filed June 18, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and COPD resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, as well as restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the sixth class action pending in Canada, Dorion v. Canadian Tobacco Manufacturers' Council, et al., The Queen's Bench, Alberta, Canada, filed June 15, 2009, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and chronic bronchitis and severe sinus infections resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers, their estates, dependents and family members, restitution of profits, and reimbursement of government health care costs allegedly caused by tobacco products. To date, we, our subsidiaries, and our indemnitees have not been properly served with the complaint. No activity in this case is anticipated while plaintiff's counsel pursues the class action filed in Saskatchewan (see description of Adams, above).
In the seventh class action pending in Canada, McDermid v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges his own addiction to tobacco products and heart disease resulting from the use of tobacco products. He is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from heart disease allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed.

In the eighth class action pending in Canada, Bourassa v. Imperial Tobacco Canada Limited, et al., Supreme Court, British Columbia, Canada, filed June 25, 2010, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, the heir to a deceased smoker, alleges that the decedent was addicted to tobacco products and suffered from emphysema resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who were alive on June 12, 2007, and who suffered from chronic respiratory diseases allegedly caused by smoking, their estates, dependents and family members, plus disgorgement of revenues earned by the defendants from January 1, 1954, to the date the claim was filed. In December 2014, plaintiff filed an amended statement of claim.

In the ninth class action pending in Canada, Suzanne Jacklin v. Canadian Tobacco Manufacturers' Council, et al., Ontario Superior Court of Justice, filed June 20, 2012, we, our subsidiaries, and our indemnitees (PM USA and Altria), and other members of the industry are defendants. The plaintiff, an individual smoker, alleges her own addiction to tobacco products and COPD resulting from the use of tobacco products. She is seeking compensatory and punitive damages on behalf of a proposed class comprised of all smokers who have smoked a minimum of 25,000 cigarettes and have allegedly suffered, or suffer, from COPD, heart disease, or cancer, as well as restitution of profits. Plaintiff's counsel has indicated that he does not intend to take any action in this case in the near future.

Health Care Cost Recovery Litigation: These cases, brought by governmental and non-governmental plaintiffs, seek reimbursement of health care cost expenditures allegedly caused by tobacco products. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including unjust enrichment, negligence, negligent design, strict liability, breach of express and implied warranties, violation of a voluntary undertaking or special duty, fraud, negligent misrepresentation, conspiracy, public nuisance, defective product, failure to warn, sale of cigarettes to minors, and claims under statutes governing competition and deceptive trade practices. Plaintiffs in these cases seek various forms of relief including compensatory and other damages, and injunctive and equitable relief. Defenses raised in these cases include lack of proximate cause, remoteness of injury, failure to state a claim, adequate remedy at law, “unclean hands” (namely, that plaintiffs cannot obtain equitable relief because they participated in, and benefited from, the sale of cigarettes), and statute of limitations.
As of April 25, 2017, there were 16 health care cost recovery cases pending against us, our subsidiaries or indemnitees in Canada (10), Korea (1) and Nigeria (5), compared with 16 such cases on April 22, 2016 and 16 such cases on April 30, 2015.
In the first health care cost recovery case pending in Canada, Her Majesty the Queen in Right of British Columbia v. Imperial Tobacco Limited, et al., Supreme Court, British Columbia, Vancouver Registry, Canada, filed January 24, 2001, we, our subsidiaries, our indemnitee (PM USA), and other members of the industry are defendants. The plaintiff, the government of the province of British Columbia, brought a claim based upon legislation enacted by the province authorizing the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, resulting from a “tobacco related wrong.” The Supreme Court of Canada has held that the statute is constitutional. We and certain other non-Canadian defendants challenged the jurisdiction of the court. The court rejected the jurisdictional challenge. Pre-trial discovery is ongoing.
In the second health care cost recovery case filed in Canada, Her Majesty the Queen in Right of New Brunswick v. Rothmans Inc., et al., Court of Queen's Bench of New Brunswick, Trial Court, New Brunswick, Fredericton, Canada, filed March 13, 2008, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of New Brunswick based on legislation enacted in the province. This legislation is similar to the law introduced in British Columbia that authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing. In September 2016, the trial court entered a consent order establishing a discovery timetable that contemplates the province of New Brunswick applying by September 2017 for a trial date.
In the third health care cost recovery case filed in Canada, Her Majesty the Queen in Right of Ontario v. Rothmans Inc., et al., Ontario Superior Court of Justice, Toronto, Canada, filed September 29, 2009, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Ontario based on legislation enacted in the province. This legislation is similar to the laws introduced in British Columbia and New Brunswick that authorize the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fourth health care cost recovery case filed in Canada, Attorney General of Newfoundland and Labrador v. Rothmans Inc., et al., Supreme Court of Newfoundland and Labrador, St. Johns, Canada, filed February 8, 2011, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Newfoundland and Labrador based on legislation enacted in the province that is similar to the laws introduced in British Columbia, New Brunswick and Ontario. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the fifth health care cost recovery case filed in Canada, Attorney General of Quebec v. Imperial Tobacco Limited, et al., Superior Court of Quebec, Canada, filed June 8, 2012, we, our subsidiary, our indemnitee (PM USA), and other members of the industry are defendants. The claim was filed by the government of the province of Quebec based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the sixth health care cost recovery case filed in Canada, Her Majesty in Right of Alberta v. Altria Group, Inc., et al., Supreme Court of Queen's Bench Alberta, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Alberta based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Pre-trial discovery is ongoing.
In the seventh health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Manitoba v. Rothmans, Benson & Hedges, Inc., et al., The Queen's Bench, Winnipeg Judicial Centre, Canada, filed May 31, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Manitoba based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in September 2014. Pre-trial discovery is ongoing.
In the eighth health care cost recovery case filed in Canada, The Government of Saskatchewan v. Rothmans, Benson & Hedges Inc., et al., Queen's Bench, Judicial Centre of Saskatchewan, Canada, filed June 8, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Saskatchewan based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.
In the ninth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Prince Edward Island v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Prince Edward Island (General Section), Canada, filed September 10, 2012, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Prince Edward Island based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in February 2015. Discovery is scheduled to begin in 2017.

In the tenth health care cost recovery case filed in Canada, Her Majesty the Queen in Right of the Province of Nova Scotia v. Rothmans, Benson & Hedges Inc., et al., Supreme Court of Nova Scotia, Canada, filed January 2, 2015, we, our subsidiaries, our indemnitees (PM USA and Altria), and other members of the industry are defendants. The claim was filed by the government of the province of Nova Scotia based on legislation enacted in the province that is similar to the laws enacted in several other Canadian provinces. The legislation authorizes the government to file a direct action against cigarette manufacturers to recover the health care costs it has incurred, and will incur, as a result of a “tobacco related wrong.” Defendants filed their defenses in July 2015. Discovery is scheduled to begin in 2017.
In the first health care cost recovery case in Nigeria, The Attorney General of Lagos State v. British American Tobacco (Nigeria) Limited, et al., High Court of Lagos State, Lagos, Nigeria, filed March 13, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the second health care cost recovery case in Nigeria, The Attorney General of Kano State v. British American Tobacco (Nigeria) Limited, et al., High Court of Kano State, Kano, Nigeria, filed May 9, 2007, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We are in the process of making challenges to service and the court's jurisdiction. Currently, the case is stayed in the trial court pending the appeals of certain co-defendants relating to service objections.
In the third health care cost recovery case in Nigeria, The Attorney General of Gombe State v. British American Tobacco (Nigeria) Limited, et al., High Court of Gombe State, Gombe, Nigeria, filed October 17, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In February 2011, the court ruled that the plaintiff had not complied with the procedural steps necessary to serve us. As a result of this ruling, plaintiff must re-serve its claim. We have not yet been re-served.
In the fourth health care cost recovery case in Nigeria, The Attorney General of Oyo State, et al., v. British American Tobacco (Nigeria) Limited, et al., High Court of Oyo State, Ibadan, Nigeria, filed May 25, 2007, we and other members of the industry are defendants. Plaintiffs seek reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. We challenged service as improper. In June 2010, the court ruled that plaintiffs did not have leave to serve the writ of summons on the defendants and that they must re-serve the writ. We have not yet been re-served.
In the fifth health care cost recovery case in Nigeria, The Attorney General of Ogun State v. British American Tobacco (Nigeria) Limited, et al., High Court of Ogun State, Abeokuta, Nigeria, filed February 26, 2008, we and other members of the industry are defendants. Plaintiff seeks reimbursement for the cost of treating alleged smoking-related diseases for the past 20 years, payment of anticipated costs of treating alleged smoking-related diseases for the next 20 years, various forms of injunctive relief, plus punitive damages. In May 2010, the trial court rejected our service objections. We have appealed.
In the health care cost recovery case in Korea, the National Health Insurance Service v. KT&G, et. al., filed April 14, 2014, our subsidiary and other Korean manufacturers are defendants. Plaintiff alleges that defendants concealed the health hazards of smoking, marketed to youth, added ingredients to make their products more harmful and addictive, and misled consumers into believing that Lights cigarettes are safer than regular cigarettes. The National Health Insurance Service seeks to recover approximately $53.7 million allegedly incurred in treating 3,484 patients with small cell lung cancer, squamous cell lung cancer, and squamous cell laryngeal cancer from 2003 to 2012. The case is now in the evidentiary phase.

Lights Cases: These cases, brought by individual plaintiffs, allege that the use of the term “lights” constitutes fraudulent and misleading conduct. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including misrepresentation, deception, and breach of consumer protection laws. Plaintiffs seek various forms of relief including restitution, injunctive relief, and compensatory and other damages. Defenses raised include lack of causation, lack of reliance, assumption of the risk, and statute of limitations.

As of April 25, 2017, there was 1 lights case brought by an individual plaintiff pending against our subsidiaries or indemnitees in Italy (1), compared with 3 such cases on April 22, 2016, and 2 such cases on April 30, 2015.

Public Civil Actions: Claims have been filed either by an individual, or a public or private entity, seeking to protect collective or individual rights, such as the right to health, the right to information or the right to safety. Plaintiffs' allegations of liability in these cases are based on various theories of recovery including product defect, concealment, and misrepresentation. Plaintiffs in these cases seek various forms of relief including injunctive relief such as banning cigarettes, descriptors, smoking in certain places and advertising, as well as implementing communication campaigns and reimbursement of medical expenses incurred by public or private institutions.

As of April 25, 2017, there were 2 public civil actions pending against our subsidiaries in Argentina (1) and Venezuela (1), compared with 3 such cases on April 22, 2016, and 2 such cases on April 30, 2015.

In the public civil action in Argentina, Asociación Argentina de Derecho de Danos v. Massalin Particulares S.A., et al., Civil Court of Buenos Aires, Argentina, filed February 26, 2007, our subsidiary and another member of the industry are defendants. The plaintiff, a consumer association, seeks the establishment of a relief fund for reimbursement of medical costs associated with diseases allegedly caused by smoking. Our subsidiary filed its answer in September 2007. In March 2010, the case file was transferred to the Federal Court on Administrative Matters after the Civil Court granted plaintiff's request to add the national government as a co-plaintiff in the case. The case is currently in the evidentiary stage.

In the public civil action in Venezuela, Federation of Consumers and Users Associations (“FEVACU”), et al. v. National Assembly of Venezuela and the Venezuelan Ministry of Health, Constitutional Chamber of the Venezuelan Supreme Court, filed April 29, 2008, we were not named as a defendant, but the plaintiffs published a notice pursuant to court order, notifying all interested parties to appear in the case. In January 2009, our subsidiary appeared in the case in response to this notice. The plaintiffs purport to represent the right to health of the citizens of Venezuela and claim that the government failed to protect adequately its citizens' right to health. The claim asks the court to order the government to enact stricter regulations on the manufacture and sale of tobacco products. In addition, the plaintiffs ask the court to order companies involved in the tobacco industry to allocate a percentage of their “sales or benefits” to establish a fund to pay for the health care costs of treating smoking-related diseases. In October 2008, the court ruled that plaintiffs have standing to file the claim and that the claim meets the threshold admissibility requirements. In December 2012, the court admitted our subsidiary and BAT's subsidiary as interested third parties. In February 2013, our subsidiary answered the complaint.

Other Litigation

The Department of Special Investigations of the government of Thailand ("DSI") conducted an investigation into alleged underpayment by our subsidiary, Philip Morris (Thailand) Limited ("PM Thailand"), of customs duties and excise taxes relating to imports from the Philippines covering the period 2003-2007. On January 18, 2016, the Public Prosecutor filed charges against our subsidiary and seven former and current employees in the Bangkok Criminal Court alleging that PM Thailand and the individual defendants jointly and with the intention to defraud the Thai government, under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with 272 import entries of cigarettes from the Philippines during the period of July 2003 to June 2006. The government is seeking a fine of approximately THB 80.8 billion (approximately $2.35 billion). The case is in the pre-trial evidentiary phase. Trial is scheduled to begin during the last quarter of 2017. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and other Thai governmental agencies.

The DSI also conducted an investigation into alleged underpayment by PM Thailand of customs duties and excise taxes relating to imports from Indonesia covering the period 2000-2003. On January 26, 2017, the Public Prosecutor filed charges against PM Thailand and its former Thai employee in the Bangkok Criminal Court alleging that PM Thailand and its former employee jointly and with the intention to defraud the Thai government under-declared import prices of cigarettes to avoid full payment of taxes and duties in connection with 780 import entries during the period from January 2002 to July 2003. The government is seeking a fine of approximately THB 19.8 billion (approximately $575 million). The case is in pre-trial proceedings and has not yet been set for trial. PM Thailand believes that its declared import prices are in compliance with the Customs Valuation Agreement of the World Trade Organization and Thai law, and that the allegations of the Public Prosecutor are inconsistent with several decisions already taken by Thai Customs and a Thai court.

The South Korean Board of Audit and Inspection (“BAI”) conducted an audit of certain Korean government agencies and the tobacco industry into whether inventory movements ahead of the January 1, 2015 increase of cigarette-related taxes by tobacco companies, including Philip Morris Korea Inc. ("PM Korea"), our South Korean affiliate, were in compliance with South Korean tax laws. In November 2016, the tax authorities completed their audit and assessed allegedly underpaid taxes and penalties. In order to avoid nonpayment financial costs, PM Korea paid approximately KRW 272 billion (approximately $240 million), of which KRW 100 billion (approximately $88 million) was paid in 2016 and KRW 172 billion (approximately $152 million) was paid in 2017.  These amounts are included in other assets in the condensed consolidated balance sheets and in cash used in operating activities in the condensed consolidated statements of cash flows. PM Korea is appealing the assessments. The tax authorities have also referred the matter to the Public Prosecutor, who will further investigate and decide whether to file criminal charges against PM Korea and/or other alleged co-offenders. If the Public Prosecutor decides to prosecute, it may seek up to three times the underpaid tax for company criminal penalties and up to five times the underpaid tax for individual criminal penalties. PM Korea believes that it has paid cigarette-related taxes in compliance with the South Korean tax laws. In addition, the South Korean Ministry of Strategy and Finance (“MOSF”) filed a criminal complaint with the Public Prosecutor against PM Korea and its managing director. In its criminal complaint, the MOSF alleged that PM Korea exceeded the monthly product withdrawal limits that the MOSF had set in its notice. The Public Prosecutor will investigate the MOSF’s criminal complaint and decide whether to prosecute. PM Korea disagrees with the MOSF’s allegations.

We are also involved in additional litigation arising in the ordinary course of our business. While the outcomes of these proceedings are uncertain, management does not expect that the ultimate outcomes of other litigation, including any reasonably possible losses in excess of current accruals, will have a material adverse effect on our consolidated results of operations, cash flows or financial position.

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for commitments and contingencies.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=73718637&loc=d3e25287-109308
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 40 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes
3 Months Ended

Mar. 31, 2017

Income Tax Disclosure [Abstract]

Income Taxes
Income Taxes:
Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets.

PMI’s effective tax rates for the three months ended March 31, 2017 and 2016 were 24.9% and 28.3%, respectively. PMI estimates that its full-year 2017 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2017, was favorably impacted by the tax benefit of a legal entity restructuring ($61 million). Excluding the effect of the legal entity restructuring, the change in the effective tax rate for the three months ended March 31, 2017, as compared to the three months ended March 31, 2016, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences.
The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in currency exchange rates, earnings mix by taxing jurisdiction, or cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions.
PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2013 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years.
It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.

X

- References
No definition available.
+ Details

Name: us-gaap_IncomeTaxDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32559-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32718-109319

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32537-109319
+ Details

Name: us-gaap_IncomeTaxDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 41 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness
3 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Indebtedness
Indebtedness:
Short-term Borrowings:
At March 31, 2017 and December 31, 2016, PMI’s short-term borrowings, consisting of bank loans to certain PMI subsidiaries, had a carrying value of $1,004 million and $643 million, respectively. The fair value of PMI’s short-term borrowings, based on current market interest rates, approximates carrying value.

Long-term Debt:
At March 31, 2017 and December 31, 2016, PMI’s long-term debt consisted of the following:

(in millions)

March 31, 2017

December 31, 2016
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.520%), due through 2044

$
21,796

$
19,857

Foreign currency obligations:

Euro notes, 1.750% to 3.125% (average interest rate 2.402%), due through 2036

7,032

6,828

Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024

1,354

1,312

Other (average interest rate 3.586%), due through 2024

160

427

30,342

28,424

Less current portion of long-term debt

1,754

2,573

$
28,588

$
25,851

Other foreign currency debt above includes mortgage debt in Switzerland and capital lease obligations at March 31, 2017 and December 31, 2016. Other foreign currency debt above also includes a bank loan in the Philippines at December 31, 2016.
PMI's debt issuances in the first three months of 2017 were as follows:
(in millions)

Type

Face Value

Interest Rate

Issuance

Maturity

U.S. dollar notes
^(a)
$700

1.625%

February 2017

February 2019
U.S. dollar notes
^(b)
$300

Floating

February 2017

February 2020
U.S. dollar notes
^(a)
$1,000

2.000%

February 2017

February 2020
U.S. dollar notes
^(a)
$500

2.625%

February 2017

February 2022

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2017.
^(b) Interest on these notes is payable quarterly in arrears beginning in May 2017.
The net proceeds from the sale of the securities listed in the table above have been and will be used for general corporate purposes.
Credit Facilities:

On January 27, 2017, PMI entered into an agreement to extend the term of its $2.0 billion 364-day revolving credit facility from February 7, 2017 to February 6, 2018.
At March 31, 2017, PMI's total committed credit facilities were as follows:

(in billions)

Type

Committed
Credit
Facilities
364-day revolving credit, expiring February 6, 2018

$
2.0

Multi-year revolving credit, expiring February 28, 2021

2.5

Multi-year revolving credit, expiring October 1, 2020 ⁽¹⁾

3.5

Total facilities

$
8.0

⁽¹⁾ On August 30, 2016, PMI entered into an agreement, effective October 1, 2016, to extend the term of its multi-year revolving credit facility, for an additional year covering the period October 1, 2020 to October 1, 2021 in the amount of $3.35 billion.

At March 31, 2017, there were no borrowings under these committed credit facilities, and the entire committed amounts were available for borrowing.

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19,20,22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 42 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1

Fair Value Measurements
3 Months Ended

Mar. 31, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements
Fair Value Measurements:
The authoritative guidance defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The guidance also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The guidance describes three levels of input that may be used to measure fair value, which are as follows:
Level 1 -
Quoted prices in active markets for identical assets or liabilities;
Level 2 -
Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and
Level 3 -
Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

PMI's policy is to reflect transfers between hierarchy levels at the end of the reporting period.
Derivative Financial Instruments
PMI assesses the fair value of its foreign exchange contracts and interest rate contracts using standard valuation models that use, as their basis, readily observable market inputs. The fair value of PMI’s foreign exchange forward contracts is determined by using the prevailing foreign exchange spot rates and interest rate differentials, and the respective maturity dates of the instruments. The fair value of PMI’s currency options is determined by using a Black-Scholes methodology based on foreign exchange spot rates and interest rate differentials, currency volatilities and maturity dates. PMI’s derivative financial instruments have been classified within Level 2 in the table shown below. See Note 5. Financial Instruments for additional discussion of derivative financial instruments.
Debt
The fair value of PMI’s outstanding debt, which is utilized solely for disclosure purposes, is determined using quotes and market interest rates currently available to PMI for issuances of debt with similar terms and remaining maturities. The aggregate carrying value of PMI’s debt, excluding short-term borrowings and $13 million of capital lease obligations, was $30,329 million at March 31, 2017. The fair value of PMI’s outstanding debt, excluding the aforementioned short-term borrowings and capital lease obligations, was classified within Level 1 and Level 2 in the table shown below.

The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2017, were as follows:

(in millions)

Fair Value
at March 31,
2017

Quoted Prices
in Active
Markets for
Identical
Assets/Liabilities
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)
Assets:

Foreign exchange contracts

$
480

$
—

$
480

$
—

Total assets

$
480

$
—

$
480

$
—

Liabilities:

Debt

$
32,005

$
31,834

$
171

$
—

Foreign exchange contracts

207

—

207

—

Total liabilities

$
32,212

$
31,834

$
378

$
—

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13537-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13504-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611
+ Details

Name: us-gaap_FairValueDisclosuresTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 43 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accumulated Other Comprehensive Losses
3 Months Ended

Mar. 31, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Accumulated Other Comprehensive Losses
Accumulated Other Comprehensive Losses:
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:

(in millions)

At March 31, 2017

At December 31, 2016

At March 31, 2016
Currency translation adjustments

$
(5,783
)

$
(6,091
)

$
(5,617
)
Pension and other benefits

(3,509
)

(3,565
)

(3,287
)
Derivatives accounted for as hedges

27

97

(10
)
Total accumulated other comprehensive losses

$
(9,265
)

$
(9,559
)

$
(8,914
)

Reclassifications from Other Comprehensive Earnings

The movements in accumulated other comprehensive losses and the related tax impact, for each of the components above, that are due to current period activity and reclassifications to the income statement are shown on the condensed consolidated statements of comprehensive earnings for the three months ended March 31, 2017 and 2016. For additional information, see Note 3. Benefit Plans and Note 5. Financial Instruments for disclosures related to PMI's pension and other benefits, and derivative financial instruments, respectively.

X

- References
No definition available.
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e689-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e640-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e716-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e709-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872
+ Details

Name: us-gaap_ComprehensiveIncomeNoteTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 44 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1

Balance Sheet Offsetting
3 Months Ended

Mar. 31, 2017

Offsetting [Abstract]

Balance Sheet Offsetting
Balance Sheet Offsetting:

Derivative Financial Instruments

PMI uses foreign exchange contracts and interest rate contracts to mitigate its exposure to changes in exchange and interest rates from third-party and intercompany actual and forecasted transactions. Substantially all of PMI's derivative financial instruments are subject to master netting arrangements, whereby the right to offset occurs in the event of default by a participating party. While these contracts contain the enforceable right to offset through close-out netting rights, PMI elects to present them on a gross basis in the condensed consolidated balance sheets. Collateral associated with these arrangements is in the form of cash and is unrestricted. See Note 5. Financial Instruments for disclosures related to PMI's derivative financial instruments.

The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:

(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet

Financial Instruments
Cash Collateral Received/Pledged
Net Amount

At March 31, 2017

Assets

Foreign exchange contracts
$
480

$
—

$
480

$
(170
)
$
(258
)
$
52

Liabilities

Foreign exchange contracts
$
207

$
—

$
207

$
(170
)
$
(11
)
$
26

At December 31, 2016

Assets

Foreign exchange contracts
$
813

$
—

$
813

$
(126
)
$
(607
)
$
80

Liabilities

Foreign exchange contracts
$
163

$
—

$
163

$
(126
)
$
(31
)
$
6

X

- Definition
The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.
+ References
No definition available.
+ Details

Name: us-gaap_FinancialInstrumentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OffsettingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 45 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1

Investments in Unconsolidated Subsidiaries
3 Months Ended

Mar. 31, 2017

Equity Method Investments and Joint Ventures [Abstract]

Investments in Unconsolidated Subsidiaries
Investments in Unconsolidated Subsidiaries:

At March 31, 2017 and December 31, 2016, PMI had total investments in unconsolidated subsidiaries of $1,079 million and $1,011 million, respectively, which were accounted for under the equity method of accounting. Equity method investments are initially recorded at cost. Under the equity method of accounting, the investment is adjusted for PMI's proportionate share of earnings or losses and movements in currency translation adjustments. The carrying value of our equity method investments at March 31, 2017 and December 31, 2016 exceeded our share of the unconsolidated subsidiaries' book value by $900 million and $867 million, respectively. The difference between the investment carrying value and the amount of underlying equity in net assets, excluding $844 million and $810 million attributable to goodwill as of March 31, 2017 and December 31, 2016, respectively, is being amortized on a straight-line basis over the underlying assets' estimated useful lives of 4 to 20 years. At March 31, 2017, PMI received no year-to-date dividends from unconsolidated subsidiaries. At December 31, 2016, PMI received year-to-date dividends from unconsolidated subsidiaries of $117 million.

PMI holds a 49% equity interest in United Arab Emirates-based Emirati Investors-TA (FZC) (“EITA”). PMI holds an approximate 25% economic interest in Société des Tabacs Algéro-Emiratie (“STAEM”), an Algerian joint venture that is 51% owned by EITA and 49% by the Algerian state-owned enterprise Société Nationale des Tabacs et Allumettes SpA. STAEM manufactures and distributes under license some of PMI’s brands.

PMI holds a 20% equity interest in Megapolis Distribution BV, the holding company of CJSC TK Megapolis ("Megapolis"), PMI's distributor in Russia.

The initial investments in EITA and Megapolis Distribution BV were recorded at cost and are included in investments in unconsolidated subsidiaries on the condensed consolidated balance sheets.

PMI’s earnings activity from unconsolidated subsidiaries was as follows:

For the Three Months Ended March 31,
(in millions)

2017
2016
Net revenues

$
840

$
777

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:
(in millions)

At March 31, 2017
At December 31, 2016

Receivables

$
394

$
289


The activity primarily related to agreements with PMI’s unconsolidated subsidiaries within the Eastern Europe, Middle East & Africa segment. These agreements, which are in the ordinary course of business, are primarily for distribution, contract manufacturing and licenses. PMI eliminated its respective share of all significant intercompany transactions with the equity method investees.

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 35
-Paragraph 35
-URI http://asc.fasb.org/extlink&oid=64825282&loc=d3e32847-111569

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 35
-Paragraph 32
-URI http://asc.fasb.org/extlink&oid=64825282&loc=d3e32787-111569
+ Details

Name: us-gaap_EquityMethodInvestmentsDisclosureTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 46 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1

Sale of Accounts Receivable
3 Months Ended

Mar. 31, 2017

Sale of Accounts Receivable [Abstract]

Sale of Accounts Receivable
Sale of Accounts Receivable:
To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2017 and March 31, 2016. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions.

Cumulative trade receivables sold, including excise taxes, for the three months ended March 31, 2017 and 2016, were $2,092 million and $1,946 million, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2017 and March 31, 2016, were $561 million, and $589 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the three months ended March 31, 2017 and 2016, the loss on sale of trade receivables was immaterial.

X

- Definition
Sale of Accounts Receivable [Abstract]
+ References
No definition available.
+ Details

Name: pm_SaleofAccountsReceivableAbstract

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Sale of Trade Accounts Receivable Disclosure [Text Block]
+ References
No definition available.
+ Details

Name: pm_SaleofTradeAccountsReceivableDisclosureTextBlock

Namespace Prefix: pm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 47 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1

New Accounting Standards
3 Months Ended

Mar. 31, 2017

Accounting Changes and Error Corrections [Abstract]

New Accounting Standards
New Accounting Standards:

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.

On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing its cost method investments and the impact that the adoption of ASU 2016-01 will have on its financial position and results of operations.

On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

Entities can apply the final standard using one of the following two methods:

1.
retrospectively to each prior period presented; or

2.
retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI plans to adopt ASU 2014-09 on January 1, 2018, and does not expect the adoption to have a material impact on its consolidated financial position or results of operations. Following the release of ASU 2016-12 in May 2016, which provided some practical expedients to the original standard, PMI is continuing to assess the standard’s policy election for gross versus net presentation of excise taxes and, related to this assessment, the method of adoption.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6507316

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Direct Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=66092750

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22583-107794

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Indirect Effects of a Change in Accounting Principle
-URI http://asc.fasb.org/extlink&oid=6515603

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22580-107794

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.10-01.(b)(6))
-URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Accounting Change
-URI http://asc.fasb.org/extlink&oid=6503790

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=64853466&loc=d3e22499-107794

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Retrospective Application
-URI http://asc.fasb.org/extlink&oid=6523989

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 270
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305
+ Details

Name: us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 48 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1

New Accounting Standards (Policies)
3 Months Ended

Mar. 31, 2017

Accounting Changes and Error Corrections [Abstract]

New Accounting Standards
New Accounting Standards:

On February 25, 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. Additionally, ASU 2016-02 modifies current guidance for lessors' accounting. ASU 2016-02 is effective for interim and annual reporting periods beginning on or after January 1, 2019, with early adoption permitted. PMI is currently assessing the impact that the adoption of ASU 2016-02 will have on its financial position and results of operations.

On January 5, 2016, the FASB issued Accounting Standard Update ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” (“ASU 2016-01”). ASU 2016-01 will require equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. Additionally, ASU 2016-01 also changes certain disclosure requirements and other aspects of current U.S. GAAP. ASU 2016-01 is effective for interim and annual reporting periods beginning on or after January 1, 2018. PMI is currently assessing its cost method investments and the impact that the adoption of ASU 2016-01 will have on its financial position and results of operations.

On May 28, 2014, the FASB issued Accounting Standards Update ASU 2014-09, “Revenue from Contracts with Customers” (“ASU 2014-09”). ASU 2014-09 contains principles that an entity will need to apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

Entities can apply the final standard using one of the following two methods:

1.
retrospectively to each prior period presented; or

2.
retrospectively, with the cumulative effect of initially applying ASU 2014-09 recognized at the date of initial application, with additional disclosures in reporting periods that include the date of initial application.

ASU 2014-09 is effective for interim and annual reporting periods beginning on or after January 1, 2017. In July 2015, the FASB approved a proposal which allows for a deferral of the implementation until January 1, 2018, and permits early application, but not before the original effective date of January 1, 2017. PMI plans to adopt ASU 2014-09 on January 1, 2018, and does not expect the adoption to have a material impact on its consolidated financial position or results of operations. Following the release of ASU 2016-12 in May 2016, which provided some practical expedients to the original standard, PMI is continuing to assess the standard’s policy election for gross versus net presentation of excise taxes and, related to this assessment, the method of adoption.

X

- References
No definition available.
+ Details

Name: us-gaap_AccountingChangesAndErrorCorrectionsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.
+ References
No definition available.
+ Details

Name: us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 49 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock Plans (Tables)
3 Months Ended

Mar. 31, 2017

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of weighted average grant date fair value and compensation expense related to share-based awards
During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the grant date fair value per share and the recorded compensation expense related to PSU awards were as follows:

Number of Shares Granted
Grant Date Fair Value Subject to TSR Performance Factor Per Share ^(a)
Grant Date Fair Value Subject to Other Performance Factors Per Share ^(b)
Compensation Expense Related to PSU Awards (in millions)
2017
393,460

$
128.72

$
98.29

$
17

2016
428,400

$
104.60

$
89.02

$
12

^(a) The grant date fair value of the PSU market based awards subject to the TSR performance factor was determined by using the Monte Carlo simulation model.
^(b) The grant date fair value of the PSU awards subject to the other performance factors was determined by using the average of the high and low market price of PMI’s stock at the date of grant.
During the three months ended March 31, 2017 and 2016, shares granted to eligible employees, the weighted-average grant date fair value per share and the recorded compensation expense related to RSU awards were as follows:

Number of Shares Granted
Weighted-Average Grant Date Fair Value Per RSU Award Granted
Compensation Expense Related to RSU Awards (in millions)
2017
1,202,060

$
98.47

$
35

2016
1,212,050

$
89.02

$
41

X

- References
No definition available.
+ Details

Name: us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901
+ Details

Name: us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 50 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1

Benefit Plans (Tables)
3 Months Ended

Mar. 31, 2017

Compensation and Retirement Disclosure [Abstract]

Components of Net Periodic Benefit Cost
Net periodic pension cost consisted of the following:

U.S. Plans

Non-U.S. Plans

For the Three Months Ended March 31,

For the Three Months Ended March 31,
(in millions)

2017

2016

2017

2016
Service cost

$
1

$
1

$
50

$
50

Interest cost

3

4

23

31

Expected return on plan assets

(3
)

(3
)

(76
)

(81
)
Amortization:

Net loss

—

1

44

44

Prior service cost

2

1

1

1

Net periodic pension cost

$
3

$
4

$
42

$
45

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_ScheduleOfNetBenefitCostsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 51 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Tables)
3 Months Ended

Mar. 31, 2017

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill and Intangible Assets, Net, by Segment or Major Class
Goodwill and other intangible assets, net, by segment were as follows:

Goodwill

Other Intangible Assets, net
(in millions)

March 31,
2017

December 31,
2016

March 31,
2017

December 31,
2016
European Union

$
1,278

$
1,238

$
473

$
479

Eastern Europe, Middle East & Africa

388

372

199

200

Asia

3,626

3,596

1,079

1,074

Latin America & Canada

2,193

2,118

766

717

Total

$
7,485

$
7,324

$
2,517

$
2,470

Additional details of other intangible assets were as follows:

March 31, 2017

December 31, 2016
(in millions)

Gross
Carrying
Amount

Accumulated
Amortization

Gross
Carrying
Amount

Accumulated
Amortization
Non-amortizable intangible assets

$
1,356

$
1,455

Amortizable intangible assets

1,773

$
612

1,598

$
583

Total other intangible assets

$
3,129

$
612

$
3,053

$
583

Movements in Goodwill
The movements in goodwill from December 31, 2016, were as follows:
(in millions)

European
Union

Eastern
Europe,
Middle East
&
Africa

Asia

Latin
America &
Canada

Total
Balances, December 31, 2016

$
1,238

$
372

$
3,596

$
2,118

$
7,324

Changes due to:

Currency

40

16

30

75

161

Balances, March 31, 2017

$
1,278

$
388

$
3,626

$
2,193

$
7,485

Gross Carrying Amount, Range of Useful Lives and Weighted-Average Remaining Useful Life of Amortizable Intangible Assets
The gross carrying amount, the range of useful lives as well as the weighted-average remaining useful life of amortizable intangible assets at March 31, 2017, were as follows:

(dollars in millions)
Gross Carrying Amount
Initial Estimated
Useful Lives

Weighted-Average
Remaining Useful Life
Trademarks
$
1,535

2 - 40 years

19 years
Distribution networks
150

5 - 30 years

10 years
Other (including farmer
  contracts and intellectual property rights)
88

4 - 17 years

9 years

$
1,773

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13854-109267
+ Details

Name: us-gaap_ScheduleOfGoodwillTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 52 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments (Tables)
3 Months Ended

Mar. 31, 2017

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Foreign Exchange Contracts
The fair value of PMI’s foreign exchange contracts included in the condensed consolidated balance sheets as of March 31, 2017 and December 31, 2016, were as follows:

Asset Derivatives

Liability Derivatives

Fair Value

Fair Value
(in millions)

Balance Sheet Classification

At March 31, 2017

At December 31, 2016

Balance Sheet Classification

At March 31, 2017

At December 31, 2016
Foreign exchange contracts designated as hedging instruments

Other current assets

$
82

$
207

Other accrued liabilities

$
10

$
66

Other assets

291

436

Other liabilities

101

36

Foreign exchange contracts not designated as hedging instruments

Other current assets

106

161

Other accrued liabilities

96

61

Other assets

1

9

Other liabilities

—

—

Total derivatives

$
480

$
813

$
207

$
163

Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings
For the three months ended March 31, 2017 and 2016, PMI's cash flow and net investment hedging instruments impacted the condensed consolidated statements of earnings and comprehensive earnings as follows:

(pre-tax, millions)
For the Three Months Ended March 31,

Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives

Statement of Earnings
Classification of Gain/(Loss)
Reclassified from Other
Comprehensive
Earnings/(Losses) into
Earnings

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings

2017

2016

2017

2016
Derivatives in Cash Flow Hedging Relationship

Foreign exchange contracts
$
(86
)

$
(79
)

Net revenues

$
9

$
5

Cost of sales

—

14

Marketing, administration and research costs

(9
)

4

Interest expense, net

(3
)

(17
)
Derivatives in Net Investment Hedging Relationship

Foreign exchange contracts
(249
)

(197
)

Total
$
(335
)

$
(276
)

$
(3
)

$
6

Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses), Net of Income Taxes
Hedging activity affected accumulated other comprehensive losses, net of income taxes, as follows:

(in millions)

For the Three Months Ended March 31,

2017

2016
Gain as of January 1,

$
97

$
59

Derivative (gains)/losses transferred to earnings

5

(7
)
Change in fair value

(75
)

(62
)
Gain/(loss) as of March 31,

$
27

$
(10
)

X

- Definition
Schedule Of Derivative Instruments Recognized In Statement Of Earnings And Other Comprehensive Income [Table Text Block]
+ References
No definition available.
+ Details

Name: pm_ScheduleOfDerivativeInstrumentsRecognizedInStatementOfEarningsAndOtherComprehensiveIncomeTableTextBlock

Namespace Prefix: pm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959
+ Details

Name: us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959
+ Details

Name: us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 53 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1

Earnings Per Share (Tables)
3 Months Ended

Mar. 31, 2017

Earnings Per Share [Abstract]

Calculation of Basic and Diluted EPS
Basic and diluted earnings per share (“EPS”) were calculated using the following:
(in millions)

For the Three Months Ended March 31,

2017

2016
Net earnings attributable to PMI

$
1,590

$
1,530

Less distributed and undistributed earnings attributable to share-based payment awards

3

5

Net earnings for basic and diluted EPS

$
1,587

$
1,525

Weighted-average shares for basic EPS

1,552

1,550

Plus contingently issuable performance stock units (PSUs)

1

—

Weighted-average shares for diluted EPS

1,553

1,550

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 54 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1

Segment Reporting (Tables)
3 Months Ended

Mar. 31, 2017

Segment Reporting [Abstract]

Segment Data
Segment data were as follows:
(in millions)

For the Three Months Ended March 31,

2017

2016
Net revenues:

European Union

$
5,889

$
6,143

Eastern Europe, Middle East & Africa

3,695

3,997

Asia

4,838

4,689

Latin America & Canada

2,134

1,959

Net revenues

$
16,556

$
16,788

Earnings before income taxes:

Operating companies income:

European Union

$
772

$
906

Eastern Europe, Middle East & Africa

690

633

Asia

852

778

Latin America & Canada

177

229

Amortization of intangibles

(22
)

(18
)
General corporate expenses

(51
)

(46
)
Less:

Equity (income)/loss in unconsolidated subsidiaries, net

(22
)

(9
)
Operating income

2,396

2,473

Interest expense, net

(219
)

(247
)
Earnings before income taxes

$
2,177

$
2,226

X

- Definition
Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8813-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=68060357&loc=d3e8736-108599
+ Details

Name: us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_SegmentReportingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 55 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Tables)
3 Months Ended

Mar. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Schedule of Tobacco Related Cases Pending Against Company
The table below lists the number of tobacco-related cases pending against us and/or our subsidiaries or indemnitees as of April 25, 2017, April 22, 2016 and April 30, 2015:

Type of Case

Number of Cases Pending as of
April 25, 2017

Number of Cases Pending as of
April 22, 2016

Number of Cases Pending as of
April 30, 2015
Individual Smoking and Health Cases

63

66

61

Smoking and Health Class Actions

11

11

11

Health Care Cost Recovery Actions

16

16

16

Lights Class Actions

—

—

—

Individual Lights Cases

1

3

2

Public Civil Actions

2

3

2

Schedule Of Verdicts And Post Trial Developments Where a Verdict was Returned In Favor of the Plaintiff(s)
The table below lists the verdict and significant post-trial developments in the four pending cases where a verdict was returned in favor of the plaintiff:

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
February 2004

Brazil/The Smoker Health Defense Association

Class Action

The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.

Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
May 27, 2015

Canada/Cecilia Létourneau

Class Action

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.

In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
May 27, 2015

Canada/Conseil Québécois Sur Le Tabac Et La Santé and Jean-Yves Blais


Class Action

On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.

In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Date

Location of
Court/Name of
Plaintiff

Type of
Case

Verdict

Post-Trial
Developments
August 5, 2016

Argentina/Hugo Lespada

Individual Action

On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages.
The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.

On August 23, 2016, our subsidiary filed its notice of appeal.

X

- Definition
Schedule of tobacco related cases pending against company and/or subsidiaries or indemnitees
+ References
No definition available.
+ Details

Name: pm_ScheduleOfTobaccoRelatedCasesPendingAgainstCompanyTableTextBlock

Namespace Prefix: pm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Schedule Of Verdicts And Post Trial Developments1 [Table Text Block]
+ References
No definition available.
+ Details

Name: pm_ScheduleOfVerdictsAndPostTrialDevelopments1TableTextBlock

Namespace Prefix: pm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_CommitmentsAndContingenciesDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 56 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness (Tables)
3 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Long-Term Debt
At March 31, 2017 and December 31, 2016, PMI’s long-term debt consisted of the following:

(in millions)

March 31, 2017

December 31, 2016
U.S. dollar notes, 1.125% to 6.375% (average interest rate 3.520%), due through 2044

$
21,796

$
19,857

Foreign currency obligations:

Euro notes, 1.750% to 3.125% (average interest rate 2.402%), due through 2036

7,032

6,828

Swiss franc notes, 0.750% to 2.000% (average interest rate 1.269%), due through 2024

1,354

1,312

Other (average interest rate 3.586%), due through 2024

160

427

30,342

28,424

Less current portion of long-term debt

1,754

2,573

$
28,588

$
25,851

Debt Issuances During Current Period
PMI's debt issuances in the first three months of 2017 were as follows:
(in millions)

Type

Face Value

Interest Rate

Issuance

Maturity

U.S. dollar notes
^(a)
$700

1.625%

February 2017

February 2019
U.S. dollar notes
^(b)
$300

Floating

February 2017

February 2020
U.S. dollar notes
^(a)
$1,000

2.000%

February 2017

February 2020
U.S. dollar notes
^(a)
$500

2.625%

February 2017

February 2022

^(a) Interest on these notes is payable semi-annually in arrears beginning in August 2017.
^(b) Interest on these notes is payable quarterly in arrears beginning in May 2017.

Schedule of Committed Credit Facilities
At March 31, 2017, PMI's total committed credit facilities were as follows:

(in billions)

Type

Committed
Credit
Facilities
364-day revolving credit, expiring February 6, 2018

$
2.0

Multi-year revolving credit, expiring February 28, 2021

2.5

Multi-year revolving credit, expiring October 1, 2020 ⁽¹⁾

3.5

Total facilities

$
8.0

⁽¹⁾ On August 30, 2016, PMI entered into an agreement, effective October 1, 2016, to extend the term of its multi-year revolving credit facility, for an additional year covering the period October 1, 2020 to October 1, 2021 in the amount of $3.35 billion.

X

- Definition
Schedule of Debt Issuances During Current Period [Table Text Block]
+ References
No definition available.
+ Details

Name: pm_ScheduleOfDebtIssuancesDuringCurrentPeriodTableTextBlock

Namespace Prefix: pm_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_DebtDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21521-112644
+ Details

Name: us-gaap_ScheduleOfDebtInstrumentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 57 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1

Fair Value Measurements (Tables)
3 Months Ended

Mar. 31, 2017

Fair Value Disclosures [Abstract]

Aggregate Fair Values of Derivative Financial Instruments and Debt
The aggregate fair values of PMI’s derivative financial instruments and debt as of March 31, 2017, were as follows:

(in millions)

Fair Value
at March 31,
2017

Quoted Prices
in Active
Markets for
Identical
Assets/Liabilities
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)
Assets:

Foreign exchange contracts

$
480

$
—

$
480

$
—

Total assets

$
480

$
—

$
480

$
—

Liabilities:

Debt

$
32,005

$
31,834

$
171

$
—

Foreign exchange contracts

207

—

207

—

Total liabilities

$
32,212

$
31,834

$
378

$
—

X

- Definition
Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19279-110258

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bb)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2C
-URI http://asc.fasb.org/extlink&oid=66048111&loc=SL7498348-110258

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19190-110258
+ Details

Name: us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 58 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accumulated Other Comprehensive Losses (Tables)
3 Months Ended

Mar. 31, 2017

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Components of Accumulated Other Comprehensive Earnings (Losses), Net of Taxes
PMI’s accumulated other comprehensive losses, net of taxes, consisted of the following:

(in millions)

At March 31, 2017

At December 31, 2016

At March 31, 2016
Currency translation adjustments

$
(5,783
)

$
(6,091
)

$
(5,617
)
Pension and other benefits

(3,509
)

(3,565
)

(3,287
)
Derivatives accounted for as hedges

27

97

(10
)
Total accumulated other comprehensive losses

$
(9,265
)

$
(9,559
)

$
(8,914
)

X

- References
No definition available.
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of the components of accumulated other comprehensive income (loss).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580
+ Details

Name: us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 59 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1

Balance Sheet Offsetting (Tables)
3 Months Ended

Mar. 31, 2017

Offsetting [Abstract]

Offsetting Assets
The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:

(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet

Financial Instruments
Cash Collateral Received/Pledged
Net Amount

At March 31, 2017

Assets

Foreign exchange contracts
$
480

$
—

$
480

$
(170
)
$
(258
)
$
52

Liabilities

Foreign exchange contracts
$
207

$
—

$
207

$
(170
)
$
(11
)
$
26

At December 31, 2016

Assets

Foreign exchange contracts
$
813

$
—

$
813

$
(126
)
$
(607
)
$
80

Liabilities

Foreign exchange contracts
$
163

$
—

$
163

$
(126
)
$
(31
)
$
6

Offsetting Liabilities
The effects of these derivative financial instrument assets and liabilities on PMI's condensed consolidated balance sheets were as follows:

(in millions)
Gross Amounts Recognized
Gross Amount Offset in the Condensed Consolidated Balance Sheet
Net Amounts Presented in the Condensed Consolidated Balance Sheet
Gross Amounts Not Offset in the
Condensed Consolidated
Balance Sheet

Financial Instruments
Cash Collateral Received/Pledged
Net Amount

At March 31, 2017

Assets

Foreign exchange contracts
$
480

$
—

$
480

$
(170
)
$
(258
)
$
52

Liabilities

Foreign exchange contracts
$
207

$
—

$
207

$
(170
)
$
(11
)
$
26

At December 31, 2016

Assets

Foreign exchange contracts
$
813

$
—

$
813

$
(126
)
$
(607
)
$
80

Liabilities

Foreign exchange contracts
$
163

$
—

$
163

$
(126
)
$
(31
)
$
6

X

- References
No definition available.
+ Details

Name: us-gaap_OffsettingAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312
+ Details

Name: us-gaap_OffsettingAssetsTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225877-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_OffsettingLiabilitiesTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 60 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1

Investments in Unconsolidated Subsidiaries (Tables)
3 Months Ended

Mar. 31, 2017

Equity Method Investments and Joint Ventures [Abstract]

Earnings and Balance Sheet Activities with Unconsolidated Subsidiaries
PMI’s earnings activity from unconsolidated subsidiaries was as follows:

For the Three Months Ended March 31,
(in millions)

2017
2016
Net revenues

$
840

$
777

PMI’s balance sheet activity related to unconsolidated subsidiaries was as follows:
(in millions)

At March 31, 2017
At December 31, 2016

Receivables

$
394

$
289

X

- References
No definition available.
+ Details

Name: us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentsTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 61 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock Plans (Narrative) (Details)
$ in Millions
3 Months Ended

Mar. 31, 2017

USD ($)

performance_metric

year

shares

May 31, 2012

shares

Dec. 31, 2008

shares

Restricted Stock Units (RSUs) [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Unrecognized compensation cost related to non-vested stock awards | $ $ 186

Award requisite service period 3 years

Minimum Retirement Age | year 58

Stock awards vested during period (in shares) 1,938,610

Restricted Stock Units (RSUs) [Member] | Grant Date Fair Value [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Fair value of vested stock awards | $ $ 151

Restricted Stock Units (RSUs) [Member] | Total Fair Value [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Fair value of vested stock awards | $ 198

Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Unrecognized compensation cost related to non-vested stock awards | $ $ 52

Minimum Retirement Age | year 58

Stock awards vested during period (in shares) 0

Performance period 3 years

Number of performance metrics used to determine the percentage of PSU's that will vest | performance_metric 3

The number of shares of common stock issue for each vested PSU 1

Aggregate weighted performance factor that determines if the target number of PSUs will vest 100.00%

Performance Shares [Member] | Minimum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage 0.00%

Performance Shares [Member] | Maximum [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage 200.00%

2012 Performance Incentive Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares) 30,000,000

Shares available for grant under the plan (in shares) 19,191,050

Non Employee Directors Plan [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares) 1,000,000

Shares available for grant under the plan (in shares) 677,539

Percentage of voting shares that PMI may own, used in determining non-employee director status 50.00%

X

- Definition
Minimum Retirement Age
+ References
No definition available.
+ Details

Name: pm_MinimumRetirementAge

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Represents the lower limit of ownership in a company by PMI used in defining Non-employee directors under the stock compensation plan.
+ References
No definition available.
+ Details

Name: pm_NonEmployeeDirectorOwnershipLimit

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Performance Metrics Predefined at Time of Grant, including Market and Non-Market Metrics, used by the Company to Determine the Percentage of PSU's that will Vest
+ References
No definition available.
+ Details

Name: pm_PerformanceMetricsPredefinedAtTheTimeOfGrantIncludingMarketAndNonMarketMetricsUsedByTheCompanyToDetermineThePercentageOfPSUsThatWillVest

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-Based Compensation Arrangement by Share-Based Payment Award, Duration of the Performance Cycle that Requires the Achievement of Predefined Performance Metrics
+ References
No definition available.
+ Details

Name: pm_ShareBasedCompensationArrangementByShareBasedPaymentAwardsLengthOfThePerformanceCyclePeriodWhichRequiresThatCertainPredeterminedPerformanceMetricsBeAchieved

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Share-Based Compensation by Share-Based Payment Awards, the Aggregate Weighted Performance Factor that Results in the Vesting of the Targeted Number of Performance Share Units
+ References
No definition available.
+ Details

Name: pm_ShareBasedCompensationByShareBasedPaymentAwardsTheAggregateWeightedPerformanceFactorThatResultsinTheVestingoftheTargetedNumberOfPerformanceShareUnits

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
The Number of shares of Common Stock Issued for each Vested Performance Share Unit
+ References
No definition available.
+ Details

Name: pm_TheNumberOfSharesOfCommonStockIssuedForEachVestedPerformanceShareUnit

Namespace Prefix: pm_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Unrecognized cost of unvested share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition
Percentage of vesting of share-based compensation awards.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_ShareBasedCompensationComponentsAxis=pm_GrantDateFairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_ShareBasedCompensationComponentsAxis=pm_FairValueMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=pm_A2012PerformanceIncentivePlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_PlanNameAxis=pm_A2008NonEmployeeDirectorsPlanMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 62 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock Plans (RSU Awards) (Details) - Restricted Stock Units (RSUs) [Member] - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Shares Granted (in shares) 1,202,060 1,212,050

Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 98.47 $ 89.02

Compensation expense for stock awards $ 35 $ 41

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 63 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1

Stock Plans (PSU Awards) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Performance Shares [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of Shares Granted (in shares) 393,460 428,400

Compensation expense for stock awards $ 17 $ 12

Performance Share Units, TSR Relative To Customer Peer Group [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 128.72 $ 104.60

Performance Share Units, Other Performance Factors [Member]

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted-Average Grant Date Fair Value Per RSU Award Granted (in dollars per share) $ 98.29 $ 89.02

X

- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 14.F)
-URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_AllocatedShareBasedCompensationExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(iii)(1)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue

Namespace Prefix: us-gaap_

Data Type: num:perShareItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pm_PerformanceShareUnitsTSRRelativeToCustomerPeerGroupMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_AwardTypeAxis=pm_PerformanceShareUnitsOtherPerformanceFactorsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 64 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1

Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

U.S. Plans - Pension [Member]

Defined Benefit Plan Disclosure [Line Items]

Service cost $ 1 $ 1

Interest cost 3 4

Expected return on plan assets (3) (3)

Amortization:

Net loss 0 1

Prior service cost 2 1

Net periodic pension cost 3 4

Non-U.S. Plans - Pension [Member]

Defined Benefit Plan Disclosure [Line Items]

Service cost 50 50

Interest cost 23 31

Expected return on plan assets (76) (81)

Amortization:

Net loss 44 44

Prior service cost 1 1

Net periodic pension cost $ 42 $ 45

X

- References
No definition available.
+ Details

Name: us-gaap_AdjustmentForAmortizationAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of gains or losses recognized in net periodic benefit cost.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(4)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The amount of the prior service cost or credit recognized in net periodic benefit cost relating to benefit changes attributable to plan participants' prior service pursuant to a plan amendment or a plan initiation.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Prior Service Cost
-URI http://asc.fasb.org/extlink&oid=49177896
+ Details

Name: us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlanDisclosureLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Expected Return on Plan Assets
-URI http://asc.fasb.org/extlink&oid=6512171

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(3)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(2)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanInterestCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The total amount of net periodic benefit cost for defined benefit plans for the period. Periodic benefit costs include the following components: service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) due to settlements or curtailments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (j)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Service Cost (Component of Net Periodic Pension Cost)
-URI http://asc.fasb.org/extlink&oid=6525008

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanServiceCost

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_UnitedStatesPensionPlansOfUSEntityDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DefinedBenefitPlansDisclosuresDefinedBenefitPlansAxis=us-gaap_ForeignPensionPlansDefinedBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 65 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1

Benefit Plans (Narrative) (Details)
$ in Millions
3 Months Ended

Mar. 31, 2017

USD ($)

Compensation and Retirement Disclosure [Abstract]

Employer Contributions $ 18

Anticipated additional employer contributions during the remainder of the current fiscal year $ 50

X

- References
No definition available.
+ Details

Name: us-gaap_CompensationAndRetirementDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of contributions made by the employer to defined benefit plans.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(5)(ii)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 35
-Paragraph 123
-Subparagraph B
-URI http://asc.fasb.org/extlink&oid=64937487&loc=d3e36068-114959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 30
-Section 35
-Paragraph 63
-Subparagraph B
-URI http://asc.fasb.org/extlink&oid=64937038&loc=d3e12551-114930

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(5)(iv)(01)
-URI http://asc.fasb.org/extlink&oid=65897934&loc=d3e1928-114920
+ Details

Name: us-gaap_DefinedBenefitPlanContributionsByEmployer

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of employer's best estimate of contributions expected to be paid to the plan in the current remaining fiscal period.
+ References
No definition available.
+ Details

Name: us-gaap_DefinedBenefitPlansEstimatedFutureEmployerContributionsInCurrentFiscalYear

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

XML 66 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Goodwill and Other Intangible Assets, net [Line Items]

Goodwill $ 7,485 $ 7,324

Other Intangible Assets, net 2,517 2,470

European Union [Member]

Goodwill and Other Intangible Assets, net [Line Items]

Goodwill 1,278 1,238

Other Intangible Assets, net 473 479

Eastern Europe, Middle East & Africa [Member]

Goodwill and Other Intangible Assets, net [Line Items]

Goodwill 388 372

Other Intangible Assets, net 199 200

Asia [Member]

Goodwill and Other Intangible Assets, net [Line Items]

Goodwill 3,626 3,596

Other Intangible Assets, net 1,079 1,074

Latin America & Canada [Member]

Goodwill and Other Intangible Assets, net [Line Items]

Goodwill 2,193 2,118

Other Intangible Assets, net $ 766 $ 717

X

- Definition
Goodwill and Intangible Assets [Line Items]
+ References
No definition available.
+ Details

Name: pm_GoodwillAndIntangibleAssetsLineItems

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph ((a)(1),(b))
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_EasternEuropeMiddleEastAndAfricaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_LatinAmericaAndCanadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 67 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details)
$ in Millions
3 Months Ended

Mar. 31, 2017

USD ($)

Goodwill [Roll Forward]

Balances, December 31, 2016 $ 7,324

Changes due to:

Currency 161

Balances, March 31, 2017 7,485

European Union [Member]

Goodwill [Roll Forward]

Balances, December 31, 2016 1,238

Changes due to:

Currency 40

Balances, March 31, 2017 1,278

Eastern Europe, Middle East & Africa [Member]

Goodwill [Roll Forward]

Balances, December 31, 2016 372

Changes due to:

Currency 16

Balances, March 31, 2017 388

Asia [Member]

Goodwill [Roll Forward]

Balances, December 31, 2016 3,596

Changes due to:

Currency 30

Balances, March 31, 2017 3,626

Latin America & Canada [Member]

Goodwill [Roll Forward]

Balances, December 31, 2016 2,118

Changes due to:

Currency 75

Balances, March 31, 2017 $ 2,193

X

- Definition
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=64834752&loc=SL49117168-202975
+ Details

Name: us-gaap_Goodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.
+ References
No definition available.
+ Details

Name: us-gaap_GoodwillRollForward

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 25
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=73531572&loc=d3e961-128460

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=35741047&loc=d3e13816-109267
+ Details

Name: us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_EasternEuropeMiddleEastAndAfricaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_LatinAmericaAndCanadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 68 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Intangible Assets, Net (Excluding Goodwill) [Abstract]

Non-amortizable intangible assets, gross carrying amount $ 1,356 $ 1,455

Amortizable intangible assets, gross carrying amount 1,773 1,598

Total other intangible assets, gross carrying amount 3,129 3,053

Accumulated Amortization $ 612 $ 583

X

- Definition
Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount before accumulated amortization of intangible assets, excluding goodwill.
+ References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsGrossExcludingGoodwill

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 69 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Dec. 31, 2016

Finite-Lived Intangible Assets [Line Items]

Gross Carrying Amount $ 1,773 $ 1,598

Trademarks [Member]

Finite-Lived Intangible Assets [Line Items]

Gross Carrying Amount $ 1,535

Weighted-Average Remaining Useful Life 19 years

Trademarks [Member] | Minimum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 2 years

Trademarks [Member] | Maximum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 40 years

Distribution Networks [Member]

Finite-Lived Intangible Assets [Line Items]

Gross Carrying Amount $ 150

Weighted-Average Remaining Useful Life 10 years

Distribution Networks [Member] | Minimum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 5 years

Distribution Networks [Member] | Maximum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 30 years

Other (Including Farmer Contracts and Intellectual Property Rights) [Member]

Finite-Lived Intangible Assets [Line Items]

Gross Carrying Amount $ 88

Weighted-Average Remaining Useful Life 9 years

Other (Including Farmer Contracts and Intellectual Property Rights) [Member] | Minimum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 4 years

Other (Including Farmer Contracts and Intellectual Property Rights) [Member] | Maximum [Member]

Finite-Lived Intangible Assets [Line Items]

Initial Estimated Useful Lives 17 years

X

- Definition
Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275
+ Details

Name: us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetUsefulLife

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsGross

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=pm_OtherIncludingFarmerContractsAndIntellectualPropertyRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 70 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1

Goodwill and Other Intangible Assets, net (Narrative) (Details)
$ in Millions
3 Months Ended

Mar. 31, 2017

USD ($)

intangible_asset

Mar. 31, 2016

USD ($)

Finite-Lived Intangible Assets [Line Items]

Number Of Intangible Assets Reclassified | intangible_asset 3

Intangible assets, pre-tax amortization expense $ 22 $ 18

Estimated Amortization Expense, Year One, assuming no additional transactions occur that require the amortization of intangible assets 86

Estimated Amortization Expense, Year Two, assuming no additional transactions occur that require the amortization of intangible assets 86

Estimated Amortization Expense, Year Three, assuming no additional transactions occur that require the amortization of intangible assets 86

Estimated Amortization Expense, Year Four, assuming no additional transactions occur that require the amortization of intangible assets 86

Estimated Amortization Expense, Year Five, assuming no additional transactions occur that require the amortization of intangible assets 86

Trademarks [Member]

Finite-Lived Intangible Assets [Line Items]

Amortizable intangible assets, gross carrying amount 153

Trademarks [Member]

Finite-Lived Intangible Assets [Line Items]

Decrease to non-amortizable intangible assets $ 153

X

- Definition
Increase (Decrease) In Finite-Lived Intangible Assets, Gross
+ References
No definition available.
+ Details

Name: pm_IncreaseDecreaseInFiniteLivedIntangibleAssetsGross

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Increase (Decrease) In Indefinite-Lived Intangible Assets (Excluding Goodwill)
+ References
No definition available.
+ Details

Name: pm_IncreaseDecreaseInIndefiniteLivedIntangibleAssetsExcludingGoodwill

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number Of Intangible Assets Reclassified
+ References
No definition available.
+ Details

Name: pm_NumberOfIntangibleAssetsReclassified

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_FiniteLivedIntangibleAssetsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 71 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments (Narrative) (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Derivative [Line Items]

Maturity of foreign currency derivatives - cash flow hedges May 31, 2024

Unrealized gain (loss) on hedges of net investments $ 303 $ 538

Foreign Exchange Contract [Member]

Derivative [Line Items]

Notional amount 31,000

Derivative Instruments, gains to be reclassified to earnings. $ 9

Foreign Exchange Contract [Member] | Maximum [Member]

Derivative [Line Items]

Maximum length of time hedged in a Cash Flow Hedge 21 months

Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member]

Derivative [Line Items]

Notional amount $ 15,300

Gain (Loss) on derivatives not designated as hedging instruments (39) 91

Foreign Exchange Contract [Member] | Cash Flow Hedging [Member]

Derivative [Line Items]

Notional amount 4,600

Foreign Exchange Contract [Member] | Net Investment Hedging [Member]

Derivative [Line Items]

Notional amount 11,100

Unrealized gain (loss) on hedges of net investments $ (294) $ (267)

X

- Definition
Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 12
-Section 13
-Sentence Column B
+ Details

Name: invest_DerivativeNotionalAmount

Namespace Prefix: invest_

Data Type: xbrli:monetaryItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Period remaining until the derivative contract matures, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeRemainingMaturity1

Namespace Prefix: us-gaap_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
The estimated net amount of unrealized gains or losses on foreign currency cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80748-113994
+ Details

Name: us-gaap_ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5618551-113959
+ Details

Name: us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Date the foreign currency exchange rate derivatives mature or expire, in CCYY-MM-DD format.
+ References
No definition available.
+ Details

Name: us-gaap_MaturityOfForeignCurrencyDerivatives1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount after tax, before reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32211-110900

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (a-c)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32022-110900

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 18
-URI http://asc.fasb.org/extlink&oid=64808268&loc=d3e32157-110900
+ Details

Name: us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 72 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Derivatives, Fair Value [Line Items]

Derivative asset fair value $ 480 $ 813

Derivative liability fair value 207 163

Designated as Hedging Instrument [Member] | Other Current Assets [Member]

Derivatives, Fair Value [Line Items]

Derivative asset fair value 82 207

Designated as Hedging Instrument [Member] | Other Assets [Member]

Derivatives, Fair Value [Line Items]

Derivative asset fair value 291 436

Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]

Derivatives, Fair Value [Line Items]

Derivative liability fair value 10 66

Designated as Hedging Instrument [Member] | Other Liabilities [Member]

Derivatives, Fair Value [Line Items]

Derivative liability fair value 101 36

Not Designated as Hedging Instrument [Member] | Other Current Assets [Member]

Derivatives, Fair Value [Line Items]

Derivative asset fair value 106 161

Not Designated as Hedging Instrument [Member] | Other Assets [Member]

Derivatives, Fair Value [Line Items]

Derivative asset fair value 1 9

Not Designated as Hedging Instrument [Member] | Other Accrued Liabilities [Member]

Derivatives, Fair Value [Line Items]

Derivative liability fair value 96 61

Not Designated as Hedging Instrument [Member] | Other Liabilities [Member]

Derivatives, Fair Value [Line Items]

Derivative liability fair value $ 0 $ 0

X

- Definition
Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4D
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=64830801&loc=SL51823488-111719
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4D
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=64830801&loc=SL51823488-111719

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativesFairValueLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=pm_OtherAccruedLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_BalanceSheetLocationAxis=us-gaap_OtherLiabilitiesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 73 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives $ (335) $ (276)

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (3) 6

Cash Flow Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives (86) (79)

Cash Flow Hedges [Member] | Net Revenue [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 9 5

Cash Flow Hedges [Member] | Cost of Sales [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings 0 14

Cash Flow Hedges [Member] | Marketing Administration And Research Costs [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (9) 4

Cash Flow Hedges [Member] | Interest Expense [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings (3) (17)

Net Investment Hedges [Member]

Derivative Instruments, Gain (Loss) [Line Items]

Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives $ (249) $ (197)

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=pm_MarketingAdministrationAndResearchCostsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_NetInvestmentHedgingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 74 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1

Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]

Derivative (gains)/losses transferred to earnings $ 3 $ (6)

Change in fair value (335) (276)

Other Comprehensive Income (Loss) [Member]

Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]

Gain as of January 1, 97 59

Derivative (gains)/losses transferred to earnings 5 (7)

Change in fair value (75) (62)

Gain/(loss) as of March 31, $ 27 $ (10)

X

- Definition
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
+ References
No definition available.
+ Details

Name: pm_HedgingActivityAffectingAccumulatedOtherComprehensiveIncomeRollForward

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Accumulated change, net of tax, in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges. Includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 10A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669646-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14A
-URI http://asc.fasb.org/extlink&oid=66004124&loc=SL7669686-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=66004124&loc=d3e681-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=35736893&loc=d3e80784-113994
+ Details

Name: us-gaap_AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4D
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624177-113959
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624171-113959
+ Details

Name: us-gaap_DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_OtherComprehensiveIncomeLocationAxis=us-gaap_OtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 75 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1

Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Earnings Per Share [Abstract]

Net earnings attributable to PMI $ 1,590 $ 1,530

Less distributed and undistributed earnings attributable to share-based payment awards 3 5

Net earnings for basic and diluted EPS $ 1,587 $ 1,525

Weighted-average shares for basic EPS (in shares) 1,552,000,000 1,550,000,000

Plus contingently issuable performance stock units (PSUs) (in shares) 1,000,000 0

Weighted-average shares for diluted EPS (in shares) 1,553,000,000 1,550,000,000

Antidilutive stock awards (in shares) 0 0

X

- Definition
Net income (loss) after adjustments for distributed and undistributed earnings attributable to share-based payment awards.
+ References
No definition available.
+ Details

Name: pm_NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Antidilution
-URI http://asc.fasb.org/extlink&oid=6505113

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Diluted Earnings Per Share
-URI http://asc.fasb.org/extlink&oid=6510752

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Contingent Stock Agreement
-URI http://asc.fasb.org/extlink&oid=6508534

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 28A
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1500-109256
+ Details

Name: us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=51831255

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=51831270

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_NetIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=64863997&loc=SL5780133-109256
+ Details

Name: us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1505-109256

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257
+ Details

Name: us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

X

- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=64863997&loc=d3e1448-109256

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Weighted-Average Number of Common Shares Outstanding
-URI http://asc.fasb.org/extlink&oid=6528421
+ Details

Name: us-gaap_WeightedAverageNumberOfSharesOutstandingBasic

Namespace Prefix: us-gaap_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: duration

XML 76 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1

Segment Reporting (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Segment Reporting Information [Line Items]

Net revenues $ 16,556 $ 16,788

Amortization of intangibles (22) (18)

General corporate expenses (51) (46)

Equity (income)/loss in unconsolidated subsidiaries, net (22) (9)

Operating income 2,396 2,473

Interest expense, net (219) (247)

Earnings before income taxes 2,177 2,226

Operating Segments [Member] | European Union [Member]

Segment Reporting Information [Line Items]

Net revenues 5,889 6,143

Operating companies income: 772 906

Operating Segments [Member] | Eastern Europe, Middle East & Africa [Member]

Segment Reporting Information [Line Items]

Net revenues 3,695 3,997

Operating companies income: 690 633

Operating Segments [Member] | Asia [Member]

Segment Reporting Information [Line Items]

Net revenues 4,838 4,689

Operating companies income: 852 778

Operating Segments [Member] | Latin America & Canada [Member]

Segment Reporting Information [Line Items]

Net revenues 2,134 1,959

Operating companies income: $ 177 $ 229

X

- Definition
Operating income before general corporate expenses and amortization of intangibles.
+ References
No definition available.
+ Details

Name: pm_OperatingCompaniesIncome

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)(2)
-URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275
+ Details

Name: us-gaap_AmortizationOfIntangibleAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.4)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_GeneralAndAdministrativeExpense

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1)(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690
+ Details

Name: us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=66022249&loc=d3e33749-111570

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(13)(f))
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_IncomeLossFromEquityMethodInvestments

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net amount of operating interest income (expense).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04.10)
-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882
+ Details

Name: us-gaap_InterestIncomeExpenseNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
The net result for the period of deducting operating expenses from operating revenues.
+ References
No definition available.
+ Details

Name: us-gaap_OperatingIncomeLoss

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1)
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_SalesRevenueNet

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_SegmentReportingInformationLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_EuropeanUnionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_EasternEuropeMiddleEastAndAfricaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=us-gaap_AsiaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_LatinAmericaAndCanadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 77 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Tobacco-Related Litigation) (Details)

Mar. 31, 2017

litigation_case

Loss Contingencies [Line Items]

Number of cases decided in favor of PM 459

Number of cases decided in favor of plaintiff 13

Cases Remaining On Appeal [Member]

Loss Contingencies [Line Items]

Number of cases decided in favor of plaintiff 4

Case Decided In Favor Of Plaintiff [Member]

Loss Contingencies [Line Items]

Number of cases that reached final resolution in favor of PM 9

X

- Definition
Loss Contingency Claims Resolved in Favor of Plaintiffs
+ References
No definition available.
+ Details

Name: pm_LossContingencyClaimsResolvedinFavorofPlaintiffs

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss Contingency Claims Resolved in Favor of Plaintiffs that have Subsequently Reached Final Resolution in Favor of the Company
+ References
No definition available.
+ Details

Name: pm_LossContingencyClaimsResolvedinFavorofPlaintiffsthathaveSubsequentlyReachedFinalResolutioninFavoroftheCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss Contingency Claims Resolved in Favor of the Company
+ References
No definition available.
+ Details

Name: pm_LossContingencyClaimsResolvedinFavoroftheCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LitigationStatusAxis=pm_CasesRemainingOnAppealMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CaseDecidedInFavorOfPlaintiffMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 78 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) - litigation_case

Apr. 25, 2017

Apr. 22, 2016

Apr. 30, 2015

Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 66 61

Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 11 11

Health Care Cost Recovery Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 16 16

Lights Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 0 0

Individual Lights Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 3 2

Public Civil Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 3 2

Subsequent Event [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 63

Subsequent Event [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 11

Subsequent Event [Member] | Health Care Cost Recovery Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 16

Subsequent Event [Member] | Lights Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 0

Subsequent Event [Member] | Individual Lights Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Public Civil Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

X

- Definition
Cases Brought Against Company
+ References
No definition available.
+ Details

Name: pm_CasesBroughtAgainstCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_IndividualSmokingAndHealthCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_SmokingAndHealthClassActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_HealthCareCostRecoveryActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_LightsClassActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_IndividualLightsCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_PublicCivilActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 79 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Verdicts and Post-Trial Developments) (Details)
1 Months Ended 3 Months Ended 12 Months Ended

Aug. 05, 2016

ARS

Aug. 05, 2016

USD ($)

May 27, 2015

CAD

May 27, 2015

USD ($)

Oct. 31, 2015

CAD

Oct. 31, 2015

USD ($)

Oct. 30, 2015

CAD

Oct. 30, 2015

USD ($)

Jul. 31, 2015

Jun. 30, 2015

CAD

Jun. 30, 2015

USD ($)

Apr. 30, 2004

BRL

Apr. 30, 2004

USD ($)

Mar. 31, 2017

Dec. 31, 2004

BRL

Dec. 31, 2004

USD ($)

Smoking And Health Class Actions [Member] | The Smoker Health Defense Association (ADESF) [Member]

Loss Contingencies [Line Items]

Smoking and health loss contingency interest rate (percentage per month) 1.00% 1.00%

Smoking And Health Class Actions [Member] | Award per smoker per year [Member] | The Smoker Health Defense Association (ADESF) [Member]

Loss Contingencies [Line Items]

Damages awarded BRL 1,000 $ 318

Brazil [Member] | Smoking And Health Class Actions [Member] | The Smoker Health Defense Association (ADESF) [Member]

Loss Contingencies [Line Items]

Smoking and health loss contingency interest rate (percentage per month) 1.00% 1.00%

Brazil [Member] | Smoking And Health Class Actions [Member] | Award per smoker per year [Member] | The Smoker Health Defense Association (ADESF) [Member]

Loss Contingencies [Line Items]

Damages awarded BRL 1,000 $ 318

Brazil [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | The Smoker Health Defense Association (ADESF) [Member]

Loss Contingencies [Line Items]

Date February 2004

Verdict The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.

Post-Trial Developments Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 131,000,000 $ 97,000,000

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 46,000,000 $ 34,000,000

Canada [Member] | Cecilia Letourneau [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days

Canada [Member] | Cecilia Letourneau [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 90,000 66,300

Compensatory damages awarded 15,500,000,000 11,400,000,000

Awarded compensatory damages that are to be deposited into trust CAD 1,000,000,000 $ 737,000,000

Payment period for compensatory damages to be deposited into trust 60 days 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 30,000 $ 22,100

Compensatory damages awarded CAD 3,100,000,000 $ 2,300,000,000

Damages allocated to subsidiary (percent) 20.00% 20.00%

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Amount of security ordered to be furnished CAD 226,000,000 $ 167,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | Cecilia Letourneau [Member]

Loss Contingencies [Line Items]

Date May 27, 2015

Verdict On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.

Post-Trial Developments In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Canada [Member] | Smoking And Health Class Actions [Member] | Cases With Verdicts And Post Trial Developments [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]

Loss Contingencies [Line Items]

Date May 27, 2015

Verdict On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.

Post-Trial Developments In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)

Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 131,000,000 97,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 46,000,000 $ 34,000,000

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 46,000,000 $ 34,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member]

Loss Contingencies [Line Items]

Payment period for compensatory damages to be deposited into trust 60 days 60 days

Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 90,000 $ 66,300

Compensatory damages awarded 15,500,000,000 11,400,000,000

Awarded compensatory damages that are to be deposited into trust 1,000,000,000 737,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 30,000 22,100

Compensatory damages awarded CAD 3,100,000,000 $ 2,300,000,000

Damages allocated to subsidiary (percent) 20.00% 20.00%

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Smoking And Health Class Actions [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Amount of security ordered to be furnished CAD 226,000,000 $ 167,000,000

Argentina [Member] | Individual Action [Member] | Cases With Verdicts And Post Trial Developments [Member] | Hugo Lespada [Member]

Loss Contingencies [Line Items]

Date August 5, 2016

Verdict On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages. The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.

Post-Trial Developments On August 23, 2016, our subsidiary filed its notice of appeal.

Argentina [Member] | Individual Action [Member] | Hugo Lespada [Member] | Judicial Ruling [Member]

Loss Contingencies [Line Items]

Compensatory damages awarded ARS 110,000 $ 7,100

X

- Definition
Date Of Verdict
+ References
No definition available.
+ Details

Name: pm_DateOfVerdict

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesAmountToBeDepositedIntoTrust

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesPaymentPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Value
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesValue

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Percentage Allocated
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPercentageAllocated

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Punitive Damages, Payment Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPunitiveDamagesPaymentPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Punitive Damages, Value
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPunitiveDamagesValue

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Motion for Security Ordered by an Appeals Court, to be Furnished by Defendants in Equal Consecutive Quarterly Installments in the Form of Cash to a Court Trust or Letters of Credit.
+ References
No definition available.
+ Details

Name: pm_LossContingencyMotionforSecurityOrderedbyAppealsCourttobeFurnishedbyDefendants

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency Post Trial Developments1
+ References
No definition available.
+ Details

Name: pm_LossContingencyPostTrialDevelopments1

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Interest rate applied on damages awarded
+ References
No definition available.
+ Details

Name: pm_SmokingAndHealthLossContingencyInterestRate

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Describes important rulings or decisions made by the judge, arbitrator or mediator in the legal matter that could impact the outcome of the case.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349
+ Details

Name: us-gaap_LossContingencyActionsTakenByCourtArbitratorOrMediator

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349
+ Details

Name: us-gaap_LossContingencyDamagesAwardedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_SmokingAndHealthClassActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_LossContingenciesByNameOfPlaintiffAxis=pm_SmokerHealthDefenseAssociationadesfMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_AwardpersmokerperyearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_BR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CasesWithVerdictsAndPostTrialDevelopmentsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CA

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CeciliaLetourneauMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_RothmansBensonAndHedgesInc.RBHMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=pm_AppellateRulingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_LossContingenciesByNameOfPlaintiffAxis=pm_CeciliaLetourneauMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_LossContingenciesByNameOfPlaintiffAxis=pm_ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_AR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_SmokingAndHealthIndividualActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_LossContingenciesByNameOfPlaintiffAxis=pm_HugoLespadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_HugoLespadaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 80 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Smoking And Health Litigation) (Details)
1 Months Ended 12 Months Ended

May 27, 2015

CAD

plaintiff

manufacturer

May 27, 2015

USD ($)

plaintiff

manufacturer

Jun. 20, 2012

cigarette

Jul. 10, 2009

cigarette

Mar. 31, 2017

CAD

Mar. 31, 2017

USD ($)

Oct. 31, 2015

CAD

installment

Oct. 31, 2015

USD ($)

installment

Oct. 30, 2015

CAD

Oct. 30, 2015

USD ($)

Aug. 31, 2015

CAD

Aug. 31, 2015

USD ($)

Jul. 31, 2015

Jun. 30, 2015

CAD

Jun. 30, 2015

USD ($)

Apr. 30, 2004

BRL

Apr. 30, 2004

USD ($)

Dec. 31, 2004

BRL

Dec. 31, 2004

USD ($)

Apr. 25, 2017

litigation_case

Apr. 22, 2016

litigation_case

Apr. 30, 2015

litigation_case

Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 66 61

Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 11 11

The Smoker Health Defense Association (ADESF) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Smoking and health loss contingency interest rate 1.00% 1.00%

The Smoker Health Defense Association (ADESF) [Member] | Award per smoker per year [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Damages awarded BRL 1,000 $ 318

Brazil [Member] | The Smoker Health Defense Association (ADESF) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Smoking and health loss contingency interest rate 1.00% 1.00%

Brazil [Member] | The Smoker Health Defense Association (ADESF) [Member] | Award per smoker per year [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Damages awarded BRL 1,000 $ 318

Canada [Member] | Cecilia Letourneau [Member]

Loss Contingencies [Line Items]

Number of additional manufacturers found liable | manufacturer 2 2

Estimated number of members in class | plaintiff 918,000 918,000

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 131,000,000 $ 97,000,000

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 131,000,000 $ 97,000,000

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 46,000,000 34,000,000

Canada [Member] | Cecilia Letourneau [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 46,000,000 $ 34,000,000

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Canada [Member] | Cecilia Letourneau [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days

Canada [Member] | Cecilia Letourneau [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days 60 days

Period between addiction warning and claim 3 years 3 years

Canada [Member] | Cecilia Letourneau [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 46,000,000 $ 34,000,000

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]

Loss Contingencies [Line Items]

Number of additional manufacturers found liable | manufacturer 2 2

Estimated number of members in class | plaintiff 99,957 99,957

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Payment period for compensatory damages to be deposited into trust 60 days 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 90,000 $ 66,300

Compensatory damages awarded 15,500,000,000 11,400,000,000

Awarded compensatory damages that are to be deposited into trust CAD 1,000,000,000 $ 737,000,000

Payment period for compensatory damages to be deposited into trust 60 days 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Punitive damages awarded CAD 90,000 $ 66,300

Compensatory damages awarded 15,500,000,000 11,400,000,000

Awarded compensatory damages that are to be deposited into trust 1,000,000,000 737,000,000

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 30,000 22,100

Compensatory damages awarded CAD 3,100,000,000 $ 2,300,000,000

Damages allocated to subsidiary (percent) 20.00% 20.00%

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Judicial Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Punitive damages awarded 30,000 22,100

Compensatory damages awarded CAD 3,100,000,000 $ 2,300,000,000

Damages allocated to subsidiary (percent) 20.00% 20.00%

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for awarded punitive damages to be deposited into trust 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Payment period for compensatory damages to be deposited into trust 60 days 60 days

Canada [Member] | Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] | Pending Litigation [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Awarded compensatory damages that are to be deposited into trust CAD 200,000,000 $ 147,000,000

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Number of consecutive quarterly installment | installment 6 6

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Imperial Tobacco Ltd. [Member]

Loss Contingencies [Line Items]

Number of consecutive quarterly installment | installment 7 7

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member]

Loss Contingencies [Line Items]

Amount of security ordered to be furnished CAD 226,000,000 $ 167,000,000

Amount of security to be furnished in each consecutive quarterly installment 37,600,000 27,700,000

Amount of security furnished by defendants in quarterly installment CAD 37,600,000 $ 27,700,000

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Rothmans, Benson, And Hedges Inc. (RBH) [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Amount of security ordered to be furnished CAD 226,000,000 $ 167,000,000

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Appellate Ruling [Member] | Imperial Tobacco Ltd. [Member]

Loss Contingencies [Line Items]

Amount of security ordered to be furnished 758,000,000 559,000,000

Amount of security to be furnished in each consecutive quarterly installment CAD 108,000,000 $ 80,000,000

Canada [Member] | Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] | Under Advisement [Member] | Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member]

Loss Contingencies [Line Items]

Motion to secure judgment, Letters of credit to be placed into trust, option 1 CAD 5,000,000,000 $ 3,700,000,000

Canada [Member] | Adams [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Plaintiff requirement, Minimum number of cigarettes smoked | cigarette 25,000

Canada [Member] | Suzanne Jacklin [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Plaintiff requirement, Minimum number of cigarettes smoked | cigarette 25,000

Subsequent Event [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 63

Subsequent Event [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 11

Subsequent Event [Member] | Argentina [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 35

Subsequent Event [Member] | Brazil [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 14

Subsequent Event [Member] | Brazil [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

Subsequent Event [Member] | Canada [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

Subsequent Event [Member] | Canada [Member] | Smoking And Health Class Actions [Member]

Loss Contingencies [Line Items]

Cases brought against PM 9

Subsequent Event [Member] | Chile [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 5

Subsequent Event [Member] | Costa Rica [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

Subsequent Event [Member] | Italy [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

Subsequent Event [Member] | Philippines [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Russia [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Scotland [Member] | Individual Smoking And Health Cases [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

X

- Definition
Cases Brought Against Company
+ References
No definition available.
+ Details

Name: pm_CasesBroughtAgainstCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Amount To Be Deposited Into Trust
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesAmountToBeDepositedIntoTrust

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Payment Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesPaymentPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Compensatory Damages, Value
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedCompensatoryDamagesValue

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Payment Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPaymentPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Percentage Allocated
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPercentageAllocated

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Punitive Damages, Payment Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPunitiveDamagesPaymentPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Awarded, Punitive Damages, Value
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesAwardedPunitiveDamagesValue

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Estimated Number Of Members In Class
+ References
No definition available.
+ Details

Name: pm_LossContingencyEstimatedNumberOfMembersInClass

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Motion Filed by Plaintiffs to Secure Judgment, Letters of Credit Amount to be Placed in Trust, Option One
+ References
No definition available.
+ Details

Name: pm_LossContingencyMotionFiledbyPlaintiffstoSecureJudgmentLettersofCreditAmounttobePlacedinTrustOptionOne

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished By Defendants, Amount Of Each Consecutive Quarterly Equal Installment
+ References
No definition available.
+ Details

Name: pm_LossContingencyMotionForSecurityOrderedByAppealsCourtToBeFurnishedByDefendantsAmountOfEachConsecutiveQuarterlyEqualInstallment

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Motion For Security Ordered By Appeals Court, To Be Furnished Quarterly By Defendants, Amount Of Quarterly Installment
+ References
No definition available.
+ Details

Name: pm_LossContingencyMotionForSecurityOrderedByAppealsCourtToBeFurnishedQuarterlyByDefendantsAmountOfQuarterlyInstallment

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Motion for Security Ordered by an Appeals Court, to be Furnished by Defendants in Equal Consecutive Quarterly Installments in the Form of Cash to a Court Trust or Letters of Credit.
+ References
No definition available.
+ Details

Name: pm_LossContingencyMotionforSecurityOrderedbyAppealsCourttobeFurnishedbyDefendants

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Loss Contingency, Number Of Additional Manufacturers Found Liable
+ References
No definition available.
+ Details

Name: pm_LossContingencyNumberOfAdditionalManufacturersFoundLiable

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Number of Equal Consecutive Quarterly Installments Ordered by Court of Appeals
+ References
No definition available.
+ Details

Name: pm_LossContingencyNumberofEqualConsecutiveQuarterlyInstallmentsOrderedbyCourtofAppeals

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Period Between Addiction Warning And Claim
+ References
No definition available.
+ Details

Name: pm_LossContingencyPeriodBetweenAddictionWarningAndClaim

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Plaintiff Requirement, Minimum Number Of Cigarettes Smoked
+ References
No definition available.
+ Details

Name: pm_LossContingencyPlaintiffRequirementMinimumNumberOfCigarettesSmoked

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Interest rate applied on damages awarded
+ References
No definition available.
+ Details

Name: pm_SmokingAndHealthLossContingencyInterestRate

Namespace Prefix: pm_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of damages awarded to the plaintiff in the legal matter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349
+ Details

Name: us-gaap_LossContingencyDamagesAwardedValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_IndividualSmokingAndHealthCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_SmokingAndHealthClassActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: pm_LossContingenciesByNameOfPlaintiffAxis=pm_SmokerHealthDefenseAssociationadesfMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_AwardpersmokerperyearMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_BR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CA

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CeciliaLetourneauMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_ImperialTobaccoLtd.RothmansBensonAndHedgesInc.AndJTIMacdonaldCorp.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_RothmansBensonAndHedgesInc.RBHMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=pm_AppellateRulingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_ConseilQuebecoisSurLeTabacEtLaSanteandJeanYvesBlaisMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_CeciliaLetourneauConseilQuebecoisSurLaTabacEtLaSanteandJeanYvesBlaisCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_ImperialTobaccoLtd.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=pm_UnderAdvisementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_RothmansBensonHedgesInc.andImperialTobaccoLtd.Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_AdamsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_SuzanneJacklinMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_AR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CL

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_IT

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_PH

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_RU

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_ScotlandMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 81 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions [Member]
$ in Millions

Apr. 14, 2014

USD ($)

patient

Oct. 17, 2008

Mar. 13, 2008

Feb. 26, 2008

May 25, 2007

May 09, 2007

Apr. 25, 2017

litigation_case

Apr. 22, 2016

litigation_case

Apr. 30, 2015

litigation_case

Loss Contingencies [Line Items]

Cases brought against PM 16 16

Korea [Member]

Loss Contingencies [Line Items]

Damages sought, number of patients | patient 3,484

Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Lagos State [Member]

Loss Contingencies [Line Items]

Damages sought, period of past reimbursements 20 years

Damages sought, period of future reimbursements 20 years

Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Kano State [Member]

Loss Contingencies [Line Items]

Damages sought, period of past reimbursements 20 years

Damages sought, period of future reimbursements 20 years

Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Gombe State [Member]

Loss Contingencies [Line Items]

Damages sought, period of past reimbursements 20 years

Damages sought, period of future reimbursements 20 years

Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Ovo State [Member]

Loss Contingencies [Line Items]

Damages sought, period of past reimbursements 20 years

Damages sought, period of future reimbursements 20 years

Nigeria [Member] | Pending Litigation [Member] | The Attorney General Of Ogun State [Member]

Loss Contingencies [Line Items]

Damages sought, period of past reimbursements 20 years

Damages sought, period of future reimbursements 20 years

Subsequent Event [Member]

Loss Contingencies [Line Items]

Cases brought against PM 16

Subsequent Event [Member] | Canada [Member]

Loss Contingencies [Line Items]

Cases brought against PM 10

Subsequent Event [Member] | Korea [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Nigeria [Member]

Loss Contingencies [Line Items]

Cases brought against PM 5

Subsidiary And Other Korean Manufacturers [Member] | Korea [Member]

Loss Contingencies [Line Items]

Damages sought, value | $ $ 53.7

X

- Definition
Cases Brought Against Company
+ References
No definition available.
+ Details

Name: pm_CasesBroughtAgainstCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Loss Contingency, Damages Sought, Future Reimbursements, Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesSoughtFutureReimbursementsPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency Damages Sought Number of Patients
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesSoughtNumberofPatients

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
Loss Contingency, Damages Sought, Past Reimbursements, Period
+ References
No definition available.
+ Details

Name: pm_LossContingencyDamagesSoughtPastReimbursementsPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The value (monetary amount) of the award the plaintiff seeks in the legal matter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349
+ Details

Name: us-gaap_LossContingencyDamagesSoughtValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_HealthCareCostRecoveryActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_KR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_NG

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheAttorneyGeneralOfLagosStateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheAttorneyGeneralOfKanoStateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheAttorneyGeneralOfGombeStateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheAttorneyGeneralOfOyoStateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheAttorneyGeneralOfOgunStateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_CA

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=pm_SubsidiaryAndOtherKoreanManufacturersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 82 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Lights Cases) (Details) - Individual Lights Cases [Member] - litigation_case

Apr. 25, 2017

Apr. 22, 2016

Apr. 30, 2015

Loss Contingencies [Line Items]

Cases brought against PM 3 2

Subsequent Event [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Italy [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

X

- Definition
Cases Brought Against Company
+ References
No definition available.
+ Details

Name: pm_CasesBroughtAgainstCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_IndividualLightsCasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_IT

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 83 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Public Civil Actions) (Details) - Public Civil Actions [Member] - litigation_case

Apr. 25, 2017

Apr. 22, 2016

Apr. 30, 2015

Loss Contingencies [Line Items]

Cases brought against PM 3 2

Subsequent Event [Member]

Loss Contingencies [Line Items]

Cases brought against PM 2

Subsequent Event [Member] | Argentina [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

Subsequent Event [Member] | Venezuela [Member]

Loss Contingencies [Line Items]

Cases brought against PM 1

X

- Definition
Cases Brought Against Company
+ References
No definition available.
+ Details

Name: pm_CasesBroughtAgainstCompany

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_PublicCivilActionsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_AR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_VE

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 84 R62.htm IDEA: XBRL DOCUMENT v3.7.0.1

Contingencies (Other Litigation) (Details) - Other Litigation [Member]
$ in Millions, ₩ in Billions, THB in Billions
3 Months Ended 5 Months Ended 12 Months Ended

Jan. 26, 2017

THB

import_entry

Jan. 26, 2017

USD ($)

import_entry

Jan. 18, 2016

THB

import_entry

defendant

Jan. 18, 2016

USD ($)

import_entry

defendant

Mar. 31, 2017

KRW (₩)

Mar. 31, 2017

USD ($)

Mar. 31, 2017

KRW (₩)

Mar. 31, 2017

USD ($)

Dec. 31, 2016

KRW (₩)

Dec. 31, 2016

USD ($)

Thailand [Member] | The Department of Special Investigations of the Government of Thailand [Member]

Loss Contingencies [Line Items]

Number of import entries 780 780

Loss contingency, damages sought, value THB 19.8 $ 575

Thailand [Member] | The Department of Special Investigations of the Government of Thailand [Member] | Pending Litigation [Member]

Loss Contingencies [Line Items]

Number of defendants | defendant 8 8

Number of import entries 272 272

Damages sought, value THB 80.8 $ 2,350

Korea [Member] | The South Korean Board Of Audit And Inspection [Member]

Loss Contingencies [Line Items]

Amounts paid ₩ 172 $ 152 ₩ 272 $ 240 ₩ 100 $ 88

X

- Definition
The monetary value related to fines, demanded payments or other legal matters sought by government and other governmental authorities.
+ References
No definition available.
+ Details

Name: pm_LossContingencyFinesOrDemandedPaymentsSought

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of Import Entries alleged to have under declared prices to avoid full- payment of excise taxes.
+ References
No definition available.
+ Details

Name: pm_LossContingencyNumberofImportEntries

Namespace Prefix: pm_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Definition
The amount of cash paid for the fines, demanded notices or for other legal issues during the period.
+ References
No definition available.
+ Details

Name: pm_PaymentsForFinesDemandedNoticesOrOtherLegalIssues

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingenciesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
The value (monetary amount) of the award the plaintiff seeks in the legal matter.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 9
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14557-108349

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349
+ Details

Name: us-gaap_LossContingencyDamagesSoughtValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Number of defendants named in a legal action.
+ References
No definition available.
+ Details

Name: us-gaap_LossContingencyNumberOfDefendants

Namespace Prefix: us-gaap_

Data Type: xbrli:integerItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LossContingenciesByNatureOfContingencyAxis=pm_OtherLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_TH

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheDepartmentofSpecialInvestigationsoftheGovernmentofThailandMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_KR

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LitigationCaseAxis=pm_TheSouthKoreanBoardOfAuditAndInspectionMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 85 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1

Income Taxes (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Dec. 31, 2017

Income Taxes [Line Items]

Effective tax rate 24.90% 28.30%

Tax benefit from legal entity restructuring $ 61

United States [Member]

Income Taxes [Line Items]

Open Tax Year 2013 and onward

Scenario, Forecast [Member]

Income Taxes [Line Items]

Effective tax rate 28.00%

X

- Definition
Income Taxes [Line Items]
+ References
No definition available.
+ Details

Name: pm_IncomeTaxesLineItems

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Open Tax Years By Major Jurisdiction
+ References
No definition available.
+ Details

Name: pm_OpenTaxYearsByMajorJurisdiction

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32698-109319

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(2))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32687-109319
+ Details

Name: us-gaap_EffectiveIncomeTaxRateContinuingOperations

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of other income tax expense (benefit).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32639-109319

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=65882285&loc=d3e32672-109319
+ Details

Name: us-gaap_OtherTaxExpenseBenefit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=country_US

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 86 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness (Narrative) (Details) - USD ($)

Oct. 01, 2020

Mar. 31, 2017

Jan. 27, 2017

Dec. 31, 2016

Line of Credit Facility [Line Items]

Short-term borrowings, carrying value $ 1,004,000,000 $ 643,000,000

Committed credit facilities 8,000,000,000

Borrowings under committed credit facilities 0

Revolving Credit Expiring February 6, 2018 [Member]

Line of Credit Facility [Line Items]

Committed credit facilities $ 2,000,000,000 $ 2,000,000,000

Scenario, Forecast [Member] | Multi-year revolving credit, expiring October 1, 2021 [Member]

Line of Credit Facility [Line Items]

Committed credit facilities $ 3,350,000,000.00

X

- Definition
The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(16))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(16))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878
+ Details

Name: us-gaap_LineOfCredit

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(19)(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(13))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-03(a)(16)(a)(1))
-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910
+ Details

Name: us-gaap_ShortTermBorrowings

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=pm_RevolvingCreditExpiringFebruarySixthTwoThousandEighteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementScenarioAxis=us-gaap_ScenarioForecastMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=pm_MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 87 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness (Long-Term Debt) (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Dec. 31, 2016

Debt Instrument [Line Items]

Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 30,342 $ 28,424

Less current portion of long-term debt 1,754 2,573

Long-term Debt 28,588 25,851

U.S. Dollar Notes [Member]

Debt Instrument [Line Items]

Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 21,796 19,857

Interest rate, average 3.52%

Due through 2044

U.S. Dollar Notes [Member] | Minimum [Member]

Debt Instrument [Line Items]

Interest rate 1.125%

U.S. Dollar Notes [Member] | Maximum [Member]

Debt Instrument [Line Items]

Interest rate 6.375%

Euro Notes [Member] | Foreign Currency Obligations [Member]

Debt Instrument [Line Items]

Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 7,032 6,828

Interest rate, average 2.402%

Due through 2036

Euro Notes [Member] | Foreign Currency Obligations [Member] | Minimum [Member]

Debt Instrument [Line Items]

Interest rate 1.75%

Euro Notes [Member] | Foreign Currency Obligations [Member] | Maximum [Member]

Debt Instrument [Line Items]

Interest rate 3.125%

Swiss Franc Notes [Member] | Foreign Currency Obligations [Member]

Debt Instrument [Line Items]

Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 1,354 1,312

Interest rate, average 1.269%

Due through 2024

Swiss Franc Notes [Member] | Foreign Currency Obligations [Member] | Minimum [Member]

Debt Instrument [Line Items]

Interest rate 0.75%

Swiss Franc Notes [Member] | Foreign Currency Obligations [Member] | Maximum [Member]

Debt Instrument [Line Items]

Interest rate 2.00%

Other [Member] | Foreign Currency Obligations [Member]

Debt Instrument [Line Items]

Long-term Debt and Capital Lease Obligations, Including Current Maturities $ 160 $ 427

Interest rate, average 3.586%

Due through 2024

X

- Definition
The average effective interest rate during the reporting period.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateDuringPeriod

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: duration

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentMaturityDateDescription

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of long-term debt and capital lease obligation due after one year or beyond the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(22))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtAndCapitalLeaseObligations

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt and capital leases due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of long-term debt and capital lease obligations including current maturities.
+ References
No definition available.
+ Details

Name: us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_UsDollarNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_EuroNotesPayableMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=pm_ForeignCurrencyObligationsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_SwissFrancNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=us-gaap_NotesPayableOtherPayablesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 88 R66.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness (Debt Issuances During Current Period) (Details) - US Dollar Notes [Member]
3 Months Ended

Mar. 31, 2017

USD ($)

1.625% US Dollar Notes Due February 2019 [Member]

Debt Instrument [Line Items]

Face Value $ 700,000,000

Interest Rate 1.625%

Issuance Feb. 01, 2017

Maturity Feb. 28, 2019

Floating Rate US Dollar Notes Due February 2020 [Member]

Debt Instrument [Line Items]

Face Value $ 300,000,000

Issuance Feb. 01, 2017

Maturity Feb. 29, 2020

2.000% US Dollar Notes Due February 2020 [Member]

Debt Instrument [Line Items]

Face Value $ 1,000,000,000

Interest Rate 2.00%

Issuance Feb. 01, 2017

Maturity Feb. 29, 2020

2.625% US Dollar Notes Due February 2022 [Member]

Debt Instrument [Line Items]

Face Value $ 500,000,000

Interest Rate 2.625%

Issuance Feb. 01, 2017

Maturity Feb. 28, 2022

X

- Definition
Face (par) amount of debt instrument at time of issuance.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399
+ Details

Name: us-gaap_DebtInstrumentFaceAmount

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Contractual interest rate for funds borrowed, under the debt agreement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(1))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentInterestRateStatedPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Date the debt instrument was issued, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentIssuanceDate1

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_DebtInstrumentLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_DebtInstrumentMaturityDate

Namespace Prefix: us-gaap_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_LongtermDebtTypeAxis=pm_UsDollarNotesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_OnePointSixTwoFivePercentUSDollarNotesDueFebruary2019Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_FloatingRateUSDollarNotesDueFebruary2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_TwoPointZeroPercentUSDollarNotesDueFebruary2020Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_DebtInstrumentAxis=pm_TwoPointSixTwoFivePercentUSDollarNotesDueFebruary2022Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 89 R67.htm IDEA: XBRL DOCUMENT v3.7.0.1

Indebtedness (Credit Facilities) (Details) - USD ($)

Mar. 31, 2017

Jan. 27, 2017

Line of Credit Facility [Line Items]

Committed credit facilities $ 8,000,000,000

Revolving Credit Expiring February 6, 2018 [Member]

Line of Credit Facility [Line Items]

Committed credit facilities 2,000,000,000 $ 2,000,000,000

Multi-year revolving credit, expiring February 28, 2021 [Member]

Line of Credit Facility [Line Items]

Committed credit facilities 2,500,000,000

Multi-year revolving credit, expiring October 1, 2020 [Member]

Line of Credit Facility [Line Items]

Committed credit facilities $ 3,500,000,000

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_LineOfCreditFacilityLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=pm_RevolvingCreditExpiringFebruarySixthTwoThousandEighteenMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=pm_MultiYearRevolvingCreditExpiringFebruaryTwentyEighthTwoThousandTwentyOneMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_LineOfCreditFacilityAxis=pm_MultiYearRevolvingCreditExpiringOctoberFirstTwoThousandTwentyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 90 R68.htm IDEA: XBRL DOCUMENT v3.7.0.1

Fair Value Measurements (Narrative) (Details)
$ in Millions

Mar. 31, 2017

USD ($)

Fair Value Disclosures [Abstract]

Capital lease obligations, carrying value $ 13

Debt excluding short-term borrowings and capital lease obligations, carrying value $ 30,329

X

- Definition
Sum of the carrying values as of the balance sheet date of total debt, excluding short term borrowings and capital lease obligations.
+ References
No definition available.
+ Details

Name: pm_TotalDebtExcludingShortTermBorrowingsAndCapitalLeaseObligations

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 840
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6455314&loc=d3e45023-112735

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_CapitalLeaseObligationsNoncurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_FairValueDisclosuresAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 91 R69.htm IDEA: XBRL DOCUMENT v3.7.0.1

Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details)
$ in Millions

Mar. 31, 2017

USD ($)

Quoted Prices in Active Markets for Identical Assets/Liabilities (Level 1) [Member]

Assets:

Foreign exchange contracts $ 0

Total assets 0

Liabilities:

Debt 31,834

Foreign exchange contracts 0

Total liabilities 31,834

Significant Other Observable Inputs (Level 2) [Member]

Assets:

Foreign exchange contracts 480

Total assets 480

Liabilities:

Debt 171

Foreign exchange contracts 207

Total liabilities 378

Significant Unobservable Inputs (Level 3) [Member]

Assets:

Foreign exchange contracts 0

Total assets 0

Liabilities:

Debt 0

Foreign exchange contracts 0

Total liabilities 0

Fair Value [Member]

Assets:

Foreign exchange contracts 480

Total assets 480

Liabilities:

Debt 32,005

Foreign exchange contracts 207

Total liabilities $ 32,212

X

- Definition
Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_AssetsFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_AssetsFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13476-108611
+ Details

Name: us-gaap_DebtInstrumentFairValue

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13495-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313
+ Details

Name: us-gaap_DerivativeAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13495-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958
+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of financial and nonfinancial obligations.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66048111&loc=d3e19207-110258
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosure

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_LiabilitiesFairValueDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 92 R70.htm IDEA: XBRL DOCUMENT v3.7.0.1

Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Mar. 31, 2016

Dec. 31, 2015

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Total accumulated other comprehensive losses $ (10,557) $ (10,900) $ (10,894) $ (11,476)

Currency translation adjustments [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Total accumulated other comprehensive losses (5,783) (6,091) (5,617)

Pension and other benefits [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Total accumulated other comprehensive losses (3,509) (3,565) (3,287)

Derivatives accounted for as hedges [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Total accumulated other comprehensive losses 27 97 (10)

Accumulated Other Comprehensive Losses [Member]

Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]

Total accumulated other comprehensive losses $ (9,265) $ (9,559) $ (8,914) $ (9,402)

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ReclassificationAdjustmentOutOfAccumulatedOtherComprehensiveIncomeOnDerivativesLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI http://asc.fasb.org/extlink&oid=65897068&loc=SL4590271-111686

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568740-111683

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=68079674&loc=SL4568447-111683
+ Details

Name: us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 93 R71.htm IDEA: XBRL DOCUMENT v3.7.0.1

Balance Sheet Offsetting (Details) - Foreign Exchange Contract [Member] - USD ($)
$ in Millions

Mar. 31, 2017

Dec. 31, 2016

Assets

Gross Amounts Recognized $ 480 $ 813

Gross Amount Offset in the Condensed Consolidated Balance Sheet 0 0

Net Amounts Presented in the Condensed Consolidated Balance Sheet 480 813

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments (170) (126)

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged (258) (607)

Net Amount 52 80

Liabilities

Gross Amounts Recognized 207 163

Gross Amount Offset in the Condensed Consolidated Balance Sheet 0 0

Net Amounts Presented in the Condensed Consolidated Balance Sheet 207 163

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Financial Instruments (170) (126)

Gross Amounts Not Offset in the Condensed Consolidated Balance Sheet, Cash Collateral Received/Pledged (11) (31)

Net Amount $ 26 $ 6

X

- Definition
Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226003-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959
+ Details

Name: us-gaap_DerivativeAssetFairValueGrossLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (d)(1)(i)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_DerivativeAssetNotOffsetPolicyElectionDeduction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13495-108611

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313
+ Details

Name: us-gaap_DerivativeAssets

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of obligation to return cash collateral under master netting arrangements that have not been offset against derivative assets.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41678-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313
+ Details

Name: us-gaap_DerivativeCollateralObligationToReturnCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Amount of right to receive cash collateral under master netting arrangements that have not been offset against derivative liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (d)(2)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41678-113959
+ Details

Name: us-gaap_DerivativeCollateralRightToReclaimCash

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4D
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=64830801&loc=SL51823488-111719
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, after effects of master netting arrangements, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against an obligation to return collateral. Includes assets not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41678-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 20
-Section 50
-Paragraph 4D
-Subparagraph (c)(2)
-URI http://asc.fasb.org/extlink&oid=64830801&loc=SL51823488-111719

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226000-175313
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeLiability

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after effects of master netting arrangements, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset offset against the right to receive collateral. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 8
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=d3e41678-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (e)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226008-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13495-108611

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=73719730&loc=d3e13433-108611

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41271-113958

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958
+ Details

Name: us-gaap_DerivativeLiabilities

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: instant

X

- Definition
Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226003-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=64837297&loc=SL5624163-113959
+ Details

Name: us-gaap_DerivativeLiabilityFairValueGrossAsset

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Fair value of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be offset, deducted from derivative liabilities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 55
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=51825145&loc=SL20226016-175313

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 20
-Section 50
-Paragraph 3
-Subparagraph (d)(1)(i)
-URI http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312
+ Details

Name: us-gaap_DerivativeLiabilityNotOffsetPolicyElectionDeduction

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- References
No definition available.
+ Details

Name: us-gaap_OffsettingDerivativeAssetsAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: us-gaap_OffsettingDerivativeLiabilitiesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 94 R72.htm IDEA: XBRL DOCUMENT v3.7.0.1

Investments in Unconsolidated Subsidiaries (Narrative) (Details) - USD ($)
3 Months Ended 12 Months Ended

Mar. 31, 2017

Dec. 31, 2016

Schedule of Equity Method Investments [Line Items]

Investments in unconsolidated subsidiaries $ 1,079,000,000 $ 1,011,000,000

Difference between equity method investment carrying value and book value 900,000,000 867,000,000

Dividends from unconsolidated subsidiaries $ 0 117,000,000

Minimum [Member]

Schedule of Equity Method Investments [Line Items]

Difference between equity method investment carrying value and book value, amortization period 4 years

Maximum [Member]

Schedule of Equity Method Investments [Line Items]

Difference between equity method investment carrying value and book value, amortization period 20 years

Equity Method Investment Goodwill [Member]

Schedule of Equity Method Investments [Line Items]

Investments in unconsolidated subsidiaries $ 844,000,000 $ 810,000,000

EITA [Member]

Schedule of Equity Method Investments [Line Items]

Ownership percentage 49.00%

STAEM [Member]

Schedule of Equity Method Investments [Line Items]

Ownership percentage 25.00%

EITA Ownership Percentage in Société des Tabacs Algéro-Emiratie (“STAEM”) [Member] | Joint Venture [Member]

Schedule of Equity Method Investments [Line Items]

Ownership percentage 51.00%

Societe Nationale des Tabacs et Allumettes SpA [Member] | Joint Venture [Member]

Schedule of Equity Method Investments [Line Items]

Ownership percentage 49.00%

Megapolis [Member]

Schedule of Equity Method Investments [Line Items]

Ownership percentage 20.00%

X

- Definition
Equity Method Investment, Difference Between Carrying Amount and Underlying Equity, Amortization Period
+ References
No definition available.
+ Details

Name: pm_EquityMethodInvestmentDifferenceBetweenCarryingAmountandUnderlyingEquityAmortizationPeriod

Namespace Prefix: pm_

Data Type: xbrli:durationItemType

Balance Type: na

Period Type: duration

X

- Definition
Difference between amount at which an investment accounted for under the equity method of accounting is carried (reported) on the balance sheet and amount of underlying equity in net assets the reporting Entity has in the investee.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(3)
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
This item represents disclosure of the amount of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporation; these investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(10))
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(12))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688
+ Details

Name: us-gaap_EquityMethodInvestmentDividendsOrDistributions

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571
+ Details

Name: us-gaap_EquityMethodInvestmentOwnershipPercentage

Namespace Prefix: us-gaap_

Data Type: num:percentItemType

Balance Type: na

Period Type: instant

X

- Definition
Total investments in (A) an entity in which the entity has significant influence, but does not have control, (B) subsidiaries that are not required to be consolidated and are accounted for using the equity and or cost method, and (C) an entity in which the reporting entity shares control of the entity with another party or group. Includes long-term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.12)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682
+ Details

Name: us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MinimumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_RangeAxis=us-gaap_MaximumMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_EquityMethodInvestmentGoodwillMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_EITAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_STAEMMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_EITAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: dei_LegalEntityAxis=us-gaap_CorporateJointVentureMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_SocieteNationaledesTabacsetAllumettesSpAOwnershipPercentageinSocitdesTabacsAlgroEmiratieSTAEMMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=pm_MegapolisMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 95 R73.htm IDEA: XBRL DOCUMENT v3.7.0.1

Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) - Eastern Europe Middle East And Africa [Member] - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Dec. 31, 2016

Schedule of Equity Method Investments [Line Items]

Net revenues $ 840 $ 777

Receivables $ 394 $ 289

X

- Definition
Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.3(a)(2))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(k)(1))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 850
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6457730&loc=d3e39622-107864
+ Details

Name: us-gaap_AccountsReceivableRelatedPartiesCurrent

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

X

- Definition
Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1(e))
-URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Related Parties
-URI http://asc.fasb.org/extlink&oid=16382449

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 946
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07.1(c))
-URI http://asc.fasb.org/extlink&oid=6488393&loc=d3e606610-122999
+ Details

Name: us-gaap_RevenueFromRelatedParties

Namespace Prefix: us-gaap_

Data Type: xbrli:monetaryItemType

Balance Type: credit

Period Type: duration

X

- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details

Name: us-gaap_ScheduleOfEquityMethodInvestmentsLineItems

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_StatementGeographicalAxis=pm_EasternEuropeMiddleEastAndAfricaMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 96 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1

Sale of Accounts Receivable (Details) - USD ($)
$ in Millions
3 Months Ended

Mar. 31, 2017

Mar. 31, 2016

Sale of Accounts Receivable [Abstract]

Trade receivables sold and derecognized from the Consolidated Balance Sheets $ 2,092 $ 1,946

Trade receivables sold and derecognized that remain uncollected $ 561 $ 589

X

- Definition
Sale of Accounts Receivable [Abstract]
+ References
No definition available.
+ Details

Name: pm_SaleofAccountsReceivableAbstract

Namespace Prefix: pm_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
Trade receivables sold without recourse to unaffiliated financial institutions and derecognized from the consolidated balance sheets.
+ References
No definition available.
+ Details

Name: pm_TradeReceivableSoldandDerecognizedfromtheConsolidatedBalanceSheets

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: duration

X

- Definition
Trade accounts receivable sold and derecognized from the consolidated balance sheets that remain uncollected by unaffiliated financial institutions.
+ References
No definition available.
+ Details

Name: pm_TradeReceivablesSoldandDerecognizedthatRemainedUncollected

Namespace Prefix: pm_

Data Type: xbrli:monetaryItemType

Balance Type: debit

Period Type: instant

EXCEL 97 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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άTV!NX]@5B!SAI-(* X45XUCM3WO7,R MI0!XON=HSE>MG[UB+=""E1J1J*S#^[B*G^:@EH;_\PWI8MEM M^,U?6)+#!5;*Y4=SZ-5YO-R;4XY2;P(9KEG%)D HJ M5LX8CH2-)R]T)$3M:-^AWPXE2$;$"0HCWB%"! ?3#H[E%R?F#ZCO78KO#("S M3N#YD7Y>_2*5 DU P%60 ;'S &[&\ )LCI]3X^\):M<*!S4Z)=HXFR6^H?M! M,AU>*,.=-K8V(?0.52VL:A:6QWIKY_]NT=0U$"#P=K)@7^G(%/M3ZS"L7UVZ MXR;@G#@YH-O&$7Z*,3J24KC_B!0[I_Q>KG!GH(%A37DR-,T_&DK>#7\?+!89 MFNO=5/(!RH? 9.49?G=X#"+<2'UHOS#H#[Q1YW+12O; )0_Z4Z*_[>L%JFZ^ MEY< A>KK5**HFT6_M*!#I3EQUA"G)PVF-7Y(V5-- DN*- MV<3CPNX[IF^I@MSU:4WUC8U9\69JJOJGYVC=TB<8NTEQM'=-34H4P"OH)NT> M[^0F6G=GS^T?29K<#(L&5.+ 4?R<<&,JV!L&SE@:XQCO=/MHGWT8DP;^5 4A" M)*%4*,<]K$%*@*%6M*%*AKY.=_3]U7#IY('IWRDTK3!DUA)@"(+LSZBFQG0(/QG/8L*SJFBRAZ4T]KB21BUU4TUD68_;#%)!O%"&5&QA M$^31@B6>*"[QW%^<7=1+&*B'EO*0WIDQ&>H\IK,+'8)%$M-"9@R7EAVUM0C* MCG>%X&8(>25I#OU')$P?]T6H[G.M:Y,NQ'`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end XML 98 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 99 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 101 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 282 278 1 false 123 0 false 20 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.pmi.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 1001501 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1002000 - Statement - Condensed Consolidated Statements of Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfEarnings Condensed Consolidated Statements of Earnings Statements 4 false false R5.htm 1003000 - Statement - Condensed Consolidated Statements of Comprehensive Earnings Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarnings Condensed Consolidated Statements of Comprehensive Earnings Statements 5 false false R6.htm 1003001 - Statement - Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfComprehensiveEarningsParenthetical Condensed Consolidated Statements of Comprehensive Earnings (Parenthetical) Statements 6 false false R7.htm 1004000 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquity Condensed Consolidated Statements of Stockholders' (Deficit) Equity Statements 7 false false R8.htm 1004501 - Statement - Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfStockholdersDeficitEquityParenthetical Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) Statements 8 false false R9.htm 1005000 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.pmi.com/role/CondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 9 false false R10.htm 2102100 - Disclosure - Background and Basis of Presentation Sheet http://www.pmi.com/role/BackgroundAndBasisOfPresentation Background and Basis of Presentation Notes 10 false false R11.htm 2104100 - Disclosure - Stock Plans Sheet http://www.pmi.com/role/StockPlans Stock Plans Notes 11 false false R12.htm 2105100 - Disclosure - Benefit Plans Sheet http://www.pmi.com/role/BenefitPlans Benefit Plans Notes 12 false false R13.htm 2106100 - Disclosure - Goodwill and Other Intangible Assets, net Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet Goodwill and Other Intangible Assets, net Notes 13 false false R14.htm 2107100 - Disclosure - Financial Instruments Sheet http://www.pmi.com/role/FinancialInstruments Financial Instruments Notes 14 false false R15.htm 2108100 - Disclosure - Earnings Per Share Sheet http://www.pmi.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 2110100 - Disclosure - Segment Reporting Sheet http://www.pmi.com/role/SegmentReporting Segment Reporting Notes 16 false false R17.htm 2111100 - Disclosure - Contingencies Sheet http://www.pmi.com/role/Contingencies Contingencies Notes 17 false false R18.htm 2112100 - Disclosure - Income Taxes Sheet http://www.pmi.com/role/IncomeTaxes Income Taxes Notes 18 false false R19.htm 2113100 - Disclosure - Indebtedness Sheet http://www.pmi.com/role/Indebtedness Indebtedness Notes 19 false false R20.htm 2114100 - Disclosure - Fair Value Measurements Sheet http://www.pmi.com/role/FairValueMeasurements Fair Value Measurements Notes 20 false false R21.htm 2115100 - Disclosure - Accumulated Other Comprehensive Losses Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses Accumulated Other Comprehensive Losses Notes 21 false false R22.htm 2116100 - Disclosure - Balance Sheet Offsetting Sheet http://www.pmi.com/role/BalanceSheetOffsetting Balance Sheet Offsetting Notes 22 false false R23.htm 2117100 - Disclosure - Investments in Unconsolidated Subsidiaries Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries Investments in Unconsolidated Subsidiaries Notes 23 false false R24.htm 2118100 - Disclosure - Sale of Accounts Receivable Sheet http://www.pmi.com/role/SaleOfAccountsReceivable Sale of Accounts Receivable Notes 24 false false R25.htm 2119100 - Disclosure - New Accounting Standards Sheet http://www.pmi.com/role/NewAccountingStandards New Accounting Standards Notes 25 false false R26.htm 2219201 - Disclosure - New Accounting Standards (Policies) Sheet http://www.pmi.com/role/NewAccountingStandardsPolicies New Accounting Standards (Policies) Policies http://www.pmi.com/role/NewAccountingStandards 26 false false R27.htm 2304301 - Disclosure - Stock Plans (Tables) Sheet http://www.pmi.com/role/StockPlansTables Stock Plans (Tables) Tables http://www.pmi.com/role/StockPlans 27 false false R28.htm 2305301 - Disclosure - Benefit Plans (Tables) Sheet http://www.pmi.com/role/BenefitPlansTables Benefit Plans (Tables) Tables http://www.pmi.com/role/BenefitPlans 28 false false R29.htm 2306301 - Disclosure - Goodwill and Other Intangible Assets, net (Tables) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables Goodwill and Other Intangible Assets, net (Tables) Tables http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNet 29 false false R30.htm 2307301 - Disclosure - Financial Instruments (Tables) Sheet http://www.pmi.com/role/FinancialInstrumentsTables Financial Instruments (Tables) Tables http://www.pmi.com/role/FinancialInstruments 30 false false R31.htm 2308301 - Disclosure - Earnings Per Share (Tables) Sheet http://www.pmi.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.pmi.com/role/EarningsPerShare 31 false false R32.htm 2310301 - Disclosure - Segment Reporting (Tables) Sheet http://www.pmi.com/role/SegmentReportingTables Segment Reporting (Tables) Tables http://www.pmi.com/role/SegmentReporting 32 false false R33.htm 2311301 - Disclosure - Contingencies (Tables) Sheet http://www.pmi.com/role/ContingenciesTables Contingencies (Tables) Tables http://www.pmi.com/role/Contingencies 33 false false R34.htm 2313301 - Disclosure - Indebtedness (Tables) Sheet http://www.pmi.com/role/IndebtednessTables Indebtedness (Tables) Tables http://www.pmi.com/role/Indebtedness 34 false false R35.htm 2314301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.pmi.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.pmi.com/role/FairValueMeasurements 35 false false R36.htm 2315301 - Disclosure - Accumulated Other Comprehensive Losses (Tables) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables Accumulated Other Comprehensive Losses (Tables) Tables http://www.pmi.com/role/AccumulatedOtherComprehensiveLosses 36 false false R37.htm 2316301 - Disclosure - Balance Sheet Offsetting (Tables) Sheet http://www.pmi.com/role/BalanceSheetOffsettingTables Balance Sheet Offsetting (Tables) Tables http://www.pmi.com/role/BalanceSheetOffsetting 37 false false R38.htm 2317301 - Disclosure - Investments in Unconsolidated Subsidiaries (Tables) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables Investments in Unconsolidated Subsidiaries (Tables) Tables http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiaries 38 false false R39.htm 2404402 - Disclosure - Stock Plans (Narrative) (Details) Sheet http://www.pmi.com/role/StockPlansNarrativeDetails Stock Plans (Narrative) (Details) Details http://www.pmi.com/role/StockPlansTables 39 false false R40.htm 2404403 - Disclosure - Stock Plans (RSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansRsuAwardsDetails Stock Plans (RSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 40 false false R41.htm 2404404 - Disclosure - Stock Plans (PSU Awards) (Details) Sheet http://www.pmi.com/role/StockPlansPsuAwardsDetails Stock Plans (PSU Awards) (Details) Details http://www.pmi.com/role/StockPlansTables 41 false false R42.htm 2405402 - Disclosure - Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Sheet http://www.pmi.com/role/BenefitPlansComponentsOfNetPeriodicBenefitCostDetails Benefit Plans (Components of Net Periodic Benefit Cost) (Details) Details http://www.pmi.com/role/BenefitPlansTables 42 false false R43.htm 2405403 - Disclosure - Benefit Plans (Narrative) (Details) Sheet http://www.pmi.com/role/BenefitPlansNarrativeDetails Benefit Plans (Narrative) (Details) Details http://www.pmi.com/role/BenefitPlansTables 43 false false R44.htm 2406402 - Disclosure - Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetGoodwillAndOtherIntangibleAssetsBySegmentDetails Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 44 false false R45.htm 2406403 - Disclosure - Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetMovementInGoodwillDetails Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 45 false false R46.htm 2406404 - Disclosure - Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetOtherIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 46 false false R47.htm 2406405 - Disclosure - Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetRangeOfUsefulLivesAndWeightedAverageRemainingUsefulLivesOfAmortizableIntangibleAssetsDetails Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 47 false false R48.htm 2406406 - Disclosure - Goodwill and Other Intangible Assets, net (Narrative) (Details) Sheet http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetNarrativeDetails Goodwill and Other Intangible Assets, net (Narrative) (Details) Details http://www.pmi.com/role/GoodwillAndOtherIntangibleAssetsNetTables 48 false false R49.htm 2407402 - Disclosure - Financial Instruments (Narrative) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsNarrativeDetails Financial Instruments (Narrative) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 49 false false R50.htm 2407403 - Disclosure - Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsFairValueOfForeignExchangeContractsDetails Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 50 false false R51.htm 2407404 - Disclosure - Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsCashFlowAndNetInvestmentHedgingActivitiesEffectOnCondensedConsolidatedStatementsOfEarningsAndOtherComprehensiveEarningsDetails Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 51 false false R52.htm 2407405 - Disclosure - Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Sheet http://www.pmi.com/role/FinancialInstrumentsQualifyingHedgingActivityReportedInAccumulatedOtherComprehensiveEarningsLossesNetOfIncomeTaxesDetails Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) Details http://www.pmi.com/role/FinancialInstrumentsTables 52 false false R53.htm 2408402 - Disclosure - Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Sheet http://www.pmi.com/role/EarningsPerShareCalculationOfBasicAndDilutedEpsDetails Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) Details http://www.pmi.com/role/EarningsPerShareTables 53 false false R54.htm 2410402 - Disclosure - Segment Reporting (Details) Sheet http://www.pmi.com/role/SegmentReportingDetails Segment Reporting (Details) Details http://www.pmi.com/role/SegmentReportingTables 54 false false R55.htm 2411402 - Disclosure - Contingencies (Tobacco-Related Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesTobaccoRelatedLitigationDetails Contingencies (Tobacco-Related Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 55 false false R56.htm 2411403 - Disclosure - Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Sheet http://www.pmi.com/role/ContingenciesNumberOfTobaccoRelatedCasesPendingAgainstUsAndOrOurSubsidiariesOrIndemniteesDetails Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) Details http://www.pmi.com/role/ContingenciesTables 56 false false R57.htm 2411404 - Disclosure - Contingencies (Verdicts and Post-Trial Developments) (Details) Sheet http://www.pmi.com/role/ContingenciesVerdictsAndPostTrialDevelopmentsDetails Contingencies (Verdicts and Post-Trial Developments) (Details) Details http://www.pmi.com/role/ContingenciesTables 57 false false R58.htm 2411405 - Disclosure - Contingencies (Smoking And Health Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesSmokingAndHealthLitigationDetails Contingencies (Smoking And Health Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 58 false false R59.htm 2411406 - Disclosure - Contingencies (Health Care Cost Recovery Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesHealthCareCostRecoveryLitigationDetails Contingencies (Health Care Cost Recovery Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 59 false false R60.htm 2411407 - Disclosure - Contingencies (Lights Cases) (Details) Sheet http://www.pmi.com/role/ContingenciesLightsCasesDetails Contingencies (Lights Cases) (Details) Details http://www.pmi.com/role/ContingenciesTables 60 false false R61.htm 2411408 - Disclosure - Contingencies (Public Civil Actions) (Details) Sheet http://www.pmi.com/role/ContingenciesPublicCivilActionsDetails Contingencies (Public Civil Actions) (Details) Details http://www.pmi.com/role/ContingenciesTables 61 false false R62.htm 2411409 - Disclosure - Contingencies (Other Litigation) (Details) Sheet http://www.pmi.com/role/ContingenciesOtherLitigationDetails Contingencies (Other Litigation) (Details) Details http://www.pmi.com/role/ContingenciesTables 62 false false R63.htm 2412401 - Disclosure - Income Taxes (Details) Sheet http://www.pmi.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.pmi.com/role/IncomeTaxes 63 false false R64.htm 2413402 - Disclosure - Indebtedness (Narrative) (Details) Sheet http://www.pmi.com/role/IndebtednessNarrativeDetails Indebtedness (Narrative) (Details) Details http://www.pmi.com/role/IndebtednessTables 64 false false R65.htm 2413403 - Disclosure - Indebtedness (Long-Term Debt) (Details) Sheet http://www.pmi.com/role/IndebtednessLongTermDebtDetails Indebtedness (Long-Term Debt) (Details) Details http://www.pmi.com/role/IndebtednessTables 65 false false R66.htm 2413404 - Disclosure - Indebtedness (Debt Issuances During Current Period) (Details) Sheet http://www.pmi.com/role/IndebtednessDebtIssuancesDuringCurrentPeriodDetails Indebtedness (Debt Issuances During Current Period) (Details) Details http://www.pmi.com/role/IndebtednessTables 66 false false R67.htm 2413405 - Disclosure - Indebtedness (Credit Facilities) (Details) Sheet http://www.pmi.com/role/IndebtednessCreditFacilitiesDetails Indebtedness (Credit Facilities) (Details) Details http://www.pmi.com/role/IndebtednessTables 67 false false R68.htm 2414402 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 68 false false R69.htm 2414403 - Disclosure - Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Sheet http://www.pmi.com/role/FairValueMeasurementsAggregateFairValueOfDerivativeFinancialInstrumentsDebtAndContingentConsiderationDetails Fair Value Measurements (Aggregate Fair Value of Derivative Financial Instruments, Debt and Contingent Consideration) (Details) Details http://www.pmi.com/role/FairValueMeasurementsTables 69 false false R70.htm 2415402 - Disclosure - Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Sheet http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesComponentsOfAccumulatedOtherComprehensiveEarningsLossesNetOfTaxDetails Accumulated Other Comprehensive Losses (Components of Accumulated Other Comprehensive Earnings (Losses), Net of Tax) (Details) Details http://www.pmi.com/role/AccumulatedOtherComprehensiveLossesTables 70 false false R71.htm 2416402 - Disclosure - Balance Sheet Offsetting (Details) Sheet http://www.pmi.com/role/BalanceSheetOffsettingDetails Balance Sheet Offsetting (Details) Details http://www.pmi.com/role/BalanceSheetOffsettingTables 71 false false R72.htm 2417402 - Disclosure - Investments in Unconsolidated Subsidiaries (Narrative) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesNarrativeDetails Investments in Unconsolidated Subsidiaries (Narrative) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 72 false false R73.htm 2417403 - Disclosure - Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Sheet http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesBalanceSheetAndEarningsActivityDetails Investments in Unconsolidated Subsidiaries (Balance sheet and earnings activity) (Details) Details http://www.pmi.com/role/InvestmentsInUnconsolidatedSubsidiariesTables 73 false false R74.htm 2418401 - Disclosure - Sale of Accounts Receivable (Details) Sheet http://www.pmi.com/role/SaleOfAccountsReceivableDetails Sale of Accounts Receivable (Details) Details http://www.pmi.com/role/SaleOfAccountsReceivable 74 false false All Reports Book All Reports pm-20170331.xml pm-20170331.xsd pm-20170331_cal.xml pm-20170331_def.xml pm-20170331_lab.xml pm-20170331_pre.xml true true ZIP 103 0001413329-17-000023-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001413329-17-000023-xbrl.zip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
Y:>VC[YRK!Y+;G'D!WX+<2^V5 TA. M53'R]&5V_4-R/?PR_<[Z\-,Y^5-*@'KC]()DZ3N&1C_ .B!2D; #Y=E1MAX MX@7/3-6^ 9WF3K*T K&I+7Q#8E_:"9(UI^?KYG\XE<9'5GT?[IX%WM+YQTN0 MDGM^JI&T[J[2Z8$?TO:8?I(N:=*VLC) M*I' )=W2>.2%U:M9/:M6;RWZ2+=YW/8F)#+G2^:TZ_5N0D?4#2;1^MQ8[Y)D M,LL;#(G@2+'Z# NKZY3*R!6'I8]:UKSDS!67+;(HZ:NU6L:.8%@EUZ9GBP-P MZ:%Z8S8>@"BG*S39L8L J$A^,7O^TRB0-ZK%(!G&GG<6@8TQY=Z4$^0Z39[, M)Y=R03A)IW2Y"IT=&Q,\^;"T2EHC?4-R@91]JJ4,,E$.-:&65; < ZM9$UVT MZC]J\V)*M*( [&3)?@.%YV.@EHF3X"D!E'KPH_0&)JR9=$[."9&7S"J/TG3/ M%NEJXDGMWBGPZI@K9Y3'$\96XR2A]_R:^3EBZ;R@)KJYB>$5F3ZLJ6*B=Y9H M=SJU5F,Q!PVGB#VV]Z5IE#L2:Q+ FOI9\JBT7^'5\AB4Q-$?9QR=UN-!N=EFGU7QN-W8J(VI6NP&KO^>BH2F%_( 5@ MC8LUU9815 "62_ KK+B<^KA00O?S=+EQETR4\-]OR5RY#<9F5/I;?9UWC;K)[;95F6EMZ-O MB14T+56AK<]#PE'J,^YC/ M^%<1B NMV^91Q6?TCZBF (H?K&Y;>[)^$N(:^S+>X<&'WU]$/#B!B/+A#C+H M^)$)^6D6^7!.9.YZ58M M#2:6873/$TE.WK,>_%3HCA[@GD%1!*'#*.V=BB?)=Z,F(Y_C"?31930:R8AH M00?MVQ.-+*SE,5:M MU^C6VDO*&FT%XWP@?2Z(+"'7E%&71ZNEJ0=2KE(J3I_V1-.^8[ED%!AS6D'750E U2I. 'K=?4*F*E30H6FL.3C0G1[/@$X M']Y^B^'M:#\<).GIB(#?H-6Z@N2E79%%R-_F9M6 ."Q4!9[8=^;$,H,]6\#E M+@MEWGJ8I"_)M0I[G!;URF[/5QH:4I74ERW>)"U,0N8R6""-DUS4)$-)I97" M,U3#:LGRD)JVO#N3R[NY[CG/0!I);:*Y[*_\-6,FU[5"U8#C(EJ61W^O#)Z[ M60D&\I5%<>B3T_N[KS\ERVQ94$ 6)'B!WX2Q,"D]M%C3P8G#D/G.\YG/XBA, M,E8G/X7.242:7X]!@JI+5Y"74YTRFH,+?JJS14S0B\#.K@63(\G@J M0=ZSA(ZEDF?2LK4P9:ZW069:$S'4R3YHBR449+I^A^4+[5Y M5?:>-'PSK0$BSOIO6-=6J\HUL$9FO4M>2?.BTY[+VE>RY%A2[$-+4X!#-2[- M%-'ETIMEIK*?$\>I',J^+.5=>TX%1"!9H8>U&6DA[1\(')/LSR4Y40 M#IC4_+F%* @M'\?CE2+K4#^16+Y[Z5+5WO^R,- T$)L_G\Z?6W$OM&!*M#/!23T0LN"G$AI3;6I< QS &L! U^W];Y^BJOV MC-9;S&@M)*.UVSEO]UH-R]:8T6K96E):=T[J[%0Y*=3J8>OW=GL;$W(Q(?? M\Q27)>1B,JAFD)N M \HPM^K-&A+UNU=<-VSM'";/C MJ-/XPK,71VKWMNO2W&U;;^>VUPP#V*)=K^>91VE6V)B&WUA$DB--T^!0,=LE MEY?)\(HEB1 R93B7QS1X)K'((IH_07,8N:2A%Q#!56"ZW$\=!R[SM*;P5G&H MW]BY+VRHEX]NH.(@EB5=O3; V:D[Z>-'T&$5C^P%3YE(34)Y+MF2]+ D#2'- M@,H*K*C68W:WIO8>:1VEEFU2&:7;3=*1EA^;"_J?\CFDY&\EQ M63W12 QR5F(:SUSU]20=SB7(!.HOPSS M$6=IH-DE$(50(8@7TBZ[I<\R15_< _ 7'DR>O_[];S\O>]3LEOQ#^R',K0\J MRU]M"_ODUQ=*G0?WC9R;94LOS,PS@ +TZC=F MYF%F'F;F868>MAXS\TS)/<#,O$/*X\#,/!.2K# S#X4&,_-0;G0,#F;F86:> MP6$+F)F':1.8-K%AI ]FYJ'&H,9@9AXJ#"H,9N89$T6*F7F8F8>9>0;.6 ;) MC,$3UR$E0V!F'JH1JA%FYJ$6H1;M6XLP,P\S\W9K;Q73M3 S[VB&&C/SMLO, M6R$F>8PP[A_C_BL?]Y^=#7>6*9GV1("OF A02") IPD+P$:ST=&8"-#3D@?0 M:.P6C2U'N+JQZ#MG0>RW]>5BCY'T&$EO1B0]!M+KQ?A?F6'13PV+Y4'2,O[Y M:Q;FBH-0O>][$$#!4&%28 M-=%HM%!;"K7G,&#R .(-"K'N++#N6ACKA5$J&*6R"R@8ZX5:A%JT)O*:A#[(F;EFH[MJDX&.O6>\U.KV;:^NZWNKVFQ?7]?:5 M=659[5[]NFX77_"Q*+?OR\ ,6*NP4+X]>46&V:SNR.(FO!;/\V)(A*GE<4'8 MN*/"&ESNQ=(QSC*09E$/IUE0D5W_<'U[-_UD??@IB6H CG#BQ*\^"UQ*XAS@ MT_:1#FO(5C7B&I+MX5[OO&FU['JSW>DVVG:K8UKL0J=9Y=U[J]*1$]7J_(&$ M+A1D?RR?%;;:9*P>IN:&@W3VL$N^MSUQ==]-D)Q&<*_B4F6L^$B0ZS?B4G6Z M1TU2Z>YV:'9W$C[#T#%7.VI>NRSH@*%#P4O$+V?#:;)&0> MCYD!4=J]49]9-%M:TR@*^2!.5INRU.6GC]KL07/@-$[ERXN%6%^;#\)/OD.@ M1!%(%;&;V^H5'Z=7":G9U:V.!(8$A@2V!P)K(('M(4Q,FKC[MV0W2][?'>/? MF1#R2,O$S)7U#GR7@+SDOEEI#*L]I[.D3,(DV09-4VAQ]:M_]?M6BES!/L\" M EYU2L%3"IIKS;@V#4%8Y>A%7(@-' M=-F?!S(BQO%@Z7[P:J\D"@HTW4*@#V%]VM67U[ASD5RK(^V7-OU MEFP#<@SWY;XH?#/3!' /A1CU8+GWY9ZV@*9C*=R"&H<:9X:#Y5@T;JU22:4U MS*3Z.G_ZCTQ(BV%U5#.)1C127AC*?0)]/ -+8\AX$A"M)%S(N&CH%@=R@!N4 M(9)$.P_,7^DGJP?162MG@F5@L@G5/ITB&!.#$WC8+ZD1Q>%#)[.U*7<=[Q8 ME@* U[X\.6Q)%:"LR(^LIC^)0Q'+$PW2H\VBI^#,\:@09,RB4>!N?_)GQS"%;*DAI0?0(\BKBQL_I@Y M'1,56>^TNEG=M97%T>8JJ('F1,^?E+Q^5&JJJK#-:K9M4E*MU6E"!A1&@(! M&5=J;>\3Z&N-*YCU^M'ZU/&&=*Y+(:K>S,P8;5@U8A87JB==,8?)XY$6&JKK M<$*8:,F(RO-G(NJ!RLRI3SRO/B*G/O*\IK*'[ >K5N_TLII5>Q@IC?VP+*W] MJ)&0B0ESY%3E/=?(TX@[H_2(1\<)8G7RI/08*;Y4%@93\TUJ(,GA3"^$B>J< MD.NY7_-RD9AJ8,11SWN>G3RI;$81P:U_KO.*Y,#+V7,)AR>[DEO2AH)@_@/, MO3"8!*'$3QY5E1A^$RI.0@7PN0H4GMR# O7J?""I1DRWWDF44A]D1J*R2O4 M-=!2>7BN0\/P6=JFTU-S@SA\T?*Y[F] 5:^-&/*/;"C[[C FQ4>"/AU>*1JO M<,\_R" (OJ4#-GC6T],?>O7Z'JGEU:9UVYT"V2)5!)0#%:6H*(1V-TZDOIPJ)\/^#@!KQ<5J4F UCCWCP GUCU]0S2B!96AYDU\DS3-.+ M2?+;/ PH:I,EPKY$/#&GP21B,+*:A-T/](RK'(RS*#A3AXG/?'?#,!B_-M>> M:P.^E*7,%/LMNZM-&W^P++US]O8NS(+7[E7S-:@5;^"!,%!-Q-O[49,QG-E, M$=AA(DH<6%R*:#^D W(]YK"49"+UVB80@'EL FNL[VIBTD3\+5UP@)8&8^[, 7(7.#SICMUH?(AF?Q(7 MM/>>#J@C2-][F/T0!FV5,/ZM5.P6#-S>ZL)[H>UX,:W-0!G(WZ8-(J\$D8^K'0^K($1-ILG]6X$>D MG@^/.^K<91&,U5+SY4;3((3[I&_ 5/HZ>KJ%-A=&MY_8 YV 82#(528YTFMT M\<_$727[(2UZN6E$_6W=)[O]O[L[3D^G?)S_54C_65!"#4+[G:RP$ MI^S^:^B1?^K"GU+AR;!,WZ4M'IKKGY;;T)O[QQ'T"%[B2<&0,2^[2 M ?625(818Q'2C5:Z61XX0.5Z7NK[FTN )RJD3R4Y+TB\US,VK\;(Y)XQ%Z!D M^/E!5KVN[\2@KI83@]H['EO3V.^A.>U*'_E3;NLKDMEN7"PEXO,Z/M/FMO%X MGK*/YS'O]*CBS!7U$0_E,DWKS3A^9>\GK&Q2_ RQF\>NH--IU@SB-RBEM>"U MGJSR&;)'YL=,6RWN"J%K'(>6GIEC?&YL:4>_[U(SSIBR<-UF:9E.QDO.5GXW M5$=41WUH=3H%5< ]0G5<*R-QTYRTS(YN+$]+RWN.[>9$[XDJ6P&BH5-%[A7, M;_PS=DL>Q MI$;7VGR6Z'0;8GG0-@*Y+I!9-#99&81=[8+B+S4Y-7Y:NLW@ ]R!-0FJM=6V M'+5$J*H/%6ZZ[ 3X5Y5A(Y>(N.=B@(&(3EYT\NZ"5J.WF#>*3E[<WO$R17)V5 MY2355(&_$/J?RVA4E21\-TM@%&D>+_/XF/NJB_(XE%GEBEDU'>IY1,! \2'T M059:DOZD+(5-%4>22 -8"9"+A9N2K"?&-J][N'9)PS4*(6Y2_K!WTVM<7E_: MEVV[UVK]GH-9HWA9<_Q"PGW+!V('68Y89;3,7(HNOC1Q;\+6ICEA#MNJ([&J"-F M.6&6$V8Y89;3P6\:8)839CF9YK= MR2Z)=&UAEE.F.5T>*D[")5^M3WRU!V$ M:INE.&ZZ8)93Q0U$=/*BDW<7M##+"?=<4!V-44?,%^\<%^BD.9LP(7? [\,/MX(4])O9?- MW"2=H]&RKJ^LWK5UW;QL-:][?:O7M.R+J_I%T^I>]ZX+3^?0.> JM>GA(60/ M\LB](>"9G*3<>@V[3+/'][8;MMZ&9NLV0E31+:Y>X[S3MJUNPVZTNNU.LZEOP\OJ M:-GQLLO==-%]>[/2K:_4?IEAMQ_UR)?;^(VJ4E>,-S=RV=Q2<-9 MK416K:!H-)_/M>R:#?=734,=);C"$OQ''$3,G>%X&W(GV6Y8)JG N7U5V&'5 M!2#KWV!%+JM)K+KDHUQ'2+!779 LZM_EEO2KKCS]G3TRCUC(_Z@]>]&>NUE% MDU4R^B6"VU?^.! L5#M\*[7%G\316PI@HP*@ IBJ '_Z@1XI;ZPMY9NMIP!N MD_:]B_3S)U/KZZ[,3=C"'-0J3!,E@E@%X(P!"R4.)0XE#B4.)#!AWYT1]1_8M/1I07&W)N!IEH3N S]3I*^@L+W5(%4A M.J_9+:A R2(LILC!*O>'R3J$'(0<=+ <- V"M$N3(5/D ;D(N0BYR" N0GL( M.0@Y"#D([:%*1 M=ENB(6N\Y.S;PD6>JP+/I2]3J97&&DB5(,$BD#P(,[O:LHE'AO>.#\H/R@_*#\H/R M8R8^*#]:;4:#%MM%&I-7;!!I6[:8 YE9TE<$>QGO+=/G8C@$/VK#KM7KK<(A M,67P"W>5(M4@U2#5+*<:J]9MZ#OJPO3!1ZI!JD&JV0_56!T+>09Y!GD&>:9R M>ZRF2\"N?(-%9[#HC/'$/FVNO8=BKAN4;BW@^+-Z:37G3=&XPBTHU+=#U;?N M=FAUBS0@4.M0ZPY;ZW"60WU#?<-9[@BT;M?5LGWD!2*\^=."C#@%^X@9<"=@ MT:%:J%A6P>':L&LPB^P=,E.$IUR;#JD.J0ZIKJ+A,DAU2'5(=4AU1E)=I[MW MO$R1'.0YY#GDNC%+CD'M^VZNE,$G1D4<,O>+_Y4Y<1B";,$%GP,_S#Y>4,'%O7SU/>!TX07. MMU___K>?%YY^Q87C!?)A8GJA"NZ!#U_9\)>3FRN[;G7^L/Y]?W5"N M?4"7E5O^BWZEW[Y-<7HY5'_IZ/F2"?V1/Y M&HSI:@K-W>YQGYV-F&)LRZ[_J&NTU<>GY+F#P',_**ERF1.$-.*!_QYDE(7R M[6D<%.!&%' D'8,Q\]\ZI/:U?N290KFW,4+C:!3 !=## M1T8>8NY2WV'$94-HG2!#V<='U4^1/AOGH3?/(= M/J&>?, X$!&A[B/U(_K @EB0,0V_PDU>#O,)( M0E.C)\;\[!D3*ID+7@7#1X+D[>/9D!*71NR<$(G7%"'JB8 P(36:BQ% 1?-@ MC3@+:>B,GFOD:<2=$2#SGYB'\C+HJQ_)Y@$<8_J=CV%0U!MCP4@P)+-#IZ$# M\G1IN,4E8^XO7!G[B]<^C62W5-M!E')->ME^EPDGY ,F1S5DC'CRJ&HA'ZN> ME SLF#[+887WJ=%+,L>#96 # ,/S*$W5$"1('&8YZ4"_\M)_41]!H9W MLL^I+,_-GG70B=?(@ZS2CF4[4T_'-MDTGN+!^?L M.0G=3F21'&5ND;.=#0.Y![A3/PNFQ3_B( )Y5V0D%(DXBAP3LA"*<;@KE=B9 M%GC/$P_,R;L;!ULK21=U9,\Z8A^!CGQ9F'@"F)CD3 SS6T85B0;5B(CE#"'( M?^842ZJ1@#G-H^$*)7IQ _>G*J@F)SGG^$&4JN<'>7?2B+1%TXMRLR181@,I&D';Q@\YR]*K0*8]6G2RG@ \SSH._6D'0&SZ##V/!*Q<"SGRZGU ML=@!F+F1"8Z7"1I'P 1_+C%"IYHGXLDD"%,- Z6($A7T@TS'E.Y*8UC:N+/; MH+%\""! <^2B890W.5]5N?.=U6V/4&[E:=AC>V\_??R'()/ XPXLMH09$TW6>F"ZUIBNB;*5!HV0]"0.?CFC(I+#(9B+*(R53Z R+@$84J58\O^6Z!U/S-\5Z5]* MB;D/\R*LBXF<67._Q4(.K)Q'71JZZI'*JP(K>U>*@U)^6&C64D<#O'8@_58U M$ OJ0KN7S- )W9RKA>U\0Z$?4U]FY\.21L,73[(=LP:" +M,SNDP!HJODA8G MG@CV2(%AY(+ZY8/$)$CZNJS[+A^"$C!E.D!/$I*3@BXF+%M41+!2!P)TU2-2 M3> ST4G7[:]W3SKZF ]:&$PDIBL[0\F%1YUO9W?.*/#@=6,6C0(W\(*'9XDV M7 H#LE,7IRUY##P8WX25$P_&7$^A6R\[X M-2 #.;[P?)<+)P8,8+Q 'MZ"[O5IT2@B?:.JFDED^;9>!D!/DO&D[KG0MJP61IE:I5284\J,$")X M+I7,I;0!IF=)[\I](40LO8 B$9Y!I-1HNAR3;TN>'K(QY;Y\9:J^G&6,1!\> M0O:@2)Z&X;.\9B4.2=^!4+Q880&*&49G:@$UD.NP)_@R>>&NRI+N(:6;2R\] M^-*F2O<%K0:!YWCPK1[]A%X[=,)52#>CTD$[ ,%3KX5!?())K;2N->JUAMW3 MVSV8G,MJ_R=I)LZVOQM6C2JE8><(26O0KNE J\4YC<$ M8M4L9JF;WYS1MN;)&3!Z\F;>#%(H8?-NMJ$UI:79((OEG/2&N2$'07$C5?=L/6*T&(H)CS"6WD ME'O-"?>BY8F;K=70BV/OLCP\O0Q^6>_%F M/J/.TC2[];UP20OM[H^;^@'G[K?V>WNSTJW?\?9J#QV.?%4ZOYD[W]@D[8)B MR]3'?+21>M"IW.1*[';QT\Y[!\9B:ES@[-IG .P!R]=ETF%RY:\5P5E@VZH= M"5@-*C.5@'6ZZIJE1BM*,$IP"1*_:B/7>S[?=5,OI%!MJL_'&Z4;=2 M6]3&W1L*8*,"H *8J@#YL)>=I+RQMI3C44PKABN96K4=Z6D0:A6FB1)!K )P MQH"%$H<2AQ*'$H<29PYP*''; (?G-. Y#69+Z#[P,T7Z"BJ\L1JD*M37:';K M9<%BBARLP@Y"#D(.0CMH4IRD7X/ MW'&=_9*4L"A+ZM #;]"48'S9T]+FBH,HG%NB(6N\Y.S;PD6>JP+/I2]3J97& M&DB5(,$BD#P(,[O:LH09ZIW!ZKZ1*P*]]@T1DL.F,\L4^;:^^AF.L&I5OU4YI= M+ZWFO"D:5[@%A?IVJ/JFY_@W3)U%K4.MPUD.]0WUS41]PUFNLJME^\@+1'CS MIP7I%[UM 3Y.!MP)6'2H%BJ657"X-NP:S")[A\P4X2G7ID.J0ZI#JJMHN Q2 M'5(=4AU2G9%4U^GN'2]3) =Y#GD.>>XP>:YP/^@1\EW.0?HN4F?)+KM^R=\_ MOXO%V0.ED_HN*V($/7]GPEY.;*[MN=?ZP_GU_=4*X"U]0)SIK6A<-V^[T M;:O?:O6[5M>^:O0;_;IM6^VKUN7ER:\OAB /YST?,T$^LR?R-1C3U;R8N]WC M/CL;,47#EEW_4=<0JH]/R7,'@>=^4*+B,B<(:<0#_ST('@OEVY-77% /$&3D M;L181+X,AX)%$:CK8L&(71NB7D=>E:(2\-E>Q%]K7$X?_XI%Q(?/6L=37?Z> M1_ &)\O&#/DC#.@C(U,=(#DE,+ G54->W7?[Z2.)!2CW<&40(*&^2[@\L)N) MB("6Y7^+ C+F$7^0WW+XS+Y/%#7)'Y('";AW]M2%9\&;PV!,HA$/W;,)#:/G MV35.,(8I KYPHEB6WH;O93,=*B+F$FB!+^ G4'IQ3LA=/! 1]2,0% ]N\3P2 M# ET[Q^"N#-A&DZ%B<^$B5!HL(@'?S$G4CV2+PB)GS %_!K*MJM+:^0)P&2# M9V@Q(VK"EG<$BE=(X#AQJ#HL?V6/<(=LAZ,13+@/(R+G!786Q-&T[>I*:+4<9^:Q M=,@F +]L&SQW3 (?6@4SMA!D0 6?-A]>#C:P8'(7V5=S/)6P#U)"%9)0)?"7 M@>?!+V%2'#T <.5E3SP:I?W)XT=FSX?NC"4Z,)RC9,P%B7TI&"%WX!%R3!DC MGP,0K=;Y(K'J(9KUV&4;U9(=).YL@B6YJ:Q1-9:[E_HS'"KQ M!XE+Q/(-]--*_THR;6-Y:\9OI@9>T2AWE>>LTO)_43]1E,>2?[ MO+G].*;A _>31M(X"K(ODD6\^N:)N]'H?:][WFZTFIU.JVMWF^T?L\6((REH M(MC[[(\/+Q<0LS[D8QIFX3'UI<$JZX=%).V#87ISE;-TJ97<;C=VN]_:[?;> M7M^^Z^UVI5N_Y]\4'.M?&Z?/>/%V]I!C0O;BK MEKL83L%^AKL\N>[Y:0.O7KXLEFGXOH[I&_;.-A;A;VJ]TQ\'L5R4?&5.\.## M%2[BN3N>J980]BW@_TSP)P)\6VRJ&=NT<"WS8XE+YPM M/@VORIT!6P6+P')K WBLJRQI92[CXP2$RAW\^T( M!',U9TG?;\Z!#(88XX_,?7?K,?=A=W/L6'&=V05&<4E9A/7ZF)L;;Y0Z8FWI M==WOU++)U%LFH @B@H@@(H@((H)XO" :84>5;RZ5Y69_(Z2P'Y%/-'1&I&'5 MB(RU1']&^=R ^" ^B _B@_@66*^:P\8"%6?&6340;-R>VV9Q X! X! Z! M0^ 0.#,-I<.UAQ*KI[#*,<-EBN3LZM=&=41UK%Z$GO$2A&J):HFSI#&2@^J( MZKCWH*;R@B[>! S#G5!;45M?T]9V>:'RJ*VHK:BM.YFZI47D&R\XNUJZ1CC; M#\9GKCZ6767G&/>($!_$!_%!?! ?,_$QPJR8-^YLW,,O9P]_$6A/JHEJB6J)_A: X:X@ M:BMJZVO:VBBHC! J*RHK*JM>M/8_KYHB-[O:N3E7^[N(#CRV]/HE?__\+A9G M#Y1.WM]PG_H.I]Y'7T1A/&9^)*ZX<+Q Q"&[A\Y?>('S[=>__^WG[);?@L!] MXI[7]]V/?D3]!PYO3O+4E]RI7,[PX2L;_G)R=.ZZ%D7U]>VU>]T6KV;SLWU=>ODUQ=CDL?WGH^9()_9$_D: MC.GJS8_<[;*FT-DHV:JW[/J/A84 O%'1* .24-\E7R)X)ID!2A)$:\1GT?M7 M!>*UGN5YP9(LH%-\Y]H?J/;S6?OIK/TU,G@F@CU(Z2)/+)0_DF'@>:"%V_=M MUJ3>=CWI[:2'VPA4[IZYB; .(Z.$A8.$^,GG_$/](!Q3;WXTY373!ROM)P[S MO/2:7T[J)^HS4)N3?=Y_N>7X^=Q\X??N??(!+S(Q*[VTUL ML]NVB6XQ#!VSHEOR,UGGK6)A1=?:?5V6'+ D6%B(Q8?2A-*T.UYJR3,#;;;V MF7V7+H)F7\!J8HO5\?KL?S0'H2TL5A-'*O<)W.7!:E48G=9SJ"SP9@'*4K!, MWZ+6F:_7^2Z=-#[1T!G-,):5H%SH2PVKM,P@?2%]&2**2%\;T%Y'1CY3YMK%U#P:H,- /WDU.AJ6QH> M"LV@/ARS/G1LU ?4!]2'S'G8TV:\HCZ@/E1>'^RZM@+LAZ(/&.BQ&MN^X-K6 M80:A5EW"T0KB?BW56EMCB:9#+Q6!RH7*M9%RM7JH7*A5" MY3I2Y6JBSO-.(^Z8^9W%/,;3)>4I^Z^A:WQL%:83+;;Z6$ M IQN-:M7V@G?AT)MJ'&H<;MHG*4O9APU#C4.->YUN#KMTHH0 MX5#T;=?%LKWE,916V/A$R'3(=,ATQG(M/9M591O@!D.F0Z M9#ID.F.8KMG1EKYR]$RWUNF#I34L!]K;I^ 5'#(T/1AO$O(Q#>%R$K*AQYQ( MD-M/'Q/NZ]I6YX,@U/E/S 67YP,*POTTK*A&+D%FQ@,.?_T6,N:P&OGHNP"% MD%]]8M^Y$]3(+?W&141]=0+?'0O5]520)R9/Y1,D&C$RB 7@(01(&CS/5R<1 MRA?)WVY'W..3B?S]G-S#%V/@?'4&I+SB(>O&, S&9 ']#9%)E2#5CI='(\I1 M3L!;7I%W:>7=;<:F5L0!A/,BD[MG;M(YIE/^;$O+*7^-.AYW5M7;J]UZ[#QV MO@*=QT.N\)"KJBS?I\TUXU2*_1X\D1V!L&JQH_=D!!1.%,Y-A#,IL[=*-M/J M>ZM^3HKRS49!/FWEFC[+IUEU@=Y:?J@(J B;(*BU?@G*'LK>!@BJQ,.5M)CD M(^90?HM(,5\1A7E_PKQ1!+!Q%;6**"]=Q,;#!?6H[S!1(YD7G:QTGF.Y!:R1 M7Y7-Z8.OD8]G%!U*O1AM&".[F2VGR&[[*"I>;9E!;D-NJX*<(K<95BFS$E*# M[(;L5@4Y17;;4QVD2DM-Q=D-">Q($SL.(7%#;S*NZ6._*]/@.9$?+D?4?V"" MN#$C4?!ZB#\>;;0)%:^]JUG.KJ5Q^*#\H/R@_*#\H/R8B0_*#\H/RD]!^.@_ M3N)8*F1>QF'(?.=9VR)7"ZY'KN*[%@4^G%-UF@65S=@ ,U,TM7 _,&HN:J[& MR,+2RNJCYJ+FHN9JC"S!.1Q.08>"+@)CBB24 M:\ A"YF GRFRARRTS"W410Y"#D(.0@[:9])CVRYH7PE9"%G('/Q,D3UDH27W MV36KUT 60A9"%D(6.HXCD4V1A%U9J*)G1W5!\'3"V(=GR^./J$=<%E'N"1(, M21#!'83[$?4?N#SQAPK!(K%P<-'BD4RYCLSQS#&=/&1UM)P\U&SB*215O;W: MK3%K;F(! MA>N8A6N#@T6U1#05"*21>8SJ(QZV9IJBFW'ZQ/I!=Z7SPF]A(,0JO\$E#<-G MZ,JJW_OC(/:C:LGUX1:Z1*%?V_/D./$X]FC$W%=$&Z#[KSJ?NUH"CC)\%#*, MQ(W$O6^@#X6XC3MRRZ!$C,^!?T933.4VR,+.C#86,0=2XQA"NV/'^/PK+ $\ MGWS1:!5_SH(I8[^*VI%I3+)%2@2Q"L 9 U;5) [GMF.?VYHM?2%DIH\]SFTX MMU5K;M-?UO3@ULC]4M;'QJ%JEISJK.E2\/Y^$9-HIU-0-L@1'TJ%&F<R,EQUD.F0Z9+K# M9+K"W*1'R'/5J: W>\G.Y89T-VW?B6-$Q ,!WT6<>MXS2*,ON(AD#< HI"X; MT_";(,,P&)/;3Q\3RN[:5N>#(-3Y3\R%*AXHX+GDH^\"'()3^<&NUUN$^B[Y MQ+YS)TB_ZIP3\FJ8'IF$'%[)YUOB@/Y1>$*N1?+1+OP<\D$L6T!\%CT%ZA <%^E)(IS1(RQX.N\2&'CFEY;C0*&=/RI/S *,PI>9")T<1),Z ) M5:G.VK#]P6HULI(N>GJ@)-Q_4UFB@+QZ /R12:$E3\SSY+_RHJ2$#7//*$P]%*X/ 5WNRV=-;QNJI[S>7!KMC'IF;:_92,[^WU];[?[[1UOW_#^ ZF"9A+S:&J+^KA8@*AGRP>5@GTUVQ-,8-\4<:'BRM$+-^S>4C<='VL M2ZBUNK(K$59H1+Y^$4@5DI'0*#Z9OQ)2LZN/>\^9_D5@7,"48Y,STJR39P#Y M$"N1'9 M9"2H!3!@;S-AW-QX.3@;Y6K9;LHV2_2W$@"KE^#7JNO2OV.9%@]M M3=6"":ZA>8+#>:RBV!7 ,!N*UG;^;R/G?NW4]D4EGIURW_%BV40RI.&8A2L9 M;XF4.O#8D#I1$F; @4T\CSE13#TR"8,)H/M,5,V]#=E91+]/H[V5CYY]GS!?,#(, MEM39(>XLOV&A5]LT064+D#'\,A*$^2YSB0KY)@VKIN4%AF5=*->/KB8MGAJS M59.>J-"4/V';>M,GM('U@]75VK(:"9F8,"?BC\Q[SJ4?+:@0HR#,,NT)-,8' M=2XM$Z(F62T>2T+S M R)G9/EBZLG$(U]0)\E!"QPG#F'\: 2#_I^8ATP-YAQIP@ O)NUL3?MS:11V MEGI18!S92&;Y."&C0OZANK8IRU+^RX2\G-U=R_OG#^O?]U0GA M+GP!LGEF7UQ:G4:SWFS=-%KU7JO;O;+[/;O9[36N>U?UBY-?7\A9'J WTFJ6 M&9UK)Q%M."CJ8SZV_R41Q& 6A/+M66BUA(T ;FR'C*VR=2QMM32W)F'PR(7B M%CE#_ 4FE7!YQC9Q)+B;4,R?/I=D>Q_TQ/-^AM7QBGY"_JID2Y :X MBR][49KJYK*(A7_R M)9P.N =$R43RS% .E+3;@#A>YO*"$+MR)G15VJU<-*G'#:A'?8<1,6([\>11 MV^XOH&;#86*.J)$/E<1(Z4)+?>_&IT9+72J MF6AG@W5('\$@&L"82Z@?.2)4_2)PK&+NAF7F*HB77( DBY.7]NULJIY#"^;"OUBZ='H%.8>*T3Q\ M$UB"R+HJEXHZ5 KYU!? OJ>$HMI56V=\:M*GM.(M,%2QYY(1?93KM)2^91^7 MDY5!2$(O$CIL6$H-EW,#A\"&M!@/^OV'V0K@OIHDL]5&HU MEJWV9%N7K@K3.$3"'JD70X,E]\H+@K3\4G5$2D*E>O\0>S3TY!#29)V;#!>A M<30*PF392E5T4%(1)PAA9!0,(AW_".Y6'H?T&WYV3(8,;8:J2B_(X4J5T/#[F45(>*JVW TOY"?.G9]&TH#4FC$2VP>P(()5;$P61]&5 1'X0R?7)F+I,5HB"KL%*BX_9 MI@[5U]RB>??I9_;4=QSIEH8AO0T#'_YT$A]NWW=37O_HYZ\!%N03CXE-W*R7 M':M5;S9O&I>75ZW&S4VW>7G=ZC2L3K?7[30;Q;M9"PK=41\W<+O*3LRPE$Y) MWP4"6>*"W;4A*RRW+1QO9H0Z[=%+^,4G-VP0@MGP3.Q6LHF2+)EN@%) &V"N M6C:HY"* ?V"UF)I@=OW#3?_N8OK1^O 3,)N(@366WO[G1'IZ2?_N3_7*L[I= M([EG_2YWFD3N:7-ORMV5?Z$DHMDOF:4#\TCX0/UT(R[U[7AJ)VM67&_*@IG5 M->>!3K;SEKNXLTDZR+ZHN,\[^Q-HS1 ,:J<4##,I\$C%"Y.PEC M,H&? AB1 8,Y59F"(350& M'CF]BP=@@7&'=.W6F57_Z3WYFBCH=-P_@1K!O*]6-3#V.;*:J>GLR]]G"OLV MIU@K.<5*Q#+;Y)?_1,^@78]@_"1].(65(9M$J:ZG&@H@22U,U@QJ29?<.&9P MF:L,IBF&:IF8W)T&%&1FVVR#+%47I4[JW8S]E 9:-^YN=6TN6SQ.5*)Q,08_ACNH6O>CJ>Y\DP;;@29*X"F^#; MIQ&3XIDL13,Z2)P6B8VO(GRF#9'7+6O*S(C*7J.: SR>:(D*FAHF_I$)(,>E M)^\AD'H+JBI8^,@=)I*@FQ1#M5[UL^"BE!&'GF(1Y=>7Q;K=5&/DGA,6A):&KOM01>V;1R.!-95270_<09EM@- ML4BHFV7S6U)W61F/3T'*R =6A5E;X6.RJDFKBP\WN^OD%G7I8Y+0>LB@,9A$1R:83,"F0/M!A M8E[!!R9DXK2K F37!61E]@=J*FJJ?DVUS=+4(J3WA;*F3AEE#\7CV*-JS30+ MD.!)J6&YRI$3KYQ-\Y9F;@68+F?LM<4U M61),IO_;8'0RI[+&]>2$H;KDMS][YZ)/_C4'^X&,KMP)3D6J/4NY4 M?9M P$L2 YZJXS940R@L(6#1(#=-,Z?'&!8A:]7./7TCTJZ9@4 MF;\R+\:#."+)AA2\))'+(.0/RAZ=(9&)ZF*7I WA2$@- Y$Y:*'5C%@N0^"5R0=)+? D UW)7@MQ_G5K22=RV M\H#G_166+?57+9:5HR\9"14,(.-NA P/F,B%KF1*U7Z7*Z](&O SA2\SYVM3 M-TL@U]>Q>GF0NEK4+=F5]76SWJRW.NW^Q66G>]WOM9M7-YU6O7.#>Y.X-VGL_(1[D[@WB7N3 M:+WBWB3N3>+>).Y-'B*%X=XD[DWBWB3N39HY*+CC484=#]R;Q+U)U-0J:"KN M3>+>9(5(!?=4>35+)X!]KED)+"CS)8B]*9?0L-]\X#"7WE#ESJ)ZE1W/9\.1S_C5^$(ZI M-Y]27<];4-ILUA,)TOGOE)(+EWH;&CD?@Z3K)82]G ML2R/53H%PSHMU;;=L8*-$^/P?1W3 @Y_^TVM ?IJ*TAD 0'_98O5P![@]-'"V>+ MS\$+$5]W35=L(U<,MQF-TZ'MKPI= 43U!%K2Z_K?J>63:;>,@%%$!%$!!%!1! 1Q.,%T0@[JGQSR9#Z;4K?]D]#.(S"SJ\,!"!P"A\ A M< C[LVI9=F@R9(@^H2ZA+.!^A#J$.&:1# MIU:G-"5:7"Q52'HVR1A#%4,5RZF8W>JBBJ&*H8H5IF(M&PW!S0Q!,SRR1[HE MG:^$OK[H%83[TK@OC:N_[4&QZYMDDN#R#W4( M=0CWI5&74)=P/D(=VCMVJ$/+-LUP7QHWS5#%BE4Q"S4,-0PUK#A#L(UV(&Y+ M&^B)51\WJ]QRQ1PV'K P*]ZRB6CCYL0VFQ,(' *'P"%P"!P"9Z:A=+CV4&+U M%%8YYA@E%O%!?! ?Q ?Q,1,?(RR*M_QU%1>T,6;@&&X M$VHK:NMKVMHN+U0>M16U%;5U)U.WM(A\XP5G5TO7"&?[P?C,U<>RJ^P_CE[.$O HU+MD+%M I+-JM=T.[$!GB9(CF[ MKME0'5$=3=_#1[5$M42UQ%D2U=$H4%$=S=C#WP(PW!5$;45M?4U;&P65$4)E M165%9=6+UO[G55/D9E<[-^=J?Q?1@<>67K_D[Y_?Q>+L@=+)^R_#H6!1!+*2 M9)K?R\?<0Y\OO,#Y]NO?__;SXI6Y3>WYRY5[&3Y\9<-?3FZN[+K5^$N?$&=Z*Q^U>ZWFOW69>?";K7ZC6ZG[K!]T-DJVY2V[_N.'W'C^%8N(#Y^U#NG]B!$0,>9$ M@@1#$HV88 2DE#_2B#\R,N0^]1U./<)]$87QF,$[J(*>4-\EW@Q;$OCD]M/' M?P@)J\M\P>3.DZ]DG$;P84 ]>!8C8L3D[4\L9/ H,@P\#\3[_:M2M"9$#C2/ MA>L /4?L=> ;]10N&YY\SK_&#\(Q]>98RY+73!^LI)DXS//2:WXYJ9^HSZ"J M3O9Y>)N-'K?ZYZW&ZUFI]/JVMUF^\>,;( L M/#H1['WVQX>7!#'K0W[W:THR=GWI=MX:&VAI;Y/VP3"]R6)+J32YW6[L=K^U MV^V]O;Y]U]OM2K=^SZ\_:NPKW?IRE;:L,(+I\]XL_532$3D&12^>3+U([^4[:R0C[=K!_!I@S(;X-857C2V@+!KZ]![#?BK8K MDRT^!R]$?-TU7;&-7#'<9C1.A[9C4.>>K+&EE&L?*>7>3'U%'Z>^HFW32(X> MS$LJ1D!7G@=4%0*D8(@Q_LC<=[<>.%=>976 4EY@1A6Y.E/G+Z21U MQ-K2Z[K?J:7"Y9<11 010400$40$\4!!-,*..IBDO 4W^]MG'GVBH3/*#CS: MI% -^C,0'\0'\4%\$)_*X6.$V6&0^^9 SAPRS,RN#@<@< @< H? (7!' IP9 M!E!)(8][MX.2[?9*'GAD"GJEE;$M#A/]J6[-\LK5FB('\KZJG;]@"G:H0ROG MSE+/'#)%'E"74)=P/D(=0ATR2(=.K4YI2K2X6*J0]!A]+(@I(*&*+5,QN]5% M%4,50Q4K3,5:-AJ"%3PNYUBWI L^1P>W'A X! Z!0^ 0. 3.?"L(]Z5Q7QI7 M?]N#8I=WY+$I)DB.;OZM5$=41VK%Z%GO 2A6J):XBQIC.2@ M.J(Z[CVHJ;R@BSTM5U>J#QJ*VHK:NM.IFYI$?G&"\ZNEJX1 MSO:#\9FKCV57V3G&/2+$!_%!?! ?Q,=,?(PP*^:-.QOW\,O9PU\$&I=LA8II M%99L5KN@W8D-\#)%/:HEJB6J)LR2JHU&@HCJ:L8>_!6"X M*XC:BMKZFK8V"BHCA,J*RHK*JA>M_<^KILC-KG9NSM7^+J(#CRV]?LG?/[^+ MQ=D#I9/W7X9#P:((9"6W57TOGW4/';_P N?;KW__V\_9Y;?,%SSP^[[[)8)^ MW08B"EG$0S9F?G3!?#;DD;CBPO$"$8>S9RC',WSXRH:_G-Q=;O?;5U?][J][G6]W^C4;Y7L^ M9H)\9D_D:S"FJ[= '^X?/!/0 NI!QV@41T'X M3$+VGSC5&W%.R$>?2,J6 E*3K^9P/^0/\_OSDFBF&X."'F[ U1*N4]@5,^67Y:TY@%>$%*O-O?^Z5LE MP*N?H#JO!@.^S>!* $@@D;U.8#O?6J;R4YXE)SB=^JLN?\\CD%EG7L:4FIK9 MZ(7HH\M@/ 'E!0F3B55-9AX'G!$[1$/WWF[IDS7>O06\5J'-C<3S[G'^H'X9AZ\PC):Z8/ M5O,U:*/GI=?\N3)C6[/[YM>"VU_M(N[7B[C:^OS.O?$"A30DE? M!MZDNM_6S(1;Q2@A5 @50H50(50(%4*%4"%4>F.;UW.XXI)SNR6GU3F(->>. MM]+:II:0(K V\CT\N4!)Z?<)W"7 MQP-?&%T5[%#YX,WSJTK!TF"&D)&G*)@HF"8*9FE%8U$P43"1,5$P*R^8:S/F M=L;\<12)NF/A(W>8BJW6INCF0&>WWE/8CDR1V2(XM JH :(85# M50F)D?<56AX$R0O)"\D+R0O)"\D+R0O)*_K0TG?L1*5%!MD+V/_EH*VMKB@H4;0.A-ARP M-C11&U ;4!NR+5R<'% =4!VFII(V'_FAJ /&;:S&]OK[A#FR"E[(HCCT2>"K MDHJ$"L$T'O!E#IC592*M(.Z5HD[UG5*"A=11[U#O4.]0[U#OS-6[CKZL#%0\ M5#Q4O'45KUM\P-AQ*![N6G[HCP/HY'^3\S?0%:>?E]Y*5BH JRK@@_*#\H/R M@_*#\F,F/B@_NNW&]18@5N4M2GDZD1<(W&;!U6\1J]__DQU69VNC^X,_#1-5 M#%5L YR*=R^A8J%B':%B-;7%N*)FH6:A9J%F[255J_IKU-N0!R$1!91W0OHY MX"AD6Y>4F*('1<_2J T'K T8DH_:@-J VH#:@-J VE#$JFN^D+&]4#VD8"=( MOG+)>!=JTR/P<*NK[;3 MKD*]9NTG?5@:7(!E:S K(G5%VX+(L,BPIL@Z,JS.?9F]@UD1J4.&189%AD6& MW9QAM6U*(<4BQ2+%(L4BQ;ZDV-;>T:R(V>DK^+Z,!CRZXOK6$YT#SNL[-1 MDC&=-O3-0(]5U5%TZ0*%#?U4!U_EH>G0(@9OBD94 M_@][)C1D)*+?B38.S&H81"_K#K^U)N3,E/"8S+G"!,JAA(!4J:%*G#[L>!.NR> MO7'8_59]+JLG2X^:W:;%(%>7<1B"('K/-2*5@?HP4?$)C9B02B#'2*JD; #U M7LA>;@Q!FBD'2$,= EDZ#++1=#()@^]\##WWGDOKP@^MNEZU V63=#*G;#4R MH *D76Z$)J.MZ$K2S(#Y;,@CXM$G23+_$SPQL%6 ZD8<= 3X5N)!X&\1#_YB M3B2?[XRH_P 4)PB%<1>Q%TG\DF\%X?[TX0%(1CCWBIJ\ZXEYGKI;UM^4>[7# M(!Q3WV%$ ,U+IJ12'@D=P,J#!/()L/I08@:WQ&/HB1?(.8*%8Q+*]L'K<[4] MTZXGY3UK\@&YMO'L7 ;9P 0-YUD]19R_;I>D?__\+A9G#Y1.WM\F+^K[[A?9 MT=M 1-"*E-@ODEZ+*RX<+Q!QR.Y!""Z\P/GVZ]__]G/VC#MG!).&Q[X,^XX3 MCV,/&I(\[C(83T(VDN]X9!]])QBSWP,A[J4=-'V44DCX\)4-?SFYN9(*\8?U M[_NK$\)=^((ZT=GU1;MU=5._;-K-BU;3MOO]?J_;;-W8EMVV[&;[Y-<7 MU.[Y&&#[S)[(UP"&:.74:]B4/LT*[7P ,9L!FTJDDX=692?+^=]G2HY!>.4G M %9PH>X9*M$;!AY((73D];HXQ1IBO376S;D6S*UUZQGTDJ?]Y'.^B;[40F]^ MN.0UTV8J$YPXH+WI-;^-QDA8V>S^^O;1:NOQ+ M[K?V>WNSTJW'SE>E\WLLHS;O4#'R?*WEJ^A3L$Q2,U!H*Q1I'J;&>9)+KFNS M$9:ORZ3#I"&K%<%^1-;\;[ILSG^Y=#6&HHNB6ZKH7C&'C0=@Y+^0SD1 M=4H M1@%% =7*K:LH=6V)W;DB4+J"T]YX AUI>M!>>!U48)! M$# \1!1)0[Z-H*EJG$V_&F[5N\9 M>M1")60-^0WY#?G-7'YKU=KZ''C(;SI7ZH>U(+_- C1>AHAH6XKC1'# Q41. M&[56O:=;5(Y[R8@*<^ *T]:6M( *@PIS^ IC=[7O91^VPABW_52!6"!UWQ7\ M\D@C_LA4J"K@(8-.AT$H0Z1'S'U@5=FA.H[=[%*KJ&O1]$U%LSNS]^SZK8K\&.8:1I)"DCH>DFJU]KNA M6Q7Y09)"DD*2V@M)=6L]2UO]:B2I%TOLU?7]7J_!LV/]G.6E>*[8(/KHBRB, M58+8)M5VKOH-JW]]85OUSF6K<]&[L&SKPKJXN+9MR[[NV@=7;:MO)U-QMI13 K&BEI%[OO%MOU=M=6U;PJG=;^BHE];042FIU=BLXL^=B/3NV MOMJU@LKM_!YK!1E@+:F/Y=0">FM[!N,9UZ]7L0?*FQ;M4Y/6RFU:HO-5LX*9#!D,&2P/3*8U:MU6Z4%09LM-KLRV+&7,[@) M0@8/GATF$0S@1SX#4.'Y0?E)^M\3'./:+- V(W"_> M7,=A,'-]=%IUY?IH)$Z0%:X/^[Q9MQ=='XWBEU5(!7M*+-IKXE"G5F_H.QO: M].J[N"I'Y2I1N=JUKMU%Y3K@!6/9)L7=$Q>"#$/J.YEE49]:%O9YO5Y?:5E8 MYW:[MVA9V-J#5Y'C#K#VD55KM+1)RJ$P%FK$<6N$I)2N\$B#1;1:6"O%^N;.LK3[(M:(="L:BZJ+HE MJFY38SF_8U==_=;1_HV@&4[=[>#M[J2QIH5 'RWC58[8&O5:HZEOZZ,B=<[V M;7V@RAVQRMG=6K.\->JAJ-Q1^51T O\[$R(-OXO() C5";_!\$7:^]ZM6Z1$ M0]==ZX?IEN][[NC;C=D:TZ,(8T:U1[4W1>WM6JNC[[1L5/L"C2[;@)5/=5TU M)J!G'%N6CI\INJPO@6U-D/1C4LA:NM75%UQ8D1J"Y5IS2$,FX&>*["$-+:.A M5JW;LI"&MK8N=Z]PNJHLZ:HBIMFY@KE[KH=#YD1?_/4KI*Y1\[33;5WWFZUN MZZIWT6KT+OJ]J[IM-9N==NNJ:W1Z#S_)%'SX0J6)F[YG$H M->*S2#HHN0*=1/2[_)**M!#G&VG#KT$Q:RY6X2R\"F?;JEN-=K-EVTVK8YM6 MA;.SYS*:.]Y>KW3K*]7YK:IPFKLD#:M6C-MS;VDN5?)LZD%'F]/=7,TUHZ"IKMV? A1= M9Z5=G#)0\#81O.H6U#7 5%3W_4;!-(2U/*SO_Y?Z,0V?R?KS,A:>,&AVKO;. M.):#7!NJ'I:"+&?7#=D+V0O92S-[Z3L[M=HBLRM[[5B7R*J\Y3K;,B2G#V#% MBI_>)1M6) JI+X8L#)DK"Q !P#YT0> B5?\B]>#JIV@[?MX4-2G:2D)M.&!M M.-7NV=OH#&%3=&B;,X)+38JK_FQ^.:*^*BA$AI2'Y)%Z,=-F*&(R3/'<=CRU M1TX[VHR$G4$[;#I%Q4;%+E.QVZ45WCARQ3[L/#8]NW+O3J4[XZ=TZZ5S6&XW>P:7!*< (]5WB)I!-]P7)A(5$2%#):4+27=NN?[B^O9M^LC[\ M1)X87 !ZY*09<[& FU6(>Y('!Y]T9,(=2KI9TVK9]6:[TVVT[58'T\VTWH[I M9IAN9L1TJSYBNIDAJP5,-\-TLT-.-SL,Y<3$'LPH0\$S5/ PHVQ7$#^S:+:T MIE$4\D&-H^)T22104C;F%0!_"^K2[ M_[/+*R%UA3O@D%V170V0QJ[S\[NQ)25^[ZPL HJ=TA_)<*?&3N&87> MT@>6>/3RZP*-:P'T7ARP]P)XJZ4M^=P4]4!_'FK$3AJA;1_O4#2B2O7# :]#C M(+_C*6%3T)F7&T!FBL:CXJ+B5DAQLU1CR]Z_A!Z*"F.5J>W=%X5O9IH [J$0 MHQXL][[;%QTVM9EQVK9K6:SV>OUKZ_Z_6ZC>=6W6M?-PDL"%5P! MZ'[$"-B[0A"'AN$S($_H&,S?J*8J!X2J 'DP)+%@P]@C'H J9/7-)^9Y\E]Y MT=-+DRED8\KE*,YN&ZJGP*-!4?ZK7$Q\.C3P'#DVA$9D0>0V[%-JLZ<*IK!S MF1.$-.*!_UZ*=M)M5?Y@QHT-JT:6)EAO VDMJ8I$15H#26Q? :G@P=]*\8^I M8E/]O&O7&Y;=TE>JJ:.E5%.CN]]R0YW]OKZWV_WVCK=O>/^!5$LRB7DTM45] M7*S4Y$K=#@7)5VQ:G)HJ4UQBO_4C?E/6Q65F7?25=5&6.V^OOJD"P/P(EBVG M'KD&8V L*RZN4J0_E>$ULW"D-:PM@\YHU(LK^_3Z7\> ;0$2/?6W]I/%PRJ! M_IJM*6:0+\KX<.WCD0ZE4DTA:\*0NH!V^&VO*;?5#B3%X@0;%2?0%YY<::DI MW/==D>2-@BN:D3/2K)-G %F?263D[%!U6\A(4 M@P-YFPEBQ&B1%V"A762T1 M6)P3GT5/P6;FR@''"&.$6^X\6RB61(PS$+5S+>$BF5F]@A=>0&JN_*;57F>BWKKI-%L7 M]G6OA9,E?78^J*P[B3MA M*?!DYNQ(7"9,>CQ4%#K\ C(KRX;#7TJ3U(FT ^HE50Q&3,68"_F:!1']N)9V\G^^.8HN-[YVVK;C7: MS99M-ZV.K2](WK:T1,E;K?V&J3)9[J M:]JR+3^/]S#_Y8-:9)(K^/T1K&J-61@H:"AH^?M^YW3 /1X];R-L.!'@1%"! M$RM-WLK?RE]@-%[&R5,^B[YTOM\ON]](/^D_I9\4Y0GY"?G)2'E"?MJ GPZD M+$9!(1#JXV)IBGQ)"EV*:QZFQBEVQ? K5M4OTBW5.[FE2BX]*@0? BQRS_!P M,35.)@VK,K-^\F_Y+KB(K/F?VK G/JIQ56WVFN>;.HZ#0F\TQ]H]61MCKD MV64"?E%AS520$7,?H&&$^R(*8QF$?H@9I,:1SCZ!.Q@A3\H>.'$8PO/3^N\5 M&8/#%=YM\*EVO3VLTKA^\0MM)S%76V3D?4=2^0+9RVQ11/9:O^1G7=^ZO-(R M@_1E*'WARF&3E0-UG#"&9;"7QCQSC8<;H 3C!(P3L/::D3C_XOR+[&60*")[ MK0U56U\$1:5%9E?VJDB6V>$S%^)3P9#P_/I'ZXX)2M !GP=A]RQ=F ^=6JH[V!^H#ZD-V'YH86 M+Y!!CNU];X&^$B'L!]$:4<)5V[RN-+-5!;A]2_72D.!#!MPX25U[#MYEPV?/ MMFGQ&SF',DNC)J$FO:));6VK/-0DU*3* V>&]81AD4CWA=!]#^TF5"14) V1 M9&@V%>HF1"5"?*J%#P:+54Z"UI^F]EOFMX!EO[;9ZPUD3-&@PJU!K/*$VK9R MU87:AMJ&UE%U ]U0WI#=WX"K:UMV:?QFBN8ASZ/>H=Y53^^VJ/HYAXR]@,QZ MWG"K\K;&?1!1C[CZ3P'5 _!QLV^!F_QZ2OAL6N8KFN MM;//,A;-KKXJ/-OB98KDE+L$09Y#GD.>*XOGNE9C[WB9(CG(+K,*-\[+R'/(<\AS)O*7_GC)@;>^S+,*V<<)T63K@,TKH)=Q&-F*R- )=PG_H.I]YM(+@\I_1>OO0> M$+KP N?;KW__V\^+S_TM"-PG[GG3RU1)!OCPE0U_.;FYDN="_F']^_[JA' 7 MOOC_[5U;<]NV$GYN?P7&(^])$F(8D-1>J0 M5!SWUQ^ NEBR)8NF !(DOX>FDLP+L-CO W:!W67O/&T;E\.V/AA>MH9]LV=< M]H?-SN"JV=;-5D]OMHD^^!%-K/V5NW.ZY/CV=T(2A M=:/QRQ:B'B/4%FKPSSR*W=&#V"VP"253QO5)#@KB^F2\E!H9A<&4/%.(5[YC MJ?Y+7"1]<:@=A$FQV0NN>(MFK H@/LX,O!+BSMJ'67JID7L:4IYY8Q1X;%*+ M+E[4])<&*,6@;DTVC2=1AOS[YD/]()Q:WO:X\VO6#T[P16SJ>@\.H_.5[KSV7)U*7?\3M(*-_EZOYA=[P+/ M63SH#5O;L+L\MNZ(?I5C"*@@4^7,]G5SU2@'7FS%[^MY&,RHY>^SO_[RF7I" M.:&YJ^_Y\PX;4HX^CP)^VU\W K^+_[;N@/PK9& ( $(1 M0.A'+G0/NE>([OUNQ>Y>"NY/:<*+CU(^1*27EF\Y4&8HAC"6 M\E7GE>'"'UB>Y=LTTLC*BT[V.L^1'DO]V.QR5R-$ Q*%U"VLN@IN"T]MVEF#LF72Z$U8#>P6QGT M%.R6/B)$TW78I55@-Q!830,ZJA"PT=&:1DNZ1%09^V.9YO7;)X4>^).Q$7*9 MQ(]$Q)E3$@E0#_8'^0'^@/] ?->4#_8'^0'\D MR>?8_,//O3]UR3]\F=15MQ^$&;E"Y%ISB!^;>EVHD O-R=Z2E)CT%3)3!:G2 M_-%=J3521G;BF:P9#YRT\5[.>63[A,I]!TS>B(.PQ[ M0#"J:$*^"SBPD KR4T7WP$*[W$)=] MH]0T7=/V#M46P=>IY)/>$5+RJ=5"^9>RWE[NUJ/S9>E\IJI'^5LN9:J[#KON ML;F= A*V%YN>?;7B@S9!FXZ7UV=N,CP*[='P>OQM88)ICS\P:R*#\8B:=\_N M2[ZBYIUJ+*!&$9#T9Q]S)XWDD..CC/EIQWWFN[Q3D-!AZ/ 1XMU=N_P%-ID"L6LK*H:$['EB]61GW*,(-P-4^XLW4KD32Y' M;G>QX2REUII]TP((# 0& E.8P% T$00& E-*%4%@Z;,J=L0=7R^USH"^0%^* MJ"+HZQ7TU0-]B: O%.QY>VU%,0U]LG @:N2&L:-'"?^9)+3&_R/]4<@$422Y M58S\4Z< DWP(2>DT"56A&>"ASG@05X,=> >2H\'O2=L\0H\ ^EQX/1$)9N MO"IXP$&/_;+M1ZXP.TPAJ967<*J3@UEL5 M2B.'+1& "^"J*;A: )<\VU6YZ!O))NSO5NSZI#^E?$]Q8Y/QTO(M1YQQJYQ8 M2TQFQ69**%4&T^J>E@#B@+AC$*=+JI\ Q %Q0-RS^SKMW)(< &_ &_"67T*& MJN!-?*7*=&X7/6\S6KCD;X/8$I8T4(Q0Z\EW1PE6:)2'*JJ96[&"8P(]E(GE MR+6*@?*ZD^\"#DP'I@/3Y<=T34/\ZX[$UOSKL^>';N!;WG$H;'E>A$)1ON* MWSVK=4>>R7:C(UL$A8IPJ A7IM:C\^A\"3J/BG!*Y/ZJF%VR;F[]:GCMJ $A MLM8#E*O.RK6[.(.$@S*GIM"#;@Z 1U%6PZ5(0V#*-KGOKBTPO"!=67?W_O3 M8.ZG+B*IAEX+2V$I2^MTO=M>SZ=>U9,G1=4FXGN7RL6650'Q T=!G&#N*'T M:A$WTH[M%_FGP#^UEC+EVR#/=F:$L8@Z(E6.(80[=I3?456B*( RN^VZUC21 M0PI,H]):)$ 4. @=A MUC\XZYL]I%8$XC#K8]8O;M8WN[ \*I_^KA15P9/<>/LB2.7H:-:1P,2!K ,2 M9Y0,:EF&J::IZ8:XG49#IIKC3P''@./ >>4X3GFEK#E.0^ M -.!ZT*=N4<_CSZN/87]Q%'8 M]YW?@L"Y=SWOEC_[E@EBX 7VMP\___3N^>V_NS[[]S*DCAL/+=OUW-BET?HF M)F6?B_(+';T_&5[QC"Y_ZG_?7IT0UV$_6'9\:K:[7?VRWVX-KQIFHVEVC6Z_ M>6F8+;W=[+0:O9,/3X9F4\PBT_PM%8HG^I-]8BY^GK\ORW/2YLS)\FR-_''S M\;\1B1.OLAU,IVX<4X?8R5"3T7JLG^4F?%&-7QH(R5+/!+M7MG=KIFO/A*6, M3+[N3+!RERK!2AK]/]CFC8=LW:-XBLENZ\S0&Z;1;NIFI]MK=<0EG#2%Y)OL M=(]+76<6FW@OW]>_?O-0L0!\Q5FNWLV[?9A14>M4Q?1..9,R=4!*WH)\6>W$ M)G9X_N#D29>K]58&7.33P&09J&KK'BV1##;5*_+[R748"8/^RQ9.LM#9/BC3 M?;*B.Q6>_KS9;ITZU@,)Z?? ^\[>O#0L-$)_S-R0_S"D=^'<"A](.S%KQ!WU M+,FH*4?8PDEZ[TB4XKR5$H',,B0EH5[&F;AJ&:76&8&N/Y73CBLXX=S,O=@] M?6!R3S7G&%T^Z1BZ6L9 J:>/U)$JI8M$,GVS,O\^)C.+%YXK_6%SYH]Z#6:52$E*B]% MYRKD0KF]*8[;,PL-DX+@PR7%^EHVIP7AL\(B"FCT:@=8Q89!.6K-_P!5&>SA MW Y15<:5TA7H2CETD*H,&B1P3MI_F*J(G-#(* B3ESGK>K/)'3:?(?D-_*DS]C%PGMF* M[-7;/^FL[>/8R_E\X$'G@1./N8Y"?:#R@ M/AVY\640Q='VRM+LF/UU%Y<8E_@$5Z%]MTA*H@*HH*H("J( M"J*"J.HHJE<'4<+DS&9RZIU*V)Q'WMXH=>O1>72^!)TOB:]A_W98-]L\V*WR MBJ'P%=6ZN1VU,ZQ+J#C\U]G7,_*'9_G"CI% G^JL3[R<\NMU"K0.6J\8#-4, M1D[N&P9ALA-[.PDI)3?LBDE$KIF=ZI DWPQIZAK4$&I8(C64$HRBT@0C*;?0 M-%5N(527*:9,:RZR5)@A=J8Z@V)",150S#84$XJIHF*",:&82BIF:L94,5.3 M JOXY+ZO-/SNVC0Y6RT,Z.J(3CF$"W=NE#N[#3(BI2]>*UU4I= 8?I_4D@\@ M+Y 7R OD!?(">8&\0%[Q6Q.I*,%>8"^55!'L!?;*F;U*?Z;L>!%^3-*1)$D8 MQ'D+0>X5SG,KK(2?*A"0O08"&BJ,AA;0 #0 #:LM7$P.@ /@L%XJ"?.15P4. M.+>Q7[;7/V;4YEGP0AK/0Y\$/IEY/&EC4I(9'CF%F*@ZF>W?B*O(?D@FCTKR M6J$4"$IQ40_ '7 'W %WP%VAN.N(B\H \ \ "\M\+KR#XS5 WC8M7S;GP:L MD_]:O);!RSGBX8K+Q$N'@I4DR*H,\H'^0'^@/] ?Z(^:\H'^B%XWIC- ]-*O M*'EU(B^(L,T"ZU>&];N04]?0#6%T7_E"P8 8(/8*.)8]1+(39#-SR9FI;.X2ON$X8W\-'-=F'_S(#7RQ M*7LK,PS*,>!1A16=G&YG8Y5ZI2YG\3)4N$$+)F%61*MD[T6!,." M8571=3"LR'V9PH59$JT#PX)AP;!@V-V:U_U^KS<8#H:M M0:<_Z V;S=;)AR>#LRGH6W=*(_*)WI,OP=3:S\(;MWNN3T\GB]K3NM'XY>W& M8/\SCV)W]"!TO)AI18$1D%'IL[HI>CR5]J=(J.;G%Z@W%)TE'7 M9[/5XOOF0WT^AMX6(^G\FO6#$U4C-O6\Y37O3QHGR7>&(WOU_?5#=.\Z\81] M9'U: IA!T[-F$;U8?7C[%(Z/C=K<)EI#NK=S6R_]1M.B2>WV+XO+;M4 M[.VM4K>^5)T7L&^I0C%;29->\O5^P3)W@>6S6B,0E 5).ILI9 M">OF=@HH$%QLQ=]A$))X0LGM)*24W+ K)A&Y9M.A0VZLT)Z0IJYE6(25,RM. M-YLTN_),5(!3M>K=A1?H%E8Y'KH%W7JB6Y**OS,AJ!1W)_M,64B_4W].#QBR MB%G,&<(Y"K$,@E-&6-"X.FC,BH6.7L_#8$8MG_SE,_L>B[A\B.QHB[P* M>W'R^BRAL*K6[?9$=5R5D>3W(20*+ 62-GIMJ:W4,@N)Z.[ FLK*XIIZ)/% M&DLC-XR4/$KXSQMDPC_Q_TA_%#)!P5;*T5:J3T:AIM;NB3OW4_6D0@ 7P/4J M ""!BC8@V_' "+/ #!P?J M8J'_;L6N3_I3FEC>.VSR2\NW''$VN1"Q@]/4$7*Q^3LUO2DI(OT58E,%R])M M?H 7X!4G1UWKF<)6,K4'K_@ET+9"=?*OHF*6)[OY#* ML'^LMS73%%=F_H!D5%&%HA=FH"'0$&AHFX8Z76%^Y;K0D,0JJ:7WHUU;H<]: M%I$[.@I"2ES?#J:4Q-8/Q)O@]+_*@E-&6-"X.FA<[<\^?)[1D&^ZC%D;IJP) M+HV6LX6P>0+@1+E[Z _T1QT.3SD%EM[)+">8$*NP'(E,^9TB<1Z=(U)]*N/* MZ73$Y4M6?>2E^Y'!,^ 9\,S.^WH-<=M6JH]\OH[B9S9^!9:!1<8]@JPK?/R[ MW6N(TA-5P")[50,\5!D/3:0C@',HO#,)!X("=;N_S'W/I37G'O MWZ34'@E&Q/5CRQ^[=Y[ Z#O8"; 3'N][8\@WP9]KB;P]3.&0%%>Z#, #\#: MI\LWT.L!O-H?CO^-^C2T/-:"M)M0D' M:*DS6EK"CK35 RVP]O>ZW6F$,.=\BUW&MT*611GP:"X,\^4,- *-V=&86Y;8>H 1!\0/YV99+$M@7ZC$:Y79,#.T9@_1I !7 M5<&UG&;Y%0>R8>:/O%9'6,#87IFE[W^)80D/QP$!?_1C&M(H7FUAPWVA*O=5 MSF R=)A,\%\ CJK L26N-B[@*&#M860MJU1Z#\=+>2)8\2;"9; M377W@:0"%AG4L@QIR@Q-8-1B9HFIHCO274]@.C =F*X@IC,,297$:LAT&ROJ M\]BZ\^C.ZW=\?G<^CT['EC6[^&I/J#/WZ.?15SJ>4C_^0F<\!M0??_396G.: MA((.'I9_O&7"&'B!_>W#SS^]6S_BR8U7;F1[030/Z?IR)F.?"_(+';T_&5X9 M#;WSI_[W[=4)<1WV@V7'I]?7S4&OTQP,C:9AFI?]7J,S' R'?;/-YL;+Z^') MAR<#LRGD6W=*(_*)WI,OP=3:SY,;MWNN3T\G-*%EW6C\(FI@DZ_WB^?>!9[S M-E$@A]H\,H;)\H*I(PWYVQ>O6$J/K,7W\HG/ MFX^+.:YKZ)VWT=:I-&+Y#K%&(]=SK9A_9585]+AR_^Y+MV$/-^3Y_]U^^R\_1?8V3QK$?E[E1SLA23SC82;10 MG8@PH!+6VZ0703BV?"8()VD%ZT32I[L',J;!.+1F$]RJB<,?# M^4-YF[:SY+\EF=*ELO]'+ON7MRUEUI=%,UG3&(*6YJ%#0QQ M60_67;FS(B:+^2Q8C/"&1%@G+3X>]^S+)/FCS322/2-D+^,C$YVIJN9EA^5" M11,.I-\M;YZH_'+("!O;9!;R[04(+8]-)\D5;%B">6C3U:CRA 5[-4%;#BQ7 M)(>.6(^9[D0;-ZPNHS]L;\Y73TPY]@4U+AJR/U."1F;>/"(TXUE9IN\[-Z&T MY+V,/+Z[$7\I!_VF(R@!JLV$QEKM/:R1SVYB=]H%O28B(9=,@J#Z8(AJ<5G>=[]]7B%PQ]?TLW6MFY91;E:A3%,6N2>\BF?3ZN,;>X/A$AE M65)NW+-E$S>8J99TU&5K1'_Q??.A/J=";\O@T_DUZPM[RFOWBIUZTO5^6QU<)7;(9;DCGAFM2[V0+F%XGH> M6VY$V'4O8->]H_:N.U]MTE"HO(9L53D%)RPZZ81.3:Y^O.&RMD"]>F MKF5PCZ6'O$J0/GH5ID3-I*J"\V!H;?Y$ESM*I$5'E7A- ME]SW:<-=BEP?2D$8F1>@<="X\N3ZJ%BDBYRJU\"C>/FHHC'"CCJ5Z<22J76[ MR* /%@ +U)D%VIK>0LW*G(SN"JRMBBPE#5M)M=0*A08R-K5VSY2N6ZH@3_;* M!N "N+; U>N)B]RJ.KAJ[W,16V'UP&(. (1;?CA M!%C@!PX.U,5"S[GDM!BQ@]/4$7+!&1'U9JMPW50%R])M?H 7X!4G1UWKF;EE M^JL\>"5G-"U_\K#-$X!Y:1V(+W_YJ:)ODA+B[!=2&?:/];9FFI(2WU0W6S5H M"#0$&A)+0YVNN+KO-:&A;*'#ZAB%1:6F1;P)3O^K*SAEA 6-JX/&U?[LP^>] MV;F$S1, 9WIPUA&#T!_H3[X<7IL*%5*"";$*RY'(E-\I$N?1J4(F]4Y'7+5S MU4=>NA\9/ .> <_LO*_70-'CG&S\"BP#BXQ[!%E7^/AWN]<0I2>J@$7VJ@9X MJ#(>FDA' .],2LF*##N$K80 Z(W[NB;<$( 6H"7%PR?NI%;5H55[RSOG>$8P M4H5M"X'%J%6!!VQMX"&S. P#B0=RLK7+?\RMO[\P).P$A5BH.G;"&T.^"?Y< M2^3M80J'I+C290 >@+ZM-PT*!A7*8B4Q=M)Y4FW" MECJCI27L2%L]T )K?Z_;G48(<\Z5C1!TBC!G:)RR@I. M+$*??SWW@HC'09,Y^^XG/6?6'Y/7_"YR'=<*71IIQ*>Q,,@C9Y(X5Y;L_$EE M=B6GE$VU5\Y (]"8'8VY98FM!QAQ0/QP;I;%L@3VA4J\5ID-,T-K]A!-"G!5 M%5S+:99?<2 ;9O[(:W6$!8SME5GZ_I<8EO!P'!#P1S^F(8WBU18VW!>J1M:R2J7W<+R4IUR.CF:6=2U9\BC!9K+5 M5'4AO6<<'7F!_ M^_#S3^\\U_]V,0J"V ]B^CO[0GXD/X4![^\DCF<7Y^?W]_=G/^Y"[RP(Q^=& MH]$\YW\^YQ>>+*^/'V;L>O9DZCO4.>&//G_V[ \_OSOGSW$O^+\?_@]02P,$ M% @ )U2;2K&0KJ'8&0 AQ,! \ !P;2TR,#$W,#,S,2YXR923)3F6S)5^*L;3F2G-E]7[8@$I*P0P$* -I6?OWK M!@^1$@^0THSHR%4Y9!+=Z OH;AS-G_[Q-/.=!RH5$_SCP?'KSH%#N2L\QBFI\\FCZK,S MEF+F?!+R,WL@AX7-\X "'7'WP&?^<:?@TDOYK(2?0LO/F"%^/B*)Q'_WKYGI@%'SP\S>.8Q3.9G,AM45^K^,GA$M5KH.' .:I'CA0^ M55NBQ^#:E" TFFT19' U(:C,B@K(60?!OPYCN$-\='A\LAD5RV%;CXH8;AM4 MO#\BTD55@]I4& 9_ M'"Z!FQ% G]QI;6$D0.;7QD)@_($JC0C?U*$B!1;]/ERB:$8))\PUSO>X#B%+ MJ/#GX1)!,S(4.B4P_1%ZS/'X]FDLQIU(SB*12D;Y!,)5T_/%@/CN,0^[_N,1_ M#?%NW& -?3:>,/X)0-S -RQ<+TF,,>",_?% @:A]&O']E5GRZ+@N2P#".&LM M1SX9U>4(0*C?2F;FDM9E!D 4I,B-3 X1#*&!PR"=Z[J0SZ/M4J^GIU2>B1G@ MGE*NV .]%DI1=> @Q'W_*C=5->388(F)B,E86MC/)\?'[XX['>?0.6?*]84* M)(4_4E@=@];)X'5"Q#\=K:);Z2A00!7_V?Q>E5L$'#4I 5P9XM9PV7&4"Q8] MC-6RF;+PD># HNJ-2YM?$,D9GZ@0[);JWGA(GLZI)LS?DLJW1$N9X;P]?O>V M<]+,<)Q72P(=,:Z$BJET7H7PWW[G *D("<1^Z[R*Z/WVQ2#31C D(W];],Y;FH080?[I,%3XGZ>2$BGO"[W3HEB,%;O4AQ9**X21>G,WSG) MF?F7*!T"_QJD.-#2:/=*23XNF@VF%*?&L:):PT1DI9I.*%^XUKZG%+S2E#!.X8^#V5S3E[$ MGM';:F".47;<6](2^]O/H#NMDULB)9#S0)NI= V\4G-O*C278'S1C;WW60_%#"9QYF>VG';J,*"R0EJ@&'!/^@4QJ %,TA M%OB=X'322+-!PC[YJFH9WQ$)[$VI9D#P5K26Q5BAPG=F=-56H?,JT\O>C[U$ M@! OG!$UO?3%8^,QF(^L7)'OK,?B$CO&&XC?,1V\J# E];P5VZVH,Q=QN6K? M-%5M[HKNBYHKM+&5";EF+Y4&8#E)VQC R]1=K*IM#G7+T7W2<'2_C.=UD0^T M<#]/A>]1J@8V MAZN3?>J*!RH7U]#7Q)!IOTC7"&WY'M+QV\[WI5IS7H4=.=B365]UXKZ<96?[ MN:Z7$=0UFTRU@BR1JH8:S<%0J;P?*I07XG0,TA1SAWE>,.M.R%X'>5>=;G7D[U #H*18AXC$L![\@K;?5V@^//CT,I.GA'(7C'SFGK$'YG==[*#I4"]&5*FV'RO4%J)V M#&XG0OZB.C68B<\X@W(OC%HV'G;5""M5^:Y"E5$7#O3A1+'6RW!,2[.C1].>G.]E/- M<0$.4,$%B$POKOA8R)GM8>U2\!*U=9*C#4D%D-1/U%*(SDGAVR.M)%M85 ZF M1%(+3:R!E"ZZ=7[,671+MJ\ AV.0[+'(SY9$]<9X8\ %&S]G?@#.X6)>8\9K MB+ATSNO\F./0UM7GO$IUACFZZ+'S8TZ\ MF*>O_0L:+PF3?Q _H#>4H&",+[900SY<^4[#VYQ)#_$X!I&3QK3O&NA.)M*4 M:DG>]L;G5+(' MU+?GTH\/'H.;NJ7ZRA09PA>_4F^"2\%^^$+7EQ(F:<)3=.R(X#>52MLX,&>UGY MASWU$3F6E0KM+H6D;,(OGMPI@7@(XR))W#KKC!MV4&EFZW%AOIEE8\&H6R?N MUTDZ?C&9-(CP;-)4J70_P\E6Z[^%=CK!_-^64%S"?9=W HD^Q(!SUKGC= MBCU7'-1+A^2ISGF9W=%6:5UKF[D%UK4D=]4++9R88H?Q^N6%XNI"(?&.H?[% M@F/!V^NN05JXFQID*Y)6(GQ/R=PZE^T5=:TE5-3A<#.D&#MY_>OT2OY1-W7J4< M:WMP7MDU'2V:QE@C4,(^X6VB0@+V8 M0(&.&N0%3;!6*GSMUD,-A>]YZF"AC]SG6]5X:0^5VE];7JJA_8*W+[90H*D^ M+I'TQO>*C@/_&D8-+A%^HG@QA7K=!RK)A/;IC#!,=%*M>N/N#/(D]A>&T5_4 MEKXHA96VN)92UK!%0SFF@R%5CB'+P,7D'T;T.PD#V;98XG;)Q(M96YNU=:II MCZL\\\RK*5C#5/8O&TVM[UBH*=VZ_/Q)7FW:]'+,?HK8?D:NN^YV#//DFN6G M!;Z74Q1>LAO!!,^ILA-ZJGFY?;_)M>\E^)X*^4Q2C^E+XC+?["76,?AJ+.4C MX$U.F)#&ZKP*\3I+Q/OIN--"P0-95TH%6(U-G0<28I\S\TVFJ$II,P7:8JU4 MZ%H.DE6H.4Z6=.2$/3E15U'ETQ<=7PL^&5+\).BHQ@ID%89*W:TM%V5UAS@/ M$:DY%/BBI0:+/J7@E?I96^W-ZF?/%W#2PK!.8W* R@_RO4)#Z< MI*[X/82PJ;-4J2(*5NJPPU0>ZN6=\4MAQAWJ+.Y,K8<7Q:V*.UU>%B_3Q6?B MHJW_.M/?-OLKGR_SSD'9&X'S*BYXJ\R'#7 E@B;'YB)"]G6>M5)B(^_8#'.E M(>0X3GM#V'NW:J64&AZW#KYR9YQW;*6.:O?/5=_2QZYK/BD,,]E P[1&I&>C MM@+ 6A^M2E[ %G"@O-%(*6#Y2\&^^(*OI6HT'F++&]Z*)&5%&%H3QZ M^#%GE;Y$,WL9(D0'Q,(3P'9?ZUL#*1\?G;SQ$:)P$AQ[+/$:HZ$ LGP4=')B MZ#7YO]A^G>_P%0"6![R=G( W1P_[%]>:XMBV']Y+-2Z==CIY-1D,\-Y]=&\I ML@9Y?0EPZ;33R;O9GI+_WN?F2\'>J:#[B!%[$ZVL 5=J96V7+Z.5N\&]$R+< M=[7T-U'+&G"E6M86/#-JZ;^H)9*LO9->!2EUSYV\*@\9%?RM'?-/1T_*^T#F M<\;' A]%#S@7(?7F&3ZB?GBU@(R4N6'\\4#+ -)KU-)\]I_N2:?SXZW@%[.Y M+Q:4GC-)72VD0BG>4"SJ?>!P,J,?#^R:,M]'P(*,'3MAP;@XJ#$U#+Y!11<*C&@P> MG]Q1:P;\@1V9JA9',H]81/)]3'R^L]@.P[,D*Z04O M=\9$3#2>A+V:S0F3<9W+I_#KQ.%58"PC<4>8E_!AW[X):^&3F>#@6N1BE;=1 MN)\&C-$1T]M2&[HSP*%FXC.5\&-!B5Q17FF3MMDA?IC@G+K,PZO?E^1!R-X8 M1CJ#(3\>9QFS:[IK&S5?6CB%GB93'7UG >^"$[Y(\U'8HKD=@ASHA,HR\K$K MPG5-]:CDSD&/X\Q _'6]E+1IH\6I3TQ/JPH>YW!9"ZQUC%,\5$JNJ1:!Y)0$ M6#&',O_W@(ZH*Y@:!/*:0,1&W M]309@*91P[S?XS[\?P&)AJ(6?M5D1S-;1 MMEYP%0)H+R.FS@WCKCE^ZBZ@#5=AP$R\_P;A+G(W@DW8JPG4? 8#%#"!;)OG M'&NDY=:XHMX-$.S:&9U##-<;1S-6S-#JPY8IK*R*^:IM6K9M&8<75\-NUL8R M3]HV:R!QO4<.$>64S2$SPWR,X(PP$"[3GCFZ0ES5]2=27,P8XJ>#8??B9IW' MS="T3C!$:2KY12#%G-XPS_,I/@)C[(XE<\D*_[:M=SUIA-_7O*%Z*KSEX:)S M"+(I.@!Z2O4CI?R,2(F5D;HSW!.&*?">>U3Z^"C$$%](Q>["BPZ)*+YD#\T' M>RR;;9M)+K?QG<\5([%KV[J1 $9]*S15=V2!A*TP5?2V;6RDRMVFZ5]_W#K" M?4%P)[0/KOU^<"Z /&DD?A[02SJ2 9&+D\Y)9X6ONE"M8SNLX'@61::]D1]] M)6@EA+-HUS;64M?-5V^:7S-.L3<5LV?9MF51T"^01^CS=!7YK-)*WK=-6?D? M\8V^YY?ERJYI^QC,%&OLFO*[YD%)K<;P;G6>_C %8J0;C S/V^1A2;.DX7Z&^;\I>PLT>=>,C**K_TD)]O"R>.C0 M4\PU1O %][I<4[]@:T*YQ'UYBB6.UB(;H%252,,"LFU;?H52P.NVXV)^+IY< M/\#O>L=Q8+%4&F!JFY0*)P$/@@DO(/XU5LS*VZ@H;]*^>3FF=O7CQ:6LE3?> M]=(2+FEP+>3BFI)QY$R7/.2^VX7]U=\GO<9$NCNCN)"''[HB?"T(+&_2-O.+ MAHA/E,K-8TK>MXX5F.XSGZ ]7=P"#ZG# ]TGEK@2Z];6L83'9IC"A.N*7R$> MJN;@W(C9GN.D_:[GCRRI"S _-E-]JH0/WHR%AT+$DNX"I5K![>H@1D-.]93 M/P\4[_O2/P/ Y"_ZE+A3ZF%=>]^ &NH38 @-5TZF?.U.GX6,FXJIQ9R>DQF! M7-6<%,-/04%VRQ5!WQN_,3LN0W$*L>-<*&8^S*'%4 9*%TAA4YQMBS,;2NZ. M+&9)$;&FHEI%LKLMK892,,NU3;F/@9^C1=17__/2]7+?ONO[PL6E6CLN<^$: MA1,02\Q#;%^4T0!O!#S0QL.Z D'+U9PEWGXX%P ^JZ$\,"=S+P,=2-JG;#8* MI J_)6BC?@OHENH^I/PVP#0.HCP\?\-U40A=!?-% YX-6;PCN//63+$EL&U3 MZP5T/\.9-E1/+SHCKZZX2=L+N*V&:IEJ(=.@JB?/Z8SPI3^-U%7 9!7,\YBO M;@2VOV0^]4:+5%8F!M2%V>>WP#,7Y:^IUJ! ,0Z+"X=QN!8CO%'E8L)B0O#> M')'U>-$\_\4Z>U:R%M*PR_2B!^X.6#Q=A-<=H&T@379S&4C.U!1?G=,QY1ZD M9E'R@Y_7=:?F0+$;H)O\/2!2XY&VBS^#\"-VQ/>1BG(E?$4J_K;:29C.$U#R M\HNHI$G7STD/XS5AC#+"P.D@$<8H)8-2$6^"]7E(+_:X7<\SMY&)?T-X,"8N MQI)278*!F.U=OVB.KH6@96X\CB'-')0W.:7&@TH,P&A>C",[*!7+QJA;*K"K M&9;!N> Z+#E<*H'5MBUC*0REH]/?:,1F9^E36(86]\QPI;6 15O8MD7I22C5 MIW\&3)JF-XRS63"+A_,9FQ")<97"W=W"%9=FF-IF GE7*H^+."YJO*L32A%/ M-T1^IN9$HS<#!> N'4* %?:IHD1B]*66[LZ^>=O\6,$.I"5#V1WEND!MVV:^ MH1,R%_[J]<'UQ[O>1(WFA#X(.YPDNI,DH"AXM[-)HDC6@:_9O\$H^O1!^ _X M\1:3;EX\S1F.W_CVPO 1D"PN\*S"=/@HAE,1*,CXP\>0?JZH:MM86V>B%0SV M7 RBY263,*^N,E9/5G:H_E8"JFU/UMAV/6/<4AT>ID7_VWT@S) S%&=B!G[% M%'R:"A_B9G5*%'-ARCYG?I#:&]H$05M/J^8484JNMUZS&4L6#&P:?L&=L.K3 M 7%TN'HF#TFL'W^V;M^PL?#GA MF>/Q=DUW?V*^B%-.[P08RX ]P=QYB07"PK%0?)/Q^'UV?MX,Q:XGY=Z<\B%Y M0O^B3AP<_C->;EK\X_WB"^%-+O'\=XQ^ @P4]63(>&0[?OXN<_E4FP3P-89 M>2R$95W.&PJ3OZON !U>*:)>5P^G=,CPX+BYNIW8;+BP Z8*@7#X.X*]5[A- M-DS.R0[%.=54S@ ;/%P>&>N-[P;W:C@E^A,(Y@^Z/(/:(GK:%O&F1#.8$DGO M.=/*F%KJS24QM6.S([ 19-OFF%PFAH-^G_JF?CKDGH'2X'B *2H-B192L$30 M.F$$(Y^Y9^R!^;F7>4K>MXV5BJ4Y".4S:W)FD8[2%1^S*9+6":7X+GK_]-<5 MWNW:MIO%)X KP(V+XW?/DX_7AM^NC8@+A M=KM9)5KGNCE\R[B7H"EM7!IIH XM'ZJ)O]O+"VC75 MPOJRW>U2MD4S1,)\20VKS*IE+8C=+UZN\1DY&A-%4L_O/MWU"HA)@T[!TI:7]O!\AI18'QH; MGBZ63:)5C_#S.]>43_04C-9DT7%:=;9P?1KZ@4]3YDZC8TLFL3ZC4@/%)IN/ M4G!O/=D_!:\Z9:#N9'NJY33N_/!9OGP*A0+"Z$XFDDY@DOE$31KDK2T"H"SZ M5 6^5HP#!"Z(P#QD;D /B9S0U&62W*RZ7'F[)VY'UQ2+9HM<*>%OP0$L6]O! MMG'K4H=RNE6Z8H=EV];6ZS!',658KL><6E<8Q@B7&420.JB5#Z'4 6B=8E?K M$Q56F+%JV7;VEH69K'@L;KYSY[]"ZHL91P$7/E(+LY 5.D1AA, MX!ENPP'ETZ0Z/=5=WX?,S!RAGF^C+/[7Z:IUXP0(8!XCN:^R M(JA:(.UC^"_".?V-N)]]QEF5*7$$F[YES,"@\%+]O&! :-&N)" M3A>_4!A1Q,>5!"#6+*YD>;)L^QQ8_"?API+#]:;/@<%K,A'*DL.#"G$)W[X1<]XF\/F!ST%ZS_SL-6 MD*NR]76@[:#:=?P(7,1IMLG75&^<.OQM#KYXET+BS71,T3.9?)*,IT2R%60; M["J9;K=O- ,1Z&D8UYP*(KW>N!M@&05J#'0G;&Z/9R1FKZL/X9K-PN4DX$+X' MX_@<4J5X(V@LQ!Y%B8>/HN[Y]I.3E=EE(Q2M\\H1-_]'I:CFHY,OBKK M;1."^8A:UWM@8?VJ+)-%+UO'A$I)?H6%W%=?CX&?CI!^Y4YAYOCYF_\'4$L# M!!0 ( "=4FTH/?AS8,"0 YO 0 3 <&TM,C Q-S S,S%?8V%L+GAM M;.U]67<;.9+N>_\*3\TSVMB7/ET]1^6E6O?8ED=R=<];'JQ23E&D)DG*]OSZ M&TA2$B519#*9F:1KV@^61&()? @$(@*!P%__X]OUZ-5MK*;E9/SS3^3/^*=7 M<>PGH1Q?_OS3;Q?HY.+-Z>E/__&W/_WUWQ#ZKU_./[QZ._'SZSB>O7I313N+ MX=77(BK'TYD=^_C3W_[TZM5?J\DHGL?T*O_\[?ST4?V;Z_+/?G+].G_W^L0# MQO-1AO=L=A6K-Y/KFRI>Q?&TO(T?)M-IG (=F9R_7%4Q_?S3S36,G2C,%B/_ M]QT:F'V_B3__-"VO;T: P^O."VFBVJ?XNPL?;'? MWL:9+4?[#[=;,OH&[8MUHP[F^'$S>Q']B_6_7U:3^3BDYGZD MQ7%,Y>PS=+.-E#4E.^MZ56" %/@3<0!Q&0/\,IV,RI!EZ2I_;R&K>?V>R?QL*^"J MJS@KO1WM2_/:QKH?P 5(_GB]6 QO[/3J_6CRM0W>&]OIF>QU>L.^0]C4Y@&& MLR]KM>N@WX%V-%7#SL[%;.)_OYJ, AAK;T$:^G+V[G_FY>S[GJ/8VNZ!AM4E MX^W6R;X#SOH0&-'EMEUM;='N.O][M*/9U1L88=8LSJ.?@)W__4,Y*R]KG;N1 M*K!/B]T-Y4-Y>36;@G2/T]VI?KER=P1^FE^[6(&E.''6^\EYK,VRNL_/<9R] M*2>7-CL#?IN" 716G)6:U-R+M'L=-5875[#M;2;GI=*=DO#&CGQV M^L$0SU+VI'D8_=MR- =6>W?3;*KW:[/3X319_IOK[$7.>UM6_["C>?P8[71> M+?3%S=1LK-(],2>7EU4$^1'OOSU+;V-5WM9.F??E& QW6)RGL+M7\^7:='E% MW*_G6=:*2U!]FXNS0U#2/72[.;UV:J)[8ILLA 85]R-LS1QNH6A#CM^,6#H&;<<[3T M=CX-*\O__:2*Y>7XW3=_96&!YX5>6=]0X>BF[D[ M3/ICEOI^'F\F%?#.Z7C7H\[3,?0(.^RWAG;HPANF9^.9[ $2FC_!!"994@VT[=# WT3NJW(+]\OXF4&L!&[]=AAWT!\G-S6 M8OQT?%>XJQ%O;;GOH>TF,O=HL.^!K/V\JT$U:;SO 9[GK?0L_3:-:3[Z !G M5>*?,7M(8SBY!96/R1;Q*CL3OF.#G0WDPV1\^256U[G_ MG8G>4+DS G?;-IO4[(RT)F+LY?)[DG%G)T]/Q[^!3%@QA5<.K;;1ME,C0Q"\ M&F.3'=9WIOS2-FK( SUT-<3@=V7UO1H=8D#-%DB+IO8B_E/\"I;U9%[[6R] MJPBV"ENHW%RG!W(^ PC;@R.:U=V+O L[BG4P>.YE>AY]+&_S7&PF;%NM7DAJ MM&P:5MZ/P(7MO/#D;(VN?JETIR0TPV9SI4X):B(;-M?9CYP<[-0@>OIYN8ZZ MW4W8;Z_7$5F?I_.3KUF([$C62_4Z(NN\)5DOU>N(K$9,_$+I=23XAS/F#U!F M63)WVLDUJ$67\=LL@E8:>NZTC[M$ Y&^;J*ZZ'JW"S[=]+C]YDY__6R>P]P9 M=#>:^$?K9]E%?0\^R6M-(DR6MQG_??EQ ML7+FONX@OO8AG5QG'6!![C+V[\UDE#FC>HAS'5D71S__!%06G;5=&")DE$H@ MJ85 U B,#'$!A:1E3-PG;LECU$;Y'NBD6L[1 + MO&R-4%@4+3RUSN!@D)>< M(2:=0,D[@CAGQB1A$R9ARZ!66.^D\J\F58C5SS\!%%]K!V?]ZZ(!6_EG'/GX MVNJRQ.OI_'H1[(3*6;R^JY\OX1YT5B>=HPD#'HX]7L9HSX53:$J3=I8B1V'@ M5#(. ]<1L:0$)Y1(+.P/P49M)O)%KN@4L$$YI2;RGOQ?*]AA/Y3690?M]^;B MY84&"AD-"21QI+R(*"I*$/4:(R=BD(XX*JAIQ2WT@5O0C\$P1"<.H"HF'P-KM M6X.ST!%L7#V@/2CS/:!RYD;+D/0OD_,XFU?C'*K6B.^V-5(00[2/,2*7," A MO4B[H7U#W9)\W:+R23*3GA$-54(RT, M05YACZ0G@F-MO!'QP#;*W4A6?-T;X5@I7W ;L2<\ "MPC+!RP!G48!29 T* M^,9R_D.HF8/-\8NK<#]8CVC!=;"F"J\E9WLV'V06Y0UKDG]+%:W=SFW=1 06QRF$>'&$T$)0L;58*M$6DM)#:& M8FGECZ&$=L\W'0-W&*[IQ*!IW%K!0; +$PURSH)DY]PBHRT%R2ZYH3IQI=N) MH>,P:@ZRO_6!^H&,F_,\@UE3]B-;7KP0N]Z$C>NYF9-%,DQ(:0*R";#431:(L6I0(E)X[%@FB=_( /PZ0@N8G5; M^KCSR%?J%8G&P&B@L&8M*"Q")V0=#8@Y2I3A$D?CCEIQ[V-:GPFH;A$<9/=[ M2O+I& 1KG.Z^3E8K%CYH'35FB J0Q($GA[#1!@7K+.&.6B_UO@K6'X]=]H3P M(/SR[ML-Z'DQ+-R*9^/\68/3\>;-%)Z8I",!G0$SC 0)$M'D+"B0&@RGJ&5H M>>0YF.9T$&;J%-&#L-;=E:Q%4I%?LR[Y.&*K$6>]V$H!PMA): (%%1*21@?$ MA70@FZD(VE-.'6[%6/P/S5A= GH$?/49\*I6-NK%):D]6&Q]@X7BAF$*D!CJ M. (H*("C8!*LCC9'*#C?CMO$'WE+[ G:7DR^QBF/NS;*^C(K=TU./(R5MU6[ M6.YR6+L("I1!D:J(N/8,="=0N$40U' ='5?;%ER? UA>8-PZCF6Y(C@83DH& MI< 9DD001(P(")84551;3TD['_@P%EB;29ETB\< FTWV0.5T5? C9X>]M:,Z M[=7L#>):F2\-YZ6JQP@IHC&&!O),@1DD$C8='!:)5<&R2$X'M M;1C_$-.])RI#3N^Y_?HQ'UV4=K1)A5E;OJ!8@R%%,>).)^2Y!=.*!XHBL+21 M(BA^U'<(VD_32_.])SI#3OS[O.UP&6+3US<>F5MKSPD4*3JG(,')6 M:H0C)\@Z3Y#"6F@'0XNBW6$9_\$VYDZP&6#"/U>3FUC-OF=O2IWN!(R).DOY M9FUL4[5"ZJ@\@Y$9IX&I>8J(6>%1D,83$5)4]I@E=@?V>L?P#&.4W=U^?AMO MJNA+NPAANAG%>A;&8=4A^>( -QMPG711&!&==U@ADL4GK)N F!0)U!UO?*#) M$KSMENQ69;#/TXONN..Y\7D&5(X+!<)F6 M%B6C&?($_E2,!!F89\D=O[ZZ%P_T!-.PMLJGR=CO8JX\E"^BM"$20Q'POT$N M!(T"X)D#1+2R.&K:4ID8YG"Z P[H"I>!?$KW20%/4BI'H.'$Z6I"0!C(Q->? MPI;U_R;E>/8/*#ZO-L;.[-4N@"^L,\$@$AGLM((;A*G0*&*K+,<>-LEV(7_R M1V&AH?$;)G@FPDH(]XF5GR7_7Q\@\T*EPC"1?!04>4H]L7%@#EEU]!?7Q$Z]K^&!;U0+S2%1R#/1RE:TLHU'B M$B.51 C8@\:%MXF,W@?=;'P%[/\13 &!!)84Q01;1@!]$CFAL"?1IM!2^@US M--/M5$VZQ&E8'M_N[WU>N+!:&.B0(DTBS%!SA42?6SM4W^.3O M-C\OSW-[9 :8[HNK237+F=E_F535Y.OJ^]MKYGM-Z4*1@#D6&#'%01DD'/!B M :/@L=%))N%,NPPE@T]XJXF:]('0$.M\)2-_'39T4\[LZ$.TT_B0(:6)"-BE MG4(QIW'@"EGB %!./-(>!\1)\IR#>J=-.F+/6L?,TC=V X9N?;;?98]"8!O1NJ%5@Q+F7,1H6+*'*'D4O*(P;;KL$N4JW8$3OANN>&+J$: M0JNPHUIY?O?-E]-LV#46#UMJ%M$*6 +)(F$L04I' -.[@**6V!K.(HOMM(UA MG'-=:QN=HS4 <[R[OAE-OL=X_Z#[#@;'UKI%I#AR9B0BUBD4#, )5AHL#V(5 MM5%2'-J=X0SC>NN80?K :PA76WE;AC@.S=6*%VJ >.0N,%"[4Q0"&2P,XH$' MZ#,I9Z-A1A^SDZUC=N@.I<%." /V= M)>U'<&OVA=8ASN]60-GQ$.]QS2(%XYT-@*.0"5&AP23G%",3*&?.N9!XN^OL M@SLO]F*.[F$:(H8P/^=3!T+6.^%GL*TKL+*K^@EP^#1_$&LM.G^P>M-\=71- MHDTZ[JG@GE-%M ;\N,U!=@*E')1A&!&PVA2AJ5V_Q]$CWQQB:K=R5PM0#\(IO\0TJ>*7"FR)>?6]_GXGYEE3OPC1 M.2M]R"HFAFV!<"1T$D@;V,A]HE:J8PY&V7W4,;_?T<.L/!'=R)3Z3N0 +T40%]H%)/"'#242$,(VX M<9[S)!TA[<)=A_'^],\XO6 X[ WHY^\_+YQ<.=GGW3O4FP\?=FFIL-$13+$% MFU9;9+4G*#'ND;,I)2+S_8=COH0V@"SJ'= !^.L1'-O4FN>%B\!D2-YKY"2U MV4^A$0.(!W(WBD7U^?R,1M@ ../8[_Y M$LZ&6@4W00HKH3/..7+$9 +VP![=Y5/> MGGWXL\UNZZLX*_W#DY\]IS^^F,'_UXL'<'+>T?>CR=>#I$%>G_MTD9$;)$S> M&.+;N/BY:?WLT$Q!,+=)@=+"-#5(!&40R_R'A4E:>B;EUD##?L#(Z3UA!)^K M20[V"K]\_VV:SV3?EV/@%F#L$S\K;[?=YVO>2(&U)#QACSRS%'%O*%*>!&1C M$"$2G>+6W-*']*_T-^F3 2$=)MN.CS%,WP.$Y_'&?E^N_/LK3SDHY*.=S:MZ MK_X"?<>/($NOIF?5A[@M'\]>31=@)29BK4$&Y#*2&I1'0?-#]9%:S<"R5*)= MMM]A>+ OUGB>OV=HF ?FR]/I=)[WQ+.T&JG4D//65RZTE!$'QE"T+H'IP"6R M^6$/&W$D@5)0.([Y_:8#\%9G0 [B'7Q8!PUYYJ4JA<$^U*F2$B,"*:T3"DJ M]0H*) Q>16;V]@3V:9 /Q"H=XC>$>+FG]3YZ?I,\>5ZZ #-$."$$LL&'[->T M@!J+2'#G8DJ*&M:.+09Z6VDH"=()= -O.'=$?YG<.18NKL 26]JF#3>>S8T4 MV('@3#2""0I(8.,C\BEZ1"2721,1O6_WVLDPP5H'V( Z!_1 7/5^4M7N[=UL MMQU;*D"N\!0)C$G*<74SH ;YLK< ?FK6U2'N'L)W?K9 M67KWS5_9\64\M[-X-EYO F_@L%V:*0R(:IVX@'69K3.7LP]:7'_#Q<7]/U?$-K#]@@][4>$I8_R5.^@0TVU"H8+)MH\D:9"HSAMZ>GUCRVIYZ^O=M\43 MO(L0H!H%6X8UK+!#[<*2G'A6AJ(LI.ZY@";BD$6RK/AH+FGK+P MQ M4.]?UT*D:Q /PB]WSWIMMG VUBN<<'5X*@620-B7L!0#=BF^& MR71T,+;9'\=#L M8;(D'9*=.D-T5S7X16H>1T\N(N87]]P7&??7Z\6MFRL4(\02'0!(2I /S"/N M75JJ=YYYH]M=N3-_B#UL8&R'RZ*20V?K\.TM29?6%<^7Q[1A069QZY'+ZIT( MFB)LC< D4M;V.@/!?PBNZ1B\@^Q:-3_? [*\0;CMF?>FC>3W5*VC2B"7\X&8 M)"/B@6'$M*<.Q\!Y:/DF^$#O0!YLU^H0TL.=,RW>'-KSG&E-(X4122HF,,JI M9F!=<8(B@JMCF4=OFC13&D*#S M^^Q4)(4(EB1[P332TGIO2")*MN.KPXJKO>?[A<"P7A ]!%O=W3T['3]Z#VT< M'AY*VX7!&C17V"2XY3(AK@ 36B-@NZ+ MU?J#=;"+B(_N :[>Q+_+^/"8KH'N!#Y/"= @4\.&6H64S,K\[(XCF"$2R7+> M/58Z>F4QZ-Y;&'OPH7:<'[#CGHI 8;F$'!_)L4*))3 TK')(FOQ"A7 "M[78 MAM&LN^*6YQ>2#PSSOZ*Z!N25_N?T!PO]VC/=3J.4,$P:;W @" Q:@G1^G\_# M%HJ2#8(JAHEM^>+80&')1\1./>%]0$8#I0RF<+SPO/OO7RH[GEJ_C(BK_UI, M^Z^V'.=1GE3E%-!\6]^<77A6]N#3#GLO)#%><"^12]'D!/P8.9T\@L\-<3QQ MVO(<;QBIV3UK->3=P\[!@67LQISJJRG43\)_SQ?/O"\R?)U'/[+3:9E*O^"7 M^^_WE=M]DE1$&@S/*6.H(F"W*P#,AQC!P'(DZ"@,97L_2]JGR7JP57*$,W/@ MI?/RH+)U?W+VYK0Q7GNNF!XH*11-'"=-$7$X(!>\12XFB[BD/C@*7YN]?3M_ MU'5R'/-QP.7QV[B*=E3^;PQWF^;9^"WLE+< QVWL6(=JWUD13(C:YYU:Q8 8 M8PXIHCW2DH NK(7 OMU]V&&.^P[&Y(-"?O1B_M'8>Q?E:WLKE%0:ZP2SK")' MS)J( LP\,D13YAWW3N[]S,L?5J\9#O0!>'F#NZ _EW CQT,,P24.>Y95QB$ MRB M0!)XJWP4,2;!VKGU!M*]#^ #[@G7XSDO.G0RRT.>6\$D/\B@S?%+#^4* M[6S2*C^QF&A"*H VZ)W.85N)91X M?M-",(V$5*$QO$\;KX]\Z1DD51T(H ^)S6FR$9!4(C2(6-Y/H?D!.MC3M;>>F:> M/H6X-RR#^&RF8.__.IF$Z<5DM"YYR0LE"R5T"A9CQ*.7B%IB$9/0@:-42N() M:/!'?9[9U33OC\L T_SNFR^G,;]JDIFRWM\V3/6:TH6R0BF/+0K:6S )A$%4 M,X%84+"KL:2,VOMMEQ]ANKO!9M=;UQ]M]7NL@[7#=3DNI[/J+G76>9Q&:.VJ M3H"S9DZ;5RX35,F%.3K"T=[1:KY[\CK;H7B$;8+&O M9E,[2Z"_VO%EZ4;QQ7OXS2H6,"!-O>'($)I0CUU M)D*L%Z]F=U@=Y(AV];7%Y8/-BQ$=X&3V15KZ/S)^_@1G3\W_/=K1[.H-#"@K MLN?13VYC]?U#.2LOZU;?YO>T1WU3\2&OM>D;.XW383K\-+]VL3I+7R;.>C\Y MC_7SSC4!GZ&GK/!?VG(\G?U69T:JSN;5ZIWLL^H4R+D>P_H>BN(Z>FCH>?D\ M=Z/2OREOR]%)?1]AH,%>7$]^SW,P#@O^''K<7QZE8>VKDT>\-_00_Q&K4/KZ M$=H<^_NE*NWH;;R-HTF=W:*_B7X[\?.[A+U 3U:B0;M>;)C=]W8?Y1.K^EF> M_GMX\]#&6?K%3DL/(WU;CN8PR>]NMN#:JU+VSUJEB>$$1+R]C' &]6S'E@H;.>8!E \P?#WR@02D"4DH4L8\5A$+N4U1&Q229R.H MYW%W0-:W4T3-B17:HD3RPU V>,1D@-^H,18T,V+L,=^3ZW7V)\,".U1FNBSQ M[.C-Y/IZ,EX0_S@NJOX,!A'#,E?'257EAWD:&$I[-EZ8X"S3/B*1;4?'P2C M)H%YX)/BD4O#0KO [6'<-T-RXT'0WO6,X''TW2WL-@NZEA2O/=J?UIP:M MFRN$Q)AS9A$)1B,BB4=@>]*E4SPF)=BV\]\_6-CK(:3V<%.X*0JT!7J#)*ZJ MP(8O;^K3@(OHYU6=_^AM/NC)"QJDRCC\!G+C_N\[;2^/Z>5ETVG[A58^.2H2 MHC0ZY$+2*( 00QY+:T%LY==)C]$!>C#..Q3L?7C,GIH7?9FF[VU9_<..YO%C MM--Y]5CQZ+F;D\O+*H+Q&^^_A?W[_K;3\L%+.SH=PWS-E]:IRP;DO44[RSZ\ M,BP/; YH8ZVDU+X?#/"='TWR:#>(BLT5"YZ$5#$G2M%!(9D/>G*R7(0Q5<1K M2H7<]CI4/P/.,_$P,?>D;QCI"S4*%CR+CG(DD^,H)IQO \1\I\@:FGB0@;<[ M1AS&*NIR I\]>M458@/LJ0\+=P61C>RPIGS!LT) >$ )@\C%"E1U2PU&D0G) M.#'$\KUSB/ZHS- -7D,$H-0!$+O)P1?K%$1@%HUQ2!DID,]W7:F$G3DE8U.. MFK1J6^AYWQR_-;+F:='"4^L,#@9YR1EBT@F4O",(5!]CDK )DV-.2MC1;+W( MXJU1ZD,56ZN[?+)559/:F\-\;;>]J8%KE*UA>LEY<-^/)E]!K:NMAKNCZ[_' MIQXYNU]V^;K+O^V]^TK1GCBGZ[S/EU]P!W_<*&]3V>NZRC9P#F M7=/K?\[MJ$S? ?W'<_O]/-Y,JEE.@'SB_?QZ7A^,O3QUV5A;YD)8BEM%AH0^7%R6XN T_%=X4-2 MT_\::T#$VL\/:"8_):6.R@=9N,@E>C>@S<&H#1HH*#?*^X21TBPAQ31'5F./ MF);<)/A3;KV2W1< (:8R!Y!\ -8(3X>S&Q2[-56H:*4VP2&B<$"44[ 8\U$9 M-C(PDJ0EJIUM-=0=SNZG_MDY3^^0#F!^O7]Y!#5F&WAJ6]6"XF %J/:(.JY0 M3(0@ , BH8TV/+^V[8[9/A^ AWJ L ^CIL'F<9X5U+/TVS2F^>A#G5YM')X< MNY[':UMFK6REU%FZNQD!K>VV^?2[&_:EM:UHH;TVWAMV6>XYF-1QG/;<^ILJ MAG+VWOJE VN0(=5^U.ET#FH\]%CG!ER^=[E($3@($1\FX\LOL;K.Q!SRH&*% MC/K!MOH9O@_Y7;8S-UJ&(D[OT[LO:&0)I8QH88@^3+A8LY$M![0W0LMV"L6-,>U Q.DN<\ M8JO-,6=,&)8=)L,B/8 :UVP(>W-; 4J'%"1K-](9Y'@T68<5.8>\P4Q:'E*[ M-W$'.G(Y?C9K 7$?*M_J;M2_=V*UM_X4K_N+3J?CWW*&N0>'\,JUC8-U_(L= M99WCXBK&.N[]SC&]]'OVB'TC\H9@@D:$],4?G^+7$^\G\SI:Y")'@MHJ#-;/ M9QAJ/U>Y8DPK&\S1 .UU-O'+/T(R^.!%9N(_37PP&5\:/(R]8@ MM/CAU>[)]8T= T\O2%@?.?Q2Z8(::8PV"BDM\MOQ5""=8!M87Z1"B?R44^>$3SOS("45^C6, (7O=5E/EW-[EJ=C '%MJ%M1)EJP72%E% M$=,:(Y8"19)AG->(L$FUXHX?--U,]WC]*R'$D;RFTC&G_$B9(9YJ8WV9 O6= M@_IAHS[;[M^B>NCK\W1^\C7;&0/T=3Y@7ULYX*^O\S?.3N/?_O3_ 5!+ P04 M " G5)M*&YRS,BUT #R>@4 $P '!M+3(P,3?&?SR?HA6ZR^,\LL M7673[WZ?K>Z_^]Q/Q>0^>TC?Y)-TM7GM_6KUZ4\__?3[[[__^,?'Y?S'?'GW$P( _[1K=?") M^-L/Y6,_Q*]^@.@'#'_\HYA^_UT8W**HT/_3DW^*?YVN=@U>/DQ_VOYQ]VAL M^T77O^/-LU!*^=/FK[M'B]F^!T.G\*?_\\N;]QLT?I@MBE6ZF&3?_Z__\=UW M?U[F\^PFN_TN_O?7FZLOVG]ZF/TXR1]^BG_[24T".];SR(GKU7VV-/G#IV5V MGRV*V>?L35X461'HB.3\Z7Z9W?[E^T\/ 2;( =Z"]#]K=+!Z_)3]Y?MB]O!I M'B#[J7-"XU?Y(LA6<7U[]'&7+A=!0HMML[?9ZOKV0_J'S5;I;-Y^N-V2T3=H M']*/\PYX_&4WK8C6Z>2WNV6^7DS58JK38A9P?+?,BH#H9L(?I[5JZY8DSN-< M>W^?1:;=%MEJ%1AYBK!C;7H@IY(\5VK: W%5Q*Y*RW:D98OL=K9Z%UYSBI0] M3W;VZI<+1E@%WF7+6=A!)T^/F+Q856-EFRX[&\S;=+D,$^US5IOF0RT[(ZV2 MS!U\OA49)E],PW*93<.'(I_/IG$M?2G?)\BJWKYG,M^ERR!5]]EJ-DGG;6G> MVUGW W@?5O[L83L93%K<^WG^>Q.\C_;3,]G[](:V0SC6YQF&TU:TFKV@WX%V MQ*IAN?-^E4]^N\_GTW"NLV$UG,Q6[M_KV>JQY2A.]GNF874I>/5>TG; 41\* MY^W9J5UM[Z/=O?RO63I?W9LPPJA9W&23_'.V?'PS6\WN-CIW)56@38_=#>7- M[.Y^5835/2OJ4WVX<7<$OET_?,R6X:28?TPGD_PFVQS+-N]\ERVBX47=I=$8 M\&L1#D#7R^OU\OWZ8S&;SM)E:'Z]O H2_+"8K;(F(^SQ[=U!M#FCMI&^XQUT M1^B[]-BA6[*D[TO^9+<,Q\X.8>>[I0$D\XGT>@7 MAGA]&RUIDS!Z.YNO@ZBY3]58W:[/3H=39?H?;].*')_.EO],Y^OLERPMULNM MOGBH.A(B\Y)*:T[ M0:3>9JNKQ>>L6,4__#6;WD6M)2A:G\-FFQ7N]C:;K*X7E4_P42L^>!%437I& M2V_G;'@Q_7V^S&9W"_?'Y#X-$SQ.]&4ZJ:AP=--WY\.KN6K4Z*%S4O^Q3N>S MV\? ]"]%ZO$F^Y0O@^Q<+>I>=5XMPAO##OM'Q7/HVNH1_?@^NXL 5A*W'E_8-Q"_ MY)\WR_C5HGRXJQ&?[+GOH=5;,EMTV/= ]G[?U:"J=-[W &_B5GI]^VN1W:[G M;P+ 497X5Q8MI-E4?0Z:^5UXUT,ZBPOPBZ>N;]5#6+IG_QT7N;X &H*XO@&N MLGO4[J85T2^VSN-D[7FPJQ=7DI">]OAHV_X8!&B1%2<)^/;)SEYMEMETMO+I M9#;?Z/P5(:G<06>$QD/[55&LHT- 8=?+,-?,>AFOR;;^*K4)K]EA9P-YDR_N M/F3+A_C^VD0?:=P9@?6VS2HM.R.MRC)V^/F69)3GY.)J\6M8$UXSA9 MY^N-O?5]T"JFZ7)Z@LKC;7H@YUT X;1S1+6VK?( MB^.$G6K5"TF5IDW%QNT(W)Z=MY:OK;?8GV[7$5GOBK7Z/2XB-GKFIW3^E>_?@;"O,I(K1HO1#7$O6G9( M3_@FFXQ\>LNC'UI3,?7UT M2.-]Z&HY67_,?M@!TI#2(SWMHS<(R&PQBS?F;\(C3P]&DCJ)']R^,?MCE87C MW+3?=_81@[>C/-(=*)_GDWUJ=P44:_6;<*X L 9@Q" R&% G8 F5%0*=@.IY%JGEY+M\ M.EHV>%I9:>V",Q1Z;F.3G0SP@%+[8+*]_FLSS(IO^Y?O5Z1D[_,)"8.2BGC"@1), M(TV1;,O*3FHWWXK(QUQ*^\/I%J%EQNL=&VEL^NF:5S!^) EHB";#@ GAEI+=([K 76#01 M'W)QXM,I2 /(R,O8^RTH@=[Y.D8EOXMW7X$=J]5R]G&]BF>^#_G;/-Z4KP+6 M@92[JW!^7V;%ZH@ =?."!!)OF1;84LJIEH$]LIQ<5 !H1Z4FC<[JAG2.GGAZJ:V#)G\$%Y]TJ!X MK%GBN(8$$PV1UEXA+[5"Y2 9=&RTMN5N6'=0'CJ#ZI7*Q=CLS>,3A\'%X$!8 M]'SX#B,%+5;Q$XVGG M_%AL*#\B"Z<;)TI;B S#X=!&I93&8L;* 4/D&UF2.Q>('M7/WJ :=*?8F^EE M0WZE'>-P\X0B(1D0U@!*"+(&(V++0>,P.48A'WTP\>#FT1E8@TK(AL =Z3\O M\Z(HY\]C)1DYUD&"$-5&<"DXU%AX S1QY<"M1&!4]U$F'< TO)]7.HMM' M$\$-5YA9C;B7'GN%^6[%YCFV62;[FNZ MGKRT9)X6@E,])<0C+J1@@CNOH9(>0KS;E05OM#[T=B,TG(QTC-O A]-Y-+\O MT_GUQ_E3XLP/^4VV6B\7\5*TXE'U>"=)&+VAS%MOC>1A1PT3::>/(PH;+2[T MH@6G8\A&HJ:JAQ@+N07P*0?R\T!;ZK!'^TXL <8(H0" V"I )&2RA,MS=.K2 M8*^$L8N6L&&0/-/9^<6AL>$!>D\/"5; (4.HBV[/QDFFS6[H!I%&-OC.]=\S MG:+;XW7^-:K>4>EX%PG 4"#FJ>$X3!+A(+.[4Z) >%P.#)USM-ZRTQ2U045F M1^27Y[WJ]I=C'21(( 6%">LYYHX[H8$M#9T6AK/%*-:6X<6E0\S.(BPODF-4 MDHWP?**LDM@RP)7P3'FG#"HO1BV1@#81A4&/VOV*0GV(SK-,='+PKMQ;8I@7 ME%HO85#(F&%6>%U" HQKM-\,>OCN>0'I&, SG<)O8OK%>!"*F'<0.GYJK/84O3.[# MACW?3)1OPL*>1W'02;=1/XDG$086E )"* !"J.V%[\:2SF*Q!,=\_3K>((> MX1JO%^^QD>Z+2CSEWMN@OP18@J2@"!/.:8R%Q2#\4,PCA3 G [ERUDMQQ#([WAV"KE(;2;.8^]$XFG1&"@H??4 M4&RL8)@PZ1TSF@BGAD])<-IEN%S+H$ZBSR4\>:U!>)EPP0P MA0 @00%3/@R4">J(YA YAZV5MM$A?<#UH5^):('4643"_?$IFX0-)^N)"-9D])=\^ MAU_)CK#=HGO,@^*;AQ.HH?342>*)M]!#8<(6#(D(FZW 4M?-S-;QH$ZZA'SQ M8(*E U$'=9RSL/Y[J9$O!Z/(4 ;&HSX?;5APJ$9#D\&/U8.CG[H?1A%FD W: M)!'&2<@@T"4V1N%&[OE]>V0TY&ZM0A[UKDW?,WSR:<>\HM M0E0R"!6"AA-;#DK4PZ:?9*IV?SFI_ MK%T2\*%<.,8]%U@YPXU[,2%D(QO_P'4VFO*\2V &X/]-M(8LLFEY8#O)^/T- M$@*H,-0XAH)44VFAB6:>[< <58UF^<"E+YIRO!-$AICJ@Q:SX$Q@(L):IYQ3 MUA,@"-VAB7DC4_O Q2P:+P$]@32 C'Q89FFQ7CY6V^SW/)TH2B"A4E)M)0,6 M: ;X\PI'&GDA]F8G[Y;O[>$8@,/["U.<9/6Q9LG&.6Q!BMSSO$)?+W]/E](@\U.PI41:8 MH/(ZB%C8$YTEW*.=&6TP&T]%$>G0#-@O3@.(S*64-XK^ER#\@-YX)A'3!((2 M.(3T4.$4U02L-ZGHIVI1/6P'$,IWR_QVMHK>+D<$Z_FAL!![JH%@Q#**C>:" MJ-VQVQ@UKEQ 0PE'8WP&8/ AO3E2^S:&Q7](_SC"^BK-$X0X!% AX"2$$B@H MY>Z %C2U1EI+;T?6H82B!^2&VJ2NBF*=3>UZ&5>WC3?*)@/$^_MTF>ETQY/-,-6D:#^>P5T./0Q[/#NK>Q.&$YV,;[)) M_CE;/KX)/6ZSNI\QCU34DK^@]4T%O[_#C1)'*.=(0!86&T.U(SYHVYI+ I5' M3)S2*P<:Y"D_P/T-$AG3?FC H*< .(04M^7@N.:NT25QQ_Z 7; F[P&,?OT# MBVSRXUW^.:Q8LR@5)'Z(PD!>"$/X*GF3W:7S;6J% _Y_>YY*)-,B5FJ76$M@ MC7=X!QPW"C0*$^W9VZ\MS_*NT*BL5U1EX5-BC$-.7%\_DD".K,).$FXL"N*O M('H>,B7C\]UKA7G>*0JC9]Y8G.[.PK,:O-I3X/S]^F,QF\[2Y:-:;"_]_YX' M_73Q2[I8WZ:3U7H9U+&#EZSU.D@4082A,!@@.0EX$&C0TU $9V"@Y(DG%/;F M#,@' &6 ]HWFX9^?)M&DF/$3OGUH8VS?B>),M@Q:I&TF F%P^&$N1( T? " MK/X=QSGVU=[!&EQ:GN@^Z5Q]I%7BN12(*<\#@D$YA5[[W1"=$61T6W6?;#PJ M*5W@]BI%9"P*P85(1CL58K]90VU**1Q5'2HT3## "C#@J%+ :$8XMZ8DW8.3 M@83#>D=TPH.\1WR&,.\&U2?[]SI&G'R.86;AO:=B[/:W2(*^["T0$#C%@24P MZ&&Z'!I$K)&V6/^:^YQZ03?(G(?I)]?W@VV2H&)[#QDB "$G/1(>BIU,"Z-5)PMCV^?$(P+D9?](O>^_S"1&4&HTHYH@Y#4DX OMR6%:X MH2P]%;UMVW/G.+\;@3+(%>[3M=W/67ZW3#_=QYNYJI'T7[=)@)< (N0! $)@ MZ!%FN!P>#00,XX-TUGV^(VR&8/WV/N8EH:?7]T-M$LB]ELZ%PP3$$ C-@*8[ MI9@S,=Z=OCW'OI:!CD%Z=;(PNKU^1"+0\KYF$JN*+1^WG'_ZY6NF/WV=/*=U M?<'=YS\F1",,C#+*8Z\I5C16HR\W*VR&*BM2<0=OCWC>$H%>F?7WFR/,^OM- M(B"G5$, L;=80821X3M)A=(U859OX07=,ZLV KTRZ^W/1YCU]N>4 M=):79T/IO6]TY*GO97W6ZZ_VL)R!UZ=NQZ03/6X'SBK@_-BUW#$P?G-GOLD6,-'TF]Z0UZT"+!$-*O$. (*:1 MB*[;M'3ND *A<96V:LN>K\,T.\%DT+EMTN+4;=6W#R<2!1@@UX9#ZCD/9SQ4 MVN>52[435F0]XE.%ZS]>[K(&W'VJX:)U!QI M)B0T"(?-31D&=F(>U)IQV;CZ9FP[<+K@Z\]Y>'$CQG[=,J&6,(H]P)1 )' 0 M3VA+XHUKEIJI-X-8WYQMB4X7K+U^;#9COVR7"(>A<$A[-E M,W6ZMYP4?;.U%3:=,/5NO6C&U2\;)M)@A!W!U&G@C*+D6=WPV)T,"1TVFT3O M;&T%3EV^QC$4>IFO[^Y7ZB[66UO%["7IXG$_.P\_GQCF#:#0**>HA3ZL(ZI4 M!&)ZN:'L5TW\<5M%P7:)2EWV?>56;-.']"XKWF\(>9=&S^#9P\?ULMA&TF^3 MU>QG;).>$JH]--(I@R5#&M$PHE+DO6"FT7KC3@< M[BM!\0(.0@:E!LH:JC@I+[B]87)<^<>&$XC.$!L^).>+<6SR7!VSB9QJFT#M M+-&2>Q<.C- !88TJA\NH:72EV9\&UW>JA/8(=;E&O%U'./+;=T&[B1):?V7X MNH=$$&$ADXIR[03C4B-9^E#XL 0V\MSJ3[,;;#UHB=,STSM,P?-RV('$8J/3 MO**\,\P"2!&0!'!F,2' >5E?G?/-:^'E@7&4@-@(4(& BYQ4HRR@3?#9$:S,9[D=D#&VM$5#?# M[56*R.AN.LTT^ZO%-.:?7:?S%_K;,+0[I90 MXQKE]SU+;'UES/,><+FHF'KHPK[)91@*E$8)30Q$Y=" 1 /5MSOG_M\-,A<7 M2>TQ(M)#*@ !0F,)E=P-3P"'1[O1M^97Y9#J9A"].DD8VWX^'@$X-^,;QM0# M+3!2S%B)A*=!RR%&E,/"C@ZEP+6-J:_,G4HQ]?5 N;B8>HFHUMYZ)RD6,LR3 M6+[U:7A*-'-Z.D_NG,;[?$?87%P<-9>::LJ(T("%45*J^ XPI.5XT^=UP+'* M =7-0'IULC"ZO7Y$(M"0]4TB?Z\^[.'N\Q\3%0ZB5"(G7*!6 L>QQJ7I7 @X MLAJ4[1'/6R)P1O\H*HDFGDM#$28@J*3/8\1"J7&QJL/;FBY1Z?GFWW[ M(?^83B;Y3;8I>+VA_BED[8GZ7XN8O7EYO5[N\CF'YM?+J\4T>P@49*_JZI00 MXA42497&6BL5/H%PDE),08(]O^R2'3X<$F$\(EKEE49!Y_?B:7 8<350565/MZK0>&&.].NW.*"J%=L ((!!'&A$ --G62,+J#TF@$X-R, M;V@4E48193Q5UC%I($$$L7)86LNA,LNV-8I6YDXEHV@]4 ;W9NC?/0H*132# MT@N'C69:.[[;/PE7C3S;SW,]VE03Z VLB_1]@51:3Q22AF.#(!0\P%DJWD$) M'ZV"T <;:SC!-,/M58K(V#2'D4M&5^Y1[Q_RWZ(E9S$MJVA4=I0ZTC01PBE" MC#$.((FQI-J@DGQCR9C#'QOR89_+5'<(U67P-V^>IT51H=3,Z7:)8,)@:K#' M@C"$"'%R1SC4HI%?Q$!ACJU9VSD\=?G::PVA6&=1&&N 8=8KC!$1I5I+-+"- M#G<#Q2NVYFSW^-0.1MOZ5U:>3B1GG"$33K4,>6B\<5261(8O&JGF \44 MMF9B1Z"YG4$RAGOI+F707=7 MT L:EG/$!)>[02-'AC)NMKZ3KGL-UB4J/=]);VH$/R>=>477RDQ%WUQBD6,4 M(221>LKV2HV6$IURB!CWM3(7'%!B-61"(V."4#KV-#AIA1]H9C6.R*W*FFK7 MRO7 &.NU\M F9PT(UC8H:Q9[802& (,GU)0FM)&G[GDNGROSO[G)N1Y8%VE/ M9-X9 '!,K0X<]T@!;,HA4L-'G%JX!S;6,"PVP^U5BL@%FYS/(1GM]/2O-+=C MQZN]CX8#(%!"&FR<1!BY> ZA)7G*B\LQ*5?&.>\4D8N+S;$2-#N.G>>2N>F.WQ4V%Q>/H:D/8FT1Q8H18@2S2);#PT$/'^WFW@'' M*@=F- /IU\W3.K-@)# M'(]:%E_"RFJD((7.8JH-=13N3@P"B(&2T9[5?M(6E,&Y7,E9^V *=J=5D'R$ M$#,.8@JTH+OUQDG@1ZM$M6%4U1H\S)S5I3T%/EM.,W_'/U+%MNG/MRGLWFZF)ZH'-&VXX0*Y9DT M5&ND#2/<";*[Q\!A0QR5"M:>@?D9P6L@-^_S]>K^[_DR2QPU=[:B8+O<$TZ/;0 MO)*VB47)L.+.E!- MO2L-%YI!-]2E9ZM*VI794[&2=CU,SG#7_91IQ6:W803I_FHCE=LF-.R$#A)/ MO(%&AG^P<.5PPV8Y5.;*]KEU.O&[:H]0;4_^?>_/;Z\>/N7+E5NL8G:<_3I\ ME98)(HX+;#7'UFIO+6!PMQ8&_;21)?T<=<;JLK5L8YF>VN$6LYV'P947"]M]I!&)^1WZ>.FP-F6GDJS M_F@/"4,,004D@]I"B4%0?W@Y&"1@H\7]'#7#VL_^+G&J'2_R]#*?+S=DE$2\ MS5>S2:1JZ[&3W:7SJZ)8'UKO:W>3*!%THJ *:\(DA$)S G:R[!D967783MG? M-U@]ARY\&Q_SBJ(7$#-4!2V*8N" I H*H55,'0T"=RFZ[*1X@AG'G#IIB)(R/EZ3; ]LK.&C MW@RW5RDBH[/;CELR6NK[W<2',\<%,!(;XI!T E+ X(9(R,)W8J@\\^UC&"JC M72$^O!XH0_@O=U=&#$ACP_&3V*!Y"6&PTF0+D]'8F@O*D]=TV^\&F?,PO4V> M5*"X]8YQ1P0W0E%(R^%Y3OSE9P'7"G4L;<>J!<7*@B (0*+9DV09$1%O,8 M?KD9'H0$LD;Q$N=QKF^\SW>$S<6%IR'B* &0,>1T"0(L_9/P^/.2CC>G;X] MQRK'J34#Z=7)PNCV^A&)0$/6-XE^4\>BW]1-0@UD5#$$N!5($2@,-%M2!37 M#Y6JN&WT6V7$\Y8(],JL?[HCS/JG2XQ7Q@.KE5& ZS!8@OB65,F@\XW<'\X0 MJMB46;41J&OYZC"_GG?"V+"N*(.IQ8Q:I9^,1M((K\8UKSJ\4>L2E9XOJ;]. M24D5!B!Z BP)QRH1GY934*HJ0]I0Y[K<**P 5_ M&IR@G QT;=#XLKHJ:RI>5M<"8ZR7U=W9HS&5#C)+-[L,]5!1KDL\ !XJ"4,G MY]2JG*UHCZZ'S,59(05G(%8: )A"@WW8IK0OAXW139M5&H%=F M&76$648E6F-&D8CQYB:H%MP@NY,K8MU 2?'.QJS:"/3+K#?'F/4F^I @SH@( M0X-24P<1V(U20]3HIJ>WR,<>F%47@7Z9=6P9-#>)MMQ2A#'T+OH+::#YCE3F MFWE!]1:GV .SZB+0*[.N/AQAUM6'! KI+(>*(X.)(MA3)IZU*][(;Z&WLF7= M,ZLV KTRZ]VQ1,KO_IH 1I14GG'LB-#,.X9A22J7II$]AU\.LVHCT"NS;GX] MPJR;7Q.'-+5*,8ZX$(!3(TUYGR4!H8U4=W$YS*J-0%WOA/>3?'4J=>:7SR1! MV7%<>4LTX=X&G4=2N2,H_-J$)7+\+&D+1%W.[ T'>\BN;]_- _FKV>WM >MF MY;8)H+'ZB:+A7 BUM(0K5-H&):5#:>_GL'+VA5'W3#YHO:K1.I%,.P$PDH(" MB92&^%E2J4%@=#;-'OA3A_.M8+M0&1B++?,R6-]RUWW(?\N66P^Q35:U(E-% MD4]F&T^Q=)H5MTQ]UE+WS)>T=K@-N, MMC4K NTQY,Q*K:6DVB%B4#F@<*QNI*J=)U%QTVO,UJ ,SN5*[BD'$WK'VNY( M PB--EQZXJ$I;.!)H]$&#ZP"MN25"$'RUK2LJY 9<#S'D"I':&1 M36;S6?HF6^7KY2)+U\=X=^#AQ#CM@_J@O18""F&L!+0DT5HW4+'-,_"M&T!J M\RP/:MQL_H]U]C&;Y+/B_7KY)@NJ0CIQJS?I^W2QRM+%]&_AQ__]'+3)H$4> M33C3N+O$2Q^&J.)@/6%(6\_T;JVB)V,A!LX>VR7?!X*L]6S>1VAZG-!-M%&M M5:#=2Q(6DT,H AGW'#KIM :[8XTEN)'30W]):?M4*$!80IYYV6#N\&)M2(LXFT M8U.UJCW-P'E%W!^O[>-\3!^Q?.3-.G1]=S(H:]_C"?04">$ELPAC M3TPL6U@."BLZUDJ'7HTX4QNTN!XCSU'@4ZD MRK$JKGRC>*K>^-4.X+Q3* :8C]V53F."* \DED$?HIQ(/.,54"@^8 M5Q(9@U1I9]VX1@QSB#W'":<]&IVS<$O)0?7UZT<2K6+TG6:"4HP\5)[L=#T% MJ1M?&8-6F.>=HC!ZYHWEM'$6GK7;UZX>PG(25+ /^<=T,LG?K*8_WN2K^X=T M4>@PV@!93+ UODT S@@9* MZJS%# JN26DRB^73!ZI*$XDJ+1-#G$0BZ&_& M,"NCNR$OSP"*,$F;L+MS_;8+=O> 1CM6/K\_74SW"&-UUE;K*2'1U.*<0MA9 MC+"7VNS61PF:I5KL7"_NGM6]H-/!XE]S-7\B$X?3EF!("F<X^M%^9[T Z@NL MP:6EBZI@5%$;% WJC"%A/@%A=K&/"K@Q7Q#UP,8:Y<&:X?8J160LY[H+D8R6 MRL!B.OL\FZ[3^=>IE4\Z:55JFG#&D8-0 *"IY8X "'=JK''-RK^?I:1<93[D MO2+4)!;JBS?/TZ*H4"/P=+O$:A KXQ%@J;5!ZBD2.\(=X@-5CSL/:SN'I[8? M9G=Y[[4R%D('!:&,>22AT65WSWM=,SMTE*L/OQ#9]2,-A 41ME^JO M"+I:K+)E5JQNTM4^3M?K($'( .^@TA)AHQBE$&V#@ BQ#FO1A-O]W4QV.NG[ M@ZDNQ[_>E-81ANM;-9UNH$WGOZ2+]6TZB7O5LO#Y>C%],SM0=Z%-=XDE#GCH M!'#> X6(Q+J\FM6>LT8.)/TYR'L9@]A59J60KK5-(NKQ4;] MK"0 )_I(,#,"6NTX94(Y;(04K!P0]]4FZ7R$D' %03@>@MG]OYEH,VH+64C5_R".]M MOGR?3=;+V>KQ.J*<33\^1A?)=!Z>72]7J_QCYM?+Q:RXCW_:I.J8IHM5M66C MY3L29L/JB+G"U!)O@69A\RP!T9@T6E9Z2S37JQ0-BV0G&FE^Z_Z]3N>;V,') M.@K]/];I,FC)\Z L%ZMT/H^B7^P&LAE!?OLTGAJZ:KL7)9X1SY$TGD"@.=;2 M^]V*S%BSVF*]I+%H&LL>H/1E'C#,.!><: !P$XKM,O#H#71S?R=P$4*\+BA'U[6=Y3O M&^6^6=V7@-1H2'PS:3Z0NS+X\>[I2AO]5V=K7[/ MLD6TF6RN0/Z5!NHW%K9P5)H]5)+%2CTED'!I")(((F6(L RAG076>MS(; DO MP4H]#&"=GE+C34JV*"(''EL:J@YUE3 ..-+,\7"LXMI2P^U.V($DS:Z7+\2. M/01BW9HMLN4DK%#A&S7?L")K9*WXMI>$&&H1QPH:HJBW4%BY,\,AV,QF"2_3 M@-TU6'TO"=N]+.YY-ON4%[- X=5BE7]8KHMJ2DRK-R31?*L44T1;A23UAOAG M, 1HY'0.7X.YNU\@^Y:JMB;14UTFAALG8G)[J: D!"G=P<&CDPCLRB\3$-Y MK\AUNP&U-91_,1#'0+SG8XX*Q@)L%I)R( 9CVRQ [568QEO U,W1>C:/]JQ= M=NMBE6].7-G?UM--P8HWV2J?5B>.&.6QT/,81Z;1A".S@(Z990>Q+-IV?&>&V!^:2[)OLW^O9.H;)=>$ MEVDP[Q^^9[GY\T_/R(4Q_+;Y[LNOGEI^@=_OO__^XZ>'V8^3_.&G#6[?!K$4 M7[XR^V.5+:91@'[JYAW;^*>;+&9=F3ZGB[#9*IW-#[U\V'BGG5!4=H;\0I(@ MM-;BL HXJRF'8:,2A!$#'!:!R^"4?6F@07XXX -V(L0)4$^!%UC$:@Z<.N69 M8A0@K11'T _DBY_.YXTF>676G K0:@+&9O;&(4U7?YK,\R*;_N7[U7)CRWKZ M,KPAB+R;;Y:.OWQ?;"MCC;V$A>!!$?<0$Q464.FMQ)P( K5"B&OC!RI;TT7\ M7F5^GBYA40^4(5R_NRQ@H*WW!#*G9=![B*?AL\"6"$<9AI0GX1N!@8;>4T.Q ML8+AZ-SFF-'A(=5,*ZBO%+2J;5&9@Y5+''2+VH7)3%A=A4< :V8D]=S(L/)2 M8QS%0#K%1E/<:DB)J(=)D_ >FTUFTVAB\^GG?/FB6-/1U.FG&\8P!B19&+CU MC"*(=4PA'7959%W85-W(8O):,R#O$9Q!)W+S/,T.>NFP9))01IWARFNI% 2$ M0X394*D#Q['--X;E#+QNFJE79-OPK]JN7P[ M1NV"Y"6&J<(PF[@.:Z@44AM,E3 &< "DX,W<*@;9X/N3AGJ8-(K?O\ 4R%X_)8M_1F@.=]8-+2KKOQ MM@FD%/G\<[0Q;[2+_'9UGQT-RZ[;2Q*D&G,CC/+"4@V<]EY#Z"SEUG+%AEJX M6YMLZUIS^L>J'P%XOJ9H(P#/O23"A^6-""VU-I1B%W1@@BEWW&G@F6MT'W0. M![C>!* Q5GT+P.H^#?]\SMZO/Q;9O]?98C5_O,G2R7TV];-%.M\T74?6=+Q\ M=$1"(I0R,.C>'!--&2 28!=V6!/8:(+^W2ASSSE\[080O2&![OEFZ9_9,OJ6 M%FHQ?9<7JP\Q$Y[-/F?S_-,F?.05W?XH)XR'02(,HDY0P"6(I?.0A\P$/IP* M@Q_W[0\74GIC) QG&:@Q-@C2I\%) ZD>]^U/9=94N_VI!\98;W^>5Q?W.?R( MQK$3UJ$#+1+CD##8*VPH8$)RJ(4L\0",-7.@/8N!J#)G\SZ0&>#,OX?0D\?^ M@VT"7! )B4U0!J@G=;2E,,+ZA,:;<+&UOPZS?]6$+TZ21B;#6@\ G!NQI^L M*+3W^<1BZCC20E 4SLD>$X]V0#G.!E((*JKS'7#G.+\;@3($KU?I:J-5_)SE M=\OTT_ULDLY/[?*'VB2*0@D#7IAS8K$/\\3NP+("-^+Y>2Z"&N_S'6$S!.NW M6N1+0D^O[X?:),P*;<.9ESA/.(12H4V6R\WP*+=RO#M]>XY]+0,=@_3J9&%T M>_V(1* AZ\LR29/HC;Y\W'+^Z9>OF?[T=:)O]G#W^8\) !P):;VGF&-(O2(4 M[%0=[!NE[.QO!V^/>-X2@5Z9]1RYM(=91B5&A_];2W0@5$0[,L7JB50E0+,8 MU=X,]]TSJS8"O3)+'9M9ZB;>'5(8M$E#K=+6"@J%*TF5'C:Z9>G-U-T]LVHC M,(2OP\"E3<(Y@B.I&?**2J(DAJ3$3FE(&J7%KB\"YU25>P-K<&GIHFZ%D9@ M:971@D%I,0:X/!DJ!)49K?[0\(U$!1)_ .*R ;A;G4 M3R)T5HVO+2@7%M@4/88]@L81XKVRCEFR&QS WHU7IVO!J*H13LW >642,#J5 M;02,;[=_;Y+$A"6NB%D4EN'#8Y8NC^W91QHDE$/$#,'$ACW.&RXLY26IWJ"A M+JU;AK)5!CSO 91&D0O_FJWN3SD&G@QFJ-Y)(GR@/^@KFDN+$!9A:'ZG4B(S MLN)4'?*Y7Z!J\SZ;S.:S]$VVRM?+19:NC_)X_\.)9U ;@I!@UE(/L"*@/!YH MI>@XBG_WPLM. *G-LYC_>C;_QSK[F$WR6?%^O7R3!34QG;C5F_1]NEAEZ6+Z MM_#C_W[."CU/9\=G;M/N$D8=,=&A@G,%.'%*;FII;88IM&R4+ZV_')U=\GT@ MR%K/YGV$IL<)/5DFMN.7)"B 5WP%L@)-(0J7)STYBS1HD7^\O7V>?J,2B0 M=67KK^N[_$U6?$JGZ3'I^.:QA%K@E22>2,$08I"CW26AMAHWLKSTEU>S0_ZV MA>)"4A$ 3&(931;44T:BG4CJW9*&43.OP_KS=QQ&EL:P7%!HN70B#,(IKS 0 ME@AFA-\I-XRI"S"Q-&%3M1CS9N"\(NZ/U[QR/J8/SNR_KP&S6R:SL!I/:7HC3;!8Y3>*'R&#R@L'A MJ^1-=I?.75 F5X=\U?8\E3@L!034<^4 IP );W?"#@1J%'I?_U1T#JVY/1J= MLW!+R4&5Z.M'$H$]81Y#8!F-57<< ;8DETH[/L^Q5ICGG:(P>N:-18,]"\_: M*3%7#V$Y"=OZ4U[Q-ZOICS?YZOXA710ZC#9 %EU0IG=9<;68_!A^^=N'JU_2 MR31?I/.IR9>??CRF]W35>V(MT(0J*9!PBALKD0//&Q =1Y1%<];EYT:LKM@< MH>E&__682%1IF2A/@(94(&J@]R#\LYLT1N%FJ1$[UYFZ8'!N7*-U MHIG$5BIIJ* *&@4P*@-6C*5L?+YTR6-^.Y9LJ.&=H--A?K*^2I MTI ;BH,R:R1PPJO=LL<\;92@H',?L;Y%8"#T!G/M\-@22C%&"'+"N0%:[7+X M(2,;,;5S![">F=H6E;K,LNDJ$/[D/+J?45\\DJ!X%V*0=-XXP"%088,HR0$- M/6W/D6"Z;L+(ED ,'Z_Z%(SU(?TM6^A'$[:)E5I^G*V6D2'7RU^RZ6S+FL-W M]HTZ3)CP#M 2/@OHA)89-D3,,X@.[)+I;Y3BO8$6[L#UN->%W&X?_Y7:II@ MB@ C3 !N+1:,&\_*:S-GM6MD!S]'\N<&ZT(? V_7GQ9H_F?Z7Q=/8GPOL:) M_KVT QOTDT2=%0G G0:.2@$MM2:G2 3TNP.K#^O[#Y7_\[!ZE,&WJ6/ M<7=ZERUG>;4ZXM6[2XQ$ CE,"-N1H$RF0KT *VF/5]X*@ M'F(&P ^YSFSV*2]FJU@I=95_6*Z+ ]:C+M^04(XH]18Q8I638:T$Q.[ *!9 M7EKP"B2G7R#[EJJV:LBI+A,K7(#84X*A<4YZ9:#9G;T#(QK)S858+8=$KJ6@ M_))'C&_SY?MLLE[.5H_7$>IL^O%Q6[BQV%C/5OG'S*^7BUEQ'_^TNM^]?X=+;<:,B_9&FQ7FZ2OP_T%G5W MM\SN@G*V^^OUK0VKY>S,%R/9PHF7B-8D1 M=TY@*"C13B&E%,<0,(:)0HW2/O5<8O ,PG%(/#L!=8C8U7RYX=%J1_GN@YT5 M4=+#&$['LU;O)>&26\F(8MIP:B6'0FNBPOQW"@!H>$(TUL(@;9005%HH( Y' M' >Q( PC-%2=L^J9)SIC^M<1L>=#=0#)VS.6N#5LS22G$UA4:9Z$.6N 9-Y+ M''89IY360@FC@:8TNL\.+DHGTEGT)4D]@/4JUR8D R3 H0)HBFP2@=EQ!EH M#(E^NW8IL=PKJHR4'A ' MI0;(AI58CBL#?:^BTR-L0VY+^G'W\:^S;!E>??_X)GJ05=>KCW20Z+ AE3NB0E!>M:7?"_T/B=0YX7ZT8!DR@)YQ# %Q@!Q7$ .N!U)80;,A0 MJ:N:*.'G%[)ZX TI0U>+3^M5L<$#GE2ECK1*C.0*AWGDB1%4TS!GK##Q@T5, M86/'J71WR[U#,M(:KC-)!&HD$:C,\.894]K[&"M)(31*$A3T H6!%A201NX! M_>O2@TM$,[C.)!&XD43@TKPE!-* :DD#:LASJ:AA4F-O9/C7-HUD'"G*3:"V!BY+\"0&L,8H0' UB$W7BDYMJS;AF](#O(OO%Q M]>S\M2/]Z/:QMT5B$)0*QAM6C2G 5O)P^/?":THD%V.K(]PQN[[92KK :%"U MX04BE72'%\\G,.R(&BOKE6.46"(!@SK>53 'PH%\7#M)[ZQOC]#9MY+&6TA" MK2:(1:%3J+KW*-][$G^;+I<;Z>W+ MY7KO6_ORN][CWCS(2TQ:W/MY_GO4-;*P$WS.BE7\0TQ*&U6024!X(Q?N]C:; MK*X7)@]4+(H8X[(H\OEL&L/I8N6 +3[7MZ6G>NCQ>G6?+6,LS#*[CU;[SUGY MQS,Z9S\O>R]@^#E,PAB&\::"UW6U#A*.B.:<:^B8H,HI8;UA'$BH.65*G[)^ MGF'P^O&)ZS?9-L"AN)]]TH]7BR!!V8[%;R*EX8_Z<5]G-[/BMU/^UL,1D4B) MA C'(.HPI )0J50X%!MNK35$6#*,JG?4(;MK<3JXRX\,[+&Z8A\:XPE_D6/- M$A!V8^&I$=1"RC232"D",>.0RY< M64FNOFV6,,@)ALP)$.\(F.<**@BMXZ8=C7-[(=XC/H:E!UHVZ@R9SN,&%&8*=1O(,PU"HJC*<,:&U< M3,BH&ZG:/7O"7JB.TSDS!I#2/82>W+ .MDF<4P$XXB728534&Q5&];1G&\K$ MZ]![NN1S?B9H+TZTI/58&NJ=-7'T..P:SA)KL,-1-QQ=Z>31"$X]X :0B]*T M^43R2;UH[_,)US%>)MZK&TXI0\JR>&?/&&#<*S6NQ.P=<"?O'I0!>+W/=GV2 MX8<;)1A);;6+(5**!O5.(!E70P4(GT^H3NH51]LE850J M>GES(YWWDH6EG(Y:FMG3"UFJ#T@^'%RI+#.+Q/64DAI@@J03'3@C%" MM<84CTY/'5Y2ZB$T@""\3^?9X<)=>YY*PI9* ^D8*LXI$EP[SCCW@H?S&> - MLR+VI89TQ(V\*SB&.&+DQ>KZMAI?OWDV$8(C#H7$1 LJF=-.!$U-8(4-1QXT MBMOM3P!(*!9BL%P@X+@CATFE(0:,;E=X*]O0SS;L YMQ7*3?9)+]; MS/X[YOO^UK%MB]O622[\^I1W)YRCFUZT-'Q=8H7 &H:I@[4.YW,DL34RH"F= ML\XU\W >X/YN>-^G80 >@=3.TZ*8WVD\$PI*8P9*IW,9TCL0R#VX<^_Q0WZ1]/G _?LX M?(:?"7U3RU5X3[N8>093KHEB&_.Y%% X::7AT##L_*F,*CUYE91T%B^(U^D\ M<"Q[?Y]E>^V$+[TO=M9&FQ6!C9MG*V=@[OREB;**,6\\!1= * M1X%4\5(-"PVHTH2AH=*P7;I.T@FX9Y&:JLZ0WS1)'+2, "%+&S,\E'2?=J+]]ND$8P(U119@$91UX>4V88@W D@B9:-+ M[[Z]9[MC>GM$!F#R/F7JA'IYJ$FBJ)72TB#(2%%GJ/#A,*:X\K'XJ6I6=[QG M?]D1*I@=P7LFV3FI+!QNE#B@>)ALTH>?!DBO@TY4*DO:&W=Y:F9[7E80CG[0 MNT#Y05(@8S!EW%D*+91::6.M#)H;$! /%:)36=T<4CKJ83, \[>N%NOE,E:( MWN3!/*EB'&J2(,R4A+'A]U? M#,?A, 1N' %:4PZM)(1S#;1$R%KK&RD8O>F3??&Y!2)UO62W[YM,ENOLRQ2U MA[UBCS9)K!<<0,DH!#B0JZ4,_W&><*4@8\U<('OS@NV0@1T#,]1$K<+SXPT2 MS;!CBG =]1&EK> "40 PHM:1 -NHG%[[FK)M81GTRO&%!]97^>4K73T>;IYH MZ2#"FC$F;!RG\LQ!S3@ET%LTLLI _3CC](#3^86C%._'Y@*RZR()QSGSF74:(!&8QG78 MB3W%VFAK/ (JK-E0*W'NI*W5,ZMN;5%!082.1*ME&!%T0$@BGH8#@%(#K;P5 MG1\;<.'@!&HR_/\D/T6EB)/%(. MB\MQ^@VVX4ZEM)OU0!G"5;#CM)L021LST'+I@HKND#>"[91VYBXE[693KG>& MS 5%IS 7*\H1BH2DD#G"D=([#9W1,3H/=J4R=H+(A84&Q"JU1!"((19, VV( MP+NI(9 R;!V#/)O&54,(DYA<+RW1$&-ZN> M7=^SYRP;=E,0AN+AR0GZXJG$>66EU,Y8S#F#%BD$=B(-^7AO@1IP81\?6\%P MD1P=VZXZ+",'9^ OZ1^SA_7#219^\5P"-.%,6JL$UI:'S\]00"KDN.J--,(_ M[V[XE;E89),?[_+/89SQ>!UYB)\^1^[A%]S;?OMBRWB;1S33N7K(UXM]OI G M6B2: VL9<5A0BS1& !"W&Y(U0TW+NK=IS=UQN@5DT.NSFRRB%,TNZ6J]G*T> MX9&)>ZQ98I'T4,<,Y09+C P5NIP.T LU+E-6/TY8K5$99)'>DK9+.[D-IYF\ M"/LLCLE I?8)14[#(.E,(RDYBA5)=\/&DIS*]#AL_$.7PM '/(,%J7V;#_BK M07Q8IHLBG3RE--_\MK4%EQ=!:CDKXGDR8+"X>Q>&G$_?9JOKVP_I'T=D:H"W M)XXQ(V/4@50!=\\ 1N4A%"JA&YE=>XO/Z%(BQP?N /)<$GV].#@-7[IRYZNC MB2N.V0DZ?E,"8@RSIAYH%/GJ@A+H=TN#4HTLA?02Y/2\0 [GNE8.Z^6-9U8. M_D.NLY>9KK>S[6WVQPJB7_+%ZOZ8*';S@C"9I3&&:PNUH\*X<%3=::M,D$9U MC=DE2.!9\!LF6.4?ZW0^NWT,I#[-%!5SI <]Y2;[E"]7L23 RX3JWVP9+EU& MO;:($&3%9MW?[B)A]<_&D:C\6$KZIHY_SS*EC"%^4_2<8N>(])X*1!373!L MQ2EWG;%X038M@MBIYV3C2HS>^.C>J@5QW"&(K"?FB0D:63"0J:AB=$\WXM3: MZ7(@L,<:2W1(^RU1.'$+5*5YXFF,:+;>>\)C36!C =HQDYA&^48'BRT:CQQ5 M/+>T@/Z,!^F2ZI,N!-4Z2/@FX98Q@$N,O564*[8;N*+CO/]! MTC.VB[-+$)K1"$O%]%*'&B8$$6DYA9!08)&7VD!0#M12T$BDA AQ;ZC>86>Q;&21&BS&:;3J38>07VCTK0ISD1DH M ":8\7@91OAN3@+,1ZO"=,.Z.F&XS:!ZI7(Q-N5D?.)P+M-VQU'9PCIF"?&2 M<&(,%^ Q2EH^?&>=.='%AM:Z%X91[98(Z1 673E&UVP6Q@HV2 MLW7N(7A^21\)_B,0[B;EZEL(=I/7)19HBXWB'$#""%,*\)T2)AP:*)SWXH5Z M .R'\;386(4.N4(\O;[!JW[.\^GOL_E<+;9L"C,];&^S\*YMFO07DC_D.T\] MHA_?;^]Y&[F([#F5O'CAU^\ZYNU1L67" !94*8B\@!0I)YT1A "&D9+ FE-) M>2L,X/WD/INNY]GU[1&"#OE M=XG.^9'W#]!871QV)NN?L_QNF7ZZGTW2^0F#_\$V22S"!J'C6"!&L32:(T!B M%@XB T#"#2,TE:S]/3$[[P>J ?2II[7V):$G3;$'VR3*.L0(M Z''9XRA3&S MVSI+&@#JY>55J>J E5\+QU#H79STP# @P9WG@%A*8J66L& #!IS$B,C!TB!4 MMN(/*1OUL!F ]6Z]S#]EZ>+718#JI-5^S],)H\)2QTG *BRSL9R+5<@(JS!Q M*@QM%%:L#CF3=PU)7?.\2XM5MEQL7_S+;#J=9_&KL/VIVV48T;':1=7:)F%_ M1 )PS*!A5"*JPQ'/<89HT,$@(HVF<&\1G=WQM"^ AK"8%[/#C/_VH21L410H M8TE0@@+U7F'J(#:,4"H9THV4O=["-+N?M8V1J#M9WZ2KV4(]9%%V@A"9=)%. MC\[0(PT2+9QCRD$G(:,6*M,,10$TX"BKJP ,'P?Q SN(?#J6*-9G4?ER.]BD /2'5O M]:U@%OTE_[PY2UPMRH?/&")7DG#,/GKPV40!B9A%+IQ2F:?*2AI.0%@YYQ65 MI_,2]W14_<;L,NA(&)K@"#T-C["PZ)S11MH!3[X^D78" MPG^&'910QB1Q6%H'-/<8<.E+C+'78PSJ:LW>RI;/>N!QU"AUC$KZ MO+7"<;F4=L"9"G;,>I",T(Y) )'40&>@A0:'8X@$KAP ]B(N!V(7;,IK.V,1)GM6-"C1F14$CEN-)8 ^/0 MCE3>++SC#';,!M.R.U0&M&,>#^HX\G3"C-424"X8PQ0(#K1DY9 \=..P;G9_ MVFX/Q!X@UX3$/8=0"4&7GIN@3?" MXQ(B*'$C(>E-V>I#2/H';9QRU:T\)=!2XQ3 0'N,C11,F]VJ&S@RD&&VIASU MROOV\E83U+-(5E.+QL0=#2J4:I M1CN^?>F6F0+)Y[M'ZI^_"7]KWQI8HC;B9N;FCTE!@KA9736 M(E!X)ST(V_P3?E2H@;(:-;S/Z4XZOKEP[Q/%05PSC@[@F?RWZ@OZ MHN!$,11=_V)^#P'I#GJB1UQ6JC?>UY.Q#D']?_*FQU?TZI+%;'#Q"LK\-'M( ME[\5)\W?7S^:4 HYYA2$KF-(K/ :P7(PSBD_JA-3K]S*.T5J +8?V=]KJ$0U M>DDTXLH'0*WU$&EM/:>[6::Q;W2MW7-2OP'4H?X0/*\0U=R6:O:4:.^9IMA3 M&TL=. DY\"445M#QUKCNA=_59:I#,/^CY6ML*L\EBM5%J3I2,B>X=2;LUI18 M2#4JUW=C)1Q7BN+>.'5*S:F'4EU?@+?K^))8!^;+,;W,4+3?*:!*RX011H@1 MBD,IH#',*(]*XH4Q YD&V[.XN9&P'Z3JLOEJ,5EF:9'9;/O?J\4)U;U*9$PG M_28!/J")5;U=-?8E(H/CV%Z CD#Q\S(O#N3O MJ=]/HKD.)T1H$$!,(*.QY"X,3$E##:>XT1UB;VYAPPE(Q[B=Y9IP[_?'KPQ[ M382U*0Q^??MKD=VNYQ':(CS\KVQV=Q_K$W[.ENG=6=F,$CL9C?K5T6R7JRB2DFG]B!@IU5=8[G)A$ ;,[-["+0=5%,-@:;W M]4EO7. .@! C$5ADJ<,5;MZ01([AL7Q]C:6BAZ^O'8)OVA?#);94^Z#D0:4( M-\Q#74'!&75OPM?7F-\]G3+=P/R/EJ]+]O5-1:PNRM<7IHT]YE)!126S'%(' M*F(()>92'$'].%7GZVN'4@*6V\5Z4RX^;R/R'Z,95,_Z8T,R&8.U5@=[5%C+ MG!8"'U!BR':Z0'(.1\^@(C 06FW=.7L#>.]#\K/R(9;K?NI+LWXJ"I,OE_E\ MLYTM/\1KA^7F6PW_!WAKIH"GS&"'.( .,F^M1)7YP<-:N!17SR BDA[0!!O* MSL-28Q4=GLFX91A[3Q%!P#!)@!:'Z4.9JG;AU&R>KOBD8F_M$?'LJ!R\G&[600GIONG961R!OX6T'S8/M2R\(?G M,F(MPAX:+%U @W'CN:G(\+3V8DM:?;T3_L5PY*?@XNR/9EQ\_ES&#&5.&20L M(\IH$IA#">)5-CI(9H3UWAKF=_C/ONH?J6/7OEJ?R)(T]FU(O 50<8 M"[(ED?6.,&$T0D$_<1#4;<'M)GBB^]C+IS* C5.6*D4)H<)IB3W>3PQ#0,]9 M/[%0*_)JGJ]FY:)H6BWW^?.9Q58)1Y&%E& S]:;6#?3Z@$PB$PQ? M3:BBPE. D;;P !6VJ"Y44[!ZT!O[.C#$.6^X$ 4 :Z6E% M'J5B2D&T44[VGH"DX/>@MNNX^_V7F64( M*VXH919*R(7EZ*#B*".F=8UR ,2+G@@D6*?N]C:?QPJ'AP/K8Q#=F)RS6&T7 MJ[OWX;C;E7,\=6@W?TFF#.9&"1WT7(HUM=H86_D[!)+3J LSE+-F='P2",C. MDQIF[/YX#)M?KO-58,&I>KVO#\B,DP!P#JB&2L8JMH@>" -A1YQ$W&9HQ@^" M1>NDR/"M\,U_YK.RROK^V[9D/ M"&@RC>:L SI9A\5C^%A'O%?]>9/?K/+U&"&'[R\W97ZSV/C9?+$,+^D8@QAF M*XH,?7_[PX2^G8I?-!J7$4VU4 IZY;G%+JP_J 3W))SD@%M>%S1(1VK=/<^C M8S*I"%/$4Q3D%5$II&=R1R+UCF,RA2J<9,7J.OQL%R;$BFE$?8 M,6B4\P8["KG5>T0\IB+1W=]62!P'1 )X%>]NJ"B9MP66MGUPW-@BFB M@HDBE01>(6@D0*@B5A H)NMZZ<^^!O(P %1O7#ZFYHZ9GECTT_ _YE^*Y9=@ M.#[-(%@7BS)>K,D_E]M9^>UJ\SU8W;)>SDQWL0]GUEQH6V M#E"DC1. *4]Y('-/KC9@6HZ=X9A7G 6^MM+R6]A^%M&0J9GD]=>@L7S;3>WY M7)]^_'YU_/;$X-_(9)A_@(%9APT+6,3V-Y6^YPB95C&M,>3IK'@.+6#OYYLB MS,(ORO7FITGVD:H&+\Z$-,1CH#$W'G,/":"N(MW3;G<'1LOM/(E-NH\>@B3_K MR(B,2N-%V.49TQX!A2BPU".KI4 ::7B>+DX_3K;.A_7*TYEA)FQM1$K(%<#4 M8HQ=199+5H3EI/>J-T=>EE/H#<-D/5;%ZFZ3EP^1PNLPTSIOU2N/9TI3B;6B M B&I1=::G- 0HE$Z5^M/%6]&/IR$^Z/28H3^L4LZ[T.KP[(G#+68DN$DM!' M$UTZ71&F$9INDF\_-M7PO!S\O=BDY^LDO/* M@QD -LS&0T-DI-!*R6$U-09J-9#$*G)/>(L!H4BP)'\\@FK.W9\?SBQ1&$(D M+? Q7^& M%6< K:U\^&4QBUW48_;H\^'U(QJ T\1@$3(C8'PAZ8K^?@79:_?#&]=QW1B4Y MRV,)WC)?;^)QM[N]=K.7YME=\WC-J9=DFA 9%YF&QEG&("4.[P$P"K-$_H-) MB,6 .*47E'T4U89IP^:2\7Q4IC2" &'E,%7:>(@)J!RB!F$VC?_;;+,M%YMO<;*-6?]\4$8Q!@0PSZAUC OBPA%8$>@1Z70V)-(6AN9\#US& MS96(?O'KO5_\3>1%.&_U[F:=E9XZIK6!UAC&(7?6 567N#/5O @B!# <.4>0 MH@*RF%O#H&:4>2\)Z=1E(%%>1&..-,B+: ?#5/,B^D9GN!:4>ACL%HQI;+1! MO OV#.(:4T.QL8)APJ1WS,3*4BI5B:1>89O&'&SJO1\8M0N3&42Q#01Z&!OV M:F85]Q0JJW&P3+U!J7I7]8GG#"X1[3!)FDL!J38ZF(& <48!B&UW!+=(6BQL MF.FT6HWU!_AT-D4[,-KRR6W+8O>U#[-O\1@ZQ:K7G\U,].AP)BB2G%*EM!): M!#/.<.\Y5=.ZL3(DMP;!HRW#KKXNUFM?!L.Y=FF]^F@FG:'$20<\)U0P(VWX M#RK"-$7$ZD[.J/3QC [L&@*.!.?>9=2/?\URB@=& M[8+DQ3H0]DX%L;* LICM:Y#04% 'C6%J_]YN;A[JGYW,F^I9E061!(2 ST.=@)%5@B(,:!$NYAXK_VT\M7Z E^,A4N" ME=NN=ZH(=IX7U"OI+?4Z2'.@@ 53T'D1KY*FT=3/=GAW!2(5'UNUU,1<".P$ M=P@&D422NJ!N/ITRE :M\_+.Y@[L.=%T%VU"=@8+>VJII#1!3'!$E&+?2!HG">X'!4 :Z][V1$ M)VFKVAC_DVU5VY&?@HN=VJH&7< QXH D6E(C@\D/M?!A2^$:>$:FE=L]"!=[ MD)_(I*D2+]3JQLP>%YO9\M=\MLZ?J77O5O/E]N9[ 8M]'LDBK_.+]'EUIJB$ M '@/8S_!N.DQ:YA$0?C#CT&J._<]$W>ZIATD1F\RHK8GI+=<[=^3.6J45D$' M9LA1SIARVFN H)8*Z6"M3FK#.8\0=8-J,A+36U2RL#8H9 QS&W9EJ(ARB'IG MI(*6P*#L3C@RDTI&6F+T!G/)%=3.0::E(YHJK96D5ADK <0<8M:ISD#R--)A MDN &Q.FL@O)4E.NI&E-!9\?2N$XG#;U\ M >F!T5F3S6V^GI>+QR/M*UJ-SR2QD&! C<6<.DDEYDH92;B"$ C:29-EERD: MPT T;C;Z[[,R]L;YDK^YQA.&88- ]-\QB+0()NS>+>RDX6&+KA'$=*1V;SS! M@UZBL*!::8M=D% +\)Y$K:!,Y"?JT7BB,8\:-YYH!\E4T]6':=8M2=AE9"#< M8JR-\-YC4V'A$4I41WZ@EA.-&=NH=7<[:!(P4I4=X 3ZL# M51#9*4_Z#*V[&_.G6>ON=JBD\/8-V%B*4.6DY=(Z1J! #@6CHB(.0#C%PH'# MG_(#H7,FU@_5.(ASQCSDAL4D!PZ%N2_*30R5 M'OK.G'0__?QT1HG$R'%B%%3:>\N,.8!).$Q4/F.0=CY=O93]83F3OC%VJR<3 MA%I C1C2#D#O$<,'0"VXA/YSHWBP!\(KL= T%(HLF-K62@B"Q$,59AV,\,,> MY\,O)Y5Y,C[36^(Q;A1P9WR/T>C^2[[>1'_>^MWJTVI>K-;%B4$C=P%'4,5O[D.AT!K,G'5W_)B[MR M]GB_F,^636.L+\=D5&MN,<020V$,08((<V*&Y?2SHVA.K%);. MD\0]GVA]P.W8F"SFB3I*#)%0AI.=>$IA19X26D[6 SL QU[*P, @O3E9F)JW M=4HBT,]SYF;K35ZN8NVDQ_RWQNBW#+$X6H&HT-F. .JT\T 1R M124+1KVL"- $=XJZC1=H[<^'8ER 4MRES;_DJVWN SH?\^4NDWM6UMSK.CHF MPQ1+) FDG-M G:>6HTK-HEQ,C/_CJX]#(95 $-1\'EL&K#_F\WSQ)>HY/\ZX M_EI6PS?$VA#6 4:L@(2*>#=-5ZN+ -*MQ]-H?JX$0C(.;F.X1AKY#Z:0.YW: M4P"Y=I(J"%WXG[+AK[;:U@T,['G3G@(2.Y8JZBR@-L @E8.5W"L@<*=PU_D\ M!8U9VKPV4QHJC!B#0E,C'>:05B>J9@@G MZAPYAK^ALGI@A@6G0*APM@K@D+48,U<1BJ2FTW5. M)&%OD0#,-RP]DW-G7*#0]'1[O$KG+T5Q\W6Q7)YT>C08F0&$,$2*4HZ(8XA) M8V@U>6?TM+K/#\6(8DR,6C/XW;4ZR<;#[[-8KH=CI@2"A"D*D:#52:JU8=,J M/C0"L[HBT98E5]?*_7:R0/KW!S+$A"7.>DT4X4X:1;2JIH)5MXI0HZ5 #,^4 M[E!T62COOZ[R/Q>L&&QNBKFB\U-'M7-V7RMEG=EX1X6T8K/:SG9\Z49 MCW1!ZCR@2$!A+0.'O0'X;D431JNJ,*E*\.$,:*L5HA ;&N_. :RH/RRVCI(W6KF.$?:=R4'<.A4\ MOYL]%LO%R1+.+Q[*C*204,N58\([$NL7'9#"0'G0PW?IOB?K,3O M/)51JHS@,7F$4N0)99X<)DT9[<2SD1M3C*3O]$=G<)8^S>1H1.'E(V$?"3-3 MD@IM@;($4J!P-5TIO9J<=M,+\V)0%";/O*DH,F?A6?(3T!3E8U'.-OG?B@#1 MW\.VLBWK%=,3HS(&N 3QQKIAPB#$-6+5(6,\0].(ZW1G3#$6$@F8_4,BFKJ] M72P7L^BK>I:$IM;K8K[[J5K=/*?IE%NAUWLS"Q5$6@D)) U:H!*4J0-,AD^K M64&"A*B4:)XE@2"29A>WMWGL@9;K?/,USU=F5I;?%JL[]1!S.@-9GV(IA67\ MT=,;6J4:=/M$IEQ B"(6=G7B5-"('3GL @B3:6GV"43Q3, .DZE0,\W9S],, MOR@WB__;.?:/UC8?]7N9,9PC9HV0C"%/20"N";5$QW1 F<$LIGW"2_ M+&[RU%-MWNFHX61#[C MAC<(?&>3HU/2MO4GWF0R!T/D:9D*M9%*Z?+R4E^]#I>T,] MOO=T-^)C_A@/TM7=Z!\XYP6H%U-YM[HMRH?9GISZJT\-AF=68XV0#>N<2FH, M%,QJQ:P 0!+.:WN:C'TSY00-^MO^E\UO0#5^6^9B_3+)N36 466H]$@C;R'A M'JNP_Z;Q YR^#C4H>X_>.AD+LZG>BC*'XR=0N .Q)H_E]0&9T@P23P"4.AS? M)JCW&C.@&';0(\L2U:?O&.09@>D_^2H'0"V)3_KE/&LOFQP;DJF@N\7JOFA7 M<8)) +@E2@KAC7#:\8R$U2H,TD8)0:6% F(CH8-8!&T,H4X&]Z@9,GVY6"L4 MXR!W87+#D$36&:N=,]0*KK4&#%#/$-/!*$C5^:!QNDTJJ6B'2P*FOP^;[6RG MX#]MD<=S6FM&9%S%UM1$2J8 Y=Y((YVTL02S$**:968[<^@8@Q4$C!\V&)K M4@E"+92(44<#:M+'^A 8.P<(\2!1[=C)J@Q# 9="+@:MMF44XB#\(ZWA#AOJ M, 75Z6G-PS RL;UN 9&[_*DAQ,A#0&2DT@\EEPB@3%2RBJNNK5./T^M MMA%DHQ4V*7SFN])CL]6G58"J5GMXY>D,(2F#CH4=59(&DU]8'KV[@OI +,.I M]H*^U=L:<^:EV[LW)*T#ON-7Y,- \* _:6PP#690P !YZ(&5'#G'?*?Z!..E M @S&T[$ 2K".U7IQG/$_/Y0)92&FPH39LAE^5PJ*10IV;+?+TOXOA[?JKXX8LG,XR9@H$0@(FGA!NAHM_) M$A,,6(K@Q+(!1XT']$*F[2H]V/^F>'B^D1IR!)"D2'9K 3;VL3DL^X9#)\69^2PWZOWMNY@_=;?XO,S5>IUO M3GE43@_,D$8.&F6\H(@"Y[6$D$*-'7? =O) !K[;!UG%0\*5 *)^"5?!>%= M1FWOYB$P8;UY*DKJ_G@,QN2IF&_-R,QCZPQR LD4 MG1O[Z!Y')H9%*LG%@;A]_5JLU[$B\Y'\J1.BT6A\AFS07(B36*K=11NE!=2* M8FF!09YVJH<,,!G^ MJEC4E[N(P&A%1D85@?[H)-D7-GD9Y/%ICOOMZ[2^?VQ()J%BRBB$#;?44*@P M8T0C22SP%*).UK,5\]B38#][,RU[-U?A,MY+"]S9Z61!F+542D M];?OCWR8?8L_4E]GY[\\ YPJI+",H4@@K1=8(&H15I@8+6K;L8R> MH5M'X?H8B2WR=OM](W,.88(\<$X))AT3E40,LI%HFO@I[-Y$PK*\5S?I#A/ M-0,X[DP-^AP\?RP3,:--65*^D3Y6EU3=U*QO1@,P03Z9#6[ MVM2+'Q_,K%=*$P %IDIPPC2WOB*$">@G5Q"F'SN.\+07&!?,W:EETYR#J?V" M/RK\ 'W(RYUYL)I'G3UL-T%'C+,X%:IM,#"VFP?(0NT=Q1YSR7CT8SQ-'5LY MC8(P?6$O1H2D S>!^+U8N8?'9?$MS^VBS.F#[5!\(4>1B=8?E.V.JF\<$]QNI<1G&P@L(J770"86I9$979$K*._56&"_I[:R,_JE1]'"XIC"!O]L%.XCJ M;RL>&9$9"146/#;#=@$J09&T%6F.VTZ;S'B)=E,2F6$0;6N4O0Y!_'.QB@ < M4=4;CLPT<4XP @$#5F&GH#>@>SHA1#D1?%8I=,R# @E7GDC$&I>+FZ9-^>,B+H9%IR[Y& M7'LY)20XPP:IJ3YJDVG/"?! O MIL.^7L MY+2H'EPXT8&K&PP7R=&IJ$?G861R!G9KI8:8<9A[[1@*:@!@@LC*3?A!H Z;5<&$0+O8@?PKAEV,* MP^_;2-!>Y5BK[>:^*!?_E[_60&&T;V6" <%Q,!,YQAY["+D^Z)H.J$059(?R MB8Z8?7IFY"](D+_,%LNH"_NBW)FA">3YY2"HU,0* MW*27FQ% 3+"S5?.]RLLOBWT(ZR?< EV[IO=/\;/U=;&9+7]T]*PWOQ>;?^:; MC_F\N%O5'-6C?3.SD@M'3*PQQQ@'0C%1:4"60%MWTR9Q48#S[6U3X<"4C^[= M_S[F_]XNUHM-A=13QR$/VV)_;>%/^8;\*9L9O0JPV5CCR9&<&,P!I 3R0,)J#7JE(G+'>ZD^MB MO"('9SF7!\!MRCO5TSWG=ZOUIMSN_/#O-_=Y>7T_6[U_W%V=_OMN&W]WO MA MZBEDTE-N$6(@8$VD@=(X<@"?HTZ%LLZECEC>SVS@MM0ED72\>\O>W.R?>N]5\N;U9K.Y^FY7_RF/IF6 M/_UY/_93 MP$=_"Z.>JG9^NRYL1>030OOFG>]O/UQ]VL'QC\5R&?>:UQ?65&:7$>)XT)PU MYE!S9PP&[, $:U2W\O3@;:VB"V56VQ43OOZCL_O];9CB0[':W9YXMUYO\QM? ME&XVOW\Z1%\FR\<+%J^+^R"OSF+;$.UC]7&*O Q'EIE.-CPTVYA_;<4PSL3 MTL/H04>/HD"2NKLK\[O9)O]'OKB[_W'6?A8]\W&=?,S7VV"++%9A1"0NK,+B M-JA_U[/R+BRQ0RCG-9);W:\X\U0#>[2BFBKMH++ ,>79P8,%C>^V$-Y2U.^- M<"Z58?ZYGCF?7W6Q[@'X&/%:-VH@/\KW,H^B4S<C;EE[ M;RF<.27XOTOU8"48#P4,/ZRW3^OYSP*&1V7',"L@H%!#$7O^(6 I5TISH8T$ MHK:4]DB@750!0PR$-;&\,I9,*Z" )V@/H5"V6SWBZ14P;"PHHQ4P;(?S;*(% M#+N5W+&.^, [96EQG,:% 19T:XI3-0G\$RW2QHS_F3)G7803B$,<@D53!R# M0@//%7!<04NI,-6NX*P#D[WSTE$VDI0RZ83IGP(["+A3N])SP7*:7#Z'JYF" M%/-.*L =IM1#Z+2S!](T[900>V%E=IHRMV'-E':(]HCO?/>O7%]]_)@O=Q7L MKPNS76^*A[S\D.?E+V6Q?3QU5[OSZS+-J89*6F&0XM@30UFEJDBB2*I^S@V+ M7O;EU:M1D5$1&T0P=ED /_GSCN\6G=Z348*!(L0:X2T 1%(N#H0![SKE08U7 M_W1D41@2JBEH.ITS3G9QP?59\_5^G$*\M^ %X()*&^QZAXC7H@+?>'AA)>5& M=&1,DR%O:#54H1;U)2]G=_G/U5PFL%QJYY@YBK"0"AFKH.&[7IV'S8S[;GV) MIQR.F_IZ&IIC"1:<6N[$(K]Y':/Z#JO-7I A* P7WG KE-8"&( /ISN!OE.C MU2D'RKJ*ZBAPCAGY^OAGY*M6&(A$1A-('1#<8T"PA(P;PG"P0ZBJ32#Z,_(5 M-DZ->1!SZP5"C@-E#"(5A!R1-Q+Y:BPHX[7N:H7SVXI\(<\9I\ X*A$AU#'" M#NA#E,H\.5==M::,/QGY:@?A% R*"P@D$&*0\H8R Z"D1!BL704JMAA>2.2K ML6RDB"ATP_1/@1T$W&E'OBY*3I/+YSC-)A 7"$MN 6=.(P^A /Z N;:I8J5G MC((U9G2K9A/M<)W"]O:&W-T0.*NEID(K+K$6"D-Z4*D,3;4-)O-Y=+9>ILF0 M-[0:WH:[FULK,70,&N.PLA)R<3!1H 73:O/X'[">AN;86W)W,V!=.'5C$-N9 M8%+'4_A@38-$K6^F+ZJCP#FFNWOG+#GFY(X?_>^_QM_$>RS_\U__#U!+ P04 M " G5)M*3]63$C3Y "6Z0L $P '!M+3(P,37?_A?__K?_OG_>??N?^-/5PXM MYYO'?%4[9)UG=;YP?B_J!^??%WGUFW.W+A^=?R_7OQ5?LG?OVG_D-+]8%JO? M_DG\UVU6Y<[7JOBG:OZ0/V97Y3RK&]L/=?WT3S___/OOO__T]7:]_*E^>"GK]7B#P[W<%4UMB6,=#_^]9N?_]UO M?AHD2?)S\[>['ZV*8S_(/PM^_M_OKSXW?KXK5E6=K>;Y'_[UOSE.2\>Z7.:? M\CM'_.\OGR[?1)?\+'[BYU5^+_C^F*^+6 MZ_6++PB&$L$0" 5#__W,A^OGI_Q?_E 5CT]+3L_//?!K *Z_!6L+74/"!QV0 MIUA]_4'#>&]XU\W-(O[VDX8QMPTM72ULM-_7GS6,W2QDJRVCK+.EX9;QS2?? MQ+P4/W7%?[7]0?'U$_+;&-^*ZL&'\Z]UOEKDBT8T7WS:*1;_\@?^J]FF>G>? M94\SFM_6M*CFR[+:K'-T6]7K;%[/8I8@GP21&X1I0%,OC7T21XS_+L$A-SUK MOC;+5^]^^=S9;O[(R-?_H.+]M[RN\ZK=G(K#]B9_G)4_13_6[ M%\$0HQJS3I1&6U?+"7?A&!_?=!3>*?/K.SYX6Q0UR^;%LJB?;[+;93Z+/,B0 M'T.,,/532@AU_ HDWJW>9X6R'T;>BTF?J-U+5B8XC@#GEG=-"702OZ\R9!)R2H/ZG34"$#?I2FFYN:%O')1IV+R>3G M>;[*^/ -?2VJ61($OIOP#U/?QR1FC.UUCWE>K*)#>A8L:U"'A6=MCD91/I0FFY.BEFQ-_+*JGO)Y<5?D"UH^ M9L5J%H4 0(]_'; P8)2Y!$>=O2B)E,8U^E8&TI0+YP":\VL+3E5B]*F4E)E! M6-23&D4"[2C/6_R<4I_>G$Y$@?K[\5J%##&CJD2L7.?SK*K?YX^W^7KF$AC% M?HHQ0P &B!&7P:TQ$@=)I"-#BB8&TZ .E_-KBTQ3@%095%,?B^3I2H\\;U9U MYR4S$J*C2>6T%$?7B3?DIA^BA-VYJZP504A@Q$)$SC*(U G*;0Z\QZQ"=]%4?)V#BKR!?.MG_IS;OZ M4ZRO2];8-;*X+$_L8*IU2)BB>FEQ/5T5TW-'0LUZ\'1.U9X>9Y_R+^7R2[&Z M;XVF7Y^*-?\=RV_7FVS]_+GX6C_<_%[>/)2;*ELMTN+^H<[SU78X%V$*4 !2 MAKPHBEW$8B_IX(21*[5(;1V$917<@>^Z:P??Z? [X87#^U2L. ^T'YW30CFI MP*@)J$1,&NP.!^]TZ)T._N3BM-A6&S9%@M]'O%Y 'BANLNGPZ5&DN,CUMPFN M+W%'$M]@L1@W(0[G9CEP&Y=.H.\WR[KXCSQ;OX'K>EZ7W# KUE5] .OF=]XY MGJ]7>;N1O.>J<(\\:1 M"R?O)&'KBP-$=O6 NFH/%;JS:7:"45/+MXT#CO# >5O"NW@U;KQ4\-83A[LR MW2A*)^$)1E,O&P\9U?,IV@RMQW/UP"$;/6D/[6\Y5N#@.(PC"SF:4N+TW$^0MC54=VOQ% ]'$FIX\L3T6]*QP:F0U3X[. MX5;R.J94E_&4&9[P&IZZ+S(+>)H,25=:/)3K^B9?/^)RO2Y_YR):S6"0^%X: M!00!A!FC(2&[=<(@ N[L2[Z^+:4++30LJ/2G0S#R]0("U#LN;X_.[0[6A3// MUNMG,3#YDBTWN6+%A0Z3DN46EBE4K+78.70Q<7_$M%:>**WH0-PVEZ>7! MZ[**WFST&0N]S[X6CYN];9(]\;^IGV>$#[IB@+W0PZD+&/-"?R=LU V4JKJ, M&K8\4B+EXV-1B_/?[>J$<]<"+O*J_P!)GVW]\=(@1!O:#-UB=79@G0[M^*.I MMWA4'%SU#LI"9Y0[12$K5_?MF.NEI(VG5I)J),W9]-1&'OH) M-5'T7WK>EM^+-=E/^1,?T_&^M#OR[)/$"P*<^(@DQ/7]./ ! )1$V&-\YBB[ M'O+F]_GX$ 1)"F- 8N@1C'%(/,+BR =^ BT..]H(3D[3*,=V7^+G%,SD;Y\ M3J-[]'?C]9S$#"^ZW69_9\!-_K7&W-7?9I#0V,-12HG'NU$2A@C%70]R*5 [ M/"MA+XF [X7(];@H0,B-A4D,HHC[C4,W+F(0.@T$$?6JB.D*6JYLVR MN%WFJ*KRNCIR+4KDAIAQRPA@[(9AY)(D;?HCHBS%B$GV1S6C;A0#E# ?N Q! M8=I'7-CC-*4)\?W(XH)EA],1^\I[I$X+=0IW "DQ>:*[VHG(-#JN)=_*(=JT MZNG7AWRQ6?(IQ&L('%4'L+E49"\K(8$1(LRCD<^G&+%'$0VZ+BUN0%+>AR+>_I[,%+2;'I[O\A?,AKR^G2]KE MVGF?_97_-UEFE>*J@Y5P28Z(1HZ3X@CI($#?RK"(U"YL[4U(SGBC)G5B3XVB M+(9I&N)LU<-O3@?;9E-=J'=F=Q9]"BF+*,-N@-T(!\R-VG48E+K("[&N(']K M*<$4N-R)T/<#&($(LR2*( H22J#'IUO6A?=]^:6YHJ9RBM6N"^MJJ :3JEII MET)]39R@^GU#E93*Z1,\-37KX;_QUW',8@!BQ(7^B3T60"([4/) M?UR75>60K@H(/9:;%1\H?N(_T_307ZK\;K-TA"?M@.7?\^:$R.(=XLJ9\1_Z ME(NCEN(?[W[VKOFG_%OKNOA[T[&_&?SHBJ7!P*J*Z#@QU1?7%N^[!O"1T>=T M)%>:6"DI-A^FJ4FT!0_?E&Y;;,I*.LW7Q9>LYO8O5U6];HYEB%'OG_+%O=@\ MF?._:O;-CZQ5@,#GXUTW#@+&D.NCB,' "U"$0XPA2A+I>[SM0;"G!'O4S@'L M1L*WP)T]\BFL"/:@^80N#!&\:>C#()Y^!1-U09.4X(MN4!YW%=NG"$L\X/PMT?Q3)EIU&'+C?KEZW7SLYMI_.[^=NC M7W>$\WJ7M4\H+GVRU?1;DHGD]K(1C7*U_'#LJ^:\<9O A%/DR,3(9-0IQ$XV M 5_7#_F:E(]/Z_PA7U6-;0&O0]7<-L<@Y.&CC+$@@F$8$NIZ6]/$#8C2V5 C M!BTGO0:C\P)DE\@ZF%J749HA6RZQ#,ZS6DHP0+&5C"!#VPDM-\KZ-%38K$NE MQ59J5OFZ.^E@2*.($#=*?)]1!",4[HPCZ)K4/DF34U _KY#%..NAXZJ,C]]Z&$JDXI:J$69WW5<'LC2> %"14;,@%TJ<<23(#;&:4P M5MIVZVEJ//7K9JI:[QWT);B?YEG@UIC6R=(ZJ-*=?1;!$-/35C959R0538NC M/DO*8A;=#"61Y[' 8R!($N!Y$2,0[\23^DFB5O34RY3UJJ=3BZL:D]=^O.JO MAEHAU,#ZY2C3TU,$*2XQ*O,Z#:DRXXK$,IXF/^HR1AX7:7.G":4\M^=*JJDV4FM=5)GD3+ZO0M M05+JU(/7J:E3'U?>5*?>_,BJDWC8JKA?I5_G#Z*TL+.[';C%- UI$+ DB )" MPI1;QIU-+P5*:V+]+%G6IRTXIT-WT,&T)H$]:963J>$85=.I'F1:4:N3/)V0 M*S/\3D.O#/E2VFB!!BN)KG:75")" A;YD!#HIVF0, ;CG5R"&!NK I(W.8$* M'OV[;TW1;J!:Q@[C%BI=9,@>OMSE2N**7,/\3T,#33NE4B*BRYG$TQTOBSJ? MT=U=/F\NL)G/-X^;95;GB[?6YSZ5RR77\-^S]6*6<$H!2B#UHSCR2>02NIO] M(NQ)O:P^'!K+6OJJ%/OYPMDYXAQXXIQ8[?Y5N.-L_9%_!V*H:)[6X6D&4DVB M__%C*/V6QP1CJ?>6QW Q/?^2AQE2CR3AX0,V^DL>0_M;CM4UU.8Z$B#$X(*T M/R36C9IY6'6Y^I#7W="#<:))5CVP9?F[\#:OTL9)_B/7=S?9UQGR I?Y/G9] M%\(P9H3NM^=@ZD6S)SZR*1>?ZVQ=RTV8IH%;18Y>NRBM2,V /ZO$P_&A&T,+CC:Q2NEJTNKJ-V[I+)[]<,^]JG[\>OUUQ]Z]+) ML[6XP4+Q5HKQ(FU@<7/TZ%I;#CWTK,V(+W(MN>29D\>\=:]+CN*+6P^;N_(F MM([:(U*Z*Z]#-(YIY,'Q:5!9W1TN+J:R77F_*OXN[@YY*X\?@TI=3'V"HL@% M01B$"+G1;D,O3CW8OZC2.D3KQ9CMB$=, NZR8JWS?-LXH3.3ND:/F96TM?5* M!%5B2O@])"Z=./5(6E:;Q?>1L.Q2H)BL!HC'M)8X/48QA@2&A'HP\J(([8OG M, ;A=HDS72VFM,!Y#K7Z F?GH-+RYL\_+!LE;%W55Y_>(9(N2&,7(Q@2R)4I3&/F 1XC,$BAEF\D_7 M:'S9WOAK#V:TZ^V^Y>.$"/0@;QH]MH\#K\_\]>5"HK3IP$9WK?I5D=UNGV1L MK\OQ:206B$,WA(1WP@0BNC.*L$LDZY9,F+)*CA J7:7FBE^SU82 M#4VMM@9-B57IVIZAV=4KW.G/\OF"' DFCE?;F*1P]%(:H\Z45IJ9(?V_VM74 MLBBB7DS\( C#,$X( 7&P-4QPX@=&[QC M]%6,MQB36M7H3??45CGZ._3FJH!1XGL![4S[U%>ZO]>(0A5G4#?2!6M3?$&R@7 MCH#I-#@OG"W=XB_&VLY^FS6I[6D#I$]#XLRZ].;VL3&^U&6NL;*SWS2];L3X M//,\B$D<)7$$L!\SXN(@[8S3Q%.ZF,20R0&E;CLU$O4H]4-SO<8B7U7Y0ORJ M*I?%HJFHQ!G_P#QW/C_D)_JKU2BH:N)@ 3"OBCN<8RGC*>ZDM-$(^5-31S-. MO:F/!CG35,AJ%DQA/D,^=%NRAR%*9K599TMM;3P_,>55&^'0[KG MB:-1W?#N(_^Y?%6W=7B#Z)X$MUH*9Y;6?EHVJES)74&BR-DD)4@!_FFQ4>5! M4U8^E'4[R/C(^]7\.5V*%"=Q&$HU->0(T%9I+Z:LZ[T_)KF$6=2X27HJ1QG2VO;Y?%?;/' M=E-^RNO->B4*%6?<.H$AHXR2).+SUK\G36X.[.\]%NN+ M.>=@\?/'I:@$U5YE[!]"564>)FP]1?GB@.L+9P]4' 1NH381&>^FX],<2BFQ ML4!,383-.7;B3F2CW)G<>&F5IM48U)QHK_=H9S1P"8ECY+K I\@-$A F'2X6 M>8'>!-T6FL%F].8W:7J&P=P.SG 1,+F0^7)Q>8O[0)2GM^=SDN>>&T)F8C@U MG;;NK\96DDFF^U0$'10D[3;S?>2F'@E@"@*?D30),=E9)UX0]RT+TK%I>:?I M %+_ B$M3O6KA&S3::)4Z$4%XX3JA8YPIU@TU(?]:0BE<:\DRH?ZLV9H*+O? MN7)]$'LA@R3RN>#&*0CI;F\_]GQJL(Y(WN@_0BV1 L5&1J-VV-4>=.[@3'(' M_32#^L-)]2!,0PS-NZ4V.-3E35T.=Y9>;N6WA4Y>["$0DYB//Z,T2F/L4F]K MG +L:;[1ULOD/V:M4;\HJ.KE8 &PHY:C;MZ?XDY*)XV0/S65-./4FQIID#-] MA>2#U!FB*/%IZ$8H9B%B*2)>=\R3!HD+]=8S52S\HU8=*;&L*WBF">ZO;V/+ M&&=$2;54&)RJ2"GY<%:3U!GI,4@[NP=/0A9#2%D"0)B$)*0QPQT2EZ2[&YFU MQVR]$6AL@W_W54D&XZ<]UALF< 8'?I.N4)*F56U,:"Q(4]5>@QZ>'RT:9K-/ MQ=*GXOZA%EOV\V56-->JS;"?PI3Y"6$Q@1$A24KBSG@88%/52AJ6_V^E4M_0 MZ5G)G>PCF]IQX3 ME- $C]F$//_,$1:R2>N!T.8&*Q(,H3H^ZQ*,A4.LWM!PT7"]-+G=U6A),>W M@6TE,_&S\+;"_=(2.( !$D"(N3ZD/J^GS*/XB3V M1_J\_R!SU*6N;AV_*IGCPC5;U94-6>42K$8U&6+SA_Q)]+:H9PC#Q M,8*N&X=^PF*<8+(SA6)?17JT#-BN@GS152X<@ M+:O\>C,[*X'>],8;_5QX.2BD087 M>@KR(7OLAG444H3<%*0!#5T$L$?9SAS%D.GKB(*18=7DPA'0-"=W^D3J:(LE M#GLIC"Q] RC-GAYIO=%@=(JJH^/&2>W1YD7FV:A5_K$L5O7GXNO-[R4KON0? M<][45O4OGP]&4'23L_QVOLSM^V[[F=?191"-.$^21DB0\IQ7%GWXMP*)DJ#5NUG!T[M(Z >ZXC M>ZZZ_)H.PMF\."+_:JGPNZ->.MF-& *]_&8\%.?3F1I'QS.8)9Y'3UJV_"IM MMU#IU,238Y,G_S-?EVG<;IR*2E6)Q-5..'02U?B6%_.PD0B&4'_Q.*B'3^&C\R>FG,7H3.YS,M MSHZG-;OTCY[=++M7#M2,E7.=PIS0\SHP&(5(7 $3> D('#C '5@8,*DME]V26+SU/7V6MQ$4Z^XT=$MT1*JTY^FS'M'!5K/++.G^L9E H%WD09?"W8P4RU5Z M]K4Q=!&30.8TT'H5'2B0J%-S8(>_GD5-,M0-4'"PXT:ZWD"=S2F6&VAX<;+: M0)<5/=5AV3QOCPC/0I 0L4WCAG$,0Y "%M#]'@V%^K*C8,3VE@A'TI[0[Z,R M*J3IR(PEOGJ6-C7K'K8Y(#49K3]EZ0?&%TT)U]EC'U+)3'$JKFY% 3%'OS#AV4@$-IB56U M$=?C46X;S!#V@.OY*/4APH0!/W"[@\O$\\,>EZ2HV;&M>ELPO01/C3@MA;/& M65])VP)SZ*FL,81^'3(D+UA:O$Y2H?0\.2U)/=C1TZ#W6;U9%_6SL#B#ON\& M;LA"2-,PBH,TC8+.(/."'K- )3.6%:C#TD>!U&C3$2!KC/74GP[7Z/IS2)"T M_&BQ.D7UT7/DI/CTX$96>RY7\_(QO\F^TJ*:+\MJL\YW;\G%('3=%/HD0C"$ M<1P'_#\$>QX-?1IYYPIO3)BPUXU:5 Z'Y>QQC?:LX@F.3O0D$\Q.HRL9\:0T MW^ZD2R]VQO*JO5'-]4F**$0(!@&,4YSXS.\L !=*O82H\UWK2R1=M\D5[T_4 M(NEL<8-5?G0591!JI"L*K%*D5R:@1-7Y'?_7'A[?QM?F8?2]>7WD9?]6H#:> M:)9M1(/X8U[>K[.GAV*>+9OK @"$24!2+J]I'+AN0A(&.WN02[#*5$;?BF5Y M/,2C=1=(#_[D1F/#4*>FG"JL61E^O4G*B<%7?R*G,?0RX$=INHDI:DY^_]K: M]H( %S/?QSA-:(IBE^# 0TEGSP]=I>43?2N#:H[672$]&)14G4'(ZZ,ZHUP2 M\B8MIW2G-Y43T9W^?KS6'4/,G-.=N=BC7S_/?OD\HZ'GHXA &%(@+D'B@8MX/K "ZU0Z^S0G.U+^ICL>?! MU W#!,#$HRP-PJV5( 4N45^ED?_VH"LU5ZH5O=J,J2S9V"&KS[+-<#SIK-_8 MX6J M+E:;8G5__92OFP94S1#Q(X)B##T*?0PI)H1V &(O8;,O^?JVE)UW&32LTBD. M,4KWB1U6I\Z^.FOE*D*3),M-S$9B5TVB][0>[-HU%XA\RD5G*Y9%@_&B*R0< M=A8GS^&):9V%0$QCGF?#L=)Z(U83Q^OZ(5]SL^G7)_'F+LY7^5U1STB:N&X4 MN1 #E. DQ![<&7,#DFJ\4:QI2:IO]GZ36'3+VQ:1(QJ"L^2?6CJ\0XKR%%'9 MN=[,14G#ZEY-%W7YE=- FYSJ7=TH #4BMX7D_+ %]>.PRG:!GIT'G',(; MCDCY>UX')%3S+M<^Q$IY-&(^=CC ]H@] 'SF \]R2&/6:/VM.D MIY.M%LX+I%,HW%0B\L3 R4Y IC&>LN1;.4235GV4LJI>6&Y+K2# +( TQ3#A M HZPS_RD,T;YP$_M44HM$Y9'70+5J\ZI];BV+H%RJC< =VKRID&;I>KKQ#?/41K@1%MI\/,'<5HDO[[;__%S4W0%J9>FD+K$]9B+4L#M MAAT #%*I&@4+9H=7I!:IYEOG)2KOJP(U5\MBB^%(M-MKPJ M[A_JBF35[B5>1DG""(MI%*8)C0(O G0W0"1I)%V#IF_">BE:!\UIL3D-./4K M>GO1>':)?B@&U:1H&N0I5*L-0Z)NT9HFF3*U:V\Z_E8)6W^F1E^&-^)$:;3U M*!X>VMQ6^=\VO"6E7_A_W?!_W!Y52OG$/4KXUT$B"D8" KS.FIMX2K-F71N6 M97D/RVEP.0*8WJE%71+EQHA#\*, ML-)#=;9#3^9[0<( C-W C;&? )3L[,5NZO?4'4DKXRB/WME%?2JUU<<"BT;T M9YQ#C&_QHZ9!BIQ.5H54_3BO0UK,:"K1=JSEXMCW4$AHXL4,I@ $).YL^2E4 M6B[3LS"T JE-IWJRIR4\%HCK*3JJLR8K>O/F%,L,C9/4&54?3FN,%B.RAZ0O M;V:(3]A@XJ5Q&L0X<=/(QUVMA1_'0.H6!H7/V5[,JK/EL^;A:!DR3FN#)1X4 MEZ1NT-5_#'4H^O+F2-_6H&$:AZ)5 )?:(>]92W"U.TL84A= /L\)W"BD?A"X M*<.=P32E2N\ ]# S0O72E>X32'W8U-DRLT9DKQTS:0Z'J06XDG@.R0"MTQ@L MF'#DW-Z^+C<2>V7-FB]>EYO[AQK=\YE/59/R\2E;/<]@$N" 10F!GKAZ&W@H M2G;ZAQ"4.UG=\?"^]T=.'P+.;9 ,QIR8^+65; M5,X6EK/%-0AOTOMC _&GMSVFQ^/YO;&WG3Z^-6: I-%WQDSX4)IL-HI'FM?W MV:KX>]-^N/)7Y;)8-+]!J\5'WH2ZMG5]QXI5QG-"MMS=^U?MRNQ]Y!),$PHC MS((H9<2C# !*(ISXA ]D94_H&@&#L'A'RT4^PBZDR$7 H\ -D>\&F(6AQ>VB M0_P7S@L/FF,MASXXY9VS\\+9NS':$1G,U_N^>)@&'HQI&V_]ETQT'5=1@/Q-H3E M80O)EO/-6''YWKC^DG='/YX8\.(C>7?[F\N3SQYL!@T9 3OI$#H2:''&RK@AU38([@KJA%:<8L(*'K M41"%E$M\DA+71[@S !"4+(S0^+#U:@C19?/M(%)-$U7HD=,Z2[RH:]CV&O0? M!)0?+\1OEYN%T*V/Y;J94:.Z7A>WF[J9KM6E\X'WHG)5]+W])U0*@V.IZ% .L#+WNU+33'0XJ^;JKTC[Z;L[L[/>8MJ&Y2P?%.JBAM. M4$!B1-R0A-CS81*#I(,:P4CII.PH "T/_ Y\$EUQW7GEK ZD3?Q-N1M^S,48 MY4Z,XO])3?/&";"<>DX^MFHZ_"JL.X><;P1:_/7W,NJT$:03:C]JFYA&WAB7 M@G)"?50ME]'\B4MIT=6MH$AM+.(F*MTB+J/ M'0CQ0HRAG];E8J-T M;[L953Y!W0EQ-4'X-#32B">E^>:HJEAW^7HMU'+[2M&K%T'"F :A3P,**?\5 MBER8@LYJC'RE.K:^MJPK5PN/#X":@9)X+NU)I)1*0[EZLBJK7L,1JJI@6RX/ M'D<;^=V@,V2=U"PS-$]%MPQY\XUVF61)XDP6JBH^!GQ\RHJU&!QRO4R_%C4I MJ[KB@\-VU^EC5BQF 4@BDH8!_W]I2#P4I>ENLPE!(J5A)NW9GML+G$ZQ ]H, M&W(.U9D+K!?-'+^\:R?T_(<6TH>1S#%^6M_&(EMQLMWPO,?H<)".0.F0EF;G%_'(=GZ2-@H_"M=R!L/Q]LEZX>RR_Y/E$[=^7:R22[0/V0\P\LQ=." M77=X;B::/_4X6"9+Y9&,8R,0HQ\Z,^]1::_9JHV>>:Y;YUF5T[S]WX,U!Y(] M%76VW%<\,!>DB.N"VXS "R-TB#$;NH2Z!,7)ZBSR1!*^FJ4BBWK&G4 IJ\\*7&H M*T_&R3,I3S)D#B1/!U"4Y$F'WZG*DY8O9^5)GR%]>4+SYOJ]ZF/VW+SFYT$, M4\S<* 0P\BA%/HZV=EG*,%8KM.QOSWK]90=(+-<(1'VU2IE07;VRR:01S=HQ M^_$,LP,)URO"E,1+E^RI"IBV/V=%K!]3O81LO3G8,#!,6 MNC3I-HM8$L6N 4G3M&Q=W"YWN\_]!V$]".XA<0,P:VB UNU-YU,2O./TJ4I? MSR!,6 3[>B8CAT;8DWJ#[PWC5T5V6RS;FL75XKI^R-=DLUZ+/0ZQY5'-<.32 M !."N$"#F'HH!%TQ/@OX%%EN7FH5@O7IZA:HL]PC;7;Z2H'5F;=@V\U 22FU M&Y*SN]XCQZ*?N':@N:XZ760.<#?;XPUR9PO=09.)C,)3@E.(D-[&^[ZC MW81S%INUV"1J]\"?1*4A_]U3OBY*40+7_'EV?[]N.J:HXMVT)_;SMJRG$F5R MFZ;&ZW93.ZNR=I[YMT4]R07OB?G#J=;:JLJ845MC-^$^N^Y#]7W!7\ISB<_7F6;%<4WNN!1;6CC$BQ9>=P[!%&3LQ# M>A$XC0E'/Q=>'YWMST>/0B2A::]W^S_D]8S P$^3-$&A&\5I(N[*]7=S&#<* M^FYH:1NV+D(-LMZ51]J\ZJZHV"74:.51,TP[.#O:Y-)F2G:0<)O"V+'76=XB M5:T0J6]DIB%Z-AP[7XADACOS5T/-4,!" A*(?81\Z$4P3KJ#5BP&?C*K2PY5 M3AX-FE6JU-PAE.[2HEB]+8$^.!"N-%NRSKN<@(Y$N9J :ESZ--6;GDXHIH50 M3$,Q;3BF?:.3(G<]%5,4/%1O'*H/?>8%892&!"<,!RB*=S6D+/0]S\!E>GW, M*RFHT='=7+,56836+Q--@*(A\#X9:""*=!ZH2'#JPC^NB/V^VI8VL MXRBJ))T28FHZ,-/24>/>O2&A=E@TO]XZ@SA,<4Q0C&G"8.!#$.Q&TY"YJ8$= M*AVS0^U0;=KE//Y_74\VO#NEQ;GIU52C=%M?19WJTJF1)5/I4$Q#-VTXIKU$ MJLA=3[7V M7*_+WP^&I\]-2=6ZN.>A6CJ/6;U9\S]4O O/#.N2\_ZA"5><[!].[YT?]@B= M\NY'1X <33UEF#LUKS=)_#04TJQ+WSY299JOOBK8",$-UP&!X7W3UU?WEZL; MWLKR]^6J?JBNUU=Y59;E74.ZC8=TVK)NWEU)R;?$LTXZN-PJ MV?7=5;FZ[S#-(AHG -,XC:,X3F* (4]'C6'J,D"8KN!KFK,LZ0)+*P0+,2![ MV@+6UVM=5M45>0!"^VAN!T]DPSW+ N)X8GJ<,DFY[,GW] 2QKT,G),\(5[*B M=JBO+\S!R.6JB1D%(;>50)]BTIFC,(!J._C:9JQOU;\2,3$NE7W.HS^'9S&G+4WXW2<#O3JRGB<_E"K'>N%M7,2UB$84#\ M!(IJUO6N1+7/GAR?^MP_-70Z\0^V*P)^=2B 5A M^H3O-(V2$S]#L9B(1%IP[,1$T"AW?025E>NF8O+(1O3,\_@T% 8!3$7Y#[<= M^F@GZQY5>OS,M&W+TJI3Y6V:77UU'(I8,Q)Y5ZZ[*N]CM33CJ^0).A6ETD1@ MIJN71KR3$$US+)JO6YQ1GWA^&@40(."[T&5]> _1 M#YNN1NYNUZ\-UWQK14!.6$K MG6GSCNSU7?JUO4SZ4U;GURN!":T6XG_$>?,O?"K+E7WF@]!+&783G*3,)Q&* MDZ"#(%895(:<1@U;'F^V6-N+NK=W;J_%7=K;EW>=V0+Z>EH_.NIJEO"N>%TV)VCMU*/%8!N ZY)W36:JRFH;=V72P';/OV]'?F MNU&$,* X=5/*"$YCA#L(.*1$94W J&'+JP)'NK8]H3W/LGF!-4KP ,(Z734U MI*+2 ?G^U%/>M1ZJJ["S MC9(PFK4O3GVNLW7=1RQ5[:ITXM<0I?LSSI9-67!6.[?Y?;%:B54[/A5M/VA" M-I7I[J.7-CDV)I296#QM43H-S"GHXROFE(51E_DI*Z*V3U)2V(\QLQKH!4$, MD)O"V(T!1"E@(-F-5B-,MQJ8KB3K),U855? #J"._N7B,="SRO<==TE9NK^G M+BGMDU:75&-,Z@G?A2A?W&3+SX_E;V(?9+7X4YXMZP>.)*_>YX^W^7H6QRD* M D)(ZGJ)[S>2P#P7A0@$A 92IWR-&;.\.+8'Z6Q1-F^_MCB=!JCS:POU[549 M2S2?'HF,PK#:(&3*Y"J\HCLTR7HOYDJ0W>OQ6 D6CJ0(XP1.X%%8H^Z4EAJ: M=$[XQIAX@QBU+Q-W-L.8^)#XS(^#T.-9*4UV-@&.?. .ET*/6UR0C!9P5_:&[5%'^JM$IK_M#TZHG^69I[J+X$ \=EWR1U MH^N^46=**\U+6OFOBON'NCJ28Y(HC$*/>-@+/7'M!DEATEGB?R!UQ4^?[UO6 M^!97WR&G/GMGM7P0XM0$?&S.I(5Z$.[TU/D8AST$^2U/CZMP;UY&E][^'I3F M6HFTR'[RQSCL(;)O>7I<9'OS,KK(]O>@--=* MY!>LYP_Y8K/,K^]NRMML/B\_Y4MQ:U&S2OY1O*N[ND?W6;&J:E(^/F6KYYOL M=IG?Y%]KS!W_;09@Z(5^P%(08C?Q I0F0>(R['F>&_@@EEW.MHW#]F+W%K^H M.MAZX&Q=V.[-;9UPMEXX6S?D%VJM1^K\TOB4@J2X<-[%YUHQ/LZOC0^.<,)I MO%!86[<>,OF5]RF%3G-=_J"+U=L0KKU*[ *RB(Q0C[! #?I2S$*0L!$% "[V4,JB<@$T#&"KS M"JH-^M5+DX\."S[PL5!B,Q# M+EZ[+U9U<7?W0R5Y\,1N,!5R])AQU$_.,B$$9I*R\>!H9.,Q@]0S#=L(EDJZ M5:3N7)ZU%8D))5AK+A[+K';Y/)=2Y^5F5:^?9^C3+(0049*$GHMCEC*&(G$K M7N*G+HA9!+!,@E3XG.5TA];WG+UBE2DN;ZD0OL[\52LY_*L"'73PT3H=9/\2?TGY=7 M0W52?*J3*O PC4ZJ KC4CKE:)R5HAK$?0B]FR(^(&T41\>BN]PC5# M"?8B\G>JB\C1,I(LJ '[=155]E>ZBGV:81A1ZO@]82E@48!='NP^'#'I* M7?3\YVQW43['SYQ/Q5P[ETHP(ME/S9*AV$^O/]\@Y],E&2Z?GAKT*G QDB#[L-10D*5SBKQ.=LE9CR?%D]/ MQ4KYS+ *)7*]U3 ;:KWU(\^JEQ\_7GY(/P_573_^Z41W52!C&MU5!7"I'7BU M[OKIEUGJ84@1"B,OBF,W@B0A9/OAQ V@TIJOQ.[[_+?2Q0Q*7[5>H="BT3BPKZV'N^P;SZ7A)#-_$0!OX^34'BN<;2 MA:2]J22,%JY)19,EW$#2L,!U[[2!MS1?3X1F@ZG# MV6D\+?I!0D-,%8/'>0>@'Q.D. I4KO 6I\WO;<8X>H M.22NM&;2A[33"6 @OA3G#VI467EZX5M"CNB. ?:F\:A"'P=*8RVICX+<\'^[ M'0?'+HT\[ ) ,(D2%H@;I#IS!$*I-?#>1@96$X%,<3[=GT<=:;%$84^!49P1 MVY"8/3'20J/!Y13E1L>-DZ*CS8O$G!C]GJT73[S#-N,G_HOG/%MO1THL9EX8 M\:\R+^92YU+DT\Y8+)XPDYL%]S%A678::.(I)*<%U_Q2P%.?=_4B\NRL=B@. MU71G*O1)3U2'HE%O:MJ#SO/ST1.N'Y^!FN!J]#FG$2=*H^U'6II)/B^617:5 MUZ6X@"7;; V1%#,^A\4,QS&(8T(3%W:&*$UE[\W7_;QE2=["%M7GS?HJO\ENLWE:7V6?LU6=9ZO%G_E__<>7O,++K.@N&F4)XS"0 M ,2"T,/B2I;=]!\2V5>J[ &PK= M<&>'W.'0>?]Q&O!.6CM7F=/@;QX&%AZ\ M$RXXC0\:ZF0O4N?U?A)!4LP(_SCQD<\ODXB39@:R'"^);*7+WAOYS'HPQL]X M]ETL!VS<^G.28]BRT]@.7YD,W810%( P8A%(DQ1C=U?C00-?ZE:C$6 -/P?Z M?[/'I__IO"$5F:14:+Z$.WC0U:=A$XIW[^G;?ZE0Z\\@)Q1R8S//)O3#1%YC M#MN/<?//W;+7*_YS-?^,_L+6"DA10[*7 ]TD 4N*&KM]9 M21D LJ7E.M^V+&A;3,X6E$;MLA9A9S7..E=J8C<23?+5W+;ITCSRKTJ;1(WV M$4^/:V,O3D87R7[H2S,M0[<:\C-O)YNJ/5CJNR#U10V4&&1BRM)H=[ TB@*I MG>]>!H:K@FQ!]:RJ5J'NM(H.QIJ:E"H39KGP<4^*5-&C!H=3*WC4<>'-8D=M M/G1595M5"5./!4%,W2!$*4MQDOH[8S%*I,9D/4T,KRP]BZO5"-13%PO<]=:7 MD4NK#XE1T!A%)J>I,JI.G-$9+4YDE>;/FT4Q+[+EIPW_H?OM4 DPZ,4Q2T+J M^3X+2 QQ=Z5YXB,H=?-X+P.65:;#Y+2@%& MM_VRXLR@Q9>BRD5ZZH:'P(-^P+\*(4M@0EP8I9T9Y$'9,UQZ'[>L,@TH9X]* M?32BR=G9<9M]NM14932FI,=M]AG3&[>I,W=^W';4U^/CMGZTC#YNZPF_--0\ MY#1TD1>SJ_P^6Z:KNJB?F]T!YD;0ATG,W)"AQ"/$0]UIL.;:61GYU/FN[55Z M <=I\2AM_6EQ=%HN;=.CN!"OP(S$&R?<.3'D"L0OA X$!R.M(XX?$8$^](S; M_WLA+_LW#OE>WWY\NTR/4>R&+@YC"'V/ <2"W88@ E#N-C7ECUKN[UU[5MJ* M4V?F?$>W1HI:+Y?EPT //_3XC>ZM14*K19_RA?W>76YFO_$?_/GF\OWV7Q1KK+E@I3K MIY^ZU2'7]P !"4PI]4,01SCHZHY0FKBR!>&#X;&L)9T?SM811WARX72^7#BM M-P[WP&G]<81#%\T?<)^/!&GV1'@&<@/$)_ZF[[R5($R_VXX20D";B M!9FHVS]'09A R>QNQ);ES/VZRU^\[O/.#QRKQK7[9H@^FVP'YU@MD4Z<7NG< M-SC->GG-&-WGTY4,(\=3D5$N1T\S9KTI[;0XS?2P-YFM%D=RVA9%((K"TQ1Y M?DI]SV<))KO%I\1%L@]_6;$]8:":F$6)C)E&9C9%J]I*C32:;&0[ Q+*;:>_>RG966-1;'MV:\N,HB$,O MB5.2@HA&(/*Z^X51&""I^K1>!L98P#2R:B5+H,ZRH@7N#*P3#DI;G]4["_09 M7(ZSM*:FN$BFR-'H@FW A9/+6%I\2)\0??$ZY3/-'C.>!YI[W_/%7[+E)I\! MS!*$,(SY5"<%E/^WWVD^1JXK]3BD07.697D+R5J51R)2L7KE MY4NVSQ=.Q^H6X(730!SX4.E9RHY(E 6^IU%@;-*AUP=/37,E^=8MM]MF,G>WI:%OG"*5?.0C*[R[UW*TG( M\9&O#49''PM;<:JTV@JE4\PK8Q\V8EA^?8<6BZ)YI\YE-F[?C>@.X6 [8K'4SXLN)WL?-B@/ZDF__M)WW$8 2 M E(&@S!A<8P ]KLKLW$21++G0,T;MIP!.TS2 ] !J%9-<0.S;'S):1>#[=^< M6X0:( 2ZN6S@4)C*8;U#HIR\SA,EE;0,\CVU9&72M3>3E''^U)-36M7%(Y\7 M+KJ$V6ZK5)S$:O.T/GRJ)\OWI6CE7/@_Y_/-NJB?KP7G^>+V65R>F2WY MSV[6=5W>YFRS7A75@_@KFM_EJT6VJJM92/DLTH^0#VG J(M#&NP6.[$?:,[G M;*.RG%;18[GAO9K/\JHM_K8I\ZS99M&[#K6N/%L/FVH^G5+$^B;9UI=F--1Y MXVS=<6Z?G:U#3N/1Q3:B.Z_$3^S]FFQ\=7/RE.)L*E&?B7>V4@JY6-%)_[;) MENU;R_--D_+_;9.MN9(L13E256?+I0#>_&S]P#]5KA^%7)"L>A!?SUI+SHT8 M7G/M$(_Y"AUJ?H;#*NJ?S T6>H94:@0Q5+.9VK!B,+_?'&L,R[QN?4]YUW29 M@QZSZS"'_66'O0%=WFU=F+$P8)&7$!8 %T<^3AC;+2F$82!UB]M(T :K"9H? MJ-'?=FI4[%WH5W5B.X)ZE4(3"IZA&B(>2>GLCW?P MP7BGG;I?WZ79_.&8BXWO!W[.& E]-V(H;(5+>YXKFWS\.4_8+OKMS0T'4=&7$J:9#O47!@:+* *"TG3:V13&S).EJ\9!]Q< MJ4"66?$X T&4D,!+/. A$L0T]+S=S3R4^;'>P,V,;=M%QVVQ\6V+LKFKH('I M_-[B;*[.F0NDNKG04 A41TC#L]]WB+,-Q1:RL\/L;$$W]^J0"81"=UPQ?$A, M#0P,A$8YF4NQ)96-S?(^M71JV+LW\Z$-%ON>IR'EXU.^JD0DGE^<+ TC-_)P MF$:8Q!&FD$1TEU?=))"]2-B.<S@$#J13X")$"041#39'=+@@<,W9^C8==R&MM=RMP!$E48U>:V M*A9%QKOJ#T\MYA\-G2K48;Y?.K--NO%,M@?L[!"/R+ZAHYR6HV#O!*=*-/J> MVOR6))W#FCVHGG:>ZN69[-',WNQ9F&ZUJYMB%91VA_$O5W79G!6:B=M]$ I1 M@"GR$LA(P/;H8E?V@Z=W>:# _-DFK'[+:R=:Y]>L-C ?2^+QNL!@. M--W;[H&U>V8[E\1UX&5[L&ZB@;4V0QPLP -/'/4#;7Y2>8IC,W--(U&<=FJW MYK7^S-0@ZQ:&!"_OC" 12>,@"OT$@=@%09#B765;Y!$CMQKU!F%[D_';FXV. MY__AT[YBL(SG>7MQ&BBQV[CAJ'^_$:.$\/<]O1.0;-9&&]H'QW:5?3 M3?T\VX?7WBO!+VRGH2NN:P]3&(>AER(*@LXV\7VJ>:= 'XO_15*F8AAZ+@A; MBX#YI6 ;%_NI<6UH^=<:Y_86?H>YJ*_OS7Q:Q$X[*6GZ)+O VX,Q[2-!Q5*< MB_^XS+AR%G=W55TV]:[YGS>+>X%F>]E3>==>]=1./<4-/?R?S/F?K)I9Y_63 M^-CU*I^E$0E3GV!1R1HD*2:AY^Y@!Z37'7R#@[6O6CXO# M.[;FC2_;3/?4.'*0YBZ$%1SY7?0!OJFV>X AO!1G/O:>RG" MW_KI_/E8(VF=[58?V[;RL6LK[<+CA=,Z[7"OO[>VTO,HSY3;C.G#.^.U'=WS M.H:CHW)"9ZR&,;5ASMATG#N%,VZ<-,[==$@_Y7_;%.M<8'Q?K(K'S6/W$ $I M[K.U@%V)%T[SQ2PFKD]A@G"0( A<%GDAZC QR'S-4S@6D-B>^W>0G?4>,Q>X M%O7!LS7S'7"G:I!K'PRQ$2[5\H[>-F'[=.QL.W?6ME[X7R>7MBT3_>, M'#YC9WW,AU'][(\ZEW(G@2S&:&HIW:JO;Y\2LL[PN62\J=[=9]G3+&U/)E4? M\_7G!V[P)O]:8T[5;[,P2&.8IA$&(*)N&,:^&P- 281#+\1R#^V,4N30,SHT=Y6PPU^-?]=T44ZZJXN.^ASP"^>^2(,3V>I& U1Z@<@Z M.;]VT ;N1Z=8.M&5C) [C=YDQI720N/3[%.HJO*Z0NTKY\6RJ(N\>I]G L/B M>O5)+ VLVU/)'\K5NOLMSJJBNFF>1><##NI2/O/W/)J$(8DH2;H.2+Q(:I?" M/*HT(21*(<%!',(0PH2!@($T0B&7IB!5ZK(:0X:#?KN%W5R>?.'LH#>W81R" MY^E1('^[1X\=1T4AG50(M5776/3LZG%?LF7$>[" 3DSIA_/[K;0P,//*.00_ M'W23QBSZ6E0SGIZ8GT2^1PF?B@8>CC#N%,7SD=0JK*PMAH,H@6X:^WPP&. 4 M>0BAR =\4N4'R'-M;S_O,3D-*#Y$X[!TQ5R74$6)'H!+->%5IM&NJA[G1T8K M>S([,07LZ\U;NF:$I1ZSR,LZ?VSWMRI:/F;%:A:F-&#$2Q*"_<2/04R]M.MA MO(/I#69/&>0R3-PD9"SQ(YBD"&$AYJU?\.5VNQ=G^J)*9L1E\[/YOOR):MQ'\NUV+)"]0[#$3#O<[%Y M,(N2B,_S A1B$D&:1"#>#R9<0*3JX'7L>K$+$I"Z,*$8NA3AP/53 @@)* H3 MRFSOB+=0G:QVWNJD+5!%\3-*O9P&CL6ZFA0:(-R**BJP=T(<;<1@&AIIQ;/2 M?@M6W-JLZN(QJ_/K.PD("$&2 !B%B1L@&O)Q#-TMD5$&0Z7=3A7#E"(_]2&A M$4,0D21A;I""!+L>YBW>N)HEF7)3=&Q"%;<)]W"%$58D])'%?Y. M;:/:",,T%-*.:Z\W6^WQI['.M_OEGXI\S?_]P_-5_H73+:;MJ9OZ$>^M+,(Q MB7FGC1#L^JVX6DESN>^421Q@/Z( !LR%,(J3F"M$2A.$PY!"UWIUY;Z_7C@[ M='U7_GI1K+P .!2[NM-G!6)MKP6>H$IN2= $U]-0/M-.O;U :(XS9;4[W/K[ M%D:WG 4 15'DH10',8(08[8;K*1>(O50EYYE;@6P((J ZZ;F MF69]>TLZ+3"HK*"7JZ=-736"#;8C5)C@.(6,6R5ID@+ QS"HZZ.8(*:EET?L M$#XT\KD6<#LQQ-#',8V)^ 7U0N03VP\'_-NF%%=H?%P7\[QY:!#-F_==WV?K MW_*Z:B[AN%SPV!3S;.FT^_L_'^SN.S\TWCC@1\T9=Z\8*.JD9?KUAXXM,'% ML^%RI(GT"9YDI+ 'NQ,3OCZ>O"5SO=GI(VK>UF+,0AR0!"&"J$?\.*71K@:9 M8$^OT.6('9>%(<*,H3!)(.^W* F\* Z0[^(8N@&P+&J?B_M5<<<52[Q 6#^( MHTNW5;[^(DJ,MGVMTRW/I&Y)TZRO6S88-J5;WH1TR]/2+55VIZM;RIY(Z)8> M.WUTR]]:!-B-$&1A ./0H[Z?\-E3UZ%8Y.NMV!VQ$\6QAUV($\A'F1Z+$@1) MF&"?D83_)[5]9^BA;OVR*M_2+-^D9DE3K*]9-M@UI5G^A#3+U](L57:GJUG* MGDAHEAX[0QY.N2I63=E--:,,! G0I]E[(2 FF-[&J)H MT)_25KM4$R^:KXLOF=B3:!',2)3$ 4E!0$E 7)\/H(#7];,(NV3V)5_?EK)J M]>WG@1I$WB-#J-/OS24&,RE,]G,64L]GR?SW5#BI$? QQV?2/& MF,SJLLZ6/?/X#$<^B.(($Q(Q& 0>HGQ>':.0CU-"%^%8*7_O $EWD!OQ3YRL M@6$A$+DNAC[KI=Z+'3]F 76KUT[ M0*DXJS!%J9PZC<"FFE0= )S:)$..NQ,Z9IC\:8B:::=*JPU6=>)Q6U^NN(GF MAM6=_9E'*0+41_R_4Q91YA)W-\_W,$&J\X_C5H@'$@3$L4OL0]>G210PE\4, MPR")8F!_&B* J8F9-F%RZC4$4VIR)1 Y>TB3&&*]P=+)R5L_7J>A1+V]^&8J M9X(5]46. \F;X11A'$0PC<.83Q8C"LAN4N)[<:*[TG%H _"I*.9]DZ$TA $- M$C<$6!S&"E,WB9#2O.0?9+GC@!ZI-0\=.J?2:7KY\.;JASXC9N8B,X11@$GB MTY1/?T)N*XQIUW-$V9+*.L@94Y#BP(.1N"$F@J[+>$[S0.PQXGH(>&K/EFLO MABSW&$U.0,[S:&+B891"Q1WG8I6MYH583FJWD.]V?W!^+C*E"8CVQ$.:_&DH MEBEGE"8:BAS):MCG^4.^V"SSZ[N7@XUJ?TVU./&2Q"PAB%*21B'T K^Y=AW! M.&$T5!L!R!A,^2B##S*\T.4F0C?V8,A2XM/0HY $2K>O: T'KLK5_;N;?/WH MJ$] 3! J)V@#,ZDF:ATX<5%#0V?=T7DP6:FV]\ ZHUUU?Y[#$Z)F, #3$#:3 M#I76&JOTTUBO;%;5AJ?5O*(;4?1"-NOU[LW3IA7ND<2!&S-$HP3#. [3*.;= MLNN@! *I8\J][),PBF@<>ZZH$(U2E!(083<._10B$-H^K-SVT@ZNT^)UMH!5 M'UZV%X33*CD5_O5E4R8,*@(Z7&2D7[*:1(3TWJ^R&:GSSU;I$G3R.(12W//K$"V+*!\=NPB"RG>P.^S$I'Q^+6AQ%W[Y,N\>K M.PGHS;GJ7&!(NGM,"411_/X%X#W0"\OKZ[R;[N=G\Q95X( M PBCU/-=ZGH^30.?N8"@('$CV2F]+?,6"[OVB+>GW%]@=EK0S@\"]H\7#DO*\L&8556&#[E\V565N=31=BIOKP M^I$# XQH+(C=K+-5M6S&96CQUTU5"ZG;WFR$0XP\/PY /B<.P[JW(*BB;!,0P--._7V\8O^'<4YH7O&!0;- N/ZW3;8L[IY%J4U6/;!E^?N?\L6]N :M M@19$,>:@B$==[,<0T CM9N$Q\XFF]-H#9+W6LSLO53G9?"X>W>42(1Y!T!V&D13U;*M=F7$WC[P9V< M[ _@\MO)8"B^#9;O=,^FNCCQ$M>/H]AEB"2,>LENM23V8\T\T-.J9;$_MVDK MXFA"[_MR;ZQ8R@+MBLI]32XG*\:G6>M7\*3(_.1DU91?ZD5-6LSIEC'MA^ZR M6^W7JX,AX]7NTF 78QRP).'_@QQ@-Y-#%3P=S;[6R&OYO M#P?N^E?)C]<>],JF)MD4>E94#=H*!BFX,A4EA5JLP1O&-#+6^#2 :*2[R MQ5WE_+>'#%W+9H+]DT5O M@X9W&DEE:*>_*:,;@7.)ZR1(5N4TGQ>+?'&Y8MF7P1RU?1XLKQ*7^HP-+]Z]S>\ MX+GH>"X/>.YQ/8,$!4>2CF'N1K]TP:@SI97VI23^U:=<5%KR)'.]0D]/>;;< M6DM#!AG&- ["F)$ )"$7=^A&$M5/YZS01D *.8=,64\?\4(IY2Q-&#$#1'% M< BYKYP=..>:CP@;>'IJI$^EE+P/PJ*ZKD^"0"4='X1(?0$_)+3L".VIVV^Y M_+9@]R9I$DK=WXO2;-.1UF:Q;4GX#(";$G7!A.>"1VZ]*I=?5<_ MY&*U*5L]SV+ S1+>1:*0!JX74]Y-NCXB[KJ6U&MENQ%B/A]5$<1B"K&;8L8P M "F%$:41"FT?FOFP$?R+,CG;C?Z>2\M0^9I/ZOMHS*NIO<"JG. MU6G!.AW:%V-.CMC90AZ1?NG,,&H8]+*%\7"<3R:J+!U/,-:X'CWIV/.LM-]2 M#2>GW?REFJ4DY7,4/G5)00K=V(\@A5TWC5VYPP$Z=F,6P#"(<8(Q@=!/8^8% M/HS22%RS'J;!!)+3T]FIN7WV#>4H2\1;S%%[Q".R;SA%68K" "E*(AJF,M3> M5)\,I4'U=Y*A=#Q3S5#:[%G(4/5#QO_O2_YY]PV]W.C=8,S">9Z?3 @9)TFTC M$0X[AQX[6Y>=QF?GTXMF,\!\=+#V8VVD,)UV-.@PPWI[,C]$(<)A'#L>R )05\WMO3TB;AI4C"L[.H!+[;"KE17_L2P7OQ?+)5HM+GE^ M7MT7M\L<555>5_L7W0X> 4@12D@2^PRD& =!B(G7/@*0^BD&4E5CFJ9#R#R$ M,*(^@C!,P\3S&8I=$B.?T-2U?1](A[:Y$*0]ZK!'[;2P+YQ5KO@(FVG^3ZO( M!*A74YP7K'_#]XN7[D=[AT&-S!,EO):B,HU275O.E8.T;-V';/@0K*CSJ^)+ M_@V<]B9@'Z40!2X@ +LP8 I7!FN!;.6Q?3P@946Z[L&[)$N MKG61NLD R"GJ2-RKJ:E!VBV_:'..Q!,J:B$2TU!0&XZ]^:B-8>YDE?-RM1"W M-KUE&C^_S_Y:KHDXN-=<54Q '+/$C?PP #%+$S% [E# &$G51]FR;5E#]W#? M+=_JQ!KWGAN/@)Q^CDF^FHCVY]V*=BH2>$) ;85B&BIJS;MRF 9M5$_W&#YD MC_GV>N:0Q%& 0G$,(8H8@>(N^ Y)@"/7H*9JV1]=5R^6@^,:#0O;%-G2TX$K1*EIG J'%G1 MK==!A3)BX4V"+ /E-Z M3L>D7A 9UIL- ARZC06_VK"991Z*\JFP.,)T;,1C6GHH17/ M2OMMV9B*'AWW8<9"#'T&*0M3/A\'D M#)/2.ID9KR*A>AK;*S23U]E^WLEKK0$6#>CMU>ZJQ/C_)^]=F]S(D2S1OQ)F M]]INM5EV#Q!XSW["LT;;JI*NI)JUL?Y HY*1$KHI,FI)>K/1O"6S]QC*=]\HK8PZ5P&>S+5\ 5M=T%J#5:A];>2V(KL^+M+X2]N7EF*![C#+Z\DX;@TTIW M"6[C1&ZBM 9?91J=WGXWD ;3?/ZJ4 @3ST2%U!Q>_&).6F_J/#TM. R\6EVO MJUWUO_;'5ZLS>T_VV[YP;'> =>8#$5#82& 95AP@5ZHF+>?.2LD=9[-5]:E] M0S0H5HP *&@XBMUP_ %[\)#L'&@J.Z_JU5_G=TVEW?]JBSTO'P;IO'4B6/[& M:*^S,6!&T?GQETDU7'!4FU@#]HMY M(S7D^<@XG,WGX^:(K73QJ#JFK_4EQL& B'QB@OCKNMYL9HHI(@749?.&1ZD5 M$LQZ#%)HHAE!07=8\UC./&F3IV+J5?&IP5A-\@F$NG6^GPEIB M!H,?C]WK<]-]?YS9SE1C!R#A-,*@-%0J>EC4U)J5?N:X#=M3&6@H;D:XC0M2 MKWX,3%_6U5^W\V_%_ AV47W[4JTV5>03L0,9#MM)&8/>?H_!'A-8/[/Z-?)+ ML"=Y.K%GDHC@:>R6I'+FZ4.O*3E*L#M\C,?NQN[OU;?MAS^KVZ_5;_5J^WDS MXP0"1WC)2T=4(ZP8H@X4Y"K5,<<44#*GZG:S7=ZUK]8]&K-[M%?%?U3S=?%F MY7_F1?+^KLG75W4Q7RR6S=^;WQ;;]7RUF5\WO]H4]?7U_;HKVO>?]\MUU1;$ MFC^1@Y[K;&,U_N!M[+';/>VQH.<[0N- L?.@V+DPF=WO +K[[8NG;,=IQ("Q MG W?2T_/<9X8T@CAAS_KF1+:88F$A$I 1CDFI>ZP,&>C;HSG03"%B.%Q_KP1 M([BIUV$\; >*\'!X#>K":+PHX/UQFEIM2E48U559*2@C"2!Y"DD91E?8R09A" M#&B _MPA(*RU4_JKE^5O6/*> 28=SGAN<(>TV$$MCK"VU?-;M$4'M_A'!WCD6["1=)X8 M\+D:9AHC/9MW]3C=.\G8?BC4CX M(4* (V,!L]AI:;K!C+D->HPQV)@QAAD* MF/=2$(>)%-1)#!FR0CC&URT>9VS2-0R\5ROO9_(2[5&MX @]0T#_>IY'-7#+^X MV LCYTB+%\EXOB>MBCW<"9/!OCS%OQ3R$H"VV+ZRI26&: 4 008(2("?1&.* MH"@)!E'%J!*9S*R!QT]5G!N8O1\'&<9YF.!=@.XXV4O#=.;W0$YQ=T+]$I,_ M#0U,[=2+;X DY"S@@IZ=;[Q.K.S]NOY2_;9<+&ZKYK=$BIOULOK^;[&*@7$ M*NF \MHKB:"HM**SJS""@9?R$EG+G@FV*(L=S&*'LVA^M_!(BQW4R*+*":D^ MK8"783DRYYLVP<$7ZBY =+]+=($OWK$^/S ^(#KU3%'M:XRO4B.R>$:CBCT]"E!'[4J?M:9+F"Z_89^Z;D M7K7\VJP>/#:K[]=KKWXSPZFQ@&+#(29<0$(5W%O' "L;HT&I;&96I =XD8*4 MC-,P>;H$G7%BU2$L'B!>/16MJV*/<^3R!6'DG="RU/1/0]F2>_6TLD$6UD)5 MSRPWV_7RXWVS//)N^>GSMGLE2C1/1!FE2\"-H59QCIKW30B3"M'21!6][VTD MLZX=XRI\VO5GW?_UM_Y$AFG;*!S&B=DC^G:8+O0LW$ODG!"KP7Q.0YV&NU$G M[F?!6REOMI^K]:O5OJ:BFZ_OJK6N5^T!GN9DSZO5MKJ]K:ZW]_/;M\T*WGK[ M_1$B"1RA&MF2 6@A=<:( T=F%6OQ%[\0?[&.[MM,ZEVBU/._TN;+'@C:%)-UV^+Z(<6BXU\S^P*#:7E M^?VBT)[6XW?ER#54WU>K]J%"9BA"SI$2ET!3/U=0_/!]/W6(*BL0 M_M7<*Q(-D%Y/I$80$[@FFH63R#70$#KRK'EVWI]:XXQF:!JY=0_<3]
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end

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	Apr. 24, 2017
Document And Entity Information [Abstract]
Entity Registrant Name	Philip Morris International Inc.
Entity Central Index Key	0001413329
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2017
Document Fiscal Period Focus	Q1
Amendment Flag	false
Entity Common Stock, Shares Outstanding		1,553,143,195

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
ASSETS
Cash and cash equivalents	$ 5,076	$ 4,239
Receivables (less allowances of $42 in 2017 and $42 in 2016)	3,090	3,499
Inventories:
Leaf tobacco	2,683	2,498
Other raw materials	1,531	1,569
Finished product	3,793	4,950
Total inventory, net	8,007	9,017
Other current assets	711	853
Total current assets	16,884	17,608
Property, plant and equipment, at cost	12,862	12,360
Less: accumulated depreciation	6,598	6,296
Total property, plant and equipment, net	6,264	6,064
Goodwill	7,485	7,324
Other intangible assets, net	2,517	2,470
Investments in unconsolidated subsidiaries	1,079	1,011
Deferred income taxes	834	859
Other assets	1,564	1,515
TOTAL ASSETS	36,627	36,851
LIABILITIES
Short-term borrowings	1,004	643
Current portion of long-term debt	1,754	2,573
Accounts payable	1,746	1,666
Accrued liabilities:
Marketing and selling	576	575
Taxes, except income taxes	4,275	6,204
Employment costs	719	800
Dividends payable	1,622	1,621
Other	1,329	1,553
Income taxes	330	832
Total current liabilities	13,355	16,467
Long-term debt	28,588	25,851
Deferred income taxes	1,739	1,897
Employment costs	2,840	2,800
Other liabilities	662	736
Total liabilities	47,184	47,751
Contingencies
STOCKHOLDERS’ (DEFICIT) EQUITY
Common stock, no par value (2,109,316,331 shares issued in 2017 and 2016)	0	0
Additional paid-in capital	1,892	1,964
Earnings reinvested in the business	30,367	30,397
Accumulated other comprehensive losses	(9,265)	(9,559)
Total stockholders' equity before treasury stock	22,994	22,802
Less: cost of repurchased stock (556,175,692 and 557,930,784 shares in 2017 and 2016, respectively)	35,386	35,490
Total PMI stockholders’ deficit	(12,392)	(12,688)
Noncontrolling interests	1,835	1,788
Total stockholders’ deficit	(10,557)	(10,900)
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY	$ 36,627	$ 36,851

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Receivables, allowances	$ 42	$ 42
Common stock, no par value (in dollars per share)
Common stock, shares issued (in shares)	2,109,316,331	2,109,316,331
Repurchased stock, shares (in shares)	556,175,692	557,930,784

Condensed Consolidated Statements of Earnings - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Net revenues	$ 16,556	$ 16,788
Cost of sales	2,177	2,096
Excise taxes on products	10,492	10,705
Gross profit	3,887	3,987
Marketing, administration and research costs	1,469	1,496
Amortization of intangibles	22	18
Operating income	2,396	2,473
Interest expense, net	219	247
Earnings before income taxes	2,177	2,226
Provision for income taxes	541	630
Equity (income)/loss in unconsolidated subsidiaries, net	(22)	(9)
Net earnings	1,658	1,605
Net earnings attributable to noncontrolling interests	68	75
Net earnings attributable to PMI	$ 1,590	$ 1,530
Per share data:
Basic earnings per share (in dollars per share)	$ 1.02	$ 0.98
Diluted earnings per share (in dollars per share)	1.02	0.98
Dividends declared (in dollars per share)	$ 1.04	$ 1.02

Condensed Consolidated Statements of Comprehensive Earnings - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Statement of Comprehensive Income [Abstract]
Net earnings	$ 1,658	$ 1,605
Change in currency translation adjustments:
Unrealized gains (losses), net of income taxes of $156 in 2017 and $162 in 2016	303	538
Change in net loss and prior service cost:
Net losses and prior service costs, net of income taxes of $- in 2017 and $3 in 2016	0	(10)
Amortization of net losses, prior service costs and net transition costs, net of income taxes of ($9) in 2017 and ($8) in 2016	56	55
Change in fair value of derivatives accounted for as hedges:
Gains (losses) recognized, net of income taxes of $11 in 2017 and $17 in 2016	(75)	(62)
(Gains) losses transferred to earnings, net of income taxes of $2 in 2017 and ($1) in 2016	5	(7)
Total other comprehensive earnings	289	514
Total comprehensive earnings	1,947	2,119
Less comprehensive earnings attributable to:
Noncontrolling interests	63	101
Comprehensive earnings attributable to PMI	$ 1,884	$ 2,018

Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($) $ in Millions	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Earnings Reinvested in the Business [Member]	Accumulated Other Comprehensive Losses [Member]	Cost of Repurchased Stock [Member]	Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2015	$ (11,476)	$ 0	$ 1,929	$ 29,842	$ (9,402)	$ (35,613)	$ 1,768
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,605			1,530			75
Other comprehensive earnings (losses), net of income taxes	514				488		26
Issuance of stock awards	59		(56)			115
Dividends declared ($1.02 and $1.04 per share for the three months ended March 31, 2016 and 2017, respectively)	(1,587)			(1,587)
Payments to noncontrolling interests	(12)						(12)
Other	3		1				2
Ending balance at Mar. 31, 2016	(10,894)	0	1,874	29,785	(8,914)	(35,498)	1,859
Beginning balance at Dec. 31, 2016	(10,900)	0	1,964	30,397	(9,559)	(35,490)	1,788
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	1,658			1,590			68
Other comprehensive earnings (losses), net of income taxes	289				294		(5)
Issuance of stock awards	33		(71)			104
Dividends declared ($1.02 and $1.04 per share for the three months ended March 31, 2016 and 2017, respectively)	(1,620)			(1,620)
Payments to noncontrolling interests	(17)						(17)
Other	0		(1)				1
Ending balance at Mar. 31, 2017	$ (10,557)	$ 0	$ 1,892	$ 30,367	$ (9,265)	$ (35,386)	$ 1,835

Condensed Consolidated Statements of Stockholders' (Deficit) Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Statement of Stockholders' Equity [Abstract]
Dividends declared (in dollars per share)	$ 1.04	$ 1.02

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings	$ 1,658	$ 1,605
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	197	175
Deferred income tax provision	27	10
Asset impairment and exit costs, net of cash paid	(2)	(14)
Cash effects of changes:
Receivables, net	504	(175)
Inventories	1,243	49
Accounts payable	84	223
Income taxes	(510)	(485)
Accrued liabilities and other current assets	(2,207)	(922)
Pension plan contributions	(18)	(52)
Other	(133)	48
Net cash provided by operating activities	843	462
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures	(292)	(226)
Investments in unconsolidated subsidiaries	(5)	(7)
Other	(282)	(186)
Net cash used in investing activities	(579)	(419)
Short-term borrowing activity by original maturity:
Net issuances (repayments) - maturities of 90 days or less	374	(136)
Long-term debt proceeds	2,482	1,978
Long-term debt repaid	(814)	(827)
Dividends paid	(1,618)	(1,585)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests	0	6
Other	(83)	(29)
Net cash provided by (used in) financing activities	341	(593)
Effect of exchange rate changes on cash and cash equivalents	232	77
Cash and cash equivalents:
Increase (Decrease)	837	(473)
Balance at beginning of period	4,239	3,417
Balance at end of period	$ 5,076	$ 2,944

Background and Basis of Presentation	3 Months Ended
Background and Basis of Presentation	Mar. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation: Background Philip Morris International Inc. is a holding company incorporated in Virginia, U.S.A., whose subsidiaries and affiliates, and their licensees, are engaged in the manufacture and sale of cigarettes, other tobacco products and other nicotine-containing products in markets outside of the United States of America. Throughout these financial statements, the term “PMI” refers to Philip Morris International Inc. and its subsidiaries. Basis of Presentation The interim condensed consolidated financial statements of PMI are unaudited. These interim condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America and such principles are applied on a consistent basis. It is the opinion of PMI’s management that all adjustments necessary for a fair statement of the interim results presented have been reflected therein. All such adjustments were of a normal recurring nature. Net revenues and net earnings attributable to PMI for any interim period are not necessarily indicative of results that may be expected for the entire year. These statements should be read in conjunction with the audited consolidated financial statements and related notes, which appear in PMI’s Annual Report on Form 10-K for the year ended December 31, 2016.

Income Taxes	3 Months Ended
Income Taxes	Mar. 31, 2017
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes: Income tax provisions for jurisdictions outside the United States of America, as well as state and local income tax provisions, were determined on a separate company basis, and the related assets and liabilities were recorded in PMI’s condensed consolidated balance sheets. PMI’s effective tax rates for the three months ended March 31, 2017 and 2016 were 24.9% and 28.3%, respectively. PMI estimates that its full-year 2017 effective tax rate will be approximately 28%. The effective tax rate for the three months ended March 31, 2017, was favorably impacted by the tax benefit of a legal entity restructuring ($61 million). Excluding the effect of the legal entity restructuring, the change in the effective tax rate for the three months ended March 31, 2017, as compared to the three months ended March 31, 2016, was primarily due to earnings mix by taxing jurisdiction and repatriation cost differences. The effective tax rates are based on PMI’s full-year earnings mix projections by taxing jurisdiction and cash repatriation plans. Changes in currency exchange rates, earnings mix by taxing jurisdiction, or cash repatriation plans could have an impact on the effective tax rates, which PMI monitors each quarter. Significant judgment is required in determining income tax provisions and in evaluating tax positions. PMI is regularly examined by tax authorities around the world and is currently under examination in a number of jurisdictions. The U.S. federal statute of limitations remains open for the years 2013 and onward. Foreign and U.S. state jurisdictions have statutes of limitations generally ranging from three to five years. It is reasonably possible that within the next 12 months certain tax examinations will close, which could result in a change in unrecognized tax benefits, along with related interest and penalties. An estimate of any possible change cannot be made at this time.

Sale of Accounts Receivable	3 Months Ended
Sale of Accounts Receivable	Mar. 31, 2017
Sale of Accounts Receivable [Abstract]
Sale of Accounts Receivable	Sale of Accounts Receivable: To mitigate risk and enhance cash and liquidity management PMI sells trade receivables to unaffiliated financial institutions. These arrangements allow PMI to sell, on an ongoing basis, certain trade receivables without recourse. The trade receivables sold are generally short-term in nature and are removed from the condensed consolidated balance sheets. PMI sells trade receivables under two types of arrangements, servicing and non-servicing. For servicing arrangements, PMI continues to service the sold trade receivables on an administrative basis and does not act on behalf of the unaffiliated financial institutions. When applicable, a servicing liability is recorded for the estimated fair value of the servicing. The amounts associated with the servicing liability were not material as of March 31, 2017 and March 31, 2016. Under the non-servicing arrangements, PMI does not provide any administrative support or servicing after the trade receivables have been sold to the unaffiliated financial institutions. Cumulative trade receivables sold, including excise taxes, for the three months ended March 31, 2017 and 2016, were $2,092 million and $1,946 million, respectively. PMI’s operating cash flows were positively impacted by the amount of the trade receivables sold and derecognized from the condensed consolidated balance sheets, which remained outstanding with the unaffiliated financial institutions. The trade receivables sold that remained outstanding under these arrangements as of March 31, 2017 and March 31, 2016, were $561 million, and $589 million, respectively. The net proceeds received are included in cash provided by operating activities in the condensed consolidated statements of cash flows. The difference between the carrying amount of the trade receivables sold and the sum of the cash received is recorded as a loss on sale of trade receivables within marketing, administration and research costs in the condensed consolidated statements of earnings. For the three months ended March 31, 2017 and 2016, the loss on sale of trade receivables was immaterial.

Stock Plans (Narrative) (Details) $ in Millions	3 Months Ended
Stock Plans (Narrative) (Details) $ in Millions	Mar. 31, 2017 USD ($) performance_metric year shares	May 31, 2012 shares	Dec. 31, 2008 shares
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested stock awards \| $	$ 186
Award requisite service period	3 years
Minimum Retirement Age \| year	58
Stock awards vested during period (in shares)	1,938,610
Restricted Stock Units (RSUs) [Member] \| Grant Date Fair Value [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested stock awards \| $	$ 151
Restricted Stock Units (RSUs) [Member] \| Total Fair Value [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Fair value of vested stock awards \| $	198
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to non-vested stock awards \| $	$ 52
Minimum Retirement Age \| year	58
Stock awards vested during period (in shares)	0
Performance period	3 years
Number of performance metrics used to determine the percentage of PSU's that will vest \| performance_metric	3
The number of shares of common stock issue for each vested PSU	1
Aggregate weighted performance factor that determines if the target number of PSUs will vest	100.00%
Performance Shares [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	0.00%
Performance Shares [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage	200.00%
2012 Performance Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)		30,000,000
Shares available for grant under the plan (in shares)	19,191,050
Non Employee Directors Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated common stock to be awarded under a stock benefit plan, maximum limit (in shares)			1,000,000
Shares available for grant under the plan (in shares)	677,539
Percentage of voting shares that PMI may own, used in determining non-employee director status			50.00%

Benefit Plans (Components of Net Periodic Benefit Cost) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
U.S. Plans - Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	$ 1	$ 1
Interest cost	3	4
Expected return on plan assets	(3)	(3)
Amortization:
Net loss	0	1
Prior service cost	2	1
Net periodic pension cost	3	4
Non-U.S. Plans - Pension [Member]
Defined Benefit Plan Disclosure [Line Items]
Service cost	50	50
Interest cost	23	31
Expected return on plan assets	(76)	(81)
Amortization:
Net loss	44	44
Prior service cost	1	1
Net periodic pension cost	$ 42	$ 45

Benefit Plans (Narrative) (Details) $ in Millions	3 Months Ended
Benefit Plans (Narrative) (Details) $ in Millions	Mar. 31, 2017 USD ($)
Compensation and Retirement Disclosure [Abstract]
Employer Contributions	$ 18
Anticipated additional employer contributions during the remainder of the current fiscal year	$ 50

Goodwill and Other Intangible Assets, net (Goodwill and Other Intangible Assets, by Segment) (Details) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	$ 7,485	$ 7,324
Other Intangible Assets, net	2,517	2,470
European Union [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	1,278	1,238
Other Intangible Assets, net	473	479
Eastern Europe, Middle East & Africa [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	388	372
Other Intangible Assets, net	199	200
Asia [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	3,626	3,596
Other Intangible Assets, net	1,079	1,074
Latin America & Canada [Member]
Goodwill and Other Intangible Assets, net [Line Items]
Goodwill	2,193	2,118
Other Intangible Assets, net	$ 766	$ 717

Goodwill and Other Intangible Assets, net (Movement In Goodwill) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2017 USD ($)
Goodwill [Roll Forward]
Balances, December 31, 2016	$ 7,324
Changes due to:
Currency	161
Balances, March 31, 2017	7,485
European Union [Member]
Goodwill [Roll Forward]
Balances, December 31, 2016	1,238
Changes due to:
Currency	40
Balances, March 31, 2017	1,278
Eastern Europe, Middle East & Africa [Member]
Goodwill [Roll Forward]
Balances, December 31, 2016	372
Changes due to:
Currency	16
Balances, March 31, 2017	388
Asia [Member]
Goodwill [Roll Forward]
Balances, December 31, 2016	3,596
Changes due to:
Currency	30
Balances, March 31, 2017	3,626
Latin America & Canada [Member]
Goodwill [Roll Forward]
Balances, December 31, 2016	2,118
Changes due to:
Currency	75
Balances, March 31, 2017	$ 2,193

Goodwill and Other Intangible Assets, net (Other Intangible Assets) (Details) - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Non-amortizable intangible assets, gross carrying amount	$ 1,356	$ 1,455
Amortizable intangible assets, gross carrying amount	1,773	1,598
Total other intangible assets, gross carrying amount	3,129	3,053
Accumulated Amortization	$ 612	$ 583

Goodwill and Other Intangible Assets, net (Range of Useful Lives and Weighted-Average Remaining Useful Lives of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,773	$ 1,598
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,535
Weighted-Average Remaining Useful Life	19 years
Trademarks [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	2 years
Trademarks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	40 years
Distribution Networks [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 150
Weighted-Average Remaining Useful Life	10 years
Distribution Networks [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	5 years
Distribution Networks [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	30 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 88
Weighted-Average Remaining Useful Life	9 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] \| Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	4 years
Other (Including Farmer Contracts and Intellectual Property Rights) [Member] \| Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Initial Estimated Useful Lives	17 years

Goodwill and Other Intangible Assets, net (Narrative) (Details) $ in Millions	3 Months Ended
	Mar. 31, 2017 USD ($) intangible_asset	Mar. 31, 2016 USD ($)
Finite-Lived Intangible Assets [Line Items]
Number Of Intangible Assets Reclassified \| intangible_asset	3
Intangible assets, pre-tax amortization expense	$ 22	$ 18
Estimated Amortization Expense, Year One, assuming no additional transactions occur that require the amortization of intangible assets	86
Estimated Amortization Expense, Year Two, assuming no additional transactions occur that require the amortization of intangible assets	86
Estimated Amortization Expense, Year Three, assuming no additional transactions occur that require the amortization of intangible assets	86
Estimated Amortization Expense, Year Four, assuming no additional transactions occur that require the amortization of intangible assets	86
Estimated Amortization Expense, Year Five, assuming no additional transactions occur that require the amortization of intangible assets	86
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	153
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Decrease to non-amortizable intangible assets	$ 153

Financial Instruments (Narrative) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Derivative [Line Items]
Maturity of foreign currency derivatives - cash flow hedges	May 31, 2024
Unrealized gain (loss) on hedges of net investments	$ 303	$ 538
Foreign Exchange Contract [Member]
Derivative [Line Items]
Notional amount	31,000
Derivative Instruments, gains to be reclassified to earnings.	$ 9
Foreign Exchange Contract [Member] \| Maximum [Member]
Derivative [Line Items]
Maximum length of time hedged in a Cash Flow Hedge	21 months
Foreign Exchange Contract [Member] \| Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional amount	$ 15,300
Gain (Loss) on derivatives not designated as hedging instruments	(39)	91
Foreign Exchange Contract [Member] \| Cash Flow Hedging [Member]
Derivative [Line Items]
Notional amount	4,600
Foreign Exchange Contract [Member] \| Net Investment Hedging [Member]
Derivative [Line Items]
Notional amount	11,100
Unrealized gain (loss) on hedges of net investments	$ (294)	$ (267)

Financial Instruments (Fair Value of Foreign Exchange Contracts) (Details) - Foreign Exchange Contract [Member] - USD ($) $ in Millions	Mar. 31, 2017	Dec. 31, 2016
Derivatives, Fair Value [Line Items]
Derivative asset fair value	$ 480	$ 813
Derivative liability fair value	207	163
Designated as Hedging Instrument [Member] \| Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	82	207
Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	291	436
Designated as Hedging Instrument [Member] \| Other Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	10	66
Designated as Hedging Instrument [Member] \| Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	101	36
Not Designated as Hedging Instrument [Member] \| Other Current Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	106	161
Not Designated as Hedging Instrument [Member] \| Other Assets [Member]
Derivatives, Fair Value [Line Items]
Derivative asset fair value	1	9
Not Designated as Hedging Instrument [Member] \| Other Accrued Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	96	61
Not Designated as Hedging Instrument [Member] \| Other Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivative liability fair value	$ 0	$ 0

Financial Instruments (Cash Flow and Net Investment Hedging Activities Effect on Condensed Consolidated Statements of Earnings and Other Comprehensive Earnings) (Details) - Foreign Exchange Contract [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	$ (335)	$ (276)
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	(3)	6
Cash Flow Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	(86)	(79)
Cash Flow Hedges [Member] \| Net Revenue [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	9	5
Cash Flow Hedges [Member] \| Cost of Sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	0	14
Cash Flow Hedges [Member] \| Marketing Administration And Research Costs [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	(9)	4
Cash Flow Hedges [Member] \| Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Reclassified from Other Comprehensive Earnings/(Losses) into Earnings	(3)	(17)
Net Investment Hedges [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain/(Loss) Recognized in Other Comprehensive Earnings/(Losses) on Derivatives	$ (249)	$ (197)

Financial Instruments (Qualifying Hedging Activity Reported in Accumulated Other Comprehensive Earnings (Losses) Net of Income Taxes) (Details) - Foreign Exchange Contract [Member] - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
Derivative (gains)/losses transferred to earnings	$ 3	$ (6)
Change in fair value	(335)	(276)
Other Comprehensive Income (Loss) [Member]
Hedging Activity, Affecting Accumulated Other Comprehensive Income [Roll Forward]
Gain as of January 1,	97	59
Derivative (gains)/losses transferred to earnings	5	(7)
Change in fair value	(75)	(62)
Gain/(loss) as of March 31,	$ 27	$ (10)

Earnings Per Share (Calculation of Basic and Diluted EPS) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Earnings Per Share [Abstract]
Net earnings attributable to PMI	$ 1,590	$ 1,530
Less distributed and undistributed earnings attributable to share-based payment awards	3	5
Net earnings for basic and diluted EPS	$ 1,587	$ 1,525
Weighted-average shares for basic EPS (in shares)	1,552,000,000	1,550,000,000
Plus contingently issuable performance stock units (PSUs) (in shares)	1,000,000	0
Weighted-average shares for diluted EPS (in shares)	1,553,000,000	1,550,000,000
Antidilutive stock awards (in shares)	0	0

Segment Reporting (Details) - USD ($) $ in Millions	3 Months Ended
Segment Reporting (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016
Segment Reporting Information [Line Items]
Net revenues	$ 16,556	$ 16,788
Amortization of intangibles	(22)	(18)
General corporate expenses	(51)	(46)
Equity (income)/loss in unconsolidated subsidiaries, net	(22)	(9)
Operating income	2,396	2,473
Interest expense, net	(219)	(247)
Earnings before income taxes	2,177	2,226
Operating Segments [Member] \| European Union [Member]
Segment Reporting Information [Line Items]
Net revenues	5,889	6,143
Operating companies income:	772	906
Operating Segments [Member] \| Eastern Europe, Middle East & Africa [Member]
Segment Reporting Information [Line Items]
Net revenues	3,695	3,997
Operating companies income:	690	633
Operating Segments [Member] \| Asia [Member]
Segment Reporting Information [Line Items]
Net revenues	4,838	4,689
Operating companies income:	852	778
Operating Segments [Member] \| Latin America & Canada [Member]
Segment Reporting Information [Line Items]
Net revenues	2,134	1,959
Operating companies income:	$ 177	$ 229

Contingencies (Tobacco-Related Litigation) (Details)	Mar. 31, 2017 litigation_case
Loss Contingencies [Line Items]
Number of cases decided in favor of PM	459
Number of cases decided in favor of plaintiff	13
Cases Remaining On Appeal [Member]
Loss Contingencies [Line Items]
Number of cases decided in favor of plaintiff	4
Case Decided In Favor Of Plaintiff [Member]
Loss Contingencies [Line Items]
Number of cases that reached final resolution in favor of PM	9

Contingencies (Number of Tobacco Related Cases Pending Against Us and/or Our Subsidiaries or Indemnitees) (Details) - litigation_case	Apr. 25, 2017	Apr. 22, 2016	Apr. 30, 2015
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM		66	61
Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		11	11
Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		16	16
Lights Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		0	0
Individual Lights Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM		3	2
Public Civil Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM		3	2
Subsequent Event [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM	63
Subsequent Event [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	11
Subsequent Event [Member] \| Health Care Cost Recovery Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	16
Subsequent Event [Member] \| Lights Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	0
Subsequent Event [Member] \| Individual Lights Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM	1
Subsequent Event [Member] \| Public Civil Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM	2

Contingencies (Verdicts and Post-Trial Developments) (Details)					1 Months Ended									3 Months Ended	12 Months Ended
	Aug. 05, 2016 ARS	Aug. 05, 2016 USD ($)	May 27, 2015 CAD	May 27, 2015 USD ($)	Oct. 31, 2015 CAD	Oct. 31, 2015 USD ($)	Oct. 30, 2015 CAD	Oct. 30, 2015 USD ($)	Jul. 31, 2015	Jun. 30, 2015 CAD	Jun. 30, 2015 USD ($)	Apr. 30, 2004 BRL	Apr. 30, 2004 USD ($)	Mar. 31, 2017	Dec. 31, 2004 BRL	Dec. 31, 2004 USD ($)
Smoking And Health Class Actions [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate (percentage per month)															1.00%	1.00%
Smoking And Health Class Actions [Member] \| Award per smoker per year [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Damages awarded															BRL 1,000	$ 318
Brazil [Member] \| Smoking And Health Class Actions [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate (percentage per month)												1.00%	1.00%
Brazil [Member] \| Smoking And Health Class Actions [Member] \| Award per smoker per year [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Damages awarded												BRL 1,000	$ 318
Brazil [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| The Smoker Health Defense Association (ADESF) [Member]
Loss Contingencies [Line Items]
Date														February 2004
Verdict														The Civil Court of São Paulo found defendants liable without hearing evidence. In April 2004, the court awarded “moral damages” of R$1,000 (approximately $318) per smoker per full year of smoking plus interest at the rate of 1% per month, as of the date of the ruling. The court did not assess actual damages, which were to be assessed in a second phase of the case. The size of the class was not defined in the ruling.
Post-Trial Developments														Defendants appealed to the São Paulo Court of Appeals, which annulled the ruling in November 2008, finding that the trial court had inappropriately ruled without hearing evidence and returned the case to the trial court for further proceedings. In May 2011, the trial court dismissed the claim. Plaintiff appealed the decision. In February 2015, the appellate court unanimously dismissed plaintiff's appeal. In September 2015, plaintiff appealed to the Superior Court of Justice. In addition, the defendants filed a constitutional appeal to the Federal Supreme Tribunal on the basis that plaintiff did not have standing to bring the lawsuit. This appeal is still pending.
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			CAD 131,000,000	$ 97,000,000
Payment period for awarded punitive damages to be deposited into trust			60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			CAD 46,000,000	$ 34,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust									60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust										60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			90,000	66,300
Compensatory damages awarded			15,500,000,000	11,400,000,000
Awarded compensatory damages that are to be deposited into trust			CAD 1,000,000,000	$ 737,000,000
Payment period for compensatory damages to be deposited into trust			60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			CAD 30,000	$ 22,100
Compensatory damages awarded			CAD 3,100,000,000	$ 2,300,000,000
Damages allocated to subsidiary (percent)			20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust			CAD 200,000,000	$ 147,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust									60 days
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished					CAD 226,000,000	$ 167,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| Cecilia Letourneau [Member]
Loss Contingencies [Line Items]
Date														May 27, 2015
Verdict														On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Létourneau class on liability and awarded a total of CAD 131 million (approximately $97 million) in punitive damages, allocating CAD 46 million (approximately $34 million) to our subsidiary. The trial court ordered defendants to pay the full punitive damage award into a trust within 60 days. The court did not order the payment of compensatory damages.
Post-Trial Developments														In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal covering both the Létourneau case and the Blais case described below. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling CAD 226 million (approximately $167 million) to cover both the Létourneau and Blais cases. The hearing for the merits appeal took place in November 2016. (See below for further detail.)
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]
Loss Contingencies [Line Items]
Date														May 27, 2015
Verdict														On May 27, 2015, the Superior Court of the District of Montreal, Province of Quebec ruled in favor of the Blais class on liability and found the class members’ compensatory damages totaled approximately CAD 15.5 billion (approximately $11.4 billion), including pre-judgment interest. The trial court awarded compensatory damages on a joint and several liability basis, allocating 20% to our subsidiary (approximately CAD 3.1 billion including pre-judgment interest (approximately $2.3 billion)). The trial court awarded CAD 90,000 (approximately $66,300) in punitive damages, allocating CAD 30,000 (approximately $22,100) to our subsidiary. The trial court ordered defendants to pay CAD 1 billion (approximately $737 million) of the compensatory damage award, CAD 200 million (approximately $147 million) of which is our subsidiary’s portion, into a trust within 60 days.
Post-Trial Developments														In June 2015, our subsidiary commenced the appellate process with the Court of Appeal of Quebec. Our subsidiary also filed a motion to cancel the trial court’s order for payment into a trust notwithstanding appeal. In July 2015, the Court of Appeal granted the motion to cancel and overturned the trial court’s ruling that our subsidiary make the payment into a trust. In August 2015, plaintiffs filed a motion for security with the Court of Appeal. In October 2015, the Court of Appeal granted the motion and ordered our subsidiary to furnish security totaling, together with the Létourneau case, CAD 226 million (approximately $167 million). The hearing for the merits appeal took place in November 2016. (See below for further detail.)
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			131,000,000	97,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			CAD 46,000,000	$ 34,000,000
Payment period for awarded punitive damages to be deposited into trust			60 days	60 days
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded										CAD 46,000,000	$ 34,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust			60 days	60 days
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			CAD 90,000	$ 66,300
Compensatory damages awarded			15,500,000,000	11,400,000,000
Awarded compensatory damages that are to be deposited into trust			1,000,000,000	737,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded			30,000	22,100
Compensatory damages awarded			CAD 3,100,000,000	$ 2,300,000,000
Damages allocated to subsidiary (percent)			20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust			CAD 200,000,000	$ 147,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Awarded compensatory damages that are to be deposited into trust										CAD 200,000,000	$ 147,000,000
Canada [Member] \| Smoking And Health Class Actions [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							CAD 226,000,000	$ 167,000,000
Argentina [Member] \| Individual Action [Member] \| Cases With Verdicts And Post Trial Developments [Member] \| Hugo Lespada [Member]
Loss Contingencies [Line Items]
Date														August 5, 2016
Verdict														On August 5, 2016, the Civil Court No. 14 - Mar del Plata, issued a verdict in favor of plaintiff, an individual smoker, and awarded him ARS 110,000 (approximately $7,100), plus interest, in compensatory and moral damages. The Court found that our subsidiary failed to warn plaintiff of the risk of becoming addicted to cigarettes.
Post-Trial Developments														On August 23, 2016, our subsidiary filed its notice of appeal.
Argentina [Member] \| Individual Action [Member] \| Hugo Lespada [Member] \| Judicial Ruling [Member]
Loss Contingencies [Line Items]
Compensatory damages awarded	ARS 110,000	$ 7,100

Contingencies (Smoking And Health Litigation) (Details)					1 Months Ended													12 Months Ended
Contingencies (Smoking And Health Litigation) (Details)	May 27, 2015 CAD plaintiff manufacturer	May 27, 2015 USD ($) plaintiff manufacturer	Jun. 20, 2012 cigarette	Jul. 10, 2009 cigarette	Mar. 31, 2017 CAD	Mar. 31, 2017 USD ($)	Oct. 31, 2015 CAD installment	Oct. 31, 2015 USD ($) installment	Oct. 30, 2015 CAD	Oct. 30, 2015 USD ($)	Aug. 31, 2015 CAD	Aug. 31, 2015 USD ($)	Jul. 31, 2015	Jun. 30, 2015 CAD	Jun. 30, 2015 USD ($)	Apr. 30, 2004 BRL	Apr. 30, 2004 USD ($)	Dec. 31, 2004 BRL	Dec. 31, 2004 USD ($)	Apr. 25, 2017 litigation_case	Apr. 22, 2016 litigation_case	Apr. 30, 2015 litigation_case
Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																					66	61
Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																					11	11
The Smoker Health Defense Association (ADESF) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate																		1.00%	1.00%
The Smoker Health Defense Association (ADESF) [Member] \| Award per smoker per year [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Damages awarded																		BRL 1,000	$ 318
Brazil [Member] \| The Smoker Health Defense Association (ADESF) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Smoking and health loss contingency interest rate																1.00%	1.00%
Brazil [Member] \| The Smoker Health Defense Association (ADESF) [Member] \| Award per smoker per year [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Damages awarded																BRL 1,000	$ 318
Canada [Member] \| Cecilia Letourneau [Member]
Loss Contingencies [Line Items]
Number of additional manufacturers found liable \| manufacturer	2	2
Estimated number of members in class \| plaintiff	918,000	918,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 131,000,000	$ 97,000,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 131,000,000	$ 97,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	46,000,000	34,000,000
Canada [Member] \| Cecilia Letourneau [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 46,000,000	$ 34,000,000
Payment period for awarded punitive damages to be deposited into trust	60 days	60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust													60 days
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust														60 days	60 days
Period between addiction warning and claim	3 years	3 years
Canada [Member] \| Cecilia Letourneau [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded														CAD 46,000,000	$ 34,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member]
Loss Contingencies [Line Items]
Number of additional manufacturers found liable \| manufacturer	2	2
Estimated number of members in class \| plaintiff	99,957	99,957
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 90,000	$ 66,300
Compensatory damages awarded	15,500,000,000	11,400,000,000
Awarded compensatory damages that are to be deposited into trust	CAD 1,000,000,000	$ 737,000,000
Payment period for compensatory damages to be deposited into trust	60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Imperial Tobacco Ltd., Rothmans, Benson And Hedges Inc., And JTI Macdonald Corp. [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	CAD 90,000	$ 66,300
Compensatory damages awarded	15,500,000,000	11,400,000,000
Awarded compensatory damages that are to be deposited into trust	1,000,000,000	737,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	22,100
Compensatory damages awarded	CAD 3,100,000,000	$ 2,300,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 147,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Judicial Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Punitive damages awarded	30,000	22,100
Compensatory damages awarded	CAD 3,100,000,000	$ 2,300,000,000
Damages allocated to subsidiary (percent)	20.00%	20.00%
Awarded compensatory damages that are to be deposited into trust	CAD 200,000,000	$ 147,000,000
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for awarded punitive damages to be deposited into trust													60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Payment period for compensatory damages to be deposited into trust														60 days	60 days
Canada [Member] \| Conseil Quebecois Sur Le Tabac Et La Sante and Jean-Yves Blais [Member] \| Pending Litigation [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Awarded compensatory damages that are to be deposited into trust														CAD 200,000,000	$ 147,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Number of consecutive quarterly installment \| installment							6	6
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Number of consecutive quarterly installment \| installment							7	7
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							CAD 226,000,000	$ 167,000,000
Amount of security to be furnished in each consecutive quarterly installment							37,600,000	27,700,000
Amount of security furnished by defendants in quarterly installment					CAD 37,600,000	$ 27,700,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Rothmans, Benson, And Hedges Inc. (RBH) [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished									CAD 226,000,000	$ 167,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Appellate Ruling [Member] \| Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Amount of security ordered to be furnished							758,000,000	559,000,000
Amount of security to be furnished in each consecutive quarterly installment							CAD 108,000,000	$ 80,000,000
Canada [Member] \| Cecilia Letourneau & Conseil Quebecois Sur La Tabac Et La Sante and Jean-Yves Blais Cases [Member] \| Under Advisement [Member] \| Rothmans, Benson & Hedges Inc. and Imperial Tobacco Ltd. [Member]
Loss Contingencies [Line Items]
Motion to secure judgment, Letters of credit to be placed into trust, option 1											CAD 5,000,000,000	$ 3,700,000,000
Canada [Member] \| Adams [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Plaintiff requirement, Minimum number of cigarettes smoked \| cigarette				25,000
Canada [Member] \| Suzanne Jacklin [Member] \| Pending Litigation [Member]
Loss Contingencies [Line Items]
Plaintiff requirement, Minimum number of cigarettes smoked \| cigarette			25,000
Subsequent Event [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				63
Subsequent Event [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				11
Subsequent Event [Member] \| Argentina [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				35
Subsequent Event [Member] \| Brazil [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				14
Subsequent Event [Member] \| Brazil [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				2
Subsequent Event [Member] \| Canada [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				2
Subsequent Event [Member] \| Canada [Member] \| Smoking And Health Class Actions [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				9
Subsequent Event [Member] \| Chile [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				5
Subsequent Event [Member] \| Costa Rica [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				2
Subsequent Event [Member] \| Italy [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				2
Subsequent Event [Member] \| Philippines [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				1
Subsequent Event [Member] \| Russia [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				1
Subsequent Event [Member] \| Scotland [Member] \| Individual Smoking And Health Cases [Member]
Loss Contingencies [Line Items]
Cases brought against PM																				1

Contingencies (Health Care Cost Recovery Litigation) (Details) - Health Care Cost Recovery Actions [Member] $ in Millions	Apr. 14, 2014 USD ($) patient	Oct. 17, 2008	Mar. 13, 2008	Feb. 26, 2008	May 25, 2007	May 09, 2007	Apr. 25, 2017 litigation_case	Apr. 22, 2016 litigation_case	Apr. 30, 2015 litigation_case
Loss Contingencies [Line Items]
Cases brought against PM								16	16
Korea [Member]
Loss Contingencies [Line Items]
Damages sought, number of patients \| patient	3,484
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Lagos State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements			20 years
Damages sought, period of future reimbursements			20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Kano State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements						20 years
Damages sought, period of future reimbursements						20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Gombe State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements		20 years
Damages sought, period of future reimbursements		20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Ovo State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements					20 years
Damages sought, period of future reimbursements					20 years
Nigeria [Member] \| Pending Litigation [Member] \| The Attorney General Of Ogun State [Member]
Loss Contingencies [Line Items]
Damages sought, period of past reimbursements				20 years
Damages sought, period of future reimbursements				20 years
Subsequent Event [Member]
Loss Contingencies [Line Items]
Cases brought against PM							16
Subsequent Event [Member] \| Canada [Member]
Loss Contingencies [Line Items]
Cases brought against PM							10
Subsequent Event [Member] \| Korea [Member]
Loss Contingencies [Line Items]
Cases brought against PM							1
Subsequent Event [Member] \| Nigeria [Member]
Loss Contingencies [Line Items]
Cases brought against PM							5
Subsidiary And Other Korean Manufacturers [Member] \| Korea [Member]
Loss Contingencies [Line Items]
Damages sought, value \| $	$ 53.7